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Molecular Characterisation of the Interaction of  
Microbes with the Insulin Pathway 
Abstract 
Exposure to microorganisms is considered an environmental factor which can 
contribute to diabetes mellitus via cytotoxicity or autoimmune responses against 
pancreatic cells. Firstly, the effects on rat insulinoma pancreatic β-cell line of 
secondary metabolites pyrrolnitrin (Burkholderia spp), phenazine compounds 
(Pseudomonas aeruginosa and Burkholderia spp) were investigated. Both 
compounds separately showed significant cytotoxicity after 24 h and at 
concentrations of 10 & 100 ng/ml potentiated insulin gene transcription, Ca2+ 
content and glucose-stimulated insulin secretion (GSIS). Furthermore, the 
outward membrane current was inhibited by phenazine (100 ng/ml) or 
pyrrolnitrin (10 or 100 ng/ml).  
Secondly, the capacity of 45 microbial species to bind insulin was screened in 
order to assess how common insulin binding was amongst microorganisms 
Burkholderia multivorans, B. cenocepacia and Aeromonas salmonicida bound 
insulin. A genomic library of B. multivorans was constructed in λ Zap Express 
and screened successfully for insulin binding recombinants. Recombinant 
phagemids p1 & p2 were excised, p1, encoded an insulin binding protein (IBP1 
30 kDa) with homology to the iron complex siderophore receptor. For p2, two 
IBPs were detected at 20 & 30 kDa (IBP2 & IBP3), representing an intracellular 
and outer membrane peptide transporter. Comparison of IBP1 and human 
insulin receptor (HIR) produced 6 linear epitopes, and for IBP2 & IBP3 
produced 3 epitopes.  
 
Thirdly, glutamic acid decarboxylase GAD65 is a major pancreatic autoantigen 
contributing to autoimmune diabetes. To assess the likelihood that 
microorganisms possess epitopes that mimic regions on GAD, 45 microbial 
species were tested for homology. This was facilitated by purifying recombinant 
GAD protein which was used to produce GAD antiserum. Four E. coli cross-
reacting proteins were identified using mass spectrometry, outer-membrane 
protein A, formate dehydrogenase, superoxide dismutase and DNA starvation 
protein. Epitopes occurred at the C-terminal region of GAD65 (residues 419–
565), a region previously reported to be targeted by autoantibodies.  
 
This study suggests that pyrrolnitrin and phenazine are cytotoxic to pancreatic 
β-cells and B. multivorans IBPs linear epitopes may be diabetogenic, 
particularly in patients with cystic fibrosis related diabetes (CFRD) who suffer a 
long term infections with Pseudomonas and Burkholderia species. Furthermore, 
microbial GAD epitopes could potentially induce an autoimmune response 
leading to diabetes. 
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1.1 Introduction  
Insulin is a hormone that regulates glucose uptake and energy synthesis of 
mammalian cells (Johnston and Van Horn, 2011). Since 1970 many studies 
have shown interactions between insulin and microorganisms. Investigations in 
the field of comparative biochemistry in the last two decades have 
demonstrated that insulin and insulin-like peptides are also present in some 
prokaryotes (LeRoith et al., 1981) and unicellular eukaryotes such as the 
protozoa and yeast, besides those already identified in vertebrates (Silva et al., 
2002). Furthermore, studies seeking insulin binding to microorganisms have 
verified the presence of insulin receptors or protein-like human insulin receptor 
(HIR) on various microorganisms such as fungi, protozoa (Dietz et al., 1989) 
and bacteria (Jeromson et al., 1999). Recently, investigators in microbiology 
have reported the cytotoxicity of some microbial components to insulin 
producing cells i.e. pancreatic beta cells (pancreatic β-cells). Many of these 
components are secondary metabolites produced by soil bacteria such as 
Streptomyces and some of them are primary metabolites e.g. collagenase 
produced by e.g. Clostridium sp. These could destroy some β-cells and reduce 
insulin production (Myers et al., 2002). There are many ways by which the 
human body may be exposed to these toxic components, apart from 
contaminated food and water (Hettiarachchi et al., 2006). Moreover, studies 
have also shown modulation of the insulin pathway by microbial components, 
particularly toxins (primary and secondary metabolites) affecting specific key 
signals of the β-cells, severing insulin synthesis (Demain, 1999). The most 
important signals altered by microbial components are phosphorylation (Müller-
Wieland et al., 1991), glucose metabolism (Bkaily et al., 1998) and insulin 
binding (Salituro et al., 2001). It has been confirmed that the microbes and their 
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components can be considered as environmental factors contributing the 
development of diabetes mellitus (Williams and Pickup, 2004), however, 
diabetes is not a single disease but a group of clinical disorders or forms which 
is characterized recently by chronic hyperglycemia (CDCP, 2011). Traditionally, 
two main types of diabetes, Type 1 Diabetes (TID) which occurs in individuals 
who have genetic disorders of certain genes leading to an autoimmune 
response against the pancreatic auotoantigenes in addition to some 
environmental factors (Maclaren and Atkinson, 1997; MacFarlane et al., 2003), 
and Type2 diabetes (T2D) the more prevalence type of diabetes which results 
from metabolic disorders such as obesity and cellular resistance to the insulin 
effect and it appears to be more common amongst particular ethnic groups than 
others (Kazlauskaite and Fogelfeld, 2003) .  
A new category of diabetes, Gestational Diabetes Mellitus (GDM) is a disorder 
in which pregnant women exhibit high blood glucose levels during pregnancy 
without previously being diagnosed with diabetes (McCance and Huether, 
2002). 
However, recently the terms of diabetes have included new forms of diabetes 
such as a diabetes which results from the destruction of β-cells by toxins or 
chemicals or viral infection and diabetes associated with genetic defects in β-
cells in insulin gene such as Maturity Onset Diabetes of the young (MODY), and 
a form that results from production of antibodies against the insulin receptor 
(MacFarlane et al., 2003). Exposure to certain microorganisms appears to be a 
major environmental factor in T1D causing autoimmunity by molecular 
mimicries (MacFarlane et al., 2003). Studies in the field of infectious immunity 
showed autoimmune responses against β-cells can be caused by microbial 
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infections and by viral agents destroying β-cells completely and causing T1D 
(Maclaren and Atkinson, 1997; MacFarlane et al., 2003). However, these 
studies suggest an autoimmune response against β-cell autoantigens could be 
initiated after regular immune responses against microorganisms which have 
proteins with homology to β-cell components and cause a diabetogenic 
autoimmune response (Davies, 1997). However, No direct role has been found 
for microorganisms in triggering T2D or progression. However, microbial 
infection is one of the major secondary complications that occur in T2D patients 
whose immune system is compromised because of the elevation of glucose 
concentration in the blood. Different types of infection have been specifically 
associated with T2D, such as urinary tract infection (Hammar et al., 2010), skin 
infections and foot ulcers (Tiwari et al., 2012). 
The microbes which reached the blood stream during infection and microbes 
which are ingested in contaminated food may present antigens which lead to a 
diabetogenic response (Vaarala, 2000; Vercelli, 2006). The autoimmune 
disease can be initiated and accelerated by microbial infection leading to a 
breakdown in self-tolerance which causes a destructive autoimmune response 
via activation of antigen presenting cells (APC) and subsequently production of 
autoantigens. On the other hand infection may have a therapeutic application 
achieved by immune-suppression or the remodelling the anti-inflammatory 
cytokines status with activation induced cell death of auto-reactive T-cells 
(Fujinami et al., 2006). Recent studies have shown a new beneficial effect 
achieved by microbes used as probiotics in regulating the diabetic inflammation 
response initiated by gut microbiota (Delzenne and Cani, 2011).  
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1.2 Literature review 
1.2.1 Insulin  
Insulin is an anabolic hormone, a 51 amino acid peptide in humans, secreted 
from β-cells in the islet of Langerhans of the pancreas. Insulin is composed of 
two polypeptide chains (A & B) connected by disulfide bridge bonds and has a 
central role in regulating carbohydrates, fat and many other metabolic functions 
in the body (Betley et al., 1989; Arumugam et al., 2008). Insulin plays a vital role 
in regulating glucose uptake from the systemic circulation, stimulating specific 
membrane transporters to facilitate glucose transport into the cells, reducing 
plasma glucose concentration (Straub and Sharp, 2002). After insulin binds to 
its receptor many protein activation and biochemical cascades follow, including 
influx of glucose by a specific transporter, the glucose transporter 4 (Glut-4), 
into the cells and produce energy (Muretta and Mastick, 2009).  
Insulin can also stimulate cells in the liver and fat tissue to convert the blood 
glucose into glycogen and store it in the liver and muscles (Bouskila et al., 
2008). When blood glucose level drop the body turns glycogen in adipose tissue 
into glucose via glycogenolysis, which is regulated by another pancreatic 
hormone produced by pancreatic alpha cells ( α-cells) called glucagon (Kieffer 
and Francis, 1999) (Figure 1.1) . 
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Figure 1.1 Schematic graph illustrating the role of insulin in glucose uptake. 
Insulin binding to its receptor induces a signal transduction pathway which 
allows the glucose transporter (GLUT4) to transport glucose into the cell and 
subsequently glucose is metabolised adapted from Beta Cell Biology 
Consortium (2004). 
 
                                                                                                                                         Chapter 1 
7 
 
1.2.2 The Insulin receptor & biology of receptors mediating cell signaling  
The cell communicates and responds via various types of receptor that react 
with signal molecules (specific ligands) from its environment such as nutrients 
or components of the vascular system (proteins, hormone, signal peptides etc.). 
Structurally, a receptor typically has α helix protein passing through the 
membrane and ligand-binding components react outside of the cell, allowing 
sensing of the concentration of the signal molecule even at low concentration 
(Pierce et al., 2002). Ligand binding produces receptor conformational changes 
that transfer the signal through the membrane, initiating downstream 
biochemical cascades. There are various types of cell receptor and many 
extracellular signals have been detected, but the majority of receptors can be 
divided into four classes (Hancock, 2005). These are now described below. 
G protein linked receptors 
These are receptors in which the binding of ligand leads to activation of G –
protein subunits, passing signals to the next component in the signal pathway. 
The general topology of these kinds of receptors is seven hydrophobic α-helices 
regions with approximately 22-24 amino acids at each span into the plasma 
membrane (Sheldon, 2004). In mammalian cells such receptors are normally 
specified in hormone binding e.g. epinephrine, serotonin, and glucagon. These 
receptors are great of interest to the pharmaceutical industry as targets for 
therapeutic interest e.g. some drugs that have action as anti-histamines 
(Bouskila et al., 2008; Campanile and Iaccarino, 2009). Two other major signal 
transduction pathways regulated by the G protein-coupled receptors (GPCR) 
are the cyclic adenosine monophosphate (cAMP) signal pathway and 
phosphatidylinositol signal pathway (Brown et al., 2009). 
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Ion channel – linked receptors 
These kinds of receptors are involved with neurotransmitter molecules and are 
classified as transmitter-gated ion channels in which the ligand binding to 
receptor changes the ion permeability of the plasma membrane leading to 
conformational changes of receptors which opens and closes an ion channel 
allowing efflux or influx of specific ions serving the reaction (Mercado et al., 
2005). In mammalian cells a clear example of such receptors are the 
acetylcholine receptors, composed of two identical α polypeptides which contain  
the acetylcholine binding sites along with three different peptides belonging to β, 
λ, and δ groups (Hancock, 2005). 
Receptors have enzyme activity 
These receptors have intrinsic enzyme activity which is characterized by the 
presence of a catalytic domain coupled to the receptor polypeptides (Nelson, 
2008). The activity possessed by the receptor catalytic domain is controlled by a 
ligand binding domain. The ligand binds on the extracellular side of the 
membrane and the catalytic domain is on the cytoplasmic side. The catalytic 
activity is attributed either to a guanyl cyclase or phosphatase kinase. The 
receptor structure contains serine /threonine kinase activity which is diminished 
by serine /threonine phosphatase or they may contain receptor tyrosine kinase 
enzyme activity (RTK) (Sheldon, 2004; Nelson, 2008). 
Tyrosine Kinase Receptors (RTK) 
A class of receptor with intrinsic enzyme activity that has been studied widely, 
involving ligand binding, leading to activation of kinase activity of the receptor 
which causes phosphorylation of the receptor on its tyrosine residues (Hancock, 
2005). A clear example of a tyrosine kinase enzyme receptor is the mammalian 
insulin receptor (IR).  
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1.2.3 Insulin receptor  
Insulin binds with the cell membrane via heterotetrameric components making 
up the insulin receptor which consists of two extra cellular α subunits connected 
by disulfide bonds with two transmembrane β subunits whose intrinsic tyrosine 
kinase activity will be stimulated by autophosphorylation once insulin binds to 
the α subunit of the receptor (Ellis et al., 1987) (Figure 1. 2).  
Many studies have demonstrated the autophosphorylation and phosphorylation 
of intracellular substrates is essential for the signal transduction system to 
mediate a cellular response by the insulin receptor (Youngren, 2007). The two α 
subunits of insulin receptor are the ligand binding domain for the extracellular 
insulin, whereas, the autophosphorylation on tyrosine residues is achieved by 
kinase domains in the two β subunits which are in juxtaposition. The insulin 
receptor activation starts after insulin binding which causes structural changes 
of the β subunits as a result of autophosphorylation of the tyrosine residues, 
providing a basis for activation of the kinase and binding of downstream 
signalling molecules (Li and zang, 2007) .  
1.2.4 Glucose sensing and insulin synthesizing mechanism in β-cells  
Pancreatic β-cells act as blood glucose sensors regulating blood glucose via 
secretion of insulin hormone. Insulin is essential, for glucose storage regulation 
and prevents glycogen depletion (Li and Zhang, 2009; Tripathy and Chavez, 
2010). In type 2 diabetes (T2D) β-cells become insensitive to glucose and cells 
become insensitive to insulin (Kahn et al., 2006; Ma et al., 2009).  
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Figure 1.2: Schematic model of human insulin receptor complex. This receptor 
composed of two extracellular alpha subunits (yellow), both connected by 
disulfide bonds(red) and another disulfide bonds within two transmembrane β 
subunits (blue), adapted from Bowen (2004) . 
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Understanding glucose sensing and insulin release mechanisms of β-cells are 
considered a key to revealing how environmental factors contribute to 
dysfunction of the pancreatic islet and development of diabetes, and may 
facilitate developing therapeutic interventions (MacDonald et al., 2005b). 
According to Straub and Sharp (2002) glucose sensing in β-cells occurs in two 
ways leading to biphasic insulin secretion. It is suggested that the glucose 
metabolism stimulates biphasic insulin secretion pathways (i) which is KATP 
channel dependent and (ii) another which is KATP channel independent, 
according to the signals produced from cytosolic and mitochondrial glucose 
metabolism respectively (Maechler et al., 2006). Glucose stimulates insulin 
synthesis and insulin secretion in β-cells and involves following stages:- 
1.2.4.1 Glucose transportation and glycolysis modeling in β -cells  
Blood glucose regulation is initiated by rapid glucose uptake into β -cells, via  an 
efficient glucose transporter-2 (GT-2) (Eisenberg et al., 2005). Glucose in β-
cells can enter two pathways, (i) glycolysis, where glucose 6 phosphate by 
hexokinase (Mercan et al., 1993; Jijakli et al., 1996) allowing glycolysis and 
pentose phosphate pathways, but in other instances some  phosphorylated 
glucose may be converted to glycogen and stored in the liver and muscles 
(Pittman  et al., 2004). (ii) The second pathway involves metabolism of 
phosphorylated glucose into pyruvate, NADH and ATP to feed into the 
mitochondrial tricarboxylic acid (TCA) cycle (MacDonald et al., 2005b). 
                                                                                                                                         Chapter 1 
12 
 
1.2.4.2 Mitochondrial metabolism and ATP generation  
The NADH and pyruvate produced by glycolysis enter mitochondrial metabolism 
to produce ATP. NADH can enter the mitochondria by two transporter systems, 
glycerol-phosphate and malate-aspartate, and these systems, play an important 
role as regulatory components in insulin secretion (Eto et al., 1999; Rubi et al., 
2004).  
There are two main sources of NADH, first is cytosolic and second is that 
liberated from the TCA cycle after mitochondrial pyruvate oxidation. Both NADH 
sources stimulate hyperpolarization of the mitochondrial inner membrane and 
increases the inner Ca2+ ion which provides a positive effect on ATP production 
by prompting dissociation of ATP synthatase inhibitor (MacDonald et al., 
2005a). Furthermore, the rise in mitochondrial Ca2+ stimulates ATP transport 
into the β-cell cytosol, raising the cytosolic ATP/ADP ratio (Maechler et al., 
2006). Approximately 98% of β-cell ATP is produced from mitochondrial 
oxidative metabolism (Erecinska et al., 1992) and production of mitochondrial 
ATP is linked to regulation of insulin secretion by regulation of the ATP sensitive 
channel (Ashcroft, 1999; Smith et al., 2007).  
The insulin secretion signals are coupled with glucose metabolism in two ways. 
Firstly, there is the glucose induced closure of the potassium ATP (KATP) 
sensitive channels which increases the Ca2+ concentration of β -cells and 
triggers insulin secretion. This is the KATP channel dependent pathway which is 
directly linked with glucose mitochondrial metabolism and generates ATP. 
Secondly there is a KATP channel independent pathway thought to have an 
activation role for the KATP channel dependent pathway which is explained by a 
different hypothesis (Straub and Sharp, 2002; Doyle and Egan, 2003).  
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1.2.4.3 Long chain acyl coA (LC-CoA) & NADPH  
Insulin secretion stimulated by glucose is correlated with increase cytosolic 
citrate concentration (LC-coA) which has been suggested to contribute 
effectively in signal modulation of insulin secretion. Part of the glucose is 
metabolized to citrate, which is converted to malonyl-CoA out of mitochondria 
and leads to inhibition of fatty acid oxidation by palmitoyltransferase1 (CPT1) 
and subsequently increasing cytosolic LC-CoA which initiates glucose 
stimulated insulin secretion (Prentki et al., 1992). However, LC-CoA may be 
converted to diacylglycerol (DAG) and other molecules are presumed 
responsible for release of insulin via increases in the intracellular Ca2+ 
concentration (Konrad et al., 1994; Thams and Capito, 1997). 
Glucose metabolism may produce another potential mitochondrial signal 
molecule, NADPH that is linked with insulin secretagogues. Inhibition of NADPH 
synthesis reduces glucose stimulated insulin secretion (GSIS), confirming a link 
between GSIS and the NADP/NADPH ratios (Hedeskov et al., 1987; Panten 
and Rustenbeck, 2008). NADPH has recently been linked with the recycle of 
pyruvate across the inner membrane of mitochondria (Figure 1.3) (Reinbothe et 
al., 2009). The key pathway of pyruvate reuse and increased NADPH is the 
pyruvate –malate shuttle and includes producing oxaloacetate (OAA) from 
pyruvate using pyruvate carboxylase in TCA (Kaneto et al., 2008). The OAA 
can be converted either to malate which can participate in numerous pathways 
like malate – aspartic transporter into mitochondria and the pyruvate – malate 
transporter from  mitochondria to cytoplasm (MacDonald et al., 2005a). 
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Figure 1.3: Mitochondrial glucose metabolism of β-cells and signalling 
contributing to insulin secretion. 1 NADH produced by glycolysis can be 2 
transported into TCA cycle cross the inner membrane of mitochondria via 
malate–aspartate (Mal–Asp) and glycerol–phosphate (Gly–P) transporters. 
3Generation changes of H gradient in action potential of the inner membrane, 
4enhances ATP production. 5Mitochondria inner membrane hyperpolarisation 
enhances drive in of Ca2+ and stimulates export of ATP. 6Production acetyl-CoA 
and then malonyl-CoA results from citrate exported be TCA, 7malonyl-CoA 
closes the LC-CoA transporters and increase in cytosolic LC-CoA and 
potentially causes diacylglycerol (DAG) accumulation, adapted from MacDonald 
et al (2005a).  
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1.2.5 Functional alterations of β-cell mediating glucose metabolism  
During insulin exocytosis, β-cells undergo physiological and metabolic alteration 
to produce signals regulating insulin synthesis, some of which are electrical 
alterations involving ion channel modulation and dynamic changes of β-cells 
organelles (Straub and Sharp, 2002; MacDonald et al., 2005b). Amongst these 
alterations is mediated insulin exocytosis:- 
1.2.5.1 Cell membrane electro-activity 
Glucose metabolism is linked tightly with insulin secretion and mediated by 
electrical excitability in β-cells (Pittman  et al., 2004). It is characterized as a 
mechanical coupling of glucose metabolism involving a large number of ion 
channels, pumps and transporters, contributing to the intracellular Ca2+ 
concentration and or other ions concentrations to form membrane potentials of 
(VM) -70 mV at  glucose concentration between 3-5 mM. Glucose stimulates 
regulating membrane depolarization of β-cells by reducing the resting K+ 
concentration and initiates an electrical activity, characterized by slow wave 
depolarization affecting the potential factors that control opening and closing 
channels and regulating ion movement from and to the β-cell (Dufer et al., 2007; 
Lim et al., 2009). The β-cell membrane potentials opening and shutting KATP 
channels lead to changes in cell membrane polarization. This depolarization 
initiates action of other potential factors increasing extracellular Ca2+ influx via 
voltage –dependent Ca2+ channels (VDCC) leading to exocytosis of insulin, 
opening of voltage –dependent K+ channels, and terminating membrane 
depolarization which reduces Ca2+ influx and consequently insulin secretion 
(Gray et al., 2006; Li and Zhang, 2009).  
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1.2.5.2 KATP sensitive channels  
Ion channels are pores in amongst macromolecules in cell membranes, e.g.  
transporting potassium ions K+ into the cell by passive transport, the potassium 
channels are the most diverse sub-group amongst ion channels existing in 
excitable and non - excitable cells (Mannhold, 2004). One of the more important 
channels in β-cells is the KATP sensitive potassium channel which is a member 
of the inward rectifier family, identified in different tissues including muscle cells 
and pancreatic β-cell and various neurons (Mannhold, 2004; Kornreich, 2007). 
The KATP channels are regulated by cell metabolism and provide an electrical 
activity to cells. In the case of the pancreatic β-cell, the  channel KATP  is 
considered one of the insulin secretion modulators (Straub and Sharp, 2002). 
KATP channels are octomeric complexes composed of two different protein 
subunits in β-cells, there are four pore forming K+ inward rectifier channel 
subunits (kir6) (passes positive charge into the cell) encoded by two different 
genes (Kir6.1 and 2) and two trans-membrane segments M1 and M2. 
Furthermore, the KATP channels have four regulatory sulfonylurea receptor 
subunits (SUR1) one of the ATP-binding cassette family with a total of 17 trans-
membrane sectors and two cytoplasmic nucleotide binding domains (NBD) 
(Wheeler et al., 2008; Amin et al., 2010) (Figure 1.4). Glucose and ATP are 
considered to be implicated in the initiation of β-cell depolarization. It is clearly 
demonstrated that ATP or ATP-Mg2+ inhibit the K+ channels activity at the Kir6.2 
subunit in which the depolarization is associated. Induction of depolarization 
increasing Ca2+ influx and subsequently insulin secretion (Ashcroft, 1999).  
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Figure 1.4: Schematic diagram showing the KATP channel topology of the β-
cells which is composed of two protein complexes Kir6.2 and SUR. (A) Made up 
of two transmembrane Kir6.2 subunits multiple SUR transmembrane domains 
and a nucleotide binding domain (NBD). (B) The Optometric KATP channel 
complex with 4 subunits of each Kir6.2 and SUR, adapted from Mannhold 
(2004). 
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Alternative studies suggest that ATP inhibits the KATP by binding with the 
nucleotide binding domains NBDs (Figure 1.4) that stimulate insulin secretion 
even if glucose is absent. From this view point many anti-diabetic drugs have 
been devised to inhibit the K channels e.g. sulfonylurea compounds, and others 
enhance release of insulin by direct interaction with SUR1 e.g. tolbutamide and 
glibenclamide which are KATP inhibitors and increase the intracellular Ca
2+ and 
thus insulin secretion (Ashcroft, 2000; Ashcroft and Gribble, 2000). 
1.2.5.3 Voltage –dependent calcium channels (VDCCs) 
The insulin secretion is coupled with increasing of intracellular Ca2+ 
concentration, which is carried by voltage –gate channels in the plasma 
membrane (Li and Zhang, 2009). The regulation of Ca2+ channels is depended 
on the membrane electro - activity that results from opening and closing KATP 
channels. At the membrane potential of -80mV, KATP  channels are closed in 
non-stimulated  β-cells (Karnieli and Armoni, 2008). However, when the Ca2+ 
channels are stimulated this leads to depolarization of the β-cell and opening of 
particular Ca2+ channels that are totally dependent on electrical activation of the 
β-cell and hence are known as VDCCs (Satin et al., 1995; Bhattacharjee et al., 
1997). Ca2+ ions could also be released from the intracellular store in β-cells in 
addition to the influx of Ca2+ that results from depolarization and the latter may 
contribute in releasing the intracellular Ca2+ by a mechanism called Ca2+ –
induced Ca2+ release (Graves and Hinkle, 2003) and prolong insulin secretion 
and increase insulin secretion via protein kinase C (PKC) activation. Many 
physiological events may increase the intracellular Ca2+ concentration such as 
accumulation of LC-CoAs that are stimulated by fatty acid palmitate and redox 
regulation of the Ca2+ channels (Fridlyand et al., 2003).  
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1.2.5.4 Insulin granule dynamics and exocytosis 
Insulin secretion, predominantly stimulated by glucose metabolism, electrical 
activity in β-cells and VDDC activation increases Ca2+ concentration and thus  
convey the insulin granule to exocytosis sites leading to the release of mature 
insulin into the blood stream (Misler et al., 2009). Furthermore, insulin granules 
are secretory vesicles which require various functional pools (Seino et al., 
2009). Generally insulin granules are produced as two pool types; a docked and 
reserve pool. However, the docked pools are present in different functional 
stages based on the competency to secrete. Some are primed pools that are 
divided into two groups (i) immediately releasable pool (IRP) and (ii) readily 
releasable pool (RRP) (Gerber and Sudhof, 2002; Hou et al., 2009) (Figure 1.5). 
The initial phase of exocytotic response can be amplified by increasing 
intracellular Ca2+ leading to insulin exocytosis from docked vesicles. The 
second phase is depolarization, in which vesicle mobilization fuels 
secretagogues. Signals generated by glucose metabolism are essential for 
encouraging mobilization, priming insulin granules from reserve pools and 
amplifying and maintaining insulin secretion (Straub and Sharp, 2002; 
MacDonald et al., 2005b).  
 
                                                                                                                                         Chapter 1 
20 
 
 
 
 
Figure 1.5: Schematic diagram of β-cell granule pools. Insulin granules 
exocytosis starts from reverse pool to exocytosis and insulin secretion. The 
process includes granules translocation from reverse site to docking, priming to 
releasable stage (ready and immediate) and exocytosis, adapted from Straub 
and Sharp (2002). 
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1.2.5.5 Mobilization of insulin granules and exocytosis of insulin 
Insulin granules undergo enormous mobilization within the β-cells mediating the 
insulin secretion process by moving the granules to the cell membrane for pre-
secretion perpetration (Bruns and Jahn, 2002). It is thought glucose stimulation 
increases the number of insulin granules connected to the plasma membrane 
by stimulating insulin granules movement, in addition to ATP and agents that 
raise the cellular cAMP (Rorsman and Renstrom, 2003; Seino et al., 2009). The 
movement of the cytoplasmic vesicles is likely to occur along microtubules 
achieved by ATP-utilizing motor protein of the classical motor proteins found in 
various eukaryotic cells (Semiz et al., 2003).   
The mechanism of insulin exocytosis has been studied extensively Insulin 
exocytosis is mediated by merging of insulin vesicles with the plasma 
membrane due to a soluble N-ethylmaleimide-sensitive factor (NSF) coupled 
with attachment protein receptor (SNARE) proteins (Hou et al., 2009). Amongst 
these proteins is a membrane protein named synaptosomal –associated 
protein25 (SNAP-25) which facilitates a specific membrane fusion by forming a 
complex bringing insulin vesicle to the vesicles associated membrane protein 
(VAMP) and plasma membrane together (Vikman et al., 2009; Wang and 
Thurmond, 2009). These synaptotagmin components are thought to be Ca2+ 
sensors for exocytosis and SNARE proteins have various ways of interacting 
with VDCC that mediate a strong coupling with Ca2+ entry events and  
exocytosis of vesicles (Misler et al., 2009). 
The first motivation of docked insulin granules exocytosis prior to Ca2+ is 
triggered by ATP-dependent chemical modification from ready to release 
granules in which the competent granules are submitted for insulin release 
stage. Furthermore, Renstrorm et al., (2002) suggested acidification results 
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from ATPase activity which also contributes to granule priming. The ATP /ADP 
ratio undergoes changes and modulates the size of the readily releasable pool 
(RRP) which is chemically stimulated for release by accelerating vesicle 
processing steps between docking, membrane fusion and granule ready for 
release and eventually exocytosis (MacDonald et al., 2005b). 
1.2.6 Insulin gene structure and regulation 
Insulin plays a crucial major role in maintaining glucose levels in mammals and 
other organisms. Insulin is encoded by a gene located on chromosome 11 
p15.5 in humans (Ohneda et al., 2000; Hay and Docherty, 2006), but rat and 
mice have two non-allelic insulin genes (Soares et al., 1985).  
Structurally the human insulin gene is composed of three exons and two 
introns. The upstream 400 bp 5' flanking sequence has been targeted by 
studies to understand insulin gene expression and regulation as it contains the 
insulin gene promoter and the binding sites for proteins contributing to insulin 
transcription such as transcription factors, DNA structural protein and RNA 
polymerase complex (Steiner et al., 1985; Ohneda et al., 2000). The linear 
structure of the human insulin gene promoter shows three major DNA elements 
A3, E1 and C1 which contribute to the glucose responsive insulin transcription 
pathway and shows homology to the insulin promoters in other mammals (Hay 
and Docherty, 2006).  
Glucose is the main modulator for regulating insulin biosynthesis gene 
expression and insulin secretion. Furthermore, glucose controls insulin mRNA 
stability and splicing actions via three main transcription factors (PDX-1, 
Beta2/NeuroD1 and MafA) regulated by signals produced from glucose 
metabolism (Evans-Molina et al., 2007; Andrali et al., 2008).  
                                                                                                                                         Chapter 1 
23 
 
1.2.6.1 Transcription factors  
Glucose metabolism in β-cells generates a discrete signal or signals that are 
widespread within different cell types. However, major signals that are affecting 
insulin secretion such as glucose metabolism signals and intracellular Ca2+, can 
regulate insulin gene transcription, via various types of transcription factor 
(Docherty and Clark, 1994; Leibiger et al., 2002). There are three major 
transcription factors that can regulate insulin gene expression in relation to the 
glucose metabolism:- 
Pancreatic duodenal homeobox (PDX-1)  
Transcription factor PDX-1 is the most important insulin transcriptional factor 
expressed in β-cells and is a key regulator of differentiation and development of 
the pancreatic progenitor cells into β-cells (Wilson et al., 2003; Cerf et al., 
2005). PDX-1 belongs to the Para HOX gene group existing prior to the major 
Hox cluster of homeodomain protein that is expressed in different tissue (Keller 
et al., 2007). The structural feature of PDX-1 is a highly conserved 
homeodomain with α helix domain type helix –trans-helix motif at amino acid 61. 
Another helix, representing the DNA –binding domain onto a N-terminal 
conserved sequence for transactivation lies at residues 32-38 and 60-73, PDX-
1 binding occurs at region A1 at -83/-75 bp from the insulin gene promoter and 
second binding sequences occur on A3 at -216/-207 bp. These are critical sites 
for the control of transcription by PDX-1 (Le Lay and Stein, 2006) (Figure 1.6).  
PDX-1 is glucose responsive, regulating insulin gene expression in 
differentiated β-cells. In addition, secondary activation can be achieved by the 
transcription factors NeuroD1, Hnf-1 and Hnf-3B. Moreover, PDX-1 regulates 
transcription of the insulin gene in β-cells, and somatostatin in α pancreatic 
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cells, together with transcription factors Nkx6.1, GT-2, and GK (Watada et al., 
1996). There is a strong correlation between insulin gene transcription by PDX-
1 and glucose metabolism (Shushan et al., 1999) via a pathway involved with 
phosphatidylinositol 3-kinase which stimulates PDX-1 translocation from the 
cytoplasm into the nucleus (Buteau et al., 1999). Recent studies have shown 
PDX-1, GK, and pre-pro-insulin gene expression, is increased after inhibiting 
GSIS by inactivating insulin like growth factor receptor suggesting a regulatory 
role of insulin receptor for insulin gene expression and insulin secretion via 
regulation PDX-1 factors (Cerf et al., 2005). Furthermore, PDX-1 regulates GT-
2 gene expression suggesting a vital role for PDX-1 in glucose uptake and 
insulin sensitivity and may contribute to the development of type 2 diabetes 
(Walker, 2004). 
Neurogenic differentiation 1 (Neurd1/Beta2) 
Neurd1 is an element of the NeuroD family of basic helix –loop –helix (bHLH) 
transcription factors which can be split into three groups according to their DNA 
binding properties (Naya et al., 1995). Class A members bind to the DNA via 
heterodimers or homodimer and are ubiquitously expressed; group B 
NeuroD1protein forms heterodimers with bHLH proteins and is involved in  
controlling insulin gene expression (Naya et al., 1995; Poulin et al., 1997). 
NeuroD1 activates transcription after binding to the sequence E element on the 
insulin gene and is a protein encoded in β-cells, through which mutations can 
cause a special type of diabetes called maturity onset diabetes of the young 
MODY6 in humans and contributes to diabetes type I and type II diabetes 
mellitus (Gu et al., 2010). 
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Figure 1.6: Schematic model illustrating insulin gene promoter and transcription 
factors PDX-1, MafA and NeuroD with transcription factors binding boxes A3, 
C1 and E1, adapted from Kaneto et al (2005). 
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Musculoaponeurotic fibrosarcoma homolog A (MafA) 
Maf is a member of the leucine zipper family of transcription factors and is 
divided into groups depending on their molecular size (large and small maf). 
MafA has been identified as a large maf member and is an important factor in 
eye lens development (Olbrot et al., 2002). Whereas, MafB is linked to 
expression of the hormone glucagon in pancreatic α-cells. MafA was initially 
detected in β-cells as a third regulatory element in β-cell differentiation, but is 
also known now to be involved in activation of transcription of the insulin gene 
linked with glucose metabolism (Kaneto et al., 2008).  
The insulin genes of various species such as human, mouse and rat contain a 
conserved Maf recognition element (MARE) in their promoters. MARE 
sequences overlap with the RIPE3b1 element (Maf), the third regulatory 
element, which has been shown to play a critical role in insulin gene expression 
and glucose-regulated expression (Kataoka et al., 2004). Zhang et al (2005) 
reported ―MafA deficient mice display intolerance to glucose and develop 
diabetes mellitus‖. Moreover, insulin production stimulated by factors such as  
glucose, arginine and KCl was affected by MafA deficiency in addition to 
inhibition of insulin 1,2 and PDX-1, Beta2 and GT-2 expression. However, it has 
been shown recently that MafA contributing to -insulin production appears not to 
be mediated by other islet-enriched transcription factors such as PDX-1 , 
Nkx2.2, Pax4 and Isl1 (Artner et al., 2008). 
                                                                                                                                         Chapter 1 
27 
 
1.2.7 Pathogenesis of diabetes mellitus 
Diabetes mellitus is a disease related to increase in the blood glucose level 
greater than 126 mg /d1 has characterizing hyperglycemia, however the 
reasons for this occurring is related to different genetic and environmental 
factors and can result in physiological complications. Aetiologically, forms of 
diabetes are classified according to the causative factors which are genetic, 
environmental and metabolic factors disrupting the maintenance of the normal 
glucose level. Amongst diabetes mellitus forms:- 
I. T1D accounts for approximately 10 % of all diabetes mellitus in the western 
world effecting children (3-11 years) and some adults before the age of 30 
years (McCance and Huether, 2002). Some studies compare the incidence 
and prevalence of T1D in particular countries such as Finland compared 
with the low occurrence in countries such as Japan. It is thought that T1D 
results from the interaction between environmental factors such as drugs, 
chemicals, nutritional intake and viral infection, leading to β-cell death and 
genetic factors (Genetic disorders of HLA genes) (Notkins and Lernmark, 
2001). This interaction mediates autoimmune responses against one or 
more β-cell autoantigens such as GAD65, and IAA producing autoimmune 
destruction by autoantibodies or migration of cytotoxic T-cells to the 
pancreas (Docherty et al., 2010). Thus, many researchers suggest that T1D 
to be results from overlapping between environmental factors and genetic 
factors in susceptible individuals (Biros et al., 2005). 
II. T2D is much more common than T1D, affecting about 25 % of the world‘s 
population. In the USA about 8.3 % of the population have T2D (CDCP, 
2011) accounting for 90% of diabetes cases. However, in some countries 
like those in the Middle East susceptibility to T2D can reach up to 29 % 
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(Harati et al., 2009). T2D results from a combination of three different 
factors; insulin resistance, excessive blood glucose, and progressive insulin 
deficiency (Kazlauskaite and Fogelfeld, 2003). Insulin resistance results 
from obesity and presents in 60% to 80% of T2D individuals. When insulin 
resistance occurs, a higher level of insulin secretion is required to maintain 
its biological activity. Insulin deficiency occurs when the amount of insulin 
producing by β-cells into the bloodstream decreases (Williams and Pickup, 
2004). Hepatic glucose production can occur in which the glucagon hormone 
secreted from pancreatic alpha-cells, stimulates the glycogenolysis and 
gluconeogenesis leading to abnormal glucose production by tissues such as 
the liver and muscles, which raises the blood glucose level (CDCP, 2011). 
The genetics of this disease is still not understood.  
III. Gestational Diabetes Mellitus (GDM) is a type of diabetes that affects 
women during pregnancy causing high levels of glucose in the blood. The 
prevalence of GDM is reported as 2%- 5% in England and Wales and has 
been increasing in recent years. It is estimated that gestational diabetes may 
affect up to 14 in every 100 pregnant women (Buchanan and Xiang, 2005; 
Chu et al., 2012). Most diabetic women giving birth in England and Wales 
have gestational diabetes, but some have type 1 or type 2 diabetes. 
However, during pregnancy, some women have slightly higher than 
normal levels of glucose in their blood and their body cannot produce 
enough insulin to transport it all into the cells (Diabetes UK, 2012) and it is 
also thought to happen when the insulin receptors and cell signalling 
pathway behind the insulin receptor do not function properly which may be 
due to pregnancy related factors (Shao et al., 2000).  
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IV. Maturity onset diabetes of the young (MODY) is a form of diabetes which is 
different from both Type 1 and Type 2 diabetes, and runs strongly in families 
(Fajans et al., 2001). MODY is very rare compared with Type 1 and Type 2 
diabetes – experts estimate that only 1-2% of people with diabetes causing 
moderate hyperglycemia (CDCP, 2011). It is caused by a mutation (or 
change) in a single gene. A mutation in genes such as Glucokinase (Osbak 
et al., 2009), insulin gene transcription factors (Gu et al., 2010) and 
hepatocyte nuclear factor 4 alpha (HNF α) (Saif-Ali et al., 2012) have been 
reported to cause MODY.  
V. Neonatal Diabetes Mellitus (NDM) is a form of diabetes that is diagnosed 
under the age of six months occurring at the rate of only one in 100,000 to 
500,000 live births (NDIC, 2012). Neonatal diabetes is very rare, currently 
there are less than 100 babies diagnosed with it in the UK (Diabetes UK, 
2012). It‘s a different type of diabetes than the more common Type 1 
diabetes as it‘s not an autoimmune condition (where the body has destroyed 
its insulin producing cells) (McCance and Huether, 2002). Neonatal diabetes 
is caused by a change in a gene of the GSIS which affects insulin production 
or the number of β-cells (Aguilar-Bryan and Bryan, 2008).  
Some other forms of diabetes have been reported to be new types of the 
disease, however some of them either do not have a clear pathogenesis 
pathway or their causes not well characterized such as diabetes created by 
initiating insulin receptor antibody (Dietz et al., 1989) or factor contributing early 
apoptosis of β-cells (McCance and Huether, 2002). 
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1.2.8 Interaction of microbes with β-cell and insulin pathway  
Various hypotheses and mechanisms have been suggested with regards to the 
role of microorganisms and microbial components in β -cell pathogenesis. This 
may be by causing direct damage or by remodelling the host immune status 
and subsequently causing protective or destructive effects to the β –cell. 
Generally these effects can be classified into three categories:- 
Cytotoxicity of Microbial Toxins. Some primary and secondary metabolites 
are thought to cause β -cell apoptosis or necrosis, and / or modulate the insulin 
secretion pathway and even interact with downstream regulation of the insulin 
gene (Hettiarachchi et al., 2006; Virtanen et al., 2008). 
Cytolysis by Viral Infections. Pancreatic β-cells cytolysis is produced by 
several viral infections, notably with the enteroviruses which are thought to play 
a vital role in the development of diabetes type 1 (Richer and Horwitz, 2009; 
Stene et al., 2010).  
Autoimmunity Damage. These can result from an autoimmune response 
caused by an initial immune response against microorganisms which presents 
antigens with molecular mimicry to the host component. This can result in 
destruction of β-cells, leading to loss of insulin production (Alberti and Zimmet, 
1998; Williams and Pickup, 2004) . 
1.2.8.1 Cytotoxicity of β-cell by microbial secondary metabolites 
With regard to diabetes studies that consider microorganisms as environmental 
factors being linked to the development of the disease, the traditional concept is 
that microbial as well as chemical, dietary factors and food may trigger 
autoimmune responses against β-pancreatic cell (Ju¨rgen Schrezenmeir, 2000; 
Biros et al., 2005). However, new research in the field of toxicology has 
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described some dietary toxins which contaminate food and water, such as 
nitrates, nitrose, methyl mercury, arsenic and persistent organic pollutants.  
These compounds may contribute to β-cell degeneration and destroy insulin 
production leading to T1D (Sharp, 2009).  
In addition, to these compounds there are a wide range of microbial secondary 
metabolites which have been shown to cause destruction of β-cells and 
subsequently diabetes type1 (MacFarlane et al., 2003). The genus 
Streptomyces is a group of soil bacteria classified as aggressive 
phytopathogenic. These bacteria can infect tuberous vegetables especially 
potatoes and beet (Myers et al., 2002). Streptomyces as a group produce more 
than 50,000 secondary compounds. Some of these compounds are antibiotics 
used in medicine and agriculture but some of them such as bafiolomycin, 
cancanomycin and streptozotocin cause β-cell destruction (Myers et al., 2003). 
Many of these toxins can be found in infected vegetables and fruits, and are 
found in water (Myers et al., 2003). Therefore, such microbial toxins could reach 
the human body via contaminated food or infection with toxin–producing 
microorganisms. Bafilomycin A1 and cancanomycin are vacuolar proton-
translocating inhibitors (vATPase) which cause glucose intolerance and 
pancreatic islet disruption and β-cell damage in mice (Hettiarachchi et al., 
2004). This suggests that such compounds should be regarded as possible 
diabetogenic environmental factors that contaminate the human diet (Myers et 
al., 2001). Moreover, vATPase inhibitor producing bacteria can cause deep 
infection, extending 5-10 millimetres into the flesh of vegetables (Myers et al., 
2002; Hettiarachchi et al., 2006). Intake of such vegetables may lead to an 
earlier progression of β-cell insufficiency and insulin deficiency in people at risk 
of diabetes.  
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1.2.8.2 Modulation of insulin secretion by microbial toxins 
In addition to the cytotoxicity of some microbial toxins to β-cells, some 
compounds interact specifically with insulin pathway. For example 
Streptozotocine secondary metabolite produced by Streptomyces 
achromogenes is an aggressive diabetogenic compound used to induce 
diabetes type 1 in laboratory animal models (Singaram et al., 1979; Baydas et 
al., 2005). Furthermore, studies have linked the toxicity of Streptozotocine to 
pancreatic β-cells to nitric oxide that may be liberated from compounds having 
nitros group in their structure (Turk et al., 1993). Streptozotocine is highly toxic 
and carcinogenic as it has a glucose pyranoside in its structure, facilitating its 
uptake by β-cells via its glucose transport (GT-2). The toxicity of streptozotocine 
is also attributed to its ability to cause DNA alkylation causing inhibition of 
insulin biosynthesis and secretion by depletion of ATP which is a key regulator 
of insulin secretion causing serious consequences such as β-cell necrosis and 
type1 diabetes (Elsner et al., 2000). However, Koulmanda et al (2003) have 
shown an anti-diabetic effect is achieved when using low concentrations of 
streptozotocine which prevent the diabetogenic autoimmune response 
progression in NOD mice via neutralizing T lymphocytes cells (T-cells) mediated 
immune response that results from genetic predisposition factors.  
1.2.8.3 Microbial proteins modulating β-cell intracellular cAMP  
Toxin proteins produced by some microorganisms cause serious diseases e.g. 
Cholera toxin produced by Vibrio cholera, an 84 kDa protein causing movement 
of ions from the tissues to the gut lumen by stimulating adenylate cyclase in the 
intestine and other cell types, like fat cells, liver, leukocytes. In β-cells, 
adenylate cyclase stimulation increases the intracellular cAMP concentration a 
key signal molecule enhancing insulin secretion (Wollheim et al., 1974).  
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Furthermore, increase in intracellular cAMP can also stimulate insulin gene 
transcription by signals regulated by the cAMP levels (Idevall-Hagren et al., 
2010).  
A similar effect was also discovered with pertussis toxin, a protein exotoxin 
produced by Bordetella pertussis, a pathogen causing whooping cough. The 
toxin can bind to a wide spectrum of cell membrane receptors, as well as the G 
-protein coupled receptor G-PCR that regulates the intracellular signals in many 
pathways (Carbonetti, 2010). Pertussis toxin can modify the heterotrimeric G 
complex by catalyzing ADP-ribosylation of the α subunits of G proteins and 
consequently impeding the G proteins from interacting with its receptor and 
disrupting the intracellular signal (Burns, 1988). Inhibition of G protein keeps the 
GDP-bound site inactive and subsequently inhibits adenyl cyclase activity, 
which increases intracellular cAMP concentration and eventually insulin 
secretion (Hesketh and Campbell, 1987; Khalaf and Taylor, 1988; Carbonetti, 
2010). The pertussis toxin has a regulatory effect on the insulin pathway and 
could also inhibit tyrosine autophosphorylation of the insulin receptors (Müller-
Wieland et al., 1991). This is the key regulator of many signals and functions 
controlling the insulin secretion pathway and metabolic activities and protein 
synthesis of the β-cells that is initiated by insulin binding (Hesketh and 
Campbell, 1987; Peschke, 2008).   
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1.2.8.4 Microbial secondary metabolites modulating β-cell KATP channels 
Amongst the secondary metabolites produced by microorganisms are the 
antibiotics that are used as treatments against microbial infections (Doyle and 
Egan, 2003). Some of these compounds stimulate insulin secretion as a result 
of inhibiting the pancreatic KATP channels and depolarization of the cell 
membrane. For example, the antifungal clotrimazole can cause hypoglycemia in 
patients after administration (Chan et al., 1997) and sulfonamide drugs such as 
tolbutamide have been used to treat patients with type II diabetes (Ashcroft, 
1999).  
It was found that the sulfonamide compounds and other compounds having 
imidazoline in their structure can inhibit the KATP channel via binding to the 
SUR1 receptor and inhibiting cell membrane current, which induces Ca2+ 
uptake via CCVD and hence insulin secretion (Mourtada et al., 1997). 
Quinolone antibiotics have recently been shown to increase insulin secretion via 
a similar interaction with the SUR1 of KATP (Maeda et al., 1996; Zünkler and 
Wos, 2003). 
1.2.8.5 Direct β –cell damage by viral cytolysis  
Recently, several viruses have been shown to infect pancreatic cells particularly 
the β –cells, and some of them can directly cause β -cell cytolysis e.g. 
Encephalomyocarditis (EMC) virus induces diabetes (Lammi et al., 2005). Many 
enteroviruses are reported to cause cytolytic infection of β-cells. Moreover,  
enterovirus infection is thought to result in a destructive autoimmune response 
initiated by the viral infection, causing T1D in early childhood (Richer and 
Horwitz, 2009). Furthermore, human Coxsackie B virus (CBV) can also cause β 
-cell death and is linked with nitric oxide (NO) production from immune 
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processing during infection (Hans et al., 2002). The Coxsackie B4 virus (CB4V) 
infection has been shown to produce tissue damage liberating β–cell 
autoantigens into the bloodstream and raising the possibility of the antigens to 
be presented by antigen presenting cells (APC) to auto-reactive T-cells and 
humoral immune responses, triggering T1D (Horwitz et al., 2002). 
 
1.2.9 Microorganisms contributing to β-cell damage via autoimmunity  
1.2.9.1 Autoimmune diseases - genetic and environmental factors  
Autoimmune disease is caused by activation of T-cell or B-lymphocytes (B-cell) 
or both against self-antigens causing damage and dysfunction of the target, 
which can be either systemic as in the case of Systematic Lupus 
Erythematosus (SLE) or organ specific as is seen with T1D (Mackay et al., 
2001; Tanaka et al., 2010). Autoimmune responses are attributed to various 
factors that are classified generally as environmental factors and genetic 
predisposition, causing humoral and/or T-cell autoimmune response against 
self-tissue (Leech, 1998; Albert and Inman, 1999). 
Several pathological complications are thought to occur, initiating events, 
leading to breakdown of self-tolerance and pathological immune response in 
which the autoantigens will be represented as foreign antigens creating 
autoimmune disease (Chan et al., 1997). Antigens are normally recognized by 
the major-histocompatibility-complex (MHC) molecules on the surface of an 
APC, or the infected cells and are able to recognize a broad range of foreign 
antigens as the recognition process is very flexible. The immune system 
normally recognizes and ignores the body‘s own cells and does not normally 
overreact to non-threatening substances in the environment by a mechanism 
known as immune tolerance (Pihoker et al., 2005). Sometimes the T-cell 
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receptor can cross-react with autoantigens, however, protection events, 
preventing autoimmunity is achieved through the negative selection of self-
reactive T-cells in the thymus, resulting in their apoptosis (Barkai-Golan and 
Paster, 2008; Zirbes and Milla, 2009). However, genetic predisposition has 
been linked extensively with serious immune diseases such as genetic 
disorders of the MHC genes which can fail in its protection selectivity 
mechanism and present ―self-antigens‖ as foreign antigens leading to an 
autoimmune response (Fujinami et al., 2006; Zirbes and Milla, 2009). In addition 
to genetic factors there are other kinds of autoimmune responses initiated by 
environmental factors such as food, bacteria and chemicals via molecular 
mimicry mechanisms. A sequence similarity between infectious agents and 
human autoantigens (self-proteins) which cross react with T or B lymphocytes, 
may then induce a pathogenic immune response that leads to tissue damage 
and disease (Davies, 1997). For example rheumatic fever instigated by group A 
streptococcal antigens on the M surface protein produces cross-reacting 
antibody to the human heart tissue (Mackay et al., 2001). In addition, to many 
enteric bacteria like Klebsiella, Shigella and Streptococcus possess an antigen 
containing 6 amino acids (GLn, Thr, Asp, Arg, Glu and Asp) which causes a 
pathogenic reactive of arthritis (Gilliland, 1989). There are a wide range of 
viruses and bacteria that are linked with autoimmune disease (Goldberg and 
Krause, 2009) in which the autoimmune response is against the β-cells such as 
Coxsackie virus, equine herpes virus type 1, homophiles influenza virus, and 
rota virus VP7 (Judkowski et al., 2004). 
1.2.9.2 Factors contributing to diabetogenic autoimmune responses 
Insulin deficiency disorder is one of the symptoms that shows β-cells decline in 
diabetes mellitus, a syndrome that includes abnormal accumulation of glucose 
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in the blood as a result of loss of insulin secretion (Alberti and Zimmet, 1998). 
There are two main types of diabetes. Type 1diabetes in which and the patients 
lose β-cells and insulin production and are totally dependent on exogenous 
insulin hormone administrated as a drug, and diabetes type 2 in which the  
body‘s cells no longer respond to the insulin (Notkins and Lernmark, 2001). 
Both genetic and environmental factors are involved in developing diabetes. 
From a genetic point of view T1D is associated with risk genes or disorders on  
human leukocyte antigen (HLA) genes of MHC genes on human chromosome 
21, which has been identified as a critically susceptible locus for many human 
diseases including T1D (Notkins and Lernmark, 2001). The studies done on this 
region show that genetic disorders of these genes could create a susceptibility 
to develop T1D and genetic engineering experiments on mice have led to the 
identification of at least 25 genes that can contribute to autoimmune diabetes 
(Biros et al., 2005). However, genetic disorders of HLA-DQ2 and HLA-DQ8 
genes are responsible for 70% of T1D cases amongst newly diagnosed patients 
(Lernmark, 2011). The genes encode cytokines, antigen co-receptor, antigen 
signalling cascade, and co-stimulatory molecules involved in the pathway that 
promotes apoptosis (Docherty et al., 2010). Furthermore, T1D has been 
identified with certain ethnic groups more than others according to genetic 
criteria (Biros et al., 2005). The autoimmune response against β-cells is 
classified as the main causative reason for T1D, but recently, in addition to 
genetic susceptibility and autoimmunity, the destruction of pancreatic beta cells 
(β-cells) and consequent development of T1D has also been linked with 
exposure to environmental factors, which may contribute up to 50% of the risk 
of developing this type of diabetes (Hans et al., 2002). Studies on genetic 
similarity of populations living in different conditions strongly suggested the 
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importance of environmental triggers of T1D and the most important factors that 
are thought to be T1D inducers are infection (e.g. viral infection), diet (i.e. the 
early presence or lack of particular food during childhood), and some inorganic 
compounds (e.g. arsenate) ions (Peng and Hagopian, 2006; Richer and 
Horwitz, 2009). New theories about overlapping between genetic predisposition 
and environmental factors in developing T1D hypothesize that T1D is a genetic 
disorder occurring on the HLA genes at positions 0501-0201 and 0301-0302 
contributing an autoimmune response against particular β-cell antigens such as 
islet antigens (IAA) and glutamic acid decarboxylase (GAD). However, the 
autoimmune response can be triggered by virus, diet, bacteria, toxins and 
vaccines, in addition to accelerators promoting immune response and 
subsequently T1D (Lernmark, 2011) (Figure 1.7). 
 
  
 
                                          
 
 
 
Figure 1.7: Schematic diagram illustrating the interaction between genetic 
predisposition of HLA gene and environmental factors (microbial infection, 
chemicals, food ) in T1D, adapted from Lernmark (2011).  
HLA- genes with genetic risk 
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1.2.9.3 Microbial infection as environmental factors in T1D 
Exposure to microorganisms appears to be one of the most important 
environmental factors and may contribute via different mechanisms to the 
development of T1D. Microbial antigens can potentially initiate auto-reactivity 
through molecular mimicry polyclonal activation or the release of previously 
sequestered antigens (Zhao et al., 1998). For example, in diabetes peptides 
derived from the β-cell antigen Glutamic acid decarboxylase (GAD) share 
mimicry with peptides from Coxsackie virus P2-C protein and during infection 
the latter activates lymphocytes to the infection and produces autoantibodies 
that persist even after eradication of the infectious agents (Kukreja and 
Maclaren, 2000). Polyclonal activation of autoreactive lymphocytes by microbial 
infection can also cause increase incidence of the autoimmune disease in 
rodents exposed to microbial pathogens and microbes that kill cells can cause 
inflammation and release of sequestered antigens for autoimmunity (Mackay et 
al., 2001). 
Furthermore, several experimental studies performed on non-obese diabetic 
(NOD) mice (Type 1 diabetes model mouse) suggest an alternative way to 
present the microbial antigens is through the gut immune system and 
subsequently creates an immune response against β-cells (Vaarala, 2000), in 
addition to stimulating the β-cell autoimmunity on the basis of molecular mimicry 
by enterovirus infection (Stene et al., 2010), some studies have demonstrated 
that the viral infection also could change the gut permeability and cause 
alterations in the mucosal immunity of dietary proteins, therefore, enteroviral 
infection and utilization of food with microbial contaminates might draw a link 
between the gut immune system and the pathogenesis of the auto immune T1D 
(MacFarlane et al., 2003; Williams and Pickup, 2004). 
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1.2.9.4 Molecular mimicry theory of epitopes 
The basic principles of β -cell immunological destruction initiated by microbial 
components has been built on the molecular mimicry concept of the similarity in 
amino acid sequences between microbial proteins and β-cell autoantigens. 
Molecular mimicry (epitope mimicry) is a widely adopted term for this 
mechanism which induces autoimmune disease (Fujinami et al., 2006).  
The theory of a mimicry mechanism in β-cell destruction may be due to an 
infectious agent having similar component amino acid sequences which may be 
as little as 10-20 or even less amino acids able to stimulate activity of (T-cell + 
cluster of differentiation CD4 or CD8) to produce specific antibody against the β-
cell as well as the infection agent (MacFarlane et al., 2003).  
The role of epitopes in the development T1D has been demonstrated between 
GAD and tyrosine phosphatase with Coxsackie virus proteins by inducing T-cell 
against β-cell autoantigens. The cross reactivity between β-cell autoantigens 
and unknown microbial epitopes are thought to be widely involved in the 
development of T1D in experimental NOD mice. Table 1.1 shows microbial 
epitopes that have a possible role as T-cell ligands involved in the activation of 
diabetogenic T-cells similar to that occurring in diabetes type 1 (Judkowski et 
al., 2004). Children recently diagnosed with T1D may have autoantibody to a 17 
amino acid domain of bovine serum albumin of cow‘s milk which can then 
initiate a destructive autoimmune response against β-cells through molecular 
mimicry with islet antigens (Alberti and Zimmet, 1998) . 
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Table 1.1: The Cross reactivity between β-cell autoantigens and microbial 
epitopes (Judkowski et al., 2004) 
Microorganisms Protein Sequence 
Bacterial   
Pseudomonas species Ferrodoxin reductase component Ac-L G V P M W V K M D-NH2 
Escherichia coli K-12 Bifunctional penicillin binding protein1C Ac-G D Q PL W L R M D-NH2 
Burkholderia sp. Strain RP007 Hydratase/aldolase PhnE Ac-L G V P M W S R M E-NH2 
Neissieria meningitidis Putative phage viron protein Ac-L V H P V W G  R M H-NH2 
Methanotroph species  Methane monooxygenase α-subunit Ac- T I G P LW K G M K-NH2  
Synechocystis species Exopolyphosphatase gb Ac-L S L P I W P E M E-NH2 
Methanotroph speices Methane monooxygenase α-subunit  Ac-A I G P L W K G M K-NH2                       
Alcaligenes faecalis Phenanthrene degradative gene cluster Ac-V G R P M W L A M D-NH2 
Synechocystis sp .PCC6803 Polyphosphate kinase Ac-K V P P L W I L M L-NH2 
Campylobacter jejuni Lipopolysaccharide biosynthesis protein wlak Ac-E T R P L W K A M H-NH2 
Acinetobacter species Terminal alkane hydroxylase Ac-M I P P L W K F M M-NH2 
Herpetosiphon aurantiacus Methyl transferase  Ac-A I Q P A W V I M E-NH2 
Mycobacterium tuberculosis  Hypothetical protein Rv0235c Ac-S F V P L W A T M L-NH2 
Mycobacterium tuberculosis Hypothetical protein Rv3629c Ac-R M S P F W Q R M F-NH2 
Streptomyces coelicolor A3(2) Anthranilate synthase Ac-S L A P F W L R M Q-NH2 
Bacillus firmus msyB gene Ac-L F S P F W G R M A-NH2 
Escherichia coli URF Ac-L T G P D W L R M G-NH2 
Synechocystis sp.PCC680 Cytochrome c  oxidase subunit I Ac-S A T P N W M R M F-NH2 
Escherichia coli 49 kDa protein Ac-K T J P H W Y R M I-NH2 
Mycobacterium tuberculosis Propable oxidoreductase Ac-K PT P G W Q R M V-NH2 
Viral   
Equine herpes virus type 1 Glycoprotein 14 Ac-K E R P L W N E M V-NH2  
Kaposi’s sarcoma- virus Glycoprotein M Ac-M P K P L W D A M Q-NH2 
Human herpes simplex virus  Tegument protein Ac-M T A P S W A R W E-NH2 
Mycobacteriophage 15 Predicated 8.2 kDa protein Ac-M W L P V W V I M A-NH2 
Reovirus type 1 Sigma-1 protein Ac-D E H P L W R Q M L-NH2  
Senadi virus C protein Ac-A T L P A W I K M P-NH2 
Clover yellow vein virus Polyprotein Ac-Y K E P K W F V M E-NH2 
Porcine adenovirus type 3 Hexon protein(virion component ii) Ac-S M M P Q W S Y M H-NH2 
Human adenovirus type 34 Hexon protein Ac-SM LP Q W S Y M H-NH2 
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1.2.10 Molecular mimicry protein theory 
T1D is an autoimmune disease characterized by the specific destruction of β-
cells due to circulating autoantibody (Abs) directed against one or more islet–
cells autoantigens such as GAD65, insulin (Siljander et al., 2009) and islet 
autoantigens IA-2 (also known as islet Ab512) (Maioli et al., 2004). The β-
pancreatic cell has many potential autoantigens, however, some of these 
antigens appear to be targeted specifically in a diabetogenic autoimmune 
response by the immune system of individuals at risk to T1D, notably GAD65 
and insulin (Maclaren, 1993; MacFarlane et al., 2003) (see Table-1.2). It has 
been hypothesised recently that some microbes possess β-cell antigen 
isoforms, furthermore, proteins performing a particular function share amino 
acids sequences homology to some β-cell pancreatic autoantigens which have 
similar function, for example, GAD from E. coli has been suggested to bring 
about a diabetogenic autoimmune response against human β-cell GAD65 
(Mulder, 2005) and heat shock protein-60 (HSP60) in Pseudomonas aeruginosa 
and human HSP60 pancreatic β-cell antigen (Jensen et al., 2001). With this is in 
mind studies have reported a possible link between microbial proteins ingested 
in contaminated food or from infection and an autoimmune response (Vaarala, 
2000; Mshvildadze and Neu, 2010). 
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Table 1.2: Islet cell autoantigens of insulin dependent diabetes mellitus  
(Maclaren, 1993; MacFarlane et al., 2003). 
Autoantigenes Antibody T-cell Responses 
Insulin + + 
ICA105 (IA-2) + ? 
GAD65/67 + + 
CarboxypeptidaseH + + 
Periphrin + + 
HSP60 + + 
P69 + + 
ICA512 + ? 
52 KDa Ag + + 
Gangliosides + ? 
Imogen ? + 
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1.2.10.1 Glutamic acid decarboxylase targeting 
GAD is an enzyme that catalyses the decarboxylation of glutamate to amino 
butyric acid (GABA) and CO2. There are two isoforms of GAD, GAD65 and 
GAD67 kDa expressed in neurons and β- cells (Notkins and Lernmark, 2001). 
The GAD in β-cell is anchored in the membrane and both GAD 65 and 67 and 
insulin are extensively targeted by the immune response in autoimmune T1D 
amongst others β-cells antigens (Fenalti and Rowley, 2008).  
Patients with T1D possess antibodies to multiple islet cell antigens including the 
GAD65 isoform of GAD. GAD65 autoantibodies are also found in patients with 
type 2 diabetes (Fenalti and Rowley, 2008). These GADAb positive T2D 
patients are diagnosed as having latent autoimmune diabetes in adult (LADA) 
specific epitopes, LADA represents an early stage of T1D (Maioli et al., 2004) . 
T1D may be mediated by T-cell activation, and it is believed that GAD is 
relevant, since autoantibodies and cell mediated responses to GAD are strongly  
correlated with the disease progression (Zechel et al., 1998; Fenalti and 
Rowley, 2008). The protein P2C of Coxsackie enterovirus B4 has a sequence 
similar to GAD amino acids 247-279 and this virus sequence is associated with 
cases of acute T1D by induction of immunological cross reactivity with β-
pancreatic cell GAD65 (Oldstone, 1998). Furthermore, a new study has 
demonstrated that protein P2C shares a six amino acid homology (PEVKEK) 
with the GAD65 protein and T –cell and antibody cross reactivity is with these 
peptides (Roep et al., 2002; Porte et al., 2003). Mudler (2005) suggested that 
GAD from E coli , Streptococcus and Lactobacillus especially, which can be 
found in raw meat and fish, may trigger T1D when forms of GAD from the 
bacteria is released by host enzyme and is absorbed in to the blood producing 
an inflammatory response leading to β-cell destruction. 
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1.2.10.2 Islet Antigen-2 (IA-2) targeting  
IA-2 also known as ICA512, is a group of antigens in the islet cell which can be 
attacked by antibody leading to β-cell destruction (Damanhouri et al., 2005). 
The major autoantigen involved (106 kDa with 979 amino acids) is a protein 
tyrosine phosphatase (PTP) an unusual transmembrane protein expressed in 
neuro and endocrine tissue and it is found in both α & β –pancreatic cells 
(Stayoussef et al., 2011; Tridgell et al., 2011). The PTP family of enzymes are 
critical and specific regulators of cellular processes, all PTP possess one or two 
conserved catalytic domains. The highly conserved active site within each 
domain contains an essential cysteine residue that functions a transient 
phosphate acceptor during de-phosphorylation (Bonifacio et al., 1998). Phogrin 
IA-2B, a strongly correlated protein represents another autoantigen in T1D 
(Notkins and Lernmark, 2001). It carries the same amino acid sequences of IA-
2 with substitution in its catalytic domain (Cui et al., 1996). Many studies 
suggest IA-2B may be more strongly expressed in β-cell than IA-2, however, 
Biros et al (2005) explained that IA-2 and IA-2B have many epitopes associated 
with development of T1D through cross reaction with microbial molecular 
mimicry or microbial antigens such as cross reactive immune dominant peptides 
with C-virus, hemophilus influenza virus and rota virus VP7 with IA-2. 
1.2.10.3 Insulin - like substances in microbes 
Insulin and pro-insulin are major autoantigens in β- cells where preproinsulin is 
primarily synthesised and expressed as a 110 amino acid precursor from which 
86 amino acid yield as proinsulin polypeptide after cleavage of the 24 amino 
acid core sequences. Upon translocation into the cytoplasm, proinsulin converts 
to insulin and C-peptide by pheromone convertase cleavage at dibasic residues 
and later are removed by carboxypeptidase (H) (Narendran et al., 2003). Insulin 
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and insulin-like peptides have been identified in different types of 
microorganisms. Since the 1980‘s some studies refer to the presence of Insulin 
related molecules in monera and protistia with the same features and functions 
of animal insulin. Furthermore, Insulin-like molecules have been discovered in 
bacteria such as E coli (LeRoith et al., 1981). The purified insulin-like material 
from E coli k12 which overlaps elution position of unlabelled and I125 labelled 
procaine insulin was recovered as a peak by gel filtration column (Leroith et al., 
1985). The insulin-like components purified by HPLC have cross reactivity with 
insulin antibody and show similar biological functionality to mammalian insulin. 
Similar studies demonstrated the occurrence of proinsulin and insulin like 
antigens in extracts of Cyanobacterium spirulina, Saccharomyces cerevisiae, 
Neurospora crassa, Aspergillus fumigatus and some plants by utilizing modified 
ELISA and western blotting (Collier et al., 1987; Souza and López, 2004).  
1.2.10.4 Heat Shock Proteins (HSP)  
HSPs are a group of proteins which are expressed when cells are exposed to 
elevated temperature or other stresses. The function of HSPs is similar in all 
living organisms from bacteria to human. HSPs are named according to their 
molecular weight such as HSP60, 70, 90 kDa. Microbial HSP(s) have been 
associated with some immune diseases (MacFarlane et al., 2003). HSP of β-
cell is considered one of the autoantigens that is frequently targeted by 
antibodies in some patients with autoimmune T1D (Horváth et al., 2002; 
Abulafia-Lapid et al., 2003). In terms of molecular mimicries Mycobacterium 
tuberculosis HSP65 has an important function in diabetogenses in NOD mice by 
T-cells responding to the HSP65 antigen and cross reacting with β-cell HSP60 
(Elias et al., 1990). The bacterial HSP60 from Pseudomonas aeruginosa which 
is often isolated from cystic fibrosis patients stimulates a humoral response and 
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cross reacting antibodies to β-cell HSP60 and may cause diabetes type 1 in 
NOD mice, raising the possibility that HSP60 autoimmunity may be involved in 
cystic fibrosis related diabetes too (Jensen et al., 2001).  
1.2.10.5 Insulin receptors on microorganisms  
Agglutination and insulin binding studies have suggested the presence of insulin 
receptors (IR) not only on mammalian and other animal cells but also on a 
spectrum of microorganisms (Souza and López, 2004). The first finding was 
with N. crassa showing the existence of insulin binding sites with high affinity on 
the fungal cell surface (Fawell et al., 1988). 
The studies performed on N. crassa and Saccharomyces cerevisiae showed 
that the receptors included a membrane binding protein and a juxtmembrane 
domain with auto phosphorylation capacity which occurs on a serine residue in 
a S. cerevisiae and a tyrosine residue in N. crassa, suggesting that these 
receptors could be a tyrosine kinase (Angermayr et al., 2000; Souza and López, 
2004). However, the fungal receptor protein has no protein kinase activity 
against itself or against substrates such as casein histone H2, in spite of the 
capacity of human insulin to bind with these receptors and enhance production 
of glucose metabolites including CO2, ethanol, and glycogen. Consequently, the 
studies suggest that the receptor mediating-insulin binding induces downstream 
metabolic pathways (Kole et al., 1991).  
Other studies have shown the presence of similar receptors on bacterial cells 
such as Streptococcus sp and Burkholderia sp. B. pseudomallei has a specific 
and saturable insulin binding capacity of approximately 5000 molecules of 
insulin (Woods et al., 1993; Jeromson et al., 1999). Kanai et al (1996) 
speculated that the B. pseudomallei insulin receptor is either for phospholipase 
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or protein tyrosine phosphatase, suggesting a signal transfer system regulated 
by the insulin receptor (Kole et al., 1991).  
Interestingly, immunological studies have indicated that the insulin binding 
structures in Streptococcus sp and Candida spp. share antigenic epitopes and 
react with antibodies to insulin and insulin receptors purified from human cells 
(Dietz et al., 1989). This fact could explain the development of autoimmune 
diabetes after infection on the basis of anti-insulin or insulin receptor 
autoimmunity being induced by microbial surface components. 
1.2.11 T-cells mediated autoimmunity of diabetes type 1 
The development of T1D is commonly dependent on the β-cell destruction rate 
by the autoimmune response (Williams and Pickup, 2004). The autoimmune 
response in T1D includes both T-cell mediated (Th1) and humoral immune 
response mediated (Th2). According to this concept, an inflammatory immune 
response resulting from a microbial infection causes breakdown of the host 
immune tolerance leading to presentation of self-antigens through MHC class II 
of the antigen presenting cells to T-cells helper (CD4) which induce Β-cell 
lymphocytes and T-cell and their cytokines products such as Interlekin2 (IL-2) 
Interferon gamma (INFγ) (MacFarlane et al., 2003) (Figure 1.7) 
The immune response targets β-cell antigens and is involved with direct binding 
of CD8 cytotoxic T-cell to β-cell, the T-cells can cross react specifically with β-
cell antigens presented by β-cell MHC I molecules leading to cytotoxic T-cell 
activation and then kill the β-cell via different mechanisms like (Fas/Fasl) 
mediated mechanism, secretion of cytotoxic molecules, granzymes and perforin 
as well as β-cell destruction by pro-inflammatory cytokines mediators 
(IL1,TNFα,TNFβ,INFγ) and free radicals oxidants O2 ,H2O2 and NO produced by 
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T-cell (CD4,CD8) and macrophages activated by cytokines which leads to β-cell 
apoptosis and T1D (Rabinovitch and Suarez-Pinzon, 1998). 
The macrophages also present the microbial antigens e.g. virus proteins to CD4 
lymphocytes, which turn activate B cells to produce antiviral antibodies in both 
models macrophages present autoantigens from the virus thus leading to the 
development of lymphocytes and autoantibody that react with β-cell (Atkinson 
and Maclaren, 1994).  
 
 50 
 
 
Figure 1.8: T-cell autoimmunity mechanism of diabetes type 1. Environmental factors (food, bacteria and virus antigens) can break the 
immune tolerance and lead to the pancreatic autoantigens presentation by the APC to the T-cell CD4 or CD8 causing β-cell death via 
macrophage pathway or cytotoxic T-cell pathway respectively, adapted from Bioinformatics resource centre ( 2008). 
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1.3 Cystic Fibrosis and diabetes and infections  
Cystic Fibrosis (CF) is an inherited disease with higher incidence in Caucasians 
compared to other ethnic groups. It results from mutation in the cystic fibrosis 
transmembrane conductor regulation genes causing dysfunction in halide and 
pseudohalide transport (Farra et al., 2010). Individuals with cystic fibrosis are 
diagnosed with many disorders including chronic respiratory infections and 
pancreatic insufficiency. An important complication associated with CF is 
diabetes; both type 1 and type 2, usually referred to as CF-related diabetes 
(CFRD) (Zirbes and Milla, 2009). Pancreatic insufficiency occurs early in life in 
approximately 85-90% of individuals diagnosed with CF and it is thought that 
CFRD results from pancreatic fibrosis and fat infiltration (Skretas and Georgiou, 
2008). However, the pathogenesis of CFRD is unclear (Hardin et al., 2001; 
Hadjiliadis et al., 2005).  
Burkholderia spp. and the fluorescent group of Pseudomonas spp. have 
emerged in the last two decades as the main opportunistic pathogens in CF and 
immune-compromised patients (Mc Manus et al., 2003; Allice et al., 2006). 
These bacteria are often found to be multi-drug resistant (Kuti et al., 2004; 
LiPuma et al., 2009) and form biofilms (Moskowitz et al., 2010) in infected lungs 
causing acute lung disease with high mortality in CF patients. Moreover, they 
produce virulence factors that contribute to the pathophysiology of CF, including 
phenazine, which is produced by both types of organism (Kanthakumar et al., 
1993; Hwang et al., 2002), and pyrrolnitrin, which is produced by a wide range 
of Burkholderia species (Hwang et al., 2002). 
Furthermore, Burkholderia species were formally classified as members of the 
Pseudomonas genus. Some phenotypically and genotypically Burkholderia 
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species of a group  called the Burkholderia cepacia complex (BCC) which is 
composed of at least 10 closely related subspecies (Baldwin et al., 2005). The 
term of genomovar had perversely been used to distinguish species in the BCC, 
These genomovars have been classified recently as species so that genomovar 
I refers to Burkholderia cepacia and B. multivorans (formally genomovar II), B. 
cenocepacia (genomovar III), B. stabilis (genomovar IV), B. vietnamiensis 
(genomovar V), B. dolosa (genomovar VI) B ambifaria (genomovar VII), B. 
anthina (genomovar VIII), B. pyrrocinia (genomovar IX) and B. ubonensis 
(genomovar X) (Mahenthiralingam et al., 2002; Coutinho, 2007). All 
genomovars have been detected in chronic infection of CF patients and the 
literature has also showed insulin receptors or insulin binding proteins (IBPs) 
are presented in B. cepacia (Jeromson et al., 1999) suggesting possible 
molecular mimicries with HIR may exist.  
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1.4 Conclusions  
The interaction of insulin hormone and microorganisms can be demonstrated 
via insulin binding to specific receptors or binding proteins on microbial cell 
envelopes. These receptors may be members of a signal transduction system 
such as tyrosine kinase or tyrosine phosphatase or hormone binding proteins. 
Examples are found in bacteria such as B. pseudomallei and Streptococcus and 
the fungus N. crassa and yeast such as S. cerevisiae. 
Microorganisms can interact with insulin producing β-cells causing damage or 
modify insulin synthesis (transcription and secretion). 
Some microbial toxins or secondary metabolites inhibit insulin production 
because the cytotoxicity of these components to insulin producing β-cell. 
Examples are the streptozocine antibiotic and macrolide compounds produced 
by Streptomyces and collagenase enzyme produced by Clostridium histolyticum 
bacteria. Other microbial compounds can enhance insulin secretion like cholera 
toxin and some imidazoline compounds.   
Some microbial components (insulin isoform, insulin receptors) as well as some 
microbial polypeptides can induce an autoimmune response (Humoral or T-cell 
reactivity) against insulin receptors, insulin or against the major β-cell 
autoantigens such as GAD, PTP, insulin, and HSP on the basis of molecular 
mimicry of epitopes (10-20 aa) between those proteins leading diabetogenic 
autoimmune response (destruction or apoptosis) against β-cell autoantigens or 
HIR.  
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1.5 Aims & Objectives  
The current study aimed to characterize the interaction between the insulin 
pathway and microorganisms by:- 
I. Studying the effect of secondary metabolites produced by bacterial 
species which infect CF patients, on pancreatic β-cells and insulin 
production. In this study, the cytotoxic effects of two bacterial secondary 
metabolites on the β-cell line, INS-1, were examined. The effects of sub-
lethal and cytotoxic concentrations of these compounds on insulin 
secretion and gene transcription were also investigated. 
II. Screening for insulin binding to microbes, in particular Burkholderia spp, 
using insulin peroxidase microcentrifuge tube assay. Any insulin binding 
proteins recognized will be characterised using a ligand blot assay and 
their gene(s) cloned and sequence followed by sequence analysis for 
molecular mimicry between insulin binding protein of microbes and the 
HIR. 
III. Using GAD antiserum to screen for bacterial components that cross react 
and identify such proteins by mass spectrometry and use the sequences 
of these microbial proteins to search for epitopes that show molecular 
mimicry with pancreatic GAD.  
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Chapter 2 
General Materials and Methods 
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2.1 Reagents and media 
Formulation and preparation of laboratory reagents and growth media are 
shown in (Appendix 1). All laboratory chemicals, unless stated otherwise, were 
obtained from Sigma-Aldrich (Poole, UK), Stratagene (Wilmington, USA), or 
Qiagen (West Sussex, UK), Cell culture reagents and plastic-wares were from 
Lonza (Slough, UK) and Sterilin Limited (Newport, UK). Promega 
(Southampton, UK), Applied Biosystems (Fisher Biosciences, Warrington, UK). 
Reagents and equipment requiring sterilization were sterilized by autoclaving 
(121 °C, 15 min, pressure 15 lbs/in2), whereas, regents containing heat 
sensitive compounds were sterilized using filtration through either 0.2 or 0.45 
µm filters (Sartorius, Ltd). 
2.2 Microbiology  
2.2.1 Microorganisms  
All microorganisms used in this study were categorized 1 or 2 according to the 
Advisory Committee on Dangerous Pathogens (ACDP). A total of 45 microbial 
species were used in this study and are listed in Table 2.1. Microorganisms 
were obtained from the School of Biomedical and Biological Sciences / 
University of Plymouth liquid nitrogen culture collection except Burkholderia 
cepacia strains were supplied by Dr. M L. Gilpin. E coli K12 strains used in gene 
manipulation experiments in this study are shown in (Table 2.2).  
All microorganisms were grown according to the optimum oxygen requirement 
temperature and incubation time for each species, and used to screening for 
insulin binding and extracting protein samples for SDS-PAGE, western blotting, 
dot blotting and mass spectrometry identification. Strains of E. coli K12 were 
used for gene manipulation, plasmid maintaining and protein expression. 
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Table 2.1: Microorganism strains used due this study and some optimum growth 
conditions. 
 
Bacteria O2 requirement Growth temp °C  
 
Growth medium 
Acetobacter  aceti 39 Aerobic (Aero) 30 Luria Bertani (LB) 
Acinetobacter spp. SDF11742 Aero 37 LB 
Aeromonas hydrophila 47 Aero 25 LB 
Aeromonas salmonicida CM30
 
Aero 25 LB 
Agrobacterium rhizogenes 15834 Aero 25 LB 
Alcaligenes viscosus 45 Aero 25 LB 
Bacillus subtilis EMG51 Aero 37 LB 
Bacteroides  fragilis  NCTC 9343 Anaerobic 37 BBE 
Brevibacterium linens 99  Aero 25 LB 
B. cenocepacia CF Aero 37 LB 
B. cocovenenans  Aero 37 LB 
B. multivorans CF Aero 37 LB 
B. thailandensis  Aero 37 LB 
Cellulomonase flavigena 53 Aero 30 LB 
Chromobacterium violaceum CUQ5 Aero 25 LB 
Citrobacter freundii 17B Aero 37 LB 
Clostridium perfringens Type A Anaerobic 37 LB 
Corynebacterium  aquaticum  3283 Aero 30 LB 
Erwinia carotovora 48 Aero 30 LB 
E. coli EMG1 Aero 37 LB 
Hafnia alvei UTI Aero 30 LB 
Klebsiella aerogenes 17A Aero 37 LB 
Lactobacillus  casei  shirota Microaerophlic 37 LB 
Listeria monocytogenes 117 Aero 37 LB 
Microbacterium lacticum  36A Aero 30 LB 
Micrococcus luteus 1270  Aero 30 LB 
Mycobacterium phlei  52 Aero 37 LB 
Nocardia cellulans 61 Aero 25/5days LB 
Ps aeruginosa  ATCC 27853 Aero 37 LB 
Ps fluorescens 11712 Aero 37 LB 
Ps putida 12593 Aero 37 LB 
Proteus vulgaris  8 Aero 37 LB 
Rhizobium sp.97 Aero 30 LB 
Rhodococcus equi 120 Aero 30 LB 
Salmonella typhimurium TA97A Aero 37 LB 
Sarcina lutea  ATCC 9341 Anaerobic 37 LB 
Serratia marcescens 410 Aero 37 LB 
Staphylococcus aureus S6 Aero 37 LB 
Streptococcus pyogenes Group A Aero 37 LB 
Vibrio anguillarum  CM19 Aero 30 LB 
Yersinia ruckeri RS6 Aero 30 LB 
Yeasts    
S. cerevisiae S28 Aero 25 Malt extract 
S. carlsbergensis 171 Aero 25 Malt extract 
Schizosaccharomyces octosporus 47B Aero 25 Malt extract 
Schizosaccharomyces pombe 188 Aero 25 Malt extract 
Zygosaccharomyces rouxii 40 Aero 25 Malt extract  
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2.2.2 Laboratory culture and storage of bacteria 
All cultures were grown in LB medium (Appendix 1) except Bacteroides was 
grown in Bacteroides Bile Esculin broth (BBE) and yeast strains were grown in 
malt extract medium. E. coli strains that bore plasmids were cultured using LB 
supplemented with appropriate antibiotic (s). Microorganisms were streaked on 
agar media to check for purity and subsequently single colonies were used to 
inoculate broth media. Cultures were incubated overnight unless otherwise 
stated according to optimum condition and growth time. Volumes of cultures 
(0.5 ml) were mixed with 0.5 ml of sterile glycerol, cryoprotectant and stored at -
20 °C. Agar cultures were stored at 4 °C and sub cultured every 3-4 weeks. 
Table 2.2: E coli K12 strains used in gene manipulation experiments in this 
study. 
Strain            .   Supplier.  Genotype                                                                      .  
XL1-Blue MRF´ 
 
Stratagene  Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-
1recA1 gyrA96 relA1 lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)]. 
XLOLR 
 
Stratagene Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 thi-1 
recA1gyrA96 relA1 lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)] 
Su–(non-suppressing) λ r (lambda resistant). 
JMM109                         Promega endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, 
supE44, Δ (lac-proAB), [F´ traD36, proAB, laqIqZΔM15]. 
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2.3 Mammalian cell culture  
2.3.1 Rat insulinoma (INS-1) cells  
Insulinoma clone pancreatic beta cells INS-1 (Asfari et al., 1992) were kindly 
gifted from Professor Noel Morgan (Peninsula School of Medicine and 
Dentistry, University of Plymouth). Cells were (passages 12-35) cultured in 
RPMI -1640 containing supplements (Appendix 1). The cells were grown as a 
monolayer and examined by inverted microscope (Olympus CK40, UK) and 
sub-cultured routinely at 80% confluence by pouring off the depleted medium 
and washing the cells using Dulbecco's Phosphate-Buffered Saline (DPBS) 
twice and trypsinized by adding 2-3 ml of trypsin (0.25%) / versene (EDTA 200 
mg/ml) for 1 min, the excess trypsin was removed and the cells were gently 
agitated until detached. Fresh medium 10 ml was used to suspend cells in 75 
cm2 tissue culture flasks by pipetting them thoroughly and carefully to get a 
homogeneous suspension. A haemocytometer was used for counting cells by 
loading a few microliters of cell suspension. The maintenance culture was 
passaged once every 5 days with a seeding density of 2 × 105 cell/ml and the 
number of cells/ cm2 needed were determined (Wood et al., 2004). Seeded 
flasks were incubated at 37 °C, with 5% CO2 in a humidified atmosphere.  
(No of cell/ml=No. of cells in large square of haemocytometer x 104)  
2.3.2 Chinese Hamster Ovary Cells (CHO)  
The CHO cell line was used in transfection experiments, and was obtained from 
the School of Biomedical and Biological Sciences, University of Plymouth liquid 
nitrogen culture collection. Cells were passage (16-24) in Hams F12 medium 
containing 0.146 gm/L glutamine and glucose 11 mM and 10% fetal bovine 
serum (FBS). The routine culture and passage procedure was performed as 
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previously mentioned for INS-1 cells (2.3.1) but the seeding density was 5 × 104 
cell/cm2 and incubated securely closed in on normal incubator at 37 °C with 
humidified atmosphere.  
2.3.3 Storage of mammalian cells  
Cells were grown to 80% confluence in order to prepare stocks for long term 
storage. Cells were cultured (2.3.1 & 2.3.2) in 75 cm2 tissue culture flasks, 
trypsinized and harvested by centrifugation at 50 × g for 10 min, the 
supernatant was aspirated and the pellet was resuspended gently by pipetting 
in 10 ml of storage medium contains 20% FBS & 10% and dimethyl sulfoxide 
(DMSO). Aliquots of 1ml suspension were placed in 2 ml vials and incubated at 
-80°C overnight in insulated boxes. Afterwards, vials were removed from the 
insulated box and returned to - 80 °C for long store.  
2.3.4 Cloning vectors   
2.3.4.1 Bacteriophage lambda (λ) express (Stratgene, Wilmington,USA) 
Cloning vector λ Zap, derived from bacteriophage λ was used to construct gene 
libraries for eukaryotic and prokaryotic organisms and express recombinant 
proteins. The Zap express was provided as arms pre-digested with BamHI and 
pre-treated with alkaline phosphatase with a total size of 38.9 kbp, thus λ 
cloning vector has 12 unique cloning sites with DNA capacity to be cloned from 
0-12 kbp in length and recombinant phages can be recognized by blue-white 
screening as the foreign DNA will fuse to the beta glactosidase gene. Inserts 
can be excised out of the phage to form Kanamycin –resistant pBK-CMV 
phagemid vector after co-infecting E coli XL1-Blue recombinants with helper 
phage provided by in the kit (Figure 2.1).  
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This phagemid contains forward and reverse T7 and T3 primers respectively, 
facilitating sequencing the inserted DNA and sequence analysis. This type of 
vector also facilitates production of recombinant proteins extracellular through 
infection E coli to produce plaques. These can then be screened with antibody 
or via protein- protein interaction assay.  
λ Zap express genomic libraries produced were amplified and chloroform 0.3% 
(v/v) was added and the amplified library was stored at 4 °C. Other aliquots of 
the amplified library were stored in 7% (v/v) DMSO in polypropylene falcon 
tubes at -80 °C. Excised filamentous pBK-CMV recombinants were stored in 
falcon polypropylene at 4 °C for 1-2 months and recombinant phagemids were 
used to transfect E. coli. Recombinant E. coli was stored as described in section 
2.2 and recombinant phagemids extracted and stored at -20 °C for long term 
storage.  
2.3.4.2 Plasmid pGEM-T Easy vector 
This vector was provided as a 3 kbp linearized plasmid with single 3` terminal 
thymidine overhang on both ends to prevent the plasmid re-annealing and 
provide compatible overhangs for PCR products with A-overhangs. This 
plasmid contains an ampicillin resistance gene for use as a selectable marker in 
addition the lacZ gene that fused once the plasmids‘ T-overhangs within PCR 
product. The pGEM-T easy plasmid also includes a multi cloning site for easy 
excision of any cloned inserts and T7 and SP6 promoter for transcription and 
sequencing (Figure 2.2). 
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   GTAAAAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTGGGTACACTGGTACCCCACCCGGGTGGAAA.. 
….ATCGATGGGCCCGCGGCCGCTCAGAAGTACTCTCGAGAAGCTTTTTGAATTCTTTGGATCCACTAGTGTCGACCTGCAG… 
GCGCGCGAGCTCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTTCGAGCTTGGCGTAATCAAGGTCATAGCTGTTTCCTGT 
 
Figure 2.1: Schematic model of expression vector λ ZAP (A) and internal 
phagemid vector pBK-CMV (B) with multiple cloning sites, lac-z gene T7 and T3 
promoters (Reproduced with permission from Stratagene, USA).  
A 
 
B 
 
T7 Promoter 
T3 Promoter 
T3primer binding site  
T7 primer binding site  
β-gal-α fragment 
BK reveres primer binding site  
M13-20 primer binding site  
Multi cloning site   
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Figure 2.2: Schematic map of plasmid pGEM-T easy cloning vector and 
relevant sequence points T7 and SP6 RNA polymerase promoter, multiple 
cloning region 10–113, lacZ start codon 165, β-lactamase coding region 1322–
2182 and phage f1 region 2365–2820 (Reproduced with permission from 
Promega, UK). 
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2.3.4.3 Plasmid pFN22A HaloTag cMVd1 Flexi vector 
The pFN22A plasmid cloning vector (4188 bp) is designed to produce 
recombinant proteins appended to the halotag sequence to the amino terminus. 
The reading frame for protein of interest is combined with the halo tag code to 
produce a fusion protein and provides constitutive expression of the fusion 
protein in mammalian cells using a modified human cytomegalovirus (CMV) 
promoter, in addition to the T7 promoter for expression into E coli. The halo-tag 
region forms a covalent bound halotag ligand enabling immobilization of 
expressed protein as the protein to be produced will be a fusion protein 
combined with the halotag sequence. Furthermore, a tobacco etch virus (TEV) 
protease site is included for cleavage of the expressed protein from the halo-tag 
ligand. The pFN22A plasmid is fused with a toxic barnase gene which is 
replaced by the target open reading frame of the gene to be cloned. Unique 
restriction sites SgfI and Pmel flanking the barnase gene are ready for cloning 
with DNA fragments carrying similar sticky ends.  
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5‘…AGAAGCTTAATACGACTCACTATAGGGTACGATTTAGGTGACACTATAGAATAAGGAGAATTCATC 
 
 
ATGGCAGAAATTTCCGGCGAGCCAACCACTGAGGATCTGTACTTTCAGAGCGATAACGCGATCGCCATGG 
 
 
 
 
Figure.2.3: pFN22A HaloTag CMVd1 Flexi vector circle map and sequence 
reference points. Following features are present in the vector based on 
nucleotide sequence, CMVd1 enhancer/promoter 1–17, T7 and SP6 RNA 
polymerase promoter 132–151 and 156–175 respectively, halo tag protein 
coding sequence 191–1081, TEV site 1094–1114, SgfI site 1121–1128, 
barnase coding region 1152–1487, PmeI site 1489–1496, SV40 late 
polyadenylation signal 1648–1869, ampicillin resistance 2130–2990, Col E1-
derived plasmid origin of replication 3145–3181, cer site (site for E. coli XerCD 
recombinase) 3852–4137 (Reproduced with permission from Promega, UK). 
  
T7 RNA polymerase promoter SP6 RNA polymerase promoter 
   TEV protease recognition sequences    HaloTag N-terminus 
SgfI 
HindIII EcoRI 
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2.4 Protein analysis  
2.4.1 Extraction of microbial soluble proteins  
A single colony of fresh culture of each bacterium was used to inoculate 10 ml 
volumes of LB and incubated overnight at optimal temperature with or without 
shaking (120 rpm). The culture (0.5ml) was used to inoculate 50 ml of fresh LB 
medium and incubated overnight as before. The bacteria were collected by 
centrifugation at 4000 × g for 20 min at 4 °C and suspended in 5 ml protein 
extraction buffer (Appendix 1) containing 100 µg/ml of lysozyme, 5 µg/ml DNase 
I and 0.5 ml of protease inhibitor cocktail (P8340, Sigma Poole, UK) and 
incubated at 55 °C in a water bath for 15 min. Yeast strains, Nocardia, and 
Mycobacterium were lysed by an extraction buffer containing chromopeptidase 
(20ng/ml) instead of lysozyme and incubated at RT for 30 min. Cell suspensions 
were then transferred into conical tubes (20 ml) and placed on ice and 
sonicated (Microson XL2000, UK) using 5 sec bursts with 5 sec cooling time for 
a total of 4 min. The cell lysate was spun at 10000 × g for 30 min at 4 °C and 
the supernatant transferred to a fresh 15 ml polypropylene tube for 
quantification. 
2.4.2 Protein quantification  
Protein quantification employed the Bradford method (Bradford, 1976) modified 
for micro plate reader. Bovine Serum Albumin (BSA) stock solution (1 mg/ml) 
was prepared in molecular grade water (MBW) and used to prepare the 
standard protein solutions ranging from 50 to 600 μg/ml using a stock solution 
to a final volume of 500 μl as listed below. 
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 Standard   Stock   ddH20 (μl) 
0    0   500 
50    25   475 
100    50   450 
200    100   400 
400    200   300 
600    300   200 
 
Aliquots (10 μl) of each standard protein solution were pipetted in triplicate into 
a 96 well plate and unknown protein samples were prepared in the same way, 
in addition to the control wells which contained 10 μl of MBW. Next, 250 μl of 
Coomassie blue R250 reagent (Thermo Fisher, UK) was added to each well 
using a multi-channel micropipette and mixed by pipetting and left at RT for 5 
min. The absorbance was determined in a micro plate reader (Molecular 
Devices, Manchester, UK) at 595 nm wave length. A standard curve was 
produced between absorbance value and protein concentrations and the linear 
equation, regression value (R) was extracted and protein concentration of each 
test sample was calculated.  
2.4.3 SDS-PAGE 
Sodium dodecyl sulphates – polyacrylamide gel electrophoresis (SDS-PAGE) 
are a widely used analytical technique for the separation of cellular proteins and 
estimate the relative molecular size. SDS-PAGE was performed using 
Laemmli‘s discontinuous buffer system (Laemmli, 1970) and a Biometra mini-
gel apparatus (Biometra, GmbH, Germany ). The glass plates were cleaned 
with decan detergent and washed with deionised water, followed by 70% 
ethanol and dried before used. The final concentration of the resolving gel was 
10% or 12 % and for stacking gel was 5% of Acryl / Bis-Acrylmide stock 
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reagents and 0.2 % or 0.05% SDS (solution A, B and electrophoresis buffer) 
concentration.  
The desired resolving gel solutions (Appendix 1) were mixed firstly followed by 
adding 40 µl the ammonium per sulphate (APS) and 15 µl TEMED for 
polymerisation. The resolving gel was poured into the preformed space 
between the glass plates and filled two thirds. Water saturated isobutanol (2ml) 
was added immediately to the resolving gel mix to keep reduced oxygen 
condition. The gel was left for at least 30 min at RT for polymerisation to occur.  
Next, the isobutanol layer was removed and the top of gel was washed 5 times 
with sterile molecular biology water (MBW) and the stacking gel was applied 
and a comb was inserted directly into the stacking gel to produce wells for 
loading protein samples. The gel was left for at least 30 min to set. After setting, 
the gel was transferred to the electrophoresis tank and fixed by clips on both 
sides and the electrophoresis buffer was poured into the tank to cover the top of 
the gel. The comb was removed carefully and each well was loaded with 
maximum 20 µl of protein sample. The gel was run at 80 V for 30 min until the 
proteins entered the stacking gel and the voltage was increased to 110 V. The 
gel was run until the dye front reached the bottom of the gel.  
The gel was removed from the electrophoresis tank, plates were removed and 
the gel placed into a tray containing 50 ml of coomassie blue staining buffer 
(Appendix 1) with gentle shaking for to 2 h, after that the staining buffer was 
discarded and replaced with 100 ml of destaining solution which was replaced 
after 30 min with fresh 100 ml for 2 or 3 times until clear bands could be seen.  
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2.4.4 Protein Blotting 
The proteins separated in SDS-PAGE gels were transferred to nitrocellulose 
membranes using an electro blotter system (Criterion blotter, BIO-RAD, UK )  
(Towbin et al., 1979). After electrophoresis and prior to blotting, the gel was 
placed in 100 ml of transfer buffer for 10 min. Pieces of nitrocellulose were cut 
to the same size as the gel, along with two pieces of Whatman filter papers (3 
MM). The blotting papers were pre-wetted for 2 sec in transfer buffer (Appendix 
1) and one of them was placed onto one of the foam pads. The gel (section 
2.4.3) was carefully placed onto the blotting paper followed by the pre-wetted 
nitrocellulose membrane, ensuring no air bubbles were trapped under the 
nitrocellulose membrane by using a clean glass rod and then the second 
blotting paper was placed on the gel with the second foam pad. The gel was 
electro blotted at 300 mA at RT for 1.5 hours; an ice pack was used to cool 
down the buffer. After blotting the membrane was washed using PBS and 
placed in 50 ml of blocking solution (Appendix1). The membrane was then 
subjected to the ligand binding protocol, or the standard western blotting 
technique involving primary and secondary antibody.  
2.5 Nucleic acid analysis  
2.5.1 Purification of genomic DNA from Gram negative bacteria  
Genomic DNA was extracted from bacterial strains using DNeasy blood and 
tissue kit (Qiagen, UK). The protocol supplied by manufacturer recommended 
using 2×109 cells from overnight culture for extraction of total DNA from Gram 
negative bacteria. A maximum 2×109 cells in overnight broth culture were 
harvested in a microcentrifuge tube by centrifugation for 10 min at 5000 × g and 
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resuspended in suspension buffer and the genomic DNA was extracted and 
purified as described by the manufacturer.  
2.5.2 DNA precipitation  
In order to obtain 2µg/µl DNA final concentration, the genomic DNA was 
concentrated as described by Sambrook and Russell (2001). A one tenth of 
volume 3M sodium acetate (pH=6) was added and mixed with DNA solution, 
followed by 3 volumes of cold ethanol (100 %) with thorough mixing. The 
mixture was stored at -20 for 2 h to precipitate DNA and centrifuged at 13000 × 
g for 3 min. The supernatant was carefully removed and the pellet was washed 
with 200 µl of 70 % ethanol and centrifuged for 3 min at 13000 × g, the washing 
was repeated twice, the DNA pellet was left to dry for 10 min at RT and finally 
resuspended in 30µl of sterile MBW.  
2.5.3 Preparation of plasmid DNA 
Plasmid DNA was extracted from bacterial cultures as described by Birnboim & 
Doly (1979) cited by Sambrook & Russell (2001). Aliquots (1.5 ml) of overnight 
broth culture were centrifuged at 6000 × g for 2 min at RT. The pelleted cells 
were resuspended and left in 100 µl of B & D solution I (Appendix 1) at RT. The 
bacterial cells were lysed by adding 200 µl of freshly prepared B & D solution II 
(Appendix 1), the tubes contents mixed by gently inverting and left for 5 min at 
RT. Ice cold B & D solution III (Appendix 1) 150 µl was added and the tube's 
contents mixed and placed on ice for 10 min. The tubes were centrifuged of 
13000 × g for 5 min at RT. Cell debris, denaturised proteins and chromosomal 
DNA are precipitated and the supernatant was transferred to a fresh 
microcentrifuge tube. Cold (-20 °C ) absolute ethanol (1ml) was added and 
mixed with the DNA solution and incubated at -20 °C for 10 min. The mixture 
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was centrifuged at 13000 × g for 3 min and the supernatant removed. The 
plasmid pellet was left for 10 min to drain and then resuspended in 100 µl of 
solution B & D IV (Appendix 1). The DNA was re-precipitated by adding 300 µl 
of cold absolute ethanol, mixed and incubated for 10 min at -20 °C. The plasmid 
DNA was pelleted by centrifugation (13000 × g) for 5 min and the B & D IV 
solution step repeated again. The pelleted plasmid washed twice with 200 µl of 
70 % ethanol, centrifuged at 13000 × g and supernatant removed and finally the 
plasmid pellet was left to dry followed by  suspension it in 20 µl of MBW and 
stored at 4 °C.  
2.5.4 Plasmid preparation using Plasmid Miniprep Kit (PLN70, Sigma, UK) 
Aliquots (1.5 ml) of overnight broth culture were centrifuged (13000 × g) at RT 
and resuspended in 200 µl of re-suspension solution. Protocol was followed as 
described by manufacturer. The purified plasmid was eluted using 100 µl MBW 
and the eluted DNA was stored at 4 °C. 
2.5.5 Determination nucleic acids quality and quantity 
The concentration of the nucleic acids (DNA, RNA and cDNA) prepared in this 
study were measured, as well as purity, using a computerized Nano-drop 
spectrophotometer (Lab Tech, UK). Aliquots (2 µl) of buffer were used to 
calibrate the nanodrop and then 2 µl of nucleic samples were measured and the 
DNA/protein rate (260nm/280nm), DNA/contaminants rate (260nm/230nm) and 
DNA concentrations were recorded. The wave length was corrected for different 
types of nucleic acid (DNA, RNA, ssDNA). The DNA quantity and quality were 
checked further by running aliquots of the extracted DNA with known amounts 
of standard Bacteriophage λ DNA (1 µg, 0.5 µg, 0.25 µg, 0.125 µg 0.1 µg, 0.05 
µg) into agarose gel electrophoresis. Depending on the fluorescence intensity of 
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intercalated ethidium bromide on the known concentrations of λ DNA standard, 
DNA concentration and molecular weight was assessed. The DNA was 
visualized and images were captured after electrophoresis using UV gel 
documentation system (UV tech, UK). 
2.5.6 DNA agarose gel electrophoresis 
In order to read the quality of DNA, agarose gel electrophoresis was used. The 
gels were prepared by dissolving 0.8 or 1.8 % of agarose into TBE buffer (1×) 
(Appendix 1) in a conical flask using a microwave oven on mid power for 2-3 
min until the agarose completely dissolved. A drop of ethidium bromide 
standard solution 625 µg/ml (Sigma, UK) was added to 50 ml of molten agarose 
solution once the solution became cooler (50 °C) and mixed well to give final 
concentration 0.5 µg/ml of ethidium bromide. The molten agarose was poured 
into an end taped tray with comb inserted in order to create wells. After 30 min 
the set gel was placed into an electrophoresis tank (Pharmacia GNA100, UK) 
and submerged with 350 ml of TBE (1×). DNA samples were prepared by 
mixing them with DNA loading buffer (Appendix 1). The comb was removed and 
the samples were loaded into the gel‘s wells. The gel was run at 50 to 120 V 
until the dye front reached the end of gel and then the DNA was visualized 
using a UV transilluminator (390 nm) and photographed with the gel 
documentation system.  
2.5.7 Elution of PCR products from agarose gels   
The DNA bands that appeared at expected molecular size required for further 
analysis were excised from the gel using a clean sterile razor and extracted 
using a cleanup system (Promega, UK) following manufacturer‘s instructions to 
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purify them. The DNA concentration was measured by the nanodrop 
spectrophotometer and the quality was checked by agarose gel electrophoresis. 
2.5.8 DNA digestion by restriction endonuclease enzymes 
Restriction enzymes cleave both strands of double stranded DNA at specific 
nucleotide sequences called restriction sites. The definition of 1 unit of 
restriction enzyme is an amount of enzyme which cut 1μg of λ DNA in 1 hour at 
37 °C in a volume of 50 µl. Digestion reactions were performed using restriction 
enzyme and restriction buffer recommended by the supplier in 1.5 ml 
microcentrifuge tubes, containing 1µl of DNA (1µg/1µl) dissolved in MBW plus 
1µl of 10 x restriction buffer, 7 µl of MBW and finally 1µl of restriction enzyme 
(1unit/µl) and mixed thoroughly. Contents were collected by brief centrifugation 
and incubated at 37 °C for 3- 18 hours. Large quantities of DNA were digested 
by scaling up the reaction mixture ensuring that the enzyme volume was always 
1:10 or less of the final volume of reaction mixture. Double enzyme digestion 
was carried out using recommended buffer by supplier or compromised buffers 
were prepared 1:1. The digested DNA was visualized using agarose gel 
electrophoresis with DNA size marker. 
2.6 Assaying gene expression using RT-PCR & qRT-PCR 
Reverse Transcriptase PCR RT-PCR and quantitative real time -PCR (qRT-
PCR) techniques were used to study gene expression, techniques involve 
extraction total RNA, cDNA syntheses, conventional PCR amplification using 
specific primers and then compare the band intensity for each treatment to the 
control after run the PCR product into agarose gel electrophoresis. 
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2.6.1 Extraction of total RNA from mammalian cells  
The total RNA was extracted using RNA sigma Kit (RTN70 sigma, UK). Cells 
were subculture in 25 cm2 flasks (section 2.3.1) and RNA was extracted at 
confluency 80%, about 5×106 - 1× 107 cell/ml were used to extract the total RNA.  
The medium was discarded and cells were washed using 3 ml of PBS twice to 
remove cell debris and medium residues. The attached cells were then lysed 
using lysis buffer containing 0.02% 2-mercaptoethanol and the RNA was 
extracted and purified using the manufacturer‘s protocol using the optional step 
involving DNase treatment to eliminate the chromosomal DNA from the RNA.  
RNA was eluted using DNase & RNase free MBW, and samples concentration 
and purity were measured using the nanodrop spectrophotometer (2.5.2).  
Aliquots of RNA were stored in 1.8 ml microcentrifuge tubes RNase, DNase free 
for long term at -70 °C freezers. All samples that showed more than 250 ng/µl 
were processed as follows:- 
2.6.2 Preparing total cDNA using reverse transcriptase  
The cDNA was prepared using extracted RNA (2.6.1). Microcentrifuge tubes 
(200 µl) RNase and DNase free were used for preparing total cDNA by using 1 
µg RNA. The RNA was mixed with 1 µl of 10 mM dNTPs solution and 1 µl of 50 
µM random nonamers and water was added to give a 10 µl final volume. The 
contents were mixed gently and briefly centrifuged to collect all components to 
the bottom; tubes were incubated in a thermal cycler (Applied Biosystem, UK) 
for 10 min at 70 °C to reduce mRNA secondary structure. After that tubes were 
placed on ice for 5 min and 10 µl of reverse transcription master mix containing 
200 units of Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV -
RT), 2 µl of 5 x reverse transcriptase buffer and 7 µl of PCR pure water were 
added to each tube to a final volume of 20 µl. The tubes were incubated for 10 
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min at RT to ensure elongation of random nonamers before being placed at 37 
°C for 50 min at and then 5 min at 94 °C to stop M-MLV reverse transcriptase 
activity. The cDNA samples were stored at 4 °C for short term storage on -20 °C 
for long term storage. The synthesised cDNA samples (section 2.6.2) were then 
amplified using specific PCR setup and specific primers prepared for this 
purpose. The synthesised cDNA samples were then amplified using PCR 
amplification as follows:-  
2.6.3 Conventional PCR amplification 
2.6.3.1 Design of primers  
The full length sequences of cDNA of the genes of interest were identified using 
ensemble software version 53 from the European Bioinformatics Institute (EBI). 
The primer blast software of the National centre of Biotechnology Institute 
(NCBI) was used to get an appropriate primer in terms of sequence, number of 
nucleotides and melting temperature. The annealing temperature of primers that 
used was either 60 or 65 °C, and the primers designed to produce amplicons of 
sizes 150-250 bp for the genes to be studied. The primers were commercially 
synthesised by Sigma genosys (Sigma Poole, Dorset, UK). Lyophilized primers 
were dissolved in appropriate volumes of MBW to prepare 100 mM and were 
stored at -20 °C.   
2.6.3.2 PCR amplification  
Amplicons of the genes of interest were amplified using total cDNA prepared in 
section 2.6.2 and primers (Section 2.6.3.1). DNase free PCR tubes (200 µl) 
were used for these experiments and reaction components were added 
respectively for individual reaction as follows:- 
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cDNA        2 µl       
PCR reaction buffer (5 ×)   2.5 µl 
Forward primer (10 µM)   0.5 µl 
Reverse primer (10 µM)   0.5 µl 
dNTPs solution (10 mM)  0.5 µl    
Taq DNA polymerase (5 U) 0.25 µl 
PCR water             18.75 µl 
Total      25 µl 
 
The contents were mixed thoroughly by pipetting and centrifuged briefly to 
collect the mixture at the bottom of the tubes. PCR controls were set using 
water instead of cDNA. Standard PCR reactions were performed using a MWG 
Thermo cycler (Primus 96 plus) under the following conditions; 94 °C for 2 min 
followed by 40 cycles start at 94 °C for 30 sec, 60 - 65 °C for 30 sec and 72 °C 
at 30 sec for individual cycle followed with hold the samples at 4 °C until collect  
them. The PCR products samples were mixed with loading buffer and run into 
1% agarose gels in TAE buffer along with a 1 kb ladder and the DNA bands 
were visualized in gel documentation system using ethidium bromide and UV 
light and images were captured. 
2.7 Quantifying gene expression by absolute qRT-PCR  
The mRNA levels were measured for mammalian genes were also quantified 
using qRT-PCR or real time PCR. qRT-PCR absolute quantification method 
was used to measure the mRNA levels in each sample exposed to a certain 
concentration of cytotoxic agents. This method requires cloning the PCR 
products of certain genes into a suitable host vector (plasmid) such as pGEMT-
easy vector, which has been extensively used for these purposes. A standard 
curve for a particular gene was achieved by preparing ten-fold serial dilution 
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series of the cloned plasmids, ranging from 5 X 102 to 5 X 106 copies were used 
to construct the standard curves. Cloning the gene amplicon produce by PCR 
into pGEMT-Easy vector requires:-  
2.7.1 PCR amplification using GoTaq DNA polymerase  
The PCR amplification of genes of interest were prepared using modified taq 
polymerase which lacks 5`-3` nuclease activity (GoTaq DNA polymerase) to 
achieve a PCR product with A-overhang in both ends facilitating cloning the 
amplicon into T-overhang ends of PGEM-T easy cloning vector. The PCR 
reaction was achieved using 200 µl PCR tubes. Products were synthesized by 
using the following reaction to final volume of 50 µl.  
cDNA      2 µl  
F/primer (10 µm)    1 µl  
R/primer (10 µm)    1 µl  
dNTPs (10mM)    1 µl  
GoTaq DNA polymerase   0.25 µl 
GoTaq buffer (5 ×)    10 µl 
MGW      34.75 µl 
Total       50 µl 
The PCR started by denaturing at 94 °C for 2 min followed with a 30 cycle set 
up at 94 °C for 0.5 min, 60 or 65 °C for 0.5 min and 72 °C for 1min. The 
products were separated into 1.8% agarose gels and desired product were 
extracted from the agarose gels (section 2.5.6) and used in the cloning 
procedure. 
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2.7.2 Ligation of PCR products into pGEMT-Easy plasmid  
The purified PCR products for particular genes were cloned into plasmid 
pGEMT-Easy using a Promega cloning system (A 1380, Promega, UK). The 
PCR products were ligated within pGEM-T plasmid using DNA ligase enzyme 
provided with the cloning system. The molar ratio for inserts was 1:1 and used 
to calculate the concentration of PCR products from the following equation. 
ng of insert = insert : vector ratio ×  
ligation was performed using 1.8 ml eppendorf tubes nuclease with 5 µl Ligation 
buffer (2 ×), pGEM-T easy plasmid 1µl (50 ng/ µl), 1 µl of T4 DNA ligase (3 
units/ µl) mixed with 1 µl of a suitable concentration of the PCR amplicon DNA 
and MBW was added to a 10 µl final volume for each sample. Two types of 
control reaction were set for ligation; a positive control using control inserts DNA 
and a background control which is unlighted free insert DNA. The contents were 
mixed by pipetting and the tubes were incubated at 4 °C overnight. 
2.7.3 Transformation into E. coli JM109 coupled with blue white screening 
The transformation protocol used frozen ready competent cells of the E coli 
JM109 (Promega, UK) provided with pGEM-T easy cloning system (stored at -
70 °C) according to manufacturer's instructions. The ligation mixtures for each 
amplicon and control samples were used for transformation. Ligation mixture (4 
µl) volumes were placed into 15 ml polypropylene tubes. Uncut pGEM-T easy 
plasmid (0.1 ng) was also used as a positive transformation control to determine 
the efficiency of competent cells. Next, competent cells were removed to thaw 
in an ice bath for 5 min and 50 µl of these were transferred gently into tubes that 
containing the plasmid DNA with gently mixing and left on ice for 20 min, after 
that the sample was heat shocked by placing at 42 °C for 50 sec. The tubes 
ng vector × kbp size of inserts 
 
kbp size of vector 
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were then immediately returned to ice for 2 min and 950 µl of SOC medium 
(Appendix 1) was added to the tubes containing ligation mixture and 900 µl of 
SOC to the tubes with uncut plasmid. Tubes were incubated at 37 °C with 
shaking (120 rpm) for 1.5 h followed by plating 100 µl samples onto LB plates 
containing ampicillin (100 µg/ml), IPTG (0.1 mM), and (40 µg/ml) X-gal 
(Appendix 1).  
The white colonies were considered recombinant transformants, while blue 
colonies lack inserts. A total of recombinant colonies (15 colonies) were 
streaked and checked again on X-gal /IPTG / ampicillin plates and a single 
colony was used to prepare stored aliquots of the recombinant E. coli.  
2.7.4 Checking recombinant pGEMT-Easy plasmid  
The recombinant pGEMT-easy plasmids DNA were excised by restriction 
enzymes in order to verify whether the right insert was cloned into the plasmid. 
The recombinant colonies were sub-cultured, in addition to colonies 
transformed within uncut pGEM-T plasmids in LB broth containing ampicillin 
and incubated overnight with shaking at 37 ºC. The cultures were used to 
extract the plasmid DNA (section 2.5.4) and 1µg of DNA was used for excision 
using EcoRI restriction enzyme and fragments were separated in an agarose 
gel (section 2.5.6). Recombinant plasmids (50 ng) were then subjected to 
further checking using PCR amplification (section 2.6.3.2). After excision and 
PCR amplification recombinant plasmids which produced inserts of the 
expected size were sequenced and plasmids possessing the right clone inserts 
in recombinant E. coli were stored as described in section 2.2.2. 
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2.7.5 Assay for mammalian expression 
Triplicates of each sample were prepared in 48 well PCR plates. Each well 
contained 12.5 µl of SYBR green master mix, 0.5 µl each of forward and 
reverse primers (10 µM), 0.25 µl reference dye, 9.5 µl water and 2 µl cDNA. 
PCR reaction was achieved using the following conditions denaturant cycle at 
94 °C for 2 min followed by 40 cycles, 94 °C 30 for 15 sec, annealing 60 °C for 
30 sec and amplification at 72 °C for 30 sec. Followed with melting cycle 94 °C 
for 15 sec and 60 °C for 1 min and 94 °C for 30 sec. The products were 
detected using an Applied Biosystems Step One real time PCR instrument and 
software v2.1. The copy number data were collected and normalized using the 
β-actin data before statistical analysis. 
2.7.6 qRT-PCR Data normalization  
The data was collected for mammalian genes tested and normalised with β-
actin gene expression data as the β-actin is used as a housekeeping gene in 
which the level of transcription level is almost do not affected by any factor. The 
normalization of β-actin copy number was done by dividing the mean of β-actin 
data copy number of individual sample into 1000000 to produce the 
normalization factor and after this the normalized β-actin values multiplied by 
test gene copy number to normalize the test gene data. 
2.7.7 Statistical analysis 
Unless stated otherwise, all the numerical data were analysed using SPSS 
version 17 statistical software, using one way analysis of variance (ANOVA) 
and multiple comparison post hoc tests (Fisher‘s LSD). Data are shown as 
means +/- SE and p < 0.05 is considered significant. 
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Chapter 3 
Effects of the microbial secondary metabolites pyrrolnitrin, 
phenazine and patulin on INS-1 rat pancreatic β-cells 
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3.1 Introduction 
Recently, in addition to genetic susceptibility and autoimmunity, the destruction 
of pancreatic beta cells (β-cells) and consequent development of Type 1 
diabetes (T1D) have also been linked with exposure to environmental factors, 
which may contribute up to 50% of the risk of developing this type of diabetes 
(Hans et al., 2002). The most important factors that are thought to be T1D 
inducers are infection (e.g. viral infection), diet (i.e. the early presence or lack of 
particular food during childhood), and some inorganic compounds e.g. arsenate 
ions (Peng and Hagopian, 2006; Richer and Horwitz, 2009). 
Amongst these potential environmental factors are microbial secondary 
metabolites that can cause β-cell dysfunction or destruction e.g. bafilomycin and 
concanomycin, produced by Streptomyces spp. (Myers et al., 2003) and 
cereulide produced by Bacillus spp. (Virtanen et al., 2008). Compounds from 
microbial sources show various interactions with β-cell proliferation and 
differentiation, in addition to interacting with the major β-cell pathways relating 
to insulin synthesis and secretion, and even with aspects of insulin gene 
regulation. Foods are thought to be the main means by which these compounds 
enter the human body, particularly through ingestion of naturally infected fruit 
and vegetables, as well as via foods that are contaminated during processing in 
the food industry. There is also the possibility that human exposure to such 
compounds may occur through infection with pathogens capable of producing 
these secondary compounds in situ (Virtanen et al., 2008). A wide range of 
microbial components could cause destruction of β-cells through a variety of 
mechanisms. Some of these components are vascular ATPase inhibitors such 
as bafilomycin and concanomycin while others are genotoxic compounds such 
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as streptozotocin or mitochondriotoxic compounds such as cereulide (Singaram 
et al., 1979; Virtanen et al., 2008). The compounds mentioned so far are 
secondary metabolites but primary metabolites such as the collagenase 
produced by Clostridium histolyticum could also destroy β-pancreatic cells 
(Moskalew et al., 1974). In some cases these compounds may be produced in 
relatively high concentration in individuals with long-term infection such as 
cystic fibrosis (CF) patients (Coutinho, 2007). 
In this study it has been hypothesized that the microbial secondary metabolites 
produced by Burkholderia sp and Ps. aeruginosa during infection of CF suffers 
may contribute the β-cells cytotoxicity and diabetogenicity and subsequently 
CFRD. The effects on pancreatic β-cell viability and function of three microbial 
secondary metabolites pyrrolnitrin produced by Burkholderia spp. and Ps. 
aeruginosa; phenazine produced by Ps. aeruginosa; as well as patulin 
produced by Penicillium and Aspergillus spp. were investigated, using the rat 
clonal pancreatic -cell line, INS-1, as a model. In addition, the effects of 
concentrated supernatants of cultures of B. multivorans and Ps. aeruginosa 
were also tested. 
Phenazine, also called dibenzo-p-diazine, is a redox-active compound that 
increases intracellular oxidative stress. It has been confirmed that phenazine 
and its derivatives interact with various human cell lines causing increased 
production of reactive oxygen species which cause cellular damage (Hamill et 
al., 1981; Denning et al., 2003). Pyrrolnitrin, 3-chloro-4-(3-chloro-2-nitrophenyl)-
1H-pyrrole, is a compound with antibiotic activity produced by Burkholderia spp. 
and the cytotoxicity of this compound to mammalian cell lines is not well tested. 
However, pyrrolnitrin has been identified as having an inhibitory effect on the 
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electron transfer chain in fungi and bacteria (Hwang et al., 2002; Zhai et al., 
2003). 
The food-contaminating toxin patulin was used as a model for exposure to 
secondary microbial metabolites via food. Patulin is a toxin produced by fungi 
Penicillium and Aspergillus, contaminating food products like apple and apple 
juice (Figure 3.1). The toxic effects of patulin have been studied extensively and 
result from its ability to bind covalently to essential sulfhydryl groups in proteins 
and amino acids with diabetogenic effect against mice diabetes model (Chan et 
al., 2001; Silva et al., 2007). 
In this chapter the cytotoxic effects of the bacterial secondary metabolites, 
pyrrolnitrin and phenazine on the rat β-cell line, INS-1 were tested. The effect of 
the fungal toxin patulin, was also examined for comparative purposes. The 
cultured INS-1 cells were exposed to serial dilution of secondary metabolites at 
three time points. The effects of sub-lethal concentrations of these compounds 
on insulin secretion after two exposure times, 2, 24 h were also examined in 
order to verify the role of sublethal concentrations on the insulin secretion 
pathway. Furthermore, the patch clamp technique was also used to detect 
changes in the membrane depolarization associated with insulin secretion. 
Moreover, the intracellular Ca2+ was measured for same purpose as the 
intracellular Ca2+ is considered a main internal signal that mediates the 
secretion process and insulin pool modifications. Influences of secondary 
metabolites at sublethal concentrations on insulin gene expression were also 
investigated using RT-PCR and qRT-PCR to assess whether insulin gene 
transcription can be modulated or affected in response to toxicity by these 
compounds. 
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Figure 3.1: Chemical structure of the microbial secondary metabolites: 
pyrrolnitrin produced by Burkholderia spp.; phenazine produced by 
Pseudomonas and Burkholderia spp.; and patulin produced by Penicillium and 
Aspergillus spp. 
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3.2 Materials and Methods 
Unless stated otherwise, all experiments in this chapter were repeated at least 
three times. 
3.2.1 Microbial secondary metabolites preparation 
Purified microbial compounds (pyrrolnitrin, phenazine, and patulin,  98% 
purity), were obtained as powders from Sigma-Aldrich (Poole, UK). The 
secondary compounds pyrrolnitrin, phenazine and patulin were prepared as 
stock solutions at 10 mg/ml, solvents were ethanol, acetone and water, 
respectively. The stock solution used to prepare ten-fold dilutions 0, 1, 10, 100, 
1000 and 10000 ng/µl. 
3.2.2 Cell culture 
Rat insulinoma cells (INS-1) cells (Asfari et al., 1992) were cultured and 
maintain as described in Section 2.3.1. The cells were grown as monolayers, 
with passage number 12- 35 used for all experiments. 
3.2.3 Pancreatic β-Cell cytotoxicity  
The cytotoxicity of the purified phenazine, pyrrolnitrin, and patulin, and 
supernatants from cultures of B. multivorans & Ps aeruginosa (BMS & PAS, 
respectively) to β-cells were tested. 
3.2.3.1 Cytotoxic effects of secondary compounds on INS-1 cells 
The cytotoxic effects of the microbial secondary metabolites were determined 
using final concentrations in the range 1-10000 ng/ml. INS-1 cells were cultured 
in 6-well plates at a seeding density of 5 × 105 cells/cm2 for 24 h, and then the 
spent medium was replaced with fresh medium containing various 
concentrations of the microbial compound to be tested. Triplicate INS-1 cell 
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samples were separately exposed to ten-fold serial dilutions of each of the test 
compounds (0, 1, 10, 100, 1000 and 10000 ng/ml) and incubated for up to 72 h. 
Two control sets of samples were prepared in the same way as the treated 
samples; in one set cells were exposed to the solvent (ethanol, acetone or 
water as appropriate, see above) at the same final concentration (0.25%) as 
used in the treated samples. The numbers of viable cells were determined at 2, 
24 and 72 h using the trypan blue viability test which depends on the ability of 
viable cells to exclude trypan blue. INS-1 cell suspension (100 µl) was mixed 
with 100µl of 4% trypan blue for 3 min at room temperature; dead and viable 
cells were then counted using a haemocytometer (Wood et al., 2004).  
3.2.3.2 Cytotoxic effects of BMS & PAS on INS-1 cells 
B. multivorans and Ps. aeruginosa were grown as described in Section 2.2.1. 
The cultures (10 ml) were incubated for 48 h and then centrifuged for 15 min at 
6000 × g and the supernatants sterilized by filtration through a 0.45 µm 
membrane filter (Millipore, UK). Different concentrations of the supernatants (2, 
4, 6 and 10 µl/ml) and LB medium (used as a control) were added to INS-1 cells 
cultured in 6 well plates, and the number of viable cells and percentage viability 
was measured as described in Section 3.2.3.1. 
3.2.4 Effects of secondary compounds on insulin secretion 
3.2.4.1 INS-1 insulin secretion stimulation 
Insulin secretion by INS-1 cells was measured in a stimulation assay which was 
used to confirm that the INS-1 cells were properly responding to insulin 
secretion stimulation factors (2 mM, 20 mM glucose and 25 mM KCl) which are 
normally used as stimulators (Asfari et al., 1992). INS-1 cells were splited into 
24 well plates with a seeding density of 1.5 × 105 cells/well and left to attach 
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overnight. The medium was aspirated off and the cells washed with 500 µl Gey 
& Gey buffer (Appendix 1). Cells were pre-incubated with 0.5 ml of Gey & Gey 
A containing 2 mM glucose (Gey and Gey, 1936) for 1.5 h, after which wells 
were treated in one of three ways: the contents were replaced with (1) 0.3 ml of 
fresh Gey & Gey A or (2) with Gey & Gey B buffer containing 20 mM glucose or 
(3) with Gey & Gey C containing 25 mM KCl, and incubated in all cases for 1 h 
at 37 °C. Finally, the stimulation buffer was removed after centrifugation (10 min 
at 800 × g) and 0.25 ml of the contents of each well subjected to 
radioimmunoassay to measure secreted insulin. 
3.2.4.2 Effects of microbial compounds on insulin secretion after 2 h 
Insulin secretion by INS-1 cells was measured after exposure to 10 fold different 
concentrations (range 1-10000 ng/ml) of the microbial compounds pyrrolnitrin, 
phenazine and patulin. The INS-1 cells were seeded in 24 well plates at a 
density of 2 × 105 cells per well. After 2 h exposure, cells were washed with Gey 
& Gey buffer and resuspended in Gey & Gey buffer containing 2 mM glucose 
and 0.1% BSA, and the same concentration of the microbial compounds, and 
pre-incubated for 1.5 h at 37 °C. Next, the buffer was replaced with 2 ml Gey & 
Gey buffer containing 2 or 20 mM glucose and 0.1% BSA again containing the 
same concentration of microbial compounds, and after 1 h at 37 °C the solution 
was removed and centrifuged at 300 × g for 10 min. The supernatants were 
used for the measurement of secreted insulin by RIA as described elsewhere 
(Alice et al., 2006). 
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3.2.4.3 Effect of sublethal concentrations on insulin secretion 
In order to investigate the effects of the microbial compounds on insulin 
secretion by INS-1 cells over 24 h sub-lethal concentrations (0, 1, 10 ng/ml, and 
the toxic concentration 100 ng/ml of the compounds phenazine and patulin; 0, 1, 
10, 100, 1000, and the toxic concentration 10000 ng/ml of pyrrolnitrin) were 
used. After incubation for 24 h and glucose concentration 2, 20 mM the 
procedure described above was carried out. 
3.2.4.4 Radioimmunoassay (RIA) 
The samples collected in sections (3.2.4.1, 3.2.4.2 and 3.2.4.3) were subjected 
to RIA to measure insulin secreted by the cells after exposing them to the toxic 
agents. The samples were collected from the wells into 1.8 ml micro centrifuge 
tubes after which 50 µl sample from each well were pipetted in 3 ml tubes (used 
for radioimmunoassay) in duplicate. Guinea pig anti bovine insulin antibody (50 
µl; Appendix 1) was added to each sample by followed by 50 µl of radio labelled 
I125 insulin (‗hot‘ insulin; 50 pg/tube with specific activity of 100 µCi/µg) an hour 
after the addition of the insulin antibody. Two controls in duplicate were used, 
one just containing ‗hot‘ insulin and the other containing 100 µl insulin assay 
buffer (IAB), representing controls for total radioactivity and non-specific binding, 
respectively. The contents of the tubes were mixed and stored at 4 °C overnight. 
Aliquots of 1 ml of 15 % polyethylene glycol 6000 containing gamma globulin 
antibody (1 mg/ml Appendix 1) reagents freshly prepared were added to each 
tube and incubated them for 1 h at room temperature. After incubation, the 
tubes were centrifuged at 2000 × g for 20 min at 4 °C; supernatants were 
aspirated and the amount of radioactivity was measured of each tube using a 
gamma counter (2470 Automatic Gamma Counter, Perkin Elmer, USA) using 
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Wizard 2 software. A standard curve was prepared in order to calculate the 
insulin content of each tube. 
3.2.4.5 Standard curve preparation samples for RIA 
A human insulin stock solution (8 ng/ml) prepared in IAB was used to create 
standard curve points corresponding to 0, 0.25, 0.5, 1, 2, 4, and 8 ng/ml. The 
standard samples were prepared freshly at the same time as the unknown 
samples; together the standard samples and unknowns were subjected to RIA 
processing as described in section 3.2.4.4. 
3.2.4.6 RIA data analysis 
The RIA data were extracted and the amount of radioactivity expressed as 
count per minute (CPM). The data were normalised by subtracting the mean 
control non-specific binding value from treatments and standard curve values. 
After this, the standard curve relating radioactivity and amount of insulin was 
prepared and fitted with a non-linear equation. From this, the amount of insulin 
in each sample was calculated. Data were normalised against number of INS-1 
cells after toxin treatment. 
3.2.5 Effects of microbial compounds on insulin gene expression 
3.2.5.1 Assay insulin gene expression using RT-PCR 
Reverse transcription PCR (RT-PCR) was used in order to identify the effect of 
these compounds on the insulin gene II transcription pathway of the INS-1 cells. 
INS-1 cells were cultured in 25 cm2 flasks at 2 × 105 cells/ml and incubated for 
24 h and exposed to microbial compounds (Section 3.2.3.1). Total RNA was 
extracted from each sample using RNA extraction Kit (2.6.1) and RNA samples 
(10 or 100 ng) were used to create total cDNA (Section 2.6.2). Four set of 
primers were used to amplify insulin gene and only one set used for β-actin 
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(Table 3.1). Insulin primers were assayed and one of them was selected to 
follow the insulin pathway. Amplification protocol achieved as previously 
mentioned in section 2.6.3.2 and amplified products were analysed on 1.8% 
agarose gels alongside with suitable molecular size ladder (Section 2.5.6) and 
images were captured using a Bio-Rad Gel Doc XR+ System. Band intensity 
was used to verify effects of the microbial secondary metabolites on insulin 
gene expression. Furthermore, β-actin amplification used as a control for 
normalization. All products sequences were justified by sequencing prior the 
actual RT–PCR assay.  
3.2.5.2 Assay insulin gene expression using absolute qRT-PCR 
qRT-PCR used as well to measure the effect of the sublethal and the lethal 
concentrations of the microbial compounds on insulin gene transcription. The 
absolute real time PCR (qRT-PCR) technique was used to measure accurately 
the expression of insulin subunits. Insulin and β-actin amplicons were produced 
using Go-Tag polymerase (Section 2.7.1) and cloned into pGEMT-easy 
(Sections 2.7.2 & 2.7.3) and cloned inserts were justified (Section 2.7.4). 
3.2.5.3 Preparation clone standard curve for absolute qRT-PCR 
The DNA concentration of recombinant pGEMT-easy produced in section 
3.2.5.2 was measured using a fluorometer (Perkin-Elmer LS50B, USA) and the 
corresponding copy number was calculated using the following equation. The 
plasmid copy number was measured as copy/ng. Ten-fold serial dilution series 
of the cloned plasmids, ranging from 5 × 102 to 5 × 106 copies/μl, were used to 
construct the standard curves for both β-actin and insulin. 
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Table 3.1: Primer sequences, product size and position using to amplify 
insulin and β-actin gene designed by this study. 
Target gene Primers 5-3 length Primer 
position 
Product 
size (bp) 
INS1-F 
INS1-R 
TCT TCT ACA CAC CCA AGT CCC G 
AGT GCC AAG GTC TGA AGA TCC 
22 
22 
186-208 
289-277 
103 
INS1m-F 
INS1m-R 
GCC CTG CTC GTC CTC TGG GA 
CAT TGC AGA GGG GTG GGC GG 
20 
20 
78-97 
 
409-390 
332 
INS2-F 
INS2-R 
AAA CAG CAC CTT TGT GGT TCT CA 
GTG CCA CTT GTG GGT CCT CC 
23 
20 
78-101 
193-177 
115 
INS2m-F 
INS2m-R 
GAT CCG CTT CCT GCC CCT GC 
GGC CTC CAC CCA GCT CCA GT 
20 
20 
12-31 
214-195 
203 
β-actin-F 
β-actin-R 
AGG CCC AAG AGC AAG AGA G 
CCT CGTAGA TGG GCA CAG T 
19 
19 
251-269 
583-574 
332 
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3.2.5.4 Assay insulin gene expression and machine setting 
Triplicates of each sample were prepared in 48 well PCR plates, each well 
containing 12.5 µl of SYBR green master mix, 0.5 µl each of forward and 
reverse primers (10µM), 0.25 µl reference dye, 9.5 µl water and 2 µl cDNA. 
PCR reaction achieved using following condition denaturant cycle at 94 °C for 2 
min followed by 40 cycles, single cycle 94 °C 30 for 15 sec, annealing 60 °C for 
30 sec and amplification at 72 °C for 30 sec. Followed with melting cycle 94 °C 
for 15 sec and 60 °C for 1 min and 94 °C for 30 sec the products were detected 
using an Applied Biosystems Step One real time PCR instrument and software 
v2.1. The copy number data were collected and normalized using the β-actin 
data before statistical analysis. 
3.2.5.5 qRT-PCR DATA normalization  
The Data was collected for insulin and normalised with β-actin gene expression 
data as the β-actin as described in section 2.6.7. 
3.2.6 Measurement of INS-1 intracellular Ca2+ concentration 
The INS-1 cells were cultured in 25 ml flasks at a density of 2 × 105 cells/ml, 
and after 24 h incubation at 37 °C and 5% CO2, the cells were exposed to 0, 10 
or 100 ng/ml phenazine or pyrrolnitrin, and incubated for 24 h. Next, the cells 
were trypsinised and centrifuged at 50 × g for 10 min followed by two washes 
with PBS containing 1 µM EDTA to remove surface Ca2+. Afterwards, 1 × 106 
cells were lysed using 2 ml nitric acid (0.1 M) in a fresh polypropylene tube and 
incubated for 1 h at 70 °C. The Ca2+ content was immediately measured using 
Inductively Coupled Plasma-Atomic Emission Spectrometry (ICP-AES) Varian 
725-ES -2007 (Australia) as described by Burke and Handy (2005). 
                                                                                                                                         Chapter 3 
 
94 
 
3.2.7 Patch-clamp electrophysiology of INS-1 cells 
INS-1 cells were grown on circular cover slips (10 mm diameter; Nunc, UK) in 6 
well plates at a seeding density of 2 × 105 cells/ml, incubated for 24 h and then 
exposed to the 10 or 100 ng/ml phenazine or pyrrolnitrin as described above. 
The cover slips were then placed on recording chambers as described by 
Hamill et al. (1981). The cells were studied using the patch clamp technique at 
room temperature and were perfused continuously with the external buffer (160 
mM NaCl, 4.5 mM KCl, 1.8 mM CaCl2, 10 mM Hepes, 1 mM MgCl2 and 3 mM 
glucose, pH 7.2), flowing at a constant rate of 0.8 ml/min to avoid any 
mechanical disturbance during the experiments. The volume of the chamber 
was maintained at 1 ml. The whole-cell patch-clamp recording technique was 
used to obtain tight seal, patch-clamp recordings from individual INS1 cells. 
These were viewed under an inverted Zeiss microscope (Axiovert 135) with a 
×60 objective lens, and equipped with a video imaging system (Hitachi). The 
patch pipettes were pulled using a vertical Narishige puller (PC-10) from 
borosilicate glass capillaries (Harvard Apparatus, 1.5 mm external diameter, 
1.17 mm internal diameter) and had tip resistances of between 2 and 3 M 
when filled with the potassium-based internal solution. Recordings were 
obtained by lowering a patch electrode directly onto an individual INS-1 cell 
while monitoring current response to 5 mV voltage pulses and then applying 
suction to form a 1 G  seal. A multiclamp 700B amplifier (Molecular Devices 
Inc., USA) was used for the recordings and Pclamp 9.2 software (Molecular 
Devices Inc., USA) for data collection, storage and analysis. Recorded signals 
were low-pass filtered at 5 kHz. The pipette series resistance was electronically 
compensated (usually to 90%); thus, voltage errors of only few millivolts 
occurred at peak current levels. Liquid junction potential (Vlj) between the 
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whole-cell pipette solution and the bath solution was calculated to be 4.8 mV 
using the liquid junction calculator provided by Molecular Devices and 
incorporated into the analysis of the current/voltage curves. The internal 
solution contained 120 mM KCl, 20 mM KF, 10 mM EGTA, 10 mM Hepes, 2 
mM MgATP. The pH was adjusted to 7.2 with KOH. Recordings were 
terminated whenever a significant increase (10%) in series resistance occurred. 
The whole-cell capacitances of the INS 1 cells ranged from 3.0 pF to 15.0 pF, 
with a mean value of 8.27 ± 3.11 pF (n = 23). 
3.2.8 Statistical analysis 
All the data were analysed using SPSS version 17 statistical software, using 
one way analysis of variance (ANOVA) and multiple comparison post hoc tests 
(Fisher‘s LSD). Data are shown as means +/- SE and P < 0.05 is considered 
significant.  
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3.3 Results 
3.3.1 Cytotoxic effects of microbial compounds on INS-1 cells 
The effects of three microbial compounds, pyrrolnitrin, phenazine and patulin, 
on the viability of the -pancreatic cell line, INS-1, were investigated. INS-1 cells 
were exposed to various concentrations of the purified microbial compounds as 
described in Materials & Methods. Their cytotoxicity was measured using a 
trypan blue exclusion test at three time points, 2, 24 and 72 h. None of the 
compounds showed toxicity after 2 h exposure at the concentrations tested (0-
10000 ng/ml), except for the highest concentration of patulin where there was 
significant decrease in viability compared to the untreated control (Figure 3.4). 
After longer exposure, INS-1 cells showed different responses to each of these 
microbial compounds. At 24 h, 10000 ng/ml pyrrolnitrin was toxic to INS-1 cells, 
but by 72 h concentrations  100 ng/ml caused a decline in cell viability (Figure 
3.2). Of the three compounds tested patulin was the most toxic; after both 24 h 
and 72 h exposure concentrations  10 ng/ml caused significant cell death, with 
complete loss of viability at 10000 ng/ml (Figure 3.4). In the case of phenazine 
after 24 h exposure concentrations  100 ng/ml caused a small but significant 
loss of viability with > 60% cell survival at 10000 ng/ml (Figure 3.3). However, 
after 72 h 10000 ng/ml phenazine was the only concentration where significant 
loss of viability was detected, indicating that the cytotoxicity of phenazine had 
declined between 24 and 72 h. 
                                                                                                                                         Chapter 3 
 
97 
 
 
pyrrolnitrin (ng/ml)
Control  0 1 10 100 1000    10000
%
 c
e
ll 
s
u
rv
iv
a
l
0
20
40
60
80
100
120
 2  h 
24 h 
72 h 
a
b
bb
 
Figure 3.2: Cytotoxicity of pyrrolnitrin to INS-1 cells, at the times indicated. In 
each case cell survival is expressed relative to the appropriate vehicle control 
(ethanol) at the relevant time. The values are means ± S.E. (n = 3). The letters 
a and b indicate statistically significant difference (p < 0.05) relative to the 
appropriate control at 24 h and 72 h, respectively. 
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Figure 3.3: Cytotoxicity of phenazine to INS-1 cells, at the times indicated. In 
each case cell survival is expressed relative to the appropriate vehicle control 
(acetone) at the relevant time. The values are means ± S.E. (n = 3). The letters 
a and b indicate statistically significant difference (p < 0.05) relative to the 
appropriate control at 24 h and 72 h, respectively. 
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Figure 3.4: Cytotoxicity of patulin to INS-1 cells, at the times indicated. In each 
case cell survival is expressed relative to the appropriate vehicle control (water) 
at the relevant time. The values are means ± S.E. (n = 3). The letters a and b 
indicate statistically significant difference (p < 0.05) relative to the appropriate 
control at 24 h and 72 h, respectively. 
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3.3.2 Cytotoxic effects of B. multivorans and Ps. aeruginosa supernatants 
(BMS & PAS) to INS-1 
The toxicity of supernatants from culture of both B. multivorans and Ps 
aeruginosa to INS-1 cells was tested. The results showed that both types of the 
supernatants had no significant effect on INS-1 cells viability after 2 h at any 
tested volume. Exposure to BMS at 6 and 10 µl/ml had a significant toxic effect 
on INS-1 cells after 24 and 72 h (Figure 3.5 A.), whereas, PAS at 6 and 10 µl/ml 
showed toxicity to INS-1 cells after 72 h, but with no toxicity after 24 h except at 
10 µl/ml (Figure 3.5 B). It was also found that the toxicity of BMS was greater 
than that of PAS, as BMS showed maximum toxicity after 72 h producing 40% 
cell death compared with PAS which produced 20% cell death after 72 h. 
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Figure 3.5: Cytotoxicity of BCS and PAS (A, B, respectively) to INS-1 cells, at 
the times indicated. In each case cell survival is expressed relative to the 
appropriate vehicle control (LB medium) at the relevant time. The values are 
means ± S.E. (n = 3), * statistically significant difference (p < 0.05) relative to 
the appropriate control at 24 h and 72 h, respectively. 
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3.3.3 Effects of microbial compounds on insulin secretion by INS-1 cells 
after 2 h of exposure  
In a preliminary experiment INS-1 cells were tested for glucose stimulated 
insulin secretion (GSIS), i.e. that the cells responded properly to glucose 
increases; 0.6 ng/ml of insulin was produced by INS-1 cells after stimulation 
with 2 mM glucose, whereas, the secreted insulin increased to at least 2 ng/ml 
with 20 mM glucose, which is about 3 times compared to 2 mM glucose (Figure 
3.6). Furthermore, INS-1 treated with the stimulation factor KCl also secreted 
insulin at about 2 ng/ml. 
The effects of the microbial compounds on insulin production by INS-1 cells 
were also investigated as described in the materials and methods (Sections 
3.2.4.). Initially, cells were exposed for 2 h to the same range of concentrations 
of each microbial compound as described above (Sections 3.2.4.2). The 
secretion of insulin was then measured after exposure of the cells to either 2 
mM or 20 mM glucose for 1 h. Under these conditions the microbial compounds 
had no significant effect on insulin secretion compared with controls (Figure 3.6) 
although in all cases 20 mM significantly stimulated insulin secretion compared 
to 2 mM. 
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Figure 3.6: Effects of exposure of INS-1 cells for 2 h to pyrrolnitrin, phenazine 
or patulin on glucose-stimulated insulin secretion (stimulation with 20 mM 
versus 2 mM glucose, as indicated; see materials and methods (Section 
3.2.4.2). The data shown are means ± S.E. (n = 4). Statistical analysis (ANOVA) 
showed no significant pattern of differences versus the appropriate vehicle 
control (p ≤ 0.05). However, in all cases there was a significant increase in 
insulin secretion with 20 mM glucose compared to 2 mM glucose (p ≤ 0.05). 
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3.3.4 Effects of microbial compounds on insulin secretion by INS-1 cells 
after 24 h of exposure 
The effects of the microbial compounds on insulin production by INS-1 cells 
were assessed using sub-lethal concentrations of the microbial compounds at 
24 h exposure time, i.e. cells were exposed for 24 h to a range of 
concentrations of each compound up to and including the lowest concentration 
that produced toxicity as described above (Section 3.2.4.3). The same glucose 
stimulation conditions were used. 
In this case all three microbial compounds had no significant effect on INS-1 
insulin secretion with a low concentration (2 mM) except for phenazine at 100 
ng/ml, which caused a slight reduction in insulin secretion (Figure 3.8), but 
effects were seen on insulin secretion with 20 mM glucose. Pyrrolnitrin at 10 
and 100 ng/ml caused a significant increase in secreted insulin but with 10000 
ng/ml (a toxic concentration) there was significant inhibition of insulin secretion 
with 20 mM glucose (Figure 3.7). Phenazine, at 1 ng/ml, 10 ng/ml and 100 
ng/ml (a toxic concentration) caused a significant increase in insulin secretion 
with 20 mM glucose (Figure 3.8), whereas patulin at 10 and 100 ng/ml (a toxic 
concentration) caused a significant reduction of insulin secretion per live cell 
with 20 mM glucose (Figure 3.9).  
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Figure 3.7: Effects of exposure of INS-1 cells for 24 h to pyrrolnitrin on GSIS 
(stimulation with 20 mM versus 2 mM glucose). The data shown are means ± S.E. (n = 
4). * indicates significant differences (p < 0.05) compared to the vehicle control at that 
concentration of glucose. # indicates significantly lower (p < 0.05) insulin secretion with 
2 mM glucose compared to that obtained with 20 mM glucose. 
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Figure 3.8: Effects of exposure of INS-1 cells for 24 h to phenazine on GSIS 
(stimulation with 20 mM versus 2 mM glucose). The data shown are means ± S.E. (n = 
4). * indicates significant differences (p< 0.05) compared to the vehicle control at that 
concentration of glucose. # indicates significantly lower (p < 0.05) insulin secretion with 
2 mM glucose compared to that obtained with 20 mM glucose. 
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Figure 3.9: Effects of exposure of INS-1 cells for 24 h to patulin on GSIS (stimulation 
with 20 mM versus 2 mM glucose). The data shown are means ± S.E. (n = 4). * 
indicates significant differences (p < 0.05) compared to the vehicle control at that 
concentration of glucose. # indicates significantly lower (p < 0.05) insulin secretion with 
2 mM glucose compared to that obtained with 20 mM glucose. 
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3.3.5 Effect of microbial compounds on insulin gene expression 
3.3.5.1 Amplification and cloning of insulin and β-actin amplicons  
RT-PCR was performed to measure the effects of the microbial compounds on 
insulin gene expression in INS-1 cells. Three of four primer sets (described in 
material and methods in section 3.2.5.1), Ins1, Ins-2, Ins-2m, which were 
designed to detect mature mRNA for the insulin gene, successfully produced 
amplicons at the expected sizes, 103, 115 and 203 bp, respectively, and 352 bp 
for β-actin (Figure 3.10 A), whereas, the primer INS-1m failed in amplification. 
The insulin amplicons produced by Ins-2m, and β-actin amplicon were 
successfully cloned into pGEMT-easy producing recombinant plasmids pM1 
and pM2 (Figure 3.10 B). Excision of recombinant plasmids containing the 
insulin and β-actin amplicons using restriction enzymes produced inserts of the 
right size, 200 and 350 bp, respectively, after running on an agarose gel (Figure 
3.10 B). 
Recombinant plasmids with inserts have been sequenced after cloning and 
Blast results with the sequences clearly show that these inserts are cDNA of rat 
insulin II and β-actin genes (accession numbers NM 019130 and NM_031144.2, 
respectively) confirming that the right inserts were used in this study. The 
recombinant plasmid copy number was determined spectrophotometrically 
assuming that there is 1 × 106 insulin or β-actin gene copy/ng DNA. The 
plasmid stock was used to prepare a standard curve for qRT-PCR. 
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Figure 3.10: Amplification and cloning of insulin and β-actin amplicons into 
pGEMT plasmid: (A) RT-PCR of insulin (lanes 1, 2, 3 and 4) and β-actin (lane 5). 
(B) The recombinant plasmids pM1 and pM2 containing the insulin and β-actin 
amplicons, respectively (lanes 2 & 3) compared with non-recombinant pGEMT-
easy (lane 1), (C) excision of recombinant plasmids pM1 (lane 2) and pM2 (lane 
3) compared to excision of non-recombinant pGEMT-easy. 
   1                           2             3              4           
5 
   100 bp          
   200 bp          
   300 bp          
1        2      3   
 1    2    3 
   100 bp            
   200 bp          
   300 bp          
                                                                                                                                         Chapter 3 
 
108 
 
3.3.5.2 Insulin gene expression using absolute qRT-PCR 
The results of RT-PCR showed bands of the expected size and the amplified 
insulin cDNA bands showed highest intensity after treatment with 10 or 100 
ng/ml pyrrolnitrin after 24 h exposure, but only showed a faint band at the toxic 
concentration of 10000 ng/ml (Figure 3.11). Phenazine treatment increased the 
band intensity with increasing phenazine concentration even at the toxic 
concentration (100 ng/ml) compared to the control treatment (Figure 3.12). 
However, treatment of INS-1 cells with patulin had no effect on insulin mRNA 
levels (Figure 3.13). 
The influence of these compounds on transcription was confirmed by qRT-PCR. 
The insulin mRNA was measured after exposure of the INS-1 cells to these 
compounds and the cDNA samples subjected to qRT-PCR. The melt curve 
analysis of insulin and β-actin products showed single peaks at the expected 
melting temperatures. Pyrrolnitrin in the concentration range 10-1000 ng/ml 
significantly up regulated insulin gene expression but a significant decrease was 
seen at the toxic concentration (10000 ng/ml) (Figure 3.10). In the case of 
phenazine, concentrations in the range 1-100 ng/ml caused an increase in 
transcription (Figure 3.12). The maximal increase in insulin gene transcription in 
each case after 24 h exposure was with 10 ng/ml pyrrolnitrin and with 100 ng/ml 
phenazine, respectively. Patulin showed no effect on the transcription of the 
insulin gene at any concentration including the toxic concentration (100 ng/ml) 
(Figure 3.13). 
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Figure 3.11: Insulin gene expression in INS-1 cells after 24 h exposure to 
pyrrolnitrin. (A) The number of copies of amplified cDNA of insulin gene II after 
reverse transcription of INS-1 RNA measured by qRT-PCR. Data shown are 
means ± S.E. (n = 3), normalised against -actin as a housekeeping gene. * 
indicates significant differences relative to the vehicle control (P ≤ 0.05). (B) 
gel-based RT-PCR for amplified cDNA of insulin gene II; -actin is again used 
as the housekeeping gene. 
B  
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Figure 3.12: Insulin gene expression in INS-1 cells after 24 h exposure to 
phenazine. (A) The number of copies of amplified cDNA of insulin gene II after 
reverse transcription of INS-1 RNA measured by qRT-PCR. Data shown are 
means ± S.E. (n = 3), normalised against -actin as a housekeeping gene. * 
indicates significant differences relative to the vehicle control (P ≤ 0.05). (B) 
gel-based RT-PCR for amplified cDNA of insulin gene II; -actin is again used 
as the housekeeping gene. 
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Figure 3.13: Insulin gene expression in INS-1 cells after 24 h exposure to 
patulin. (A) The number of copies of amplified cDNA of insulin gene II after 
reverse transcription of INS-1 RNA measured by qRT-PCR. Data shown are 
means ± S.E. (n = 3), normalised against -actin as a housekeeping gene. * 
indicates significant differences relative to the vehicle control (P ≤ 0.05). (B) 
gel-based RT-PCR for amplified cDNA of insulin gene II; -actin is again used 
as the housekeeping gene. 
B B 
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3.3.6 Measurement of intracellular Ca2+ levels in INS-1 cells 
Intracellular Ca2+ signalling pathways play a vital role in β-cell function and 
insulin secretion, so the Ca2+ content was measured to establish the effect of 
each of the microbial compounds under test on insulin secretion, resulting from 
changes in intracellular Ca2+ levels. Both pyrrolnitrin and phenazine induced 
similar and significant increases in intracellular Ca2+ in INS-1 cells at 10 and 
100 ng/ml concentrations after 24 h exposure (Figure 3.14). The highest levels 
of Ca2+ were seen after exposure of INS-1 cells to 100 ng/ml phenazine. 
3.3.7 Patch-clamp electrophysiology of INS-1 cells 
At least six INS-1 cells were patch clamped after a 24 h exposure to pyrrolnitrin 
or phenazine (10 or 100 ng/ml) study and compared to the same number of 
control cells. The outward current was recorded in response to 600 ms pulses 
ranging from -60 to 100 mV with a 10 mV increment from a holding potential of -
60 mV. The first statistically significant differences in the outward current were 
detected at 0 mV between control and treated cells. Pyrrolnitrin significantly 
reduced the outward current compared to the control (Figure 3.15 A & B). 
Furthermore, the membrane current inhibition was significantly higher after 
exposure to pyrrolnitrin using both concentrations in comparison to the control. 
In the case of phenazine, there was no significant difference in membrane 
current after exposure to 10 ng/ml, whereas, exposure to 100 ng/ml clearly 
induced a significant inhibition of the outward current compared to that of the 
control. Exposure to phenazine at 100 ng/ml produced the highest inhibition of 
current seen (Figure 3.15 C& D). 
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Figure 3.14: Pyrrolnitrin or phenazine increased the intracellular Ca2+ levels in 
INS-1 cells after exposure for 24 h in the presence of 11 mM glucose. The data 
are means ± S.E. (n = 4) * indicates significant difference compared to the 
vehicle control (P ≤ 0.05). 
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Figure 3.15: Effects of pyrrolnitrin or phenazine on membrane current of patch-
clamped INS-1 cells. A & C: whole cell outward currents from representative 
INS-1 cells in response either to a voltage step of +80 mV from a holding 
potential of -60 mV (A) or to a voltage step of +70 mV from a holding potential 
of -60 mV (C). The INS-1 cells had been pre-exposed for 24 h to solvent 
(vehicle control), 10 ng/ml or 100 ng/ml (as indicated) pyrrolnitrin (A) or 
phenazine (C). B & D: I-V plots of the instantaneous outward currents  400 ms 
after the start of the voltage step for the whole cell outward current after cells 
had been pre-exposed to solvent (vehicle control), 10 ng/ml or 100 ng/ml (as 
indicated) pyrrolnitrin (B) or phenazine (D). The data shown are the means for 
six cells. 
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3.4 Discussion 
In this study the effects of three microbial products, pyrrolnitrin, phenazine and 
patulin, on INS-1 pancreatic -cells was determined in terms of both toxicity and 
modulation of insulin production. The aim was to provide evidence in support of 
a possible link between prolonged exposure to such compounds and pancreatic 
-cell death, with the possibility of individuals developing diabetes having had 
long-term infection with phenazine- or pyrrolnitrin-producing microorganisms 
such as Pseudomonas spp. and Burkholderia spp. This is of particular 
relevance in people suffering from cystic fibrosis (CF) who have a high rate of 
infection by such organisms (Govan and Deretic, 1996; Allice et al., 2006). The 
inclusion of the fungal toxin patulin also raises the possibility of contaminated 
food as another source of such  pancreatic cytotoxins (Artigot et al., 2009). 
Patulin at 10 µg/ml was toxic to INS-1 cells within 2 h of exposure (Figure 3.4). 
This acute toxicity of patulin has already been demonstrated against various 
mammalian cells and has been attributed to its ability to inhibit RNA and protein 
synthesis, and also to interfere with the activity of many enzymes such as 
glycogen phosphorylase, glucose-6-phosphatase, hexokinase and aldolase that 
are considered crucial for cell survival (Wouters and Speijers, 1995). Genotoxic 
and neurotoxic effects of patulin have also been demonstrated (Zhou et al., 
2010). Patulin is widely found in normal food products such as fruit juice and 
cider, and particularly in products sourced from apples infected with toxin-
producing fungi. The World Health Organization (WHO) and some countries 
have established a safety level of 50 µg/l of patulin in apple juice (CAST, 2003). 
A previous study showed diabetogenic effects of patulin where 10 doses of 0.1 
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mg injected into albino mice caused a 60% increase in blood glucose levels 
(Madiyalakan and Shanmugasundaram, 1978). 
Phenazine showed a different pattern of toxicity at up to 10 µg/ml, it had no 
effect on the viability of INS-1 cells after 2 h exposure. Nevertheless, significant 
toxicity was seen after 24 h exposure to 0.1-10 µg/ml phenazine (Figure 3.3). 
Consistent with this, some phenazine derivatives are known to affect human cell 
proliferation. For example, pyocyanine inhibits epidermal cell growth and 
lymphocyte proliferation (Wilson et al., 1988; Kanthakumar et al., 1993), and 
causes neutrophil apoptosis (Allen et al., 2005) in addition to necrosis of 
respiratory epithelial cells. Another derivative, phenazine carboxylic acid, may 
modulate production of the cytokine IL-8 (Denning et al., 2003; Look et al., 
2005). These effects of phenazine and its derivatives are likely to be related to 
their ability to catalyse superoxide production, and hence hydrogen peroxide 
production, via redox cycling, thus causing oxidative stress and cell injury (Ran 
et al., 2003; Reszka et al., 2004). The concentration of phenazine and its 
derivatives can reach 27 µg/ml in sputa from CF patients (Wilson et al., 1988), 
and hence phenazine is being considered to be an important virulence and pro-
inflammatory factor which can lead to acute pneumonia in CF patients with 
chronically infected lungs. 
Pyrrolnitrin only showed toxicity at a high concentration (10 µg/ml) after 24 h 
(Figure 3.2), indicative of low toxicity of this compound in comparison to patulin 
and phenazine. Moreover, the highest toxicity of pyrrolnitrin to INS-1 cells was 
only seen after 72 h. Pyrrolnitrin is known to show toxicity against 
microorganisms, particularly fungi and Streptomyces spp. (El-Banna and 
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Winkelmann, 1998; Hwang et al., 2002), by inhibition of mitochondrial electron 
transfer, but little is known about the toxicity of pyrrolnitrin to mammalian cells. 
The toxicity of supernatants (spent medium) from B. multivorans and P. 
aeruginosa cultures (BMS & PAS, respectively) was tested in order to assess 
whether there might be other toxic compounds in addition to phenazine and 
pyrrolnitrin. The aim of this experiment was to find compounds produced by 
both bacteria which could cause high toxicity at lower levels via inhibition of key 
in vivo β-cells signals, e.g. inhibition of insulin receptor, and consequently 
glucose metabolism and glucose uptake, leading to β-cells apoptosis. The 
results showed that both of BMS & PAS had toxicity at high concentrations and 
longer exposure times suggesting that the toxicity that results from both type of 
supernatants could be related to the general cytotoxic material such as lipases, 
proteases and ribosylating compounds. In case of BMS the toxicity was 
stronger than PAS probably because the nitrite and nitrate compounds that are 
produced extensively by Burkholderia spp  as secondary products, such as 
NO3
-, and NO2
- (Major et al., 2010) are major toxicants to pancreatic β-cells 
produced during the inflammatory immune responses and recently have been 
correlated in instigating T1D (MacFarlane et al., 2003; Biros et al., 2005).  
As well as toxicity, these compounds have been shown for the first time to have 
effects on glucose-stimulated insulin secretion in INS-1 cells. Pyrrolnitrin at 10 
and 100 ng/ml caused a potentiation of glucose-stimulated insulin secretion, but 
at 10000 ng/ml significantly inhibited it, indicating two modes of action 
dependent on concentration. The inhibition of secretion at this high 
concentration corresponds with the cytotoxicity seen after 24 h at the same 
concentration (Figure 3.2), and hence may just be a consequence of the 
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cytotoxicity, whereas, the increase in insulin secretion occurs at a concentration 
well below that which is cytotoxic after 24 h. Enhancement of insulin secretion is 
also induced by a range of pharmaceutical agents containing an imidazoline 
group including the 2-adrenergic receptor antagonist efaroxan and some 
antibiotics, for example the antifungal agent clotrimazole (Chan et al., 1997; 
Chan et al., 2001), in addition to anti-diabetic drugs such as glibenclamide and 
meglitinide (Ashcroft, 1999; Mannhold, 2004). There is some structural similarity 
between the imidazoline group of these compounds and the pyrrole group of 
pyrrolnitrin. Hence, induction of insulin secretion by pyrrolnitrin might be 
explained by an ability of this compound to inhibit the ATP-dependent 
potassium channel (KATP) via its pyrrole group which may act in the same way 
as the imidazoline group of reagents. These bind to the Kir6.2 subunit of the 
KATP channel, thereby causing membrane depolarization and an influx of 
intracellular Ca2+, which in turn increases insulin secretion (Chan et al., 2001). 
The patch clamp results (Figure 3.15 A&C) demonstrated that pyrrolnitrin at 10 
and 100 ng/ml caused significant reduction of the outward current recorded in 
INS-1 cells. These results support the possibility that the KATP channel and 
hence membrane depolarization of INS-1 cells is affected by this compound. 
Pyrrolnitrin at 10 ng/ml caused the highest reduction of the outward current in 
agreement with the secretion results (Figure 3.7). 
Phenazine also increased glucose-stimulated insulin secretion in INS-1 cells 
with a maximum induction of secretion at 100 ng/ml (Figure 3.8). This induction 
by phenazine could be attributed to stimulation of glucose oxidation via the 
pentose phosphate pathway. The phenazine derivative, phenazine 
methosulphate (PMS) is known to stimulate glucose oxidation via the pentose 
phosphate pathway (Akpan et al., 1987; Muirhead and Hothersall, 1995). It 
                                                                                                                                         Chapter 3 
 
119 
 
probably catalyses the reoxidation of NADPH thereby maintaining availability of 
NADP+, enhancing glucose metabolism and hence inducing insulin secretion. In 
addition, as noted above, phenazine and its derivatives, such as pyocyanine 
(Liu and Nizet, 2009), are capable of catalysing reactive oxygen species (ROS) 
production. Hence, phenazine could also be linked with insulin secretion via the 
enhanced production of ROS in INS-1 cells. Pi et al. (2007) have shown that 
low levels of hydrogen peroxide stimulate insulin secretion in INS-1 cells and 
isolated mouse islets, and that this occurred in an extracellular Ca2+-dependent 
process. Consistent with this, it is shown here that phenazine (and also 
pyrrolnitrin) at 10 and 100 ng/ml caused an increase in INS-1 cell Ca2+ content 
(Figure 3.14). 
In contrast to phenazine and pyrrolnitrin, the only effect of patulin on glucose-
stimulated insulin secretion was inhibition (at 100 ng/ml; Figure 3.9). This effect 
may be linked with the ability of patulin to inhibit a wide range of enzymes, 
particularly enzymes that contribute to glucose metabolism, e.g. hexokinase 
(Madiyalakan and Shanmugasundaram, 1978). This may lead to a decline in 
the ATP/ADP ratio leading to hyperpolarisation of the cell membrane and 
inhibition of insulin secretion (Straub and Sharp, 2002). After injecting 10 rats 
with patulin (1 mg/kg), and noting an elevation of blood glucose levels, Devaraj 
et al (1986) suggested a diabetogenic role for patulin. Here, patulin showed 
toxicity and inhibited secretion at 100 ng/ml but not with lower concentrations. It 
is possible that at lower concentrations much of the patulin was metabolised by 
the cells. In support of this, it has already been shown that patulin can be 
metabolised in rodents (Wouters and Speijers, 1995). 
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Finally, both pyrrolnitrin and phenazine stimulated insulin gene II mRNA levels 
in INS-1 cells (Figure. 3.11 and 3.12, respectively) suggesting an additional role 
for these compounds in modulating insulin transcription. Pyrrolnitrin showed two 
effects on transcription of insulin gene II, i.e. induction at low concentrations (10 
and 100 ng/ml), but inhibition at high concentration (1000 and 10000 ng/ml). 
This is similar to the effects of pyrrolnitrin on insulin secretion as discussed 
above (Figure 3.7). A similar relationship between insulin gene transcription and 
insulin secretion was seen with phenazine; phenazine at 10 and 100 ng/ml 
caused a significant increase in both (Figure 3.12 and 3.8). Together these data 
suggest for both pyrrolnitrin and phenazine that the up-regulation of insulin gene 
expression might be the result of the increase that these compounds cause in 
insulin secretion, since insulin is known to be a key regulator of insulin gene 
expression (Leibiger et al., 2002). Another possible secretion-related signal that 
modulates insulin gene transcription is intracellular Ca2+; both pyrrolnitrin and 
phenazine affected INS-1 cell Ca2+ content (Figure 3.14). For example, it has 
been shown (Kim et al., 2002; Leibiger et al., 2002) that elevation of 
cytoplasmic Ca2+ activates Ca2+-dependent protein kinases and phosphatases, 
such as Ca2+/calmodulin-dependent protein kinases (CaM kinases) and 
Ca2+/calmodulin-dependent protein phosphatase 2B (calcineurin) both of which 
are involved in insulin gene transcription. It is also possible that pyrrolnitrin 
and/or phenazine have more direct effects on insulin transcription, i.e. not 
involving insulin secretion-related signals. It is known that oxidative stress can 
lead to depression of insulin expression via effects on the key transcription 
factor Pdx-1 either through enhanced degradation of Pdx-1 or through a failure 
of it to locate to the nucleus (Poitout et al., 2006; Andrali et al., 2008). On this 
basis, since as already noted phenazine and its derivatives enhance ROS 
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production, it would be expected that phenazine might cause a decrease in 
insulin transcription, whereas, the opposite effect was seen here. However, it 
may be at higher, more cytotoxic, concentrations of phenazine that a decrease 
in transcription would have been seen.  
In conclusion, this study shows for the first time that the bacterial compounds 
pyrrolnitrin and phenazine, which are known antimicrobial agents, are cytotoxic 
to INS-1 cells, leading to the possibility that these compounds may contribute to 
the development of diabetes, particularly CF-related diabetes (CFRD), the 
assumption being that these secondary products can be transported to the 
pancreas via the blood from the source of their production. In contrast, at lower, 
sub-lethal concentrations both compounds increase both insulin secretion and 
insulin gene expression by INS-1 cells. 
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Chapter 4 
Effect of phenazine and pyrrolnitrin on gene expression of 
insulin and some GSIS mediating signals 
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4.1 Introduction 
Recent studies on T2D have recognized factors that are the main modulators of 
the insulin synthesising pathway in β-cells; glucose and GSIS pathways are 
major contributors in insulin gene expression and hormone exocytosis (Straub 
and Sharp, 2002). Disruption of the function of any elements of the GSIS 
pathway can actively impede insulin secretion and lead to the development of   
T2D. Furthermore, the regulation pattern of these markers has been used  as 
an indicator of GSIS status (Walker, 2004). Amongst these signals which can 
provide a clear feedback about insulin synthesis in response to the GSIS 
pathway are transcription factors, especially PDX-1, MafA and NeuroD (Walker, 
2004; Habener et al., 2005). It has been found that PDX-1 transcription factors 
can regulate insulin gene expression and β-cell differentiation in response to 
rises in the intracellular glucose level (Keller et al., 2007), whereas, the 
transcription factor MafA was reported to initiate insulin gene transcription in 
response to glucose metabolism (Zhang et al., 2005). Signals like glucose 
kinase (GK) and glucose transporter-2 (GT-2) are majors indicators can be refer 
to change glucose metabolism and energy production, and compounds 
enhance glucose metabolism may enhance insulin gene expression (Lawrence 
et al., 2001; MacDonald et al., 2005b). 
In the previous chapter it has been shown that phenazine and pyrrolnitrin 
increased insulin secretion, modulated membrane electrophysiology and 
intracellular Ca2+, and insulin gene mRNA copies were significantly up regulated 
after treatment with phenazine and pyrrolnitrin. Therefore, the work described in 
this chapter was designed to confirm the effects of these compounds on insulin 
gene expression in INS-1 cells as well as expression of GK enzyme and GT-2.  
                                                                                                                                         Chapter 4 
124 
 
The transcription factors PDX-1, MafA and NeuroD were measured in order to 
assess their contribution to insulin gene transcription in response to 24 h 
exposure to phenazine and pyrrolnitrin. Recently, studies have suggested that 
Ca2+/calmodulin (CaM) – dependent protein kinase mediates insulin gene 
expression via a number of intracellular responses in response to increases in 
the intracellular Ca2+. Amongst the Ca2+ kinase enzymes that are reported to 
regulate insulin gene expression are two types of kinases, calcium/calmodulin-
dependent protein kinase-IV (CamK4) and its isoform calcium/calmodulin-
dependent protein kinase kinase-I (CamKK1) (Yu et al., 2004). We found that 
Ca2+ was increased after exposure to phenazine or pyrrolnitrin, coupled with 
insulin secretion, so it has been examined whether increase insulin gene 
expression was regulated by CamK4 and CamKK1. 
Therefore, INS-1 cells were cultured and exposed to the effective 
concentrations (10 & 100ng/ml) of phenazine or pyrrolnitrin for 24 h and then 
gene expression of insulin and transcription factors (PDX-1, MafA and NeuroD) 
was measured using absolute qRT-PCR and RT-PCR. Transcription factor 
amplicons were cloned and recombinant plasmids representing individual 
transcription factors used to generate standard curve copy number as described 
in Chapter 3. CamKK1, CamK4, GK and GT-2 gene expression were measured 
using comparative qRT-PCR using CT values of the amplified products 
normalized against CT values of β-actin. 
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4.2 Materials & Methods 
4.2.1 Effect of pyrrolnitrin and phenazine on insulin gene expression 
The effects of pyrrolnitrin or phenazine (10 & 100 ng/ml) on insulin gene 
expression were assessed again in order to verify insulin gene up regulation 
after exposure to microbial secondary metabolites have been reported 
previously. Also gene expression of transcription factors and GSIS signal genes 
were measured at the same time. INS-1 cells were cultured in RPMI-1640 
medium as described in Section 2.3.1 and separately exposed to 
concentrations of 10 or 100 ng/ml of either phenazine or pyrrolnitrin and 
incubated for 24 h at 37 °C and 5% CO2 (Section 3.2.4.3). Total RNA was 
extracted from the INS-1 cells after at 24 h exposure (Section 2.6.1). Aliquots (1 
µg) of RNA from each treated sample and control samples (vehicle + cells) 
were used for the synthesis of cDNA (Section 2.6.2). Insulin gene expression 
was measured using absolute qRT-PCR as previously mentioned (Section 
3.2.5.2) using the same primer set and the data were normalized and 
statistically analysed as described in Sections 2.5.5 and 3.2.8. 
4.2.2 Effect of pyrrolnitrin and phenazine on transcription factors genes 
In addition to the insulin gene, the effects of microbial compounds on gene 
expression of the transcription factors PDX-1, MafA and NeuroD were also 
measured and cDNA prepared as in Section 4.2.1. RT-PCR and absolute qRT-
PCR were used to measure transcription factor gene expression. Specific 
primers sets (forward & reverse) were designed (Table 4.1) as described in 
Section 2.6.3.1 and commercially sequenced. Using the MWG Eurofins read 
value service (MWG, Germany).  
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Table 4.1: Forward and reverse primers used in qRT-PCR during this study to 
measure transcription factors and GSIS signal gene expression. 
Target 
gene 
Primers 5-3 length Primer 
position 
Product 
size (bp) 
PdX-1-F  
PdX-1-R 
GAGGGGTCCGGTGCCAGAGT  
 
GCGGGGGCACTTCGTATGGG 
 
 
20 
20 
163-182 
317-298 
155 
MafA F 
MafA-R 
AGCTCCGCGGCTTCAGCAAG 
ACGCCCCACCTCCAGCTTCA 
 
20 
20 
446-465 
624-605 
179 
NeuroD -F 
NeuroD-R 
CCAGCGCTTCCTTCCCGGTG 
GCCATTGATGCTGAGCGGCG 
 
20 
20 
629-648 
843-824 
215 
GK-F 
GK-R 
TCCTGCTACTATGAAGACCGCC 
CGCTGAGCTTTCATCCACCATC 
22 
22 
583-504 
795-774 
213 
GT-2 –F 
GT-2-R 
ACACCCACTCATAGTCACACC 
AAGCCACCCACCAAAGAACG 
21 
20 
194-215 
348-328 
155 
Camk4-F 
Camk4-R 
ACATTCCAAGCCCTCCAACACC 
GATCTGTCTTGTCCTTGCCGTC 
22 
22 
859-880 
1099-1078 
241 
Camkk1 
Camkk1 
ACATCAAGCCGTCCAATCTGC 
TAACCCCAGTGGCCCATACATC 
21 
22 
824 -844 
1024-1003 
201 
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qRT-PCR was also used to verify the effects of the microbial products on 
transcription factor gene expression. In this case a PCR amplification was 
carried out using GOTaq DNA polymerase to produce transcription factors 
amplicons with T-overhang. The amplified products were separated using 1.8 % 
agarose gel electrophoresis and DNA bands with the desired molecular mass 
were eluted from the gel (Section 2.5.7). The transcription factor amplicons with 
T overhang ends were cloned into pGEMT-easy (Sections 2.7.2 and 2.7.3) and 
recombinant plasmids were checked using restriction enzyme excision and also 
by using PCR amplification followed by agarose gel electrophoresis. The 
recombinant plasmids were then sequenced to verify the nucleotide sequences 
of inserts; sequencing was obtained using the Operon Value Read service 
(MWG, Germany). The recombinant plasmids were then used to prepare 
standard curves by measuring number of copies per microlitre using a 
Spectrofluorometer (Perkin-Elmer LS50B , USA) and equation as described in 
Section 3.2.5.3 and then standard curves for each of the transcription factors 
were prepared in same way. Absolute qRT-PCR was used in order to identify 
the effect of these compounds on transcription factor copy number. Triplicates 
of each sample (treated & standard curve samples) were prepared in 48 well 
PCR plates (one plate used for each transcription factor or insulin gene). Stock 
master solution, enough to assess all samples, was pipetted into the wells. 
Each well contained 12.5 µl of SYBR green master mix, 0.5 µl each of forward 
and reverse primers, 0.25 µl reference dye, 9.5 µl water and 2 µl cDNA. The 
amplification condition was set as previously mentioned (Section 3.2.5.4) using 
65 °C annealing temperature. The data were collected, normalized and 
statistically analysed (Sections 2.5.5 and 3.2.8.). 
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4.2.3 Quantifying mRNA of GK, GT-2, CamK4 and CamKK1 genes 
The comparative qRT-PCR technique was used to measure mRNA levels or 
gene expression using cDNA samples (Section 4.2.1) to verify the effects of 
pyrrolnitrin or phenazine on INS-1 cells on expression of genes mediating 
glucose metabolism or GSIS (GK & GT-2) as well as genes which may 
contribute to modulation of insulin gene expression (CamK4 & CamKK1). The 
cDNA samples prepared in Section 4.2.1 were used to assess expression of 
these genes. 48 well plates were used; 6 wells were used for each sample, 
three of which for the target gene and the other three for the housekeeping 
gene (β-actin). Six samples were measured, two vehicle controls for pyrrolnitrin 
or phenazine were set and two concentrations each (10 & 100 ng/ml) for 
pyrrolnitrin or phenazine treated samples. The stock master solution, containing 
SYBR green dye, primers and reference dye, prepared (Section 3.2.5.3) mixed 
with 2 µl of cDNA prepared in Section 4.2.1 to the total volume 25 µl/well. PCR 
amplification conditions were as previously described (Section 3.2.5.4); the 
copy number data were collected and normalized using the β-actin data before 
statistical analysis. 
4.2.4 Normalization of qRT-PCR Data 
In most cases the data were normalized using the instrument software with 
auto-normalization. However, the data were normalized manually producing the 
relative quantification (RQ) values. The data was firstly normalized against the 
housekeeping (β-actin) gene which was achieved by subtracting the CT value of 
β -actin from the target gene CT value to produce the ∆CT. The ∆∆CT values of 
each sample were then produced by subtracting the ∆Ct of the control (vehicle 
control) from the ∆CT value for each treatment. Afterwards, the RQ of individual 
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samples was then produced using the following equation (RQ= 2 
_∆∆CT); data 
were statistically analysed (Section 3.2.8). 
4.2.5 Amplification of amplicons using RT-PCR 
Gel based RT-PCR was also used to assay the transcription factors, and GK, 
GT-2, CamK4 and CamKK1 gene expression as an additional confirmation of 
the qRT-PCR results and to check primer efficiency. RT-PCR was achieved 
using cDNA extracted from INS-1 exposed to 10 or 100 ng/ml of either 
pyrrolnitrin or phenazine (Section 4.2.1). Appropriate primer sets were used to 
amplify desired genes. Conventional PCR reaction was achieved using Red-
Taq DNA polymerase. The reaction components were added respectively to 
final volume 25 µl for one reaction as:-   
cDNA      2 µl       
Forward primer (10 pM)   1 µl 
Reverse primer (10 pM)   1 µl 
Red-Taq polymerase (5U)   1 µl 
dNTPs (10 mM)    0.5 µl  
Red-Taq reaction buffer (5x)  2.5 µl 
PCR water     17 µl 
The mixtures were mixed thoroughly by pipetting and the standard PCR were 
performed using an MWG thermocycler (Primus 96 plus) under the following 
conditions: 94 °C for 2 min followed by 40 cycles start at 94 °C for 30 s, 60 °C 
or 65 for 30 s and 72 °C at 30 s for individual cycle followed with hold the 
samples at 4 °C until collection. The PCR products samples were run into a 
1.8% agarose gel (Section 2.5.7) along with a 1 kbp ladder and then the DNA 
bands were visualized using UV irradiation in a gel documentation system. 
                                                                                                                                         Chapter 4 
130 
 
4.3 Results 
4.3.1 Quantifying mRNA expression of insulin gene transcription 
The microbial secondary metabolites phenazine and pyrrolnitrin (10 & 100 ng/ml) 
have previously been shown to up regulate insulin gene II. Firstly, 10 or 100 
ng/ml of each compound was used to confirm the previous insulin gene 
expression results. Therefore, INS-1 cells were exposed to either 10 or 100 
ng/ml of phenazine or pyrrolnitrin and insulin gene expression assessed, which 
confirmed that both phenazine and pyrrolnitrin significantly increased insulin 
gene expression after 24 h exposure (Figure 4.1). 
The current experiments aimed to identify which transcription factors mediated 
insulin gene transcription enhancement by the microbial secondary metabolites. 
Expression of insulin gene transcription factors was measured, and primers 
successfully produced amplicons of the expected molecular sizes, 155, 179 and 
225 bp for PDX-1, MafA and NeuroD, respectively (Figure 4.2 A). The amplified 
products were extracted from the gel, and were then successfully cloned into 
pGEMT-easy plasmids to produce the recombinant plasmids pM3, pM4 and 
pM5. Restriction using EcoRI confirmed cloning (Figure 4.2B). PCR 
amplification of recombinant plasmids also produced the transcription amplicons 
at expected molecular size (Figure 4.2C). Sequence analyses of the 
recombinant plasmids have confirmed these amplicons as belonging to the 
insulin gene II transcription factors PDX-1, MafA and NeuroD with accession 
numbers NM_022852.3, XR_008949, and AF107728, respectively.  
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                      Phenazine (ng/ml)                         Pyrrolnitrin (ng/ml) 
 
Figure 4.1: Insulin gene expression in INS-1 cells after 24 h exposure to 
pyrrolnitrin and phenazine: (A) the number of copies of amplified cDNA of 
insulin gene II after reverse transcription of INS-1 RNA measured by qRT-PCR. 
Data shown are means ± S.E. (n = 3), normalised against -actin as a 
housekeeping gene. * indicates significant differences relative to the vehicle 
control (p ≤ 0.05). (B) gel-based RT-PCR for amplified cDNA of insulin gene II; 
-actin is again used as the housekeeping gene. 
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Figure 4:2: Amplification and cloning of insulin gene transcription factors in. 
pGEMT plasmids: (A ) RT-PCR of insulin gene transcription factors PDX-1, 
MafA and NeuroD (lanes 1, 2 and 3, respectively); (B) excision recombinant 
plasmids pM3, pM4 and PM5 cloned with PDX-1, MafA and NeuroD  amplicons, 
respectively (lanes 2, 3 and 4, respectively) after EcoRI digestion compared 
with non-recombinant pGEMT-easy (lane 1); (C) PCR amplification recombinant 
plasmids pM4, pM3 (lanes 1 and 2) and pM5 (lanes 3 and 4). 
        1                   2                   3 
1        2       3         4 
123 bp 
246 bp 
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4.3.2 Quantifying transcription factor gene expression 
The effects of phenazine and pyrrolnitrin on insulin gene transcription factors 
(PDX-1, MafA and NeuroD) were investigated after confirming the up-regulation 
of insulin gene expression by the microbial secondary metabolites using 
absolute qRT-PCR. This clearly showed a significant increase in MafA gene 
expression by INS-1 cells corresponding to the increase in phenazine 
concentration (10 & 100 ng/ml) after exposure for 24 h (Figure 4.2A). Similar 
findings were obtained by gel-based RT-PCR in which MafA expressed band 
intensity at 10 and 100 ng/ml was stronger than the control. In addition, at 10 
ng/ml NeuroD had the strongest band intensity compared to the control and 100 
ng/ml exposures (Figure 4.2B). Furthermore, phenazine (10 ng/ml) increased 
expression of transcription factor NeuroD, whereas, no significant effect was 
seen with 100 ng/ml phenazine. The results showed no significant effect on 
PDX-1 expression at either of the test concentrations compared to the vehicle 
control. 
Interestingly pyrrolnitrin treatment increased expression of all three transcription 
factors (PDX-1, MafA and NeuroD) after 24 h incubation with 10 ng/ml, whereas, 
only an increase in MafA gene expression was seen in the 100 ng/ml treatment 
(Figure 4.4A). The results were confirmed by gel-based RT-PCR in which 10 
ng/ml pyrrolnitrin increased the band intensity of all tested transcription factors 
compare to the control and the100 ng/ml (Figure 4.4B). No significant effect was 
seen at 100 ng/ml pyrrolnitrin on PDX-1 and NeuroD compared to the vehicle 
control (ethanol).  
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Figure 4.3: PDX-1, MafA and NeuroD gene expression in INS-1 cells after 24 h 
exposure to phenazine: (A) the number of copies of amplified cDNA of 
transcription factors after reverse transcription of INS-1 RNA measured by qRT-
PCR. Data shown are means ± S.E. (n = 3), normalised against -actin as a 
housekeeping gene. * indicates significant differences relative to the vehicle 
control (p ≤ 0.05). (B) gel-based RT-PCR for amplified cDNA of transcription 
factor; -actin is again used as the housekeeping gene. 
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Figure 4.4: PDX-1, MafA and NeuroD gene expression in INS-1 cells after 24 h 
exposure to pyrrolnitrin: (A) the number of copies of amplified cDNA of 
transcription factor reverse transcription of INS-1 RNA measured by qRT-PCR. 
Data shown are means ± S.E. (n = 3), normalised against -actin as a 
housekeeping gene. * indicates significant differences relative to the vehicle 
control (p ≤ 0.05). (B) gel-based RT-PCR for amplified cDNA of transcription 
factor; -actin is again used as the housekeeping gene. 
Control      10            100   
 Pyrrolnitrin (ng/ml)           
 
 
 
 
 
 
 
 
 
 
A 
B 
* 
* 
* 
* 
                                                                                                                                         Chapter 4 
136 
 
4.3.3 Quantification of GK, GT-2, CamK4 and CamKK1 gene expression 
The effects of phenazine and pyrrolnitrin (10 & 100 ng/ml) on the glucose 
phosphorylation enzyme (GK), glucose transport (GT-2), and Ca2+ dependent 
regulation of insulin gene transcription (CamKK1 & CamK4) was measured in 
order to identify whether these compounds interact with major GSIS signals. 
The results show that the designed primer for those genes successfully 
produced amplicons with the expected molecular sizes, 215, 155, 241 and 201 
bp representing GK (M25807.1), GT-2 (NM_012879.2), CamK4 (NM_012727.3) 
and CamKK1 (NM_031662.2), respectively (Figure 4.5). Furthermore, sequence 
analysis has confirmed that amplicons belong to the targeted genes in 
pancreatic β-cells. 
Exposure of INS-1 cells to phenazine (10 and100 ng/ml) for 24 h significantly 
increased GT-2, CamKK1, and CamK4 gene expression with strong significant 
increase was seen of GT-2 gene expression at 10 ng/ml phenazine compared 
to the control sample. However, significant increase in GK gene expression 
after 24 h exposure was seen only at 100 ng/ml with no significant effect at 10 
ng/ml phenazine (Figure 4.6). 
INS-1 cells incubated within pyrrolnitrin (10 or 100 ng/ml) show a different 
pattern to that with phenazine as GK gene expression was increased 
significantly at 100 ng/ml phenazine after 24 h, whereas, no significant 
difference was seen at 10 ng/ml (Figure 4.7). However, mRNA levels of each of 
GT-2, CamKK1 and CamK4 were significantly reduced to about 50% at both 
concentrations (10 &100 ng/ml) compared to the control. 
                                                                                                                                         Chapter 4 
137 
 
 
 
 
 
 
 
 
Figure 4.5: Gel-based RT-PCR of GK, GT, CamK4 and CamKK1 amplicons 
(lanes 1, 2, 3 and 4), respectively.  
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Figure 4.6: GK, GT, CamKK1 & CamK4 gene expression in INS-1 cells after 24 
h exposure to phenazine: (A) shows relative quantitation of GK, GT, and 
CamKK1 & CamK4 amplified cDNA of INS-1 RNA measured by qRT-PCR. Data 
shown are means ± S.E. (n = 3), normalised against -actin as a housekeeping 
gene. * indicates significant differences relative to the vehicle control (p ≤ 0.05). 
(B) gel-based RT-PCR for amplified cDNA of transcription factor; -actin is 
again used as the housekeeping gene. 
A 
B 
* 
* 
                                                                                                                                         Chapter 4 
139 
 
Pyrrolnitrin (ng/ml)
Control 10 100
R
Q
0.0
0.5
1.0
1.5
2.0
2.5
GK
GT-2 
CamKK1
CamK4 
 
 
       GK       
     GT-2  
CamKK1  
 CamK4    
  β-actin   
               Control            10                100        
                        Pyrrolnitrin (ng/ml) 
 
Figure 4.7: GK, GT, CamKK1 & CamK4 gene expression in INS-1 cells after 24 
h exposure to pyrrolnitrin: (A) relative quantification of GK, GT, CamKK1 and 
CamK4 amplified cDNA of INS-1 RNA measured by qRT-PCR. Data shown are 
means ± S.E. (n = 3), normalised against -actin as a housekeeping gene. * 
indicates significant differences relative to the vehicle control (p ≤ 0.05). (B) 
gel-based RT-PCR for amplified cDNA of transcription factors; -actin is again 
used as the housekeeping gene. 
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4.4 Discussion 
One aim of this chapter was to confirm the effects of the microbial secondary 
metabolites, pyrrolnitrin and phenazine, on insulin gene expression in INS-1 
cells. It has been shown previously (Chapter 3) that insulin gene expression 
was increased after exposure to pyrrolnitrin and phenazine at 10 and 100 ng/ml. 
This was confirmed again in this chapter. However, the main aim was to study 
the mechanisms by which these compounds affect insulin gene expression, via 
determination of the expression of transcription factors related to insulin gene 
expression. Transcription factor (PDX-1, MafA and NeuroD) expression and 
insulin gene are regulated via signals generated by the GSIS pathways and 
glucose signalling in β-cells (Kataoka et al., 2002; Iype et al., 2005). 
Both phenazine and pyrrolnitrin stimulated insulin mRNA levels consistent with 
what was found in Chapter 3 which may be attributed to an enhancement of 
glucose oxidation producing signals that lead to increased insulin synthesis 
(Docherty and Clark, 1994; Poitout et al., 2006). Phenazine as a redox active 
compound appears to modulate of insulin gene expression via glucose 
metabolism more than pyrrolnitrin. However, phenazine cytotoxicity to β-cells is 
also attributable to its redox activity as enhanced glucose metabolism leads to 
increased production of cytotoxic ROS, e.g. H2O2, which can cause necrosis of 
β-cells (Allen et al., 2005). Pyrrolnitrin also increased insulin gene expression 
which also could be via glucose metabolism. However, this result needs more 
investigation because the effect of pyrrolnitrin on mammalian cells is not well 
studied. The current study attributed the augmentation of insulin secretion by 
pyrrolnitrin to inhibition of β-cell KATP channels by the pyrrole group. However, 
the signals that lead to increased insulin secretion could also lead to increased 
insulin gene expression (Doyle and Egan, 2003). 
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The expression of the insulin gene under normal conditions is affected by three 
major transcription factors (PDX-1, MafA and NeuroD) which are regulated by 
changes of glucose concentration (Kataoka et al., 2002; Kaneto et al., 2005). 
The effects of phenazine and pyrrolnitrin on insulin gene transcription factors 
confirmed the interaction between these compounds and insulin gene 
expression. Phenazine at 10 ng/ml increased the expression of MafA and 
NeuroD, but only MafA increased at 100 ng/ml phenazine (Figure 4.3). The 
effect of phenazine on expression of MafA is likely to be via GSIS; studies have 
shown that MafA is a key modulator of GSIS (Zhang et al., 2005; Artner et al., 
2008). It has been shown that MafA ‗knockout‘ mice exhibit glucose intolerance 
and develop diabetes mellitus; the analysis of GSIS signals shows that insulin I, 
insulin II, GT-2, NeuroD and PDX-1, as well as other signal molecules, that 
regulate GSIS are all inhibited (Zhang et al., 2005). Therefore, it is suggested 
that phenazine modulates insulin gene expression via MafA regulation. 
Moreover, phenazine as a redox-active compound regulates insulin secretion 
via enhancing ATP production and insulin receptor phosphorylation which 
causes glucose uptake and consequently insulin gene expression via glucose 
signalling (Kataoka et al., 2002). 
A significant increase in expression of the NeuroD transcription factor at 10 
ng/ml phenazine, in addition to MafA, was also found. NeuroD is a key regulator 
of β-cells and insulin gene expression, as well as of differentiation of neural 
cells, and many studies have shown correlation between insulin transcription 
modulation by NeuroD and glucose uptake in response to the GSIS pathway 
(Kim et al., 2002). It has been reported by many investigators that the regulation 
of NeuroD expression is controlled by MafA (Wilson et al., 2003). However, no 
significant effect of 100 ng/ml phenazine (toxic concentration) on NeuroD gene 
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expression was seen, which is probably attributable to the cytotoxic or the 
inhibitory effect of the phenazine activity at this concentration. 
Phenazine also induced significant up-regulation of glucose transporter 2 (GT-2) 
and glucokinase (GK) expression in INS-1 cells at both concentrations 
confirming the effect of phenazine on insulin gene and MafA gene expression 
(Figure 4.5). This data suggests that phenazine can enhance GSIS through 
enhancement of glucose metabolism via up regulation of glucose 
phosphorylation by GK, and through enhancement of glucose uptake via up 
regulation of GT-2 in INS-1 cells. An increase in intracellular glucose enhances 
insulin exocytosis, insulin gene expression, and transcription factors (Lipson et 
al., 2006; Brunner et al., 2009). Furthermore, enhancement of glucose 
phosphorylation by GK and subsequent glucose oxidation leads to an increase 
in ATP/ADP ratio, a key modulator of the membrane depolarization of β-cells 
that mediates insulin secretion (Straub and Sharp, 2002; MacDonald et al., 
2005b), which was up-regulated in INS-1 cells in response to the phenazine 
exposure. 
This study also investigated whether changing insulin gene transcription factor 
expression might be accomplished by the multifunctional kinases, CamKK1 and 
CamK4, which belong to the calcium/calmodulin-dependent protein family, 
which have been recently reported to mediate insulin gene transcription 
(Leibiger et al., 2002 ; Yu et al., 2004). Again, there was good evidence to show 
that phenazine could modulate CamKK1 and CamKK4 gene expression (Figure 
4.5) which in turn suggests that the regulation of insulin gene expression by 
MafA may be mediated by glucose signalling and an increase in the intracellular 
level of Ca2+. 
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The effects of pyrrolnitrin were completely different from those of phenazine; 
exposure of INS-1 cells to pyrrolnitrin (10 ng/ml) not only increased insulin gene 
expression but interestingly the expression of all the transcription factors was 
increased in response (Figure.4.4). Whereas, MafA was the only transcription 
factor where there was a significant increase in expression at 100 ng/ml. The 
effect of pyrrolnitrin at 10 ng/ml on transcription factor expression is consistent 
with its effects on insulin gene expression, insulin secretion, Ca2+, and 
electrophysiology, suggesting that pyrrolnitrin at this concentration has effects 
on GSIS signalling. The effect of pyrrolnitrin on PDX-1 supports the idea that 
pyrrolnitrin enhances GSIS, as PDX-1 is the major transcription factor that plays 
a role in the regulation of insulin gene expression and β-cell differentiation by 
GSIS (Holland et al., 2005; Keller et al., 2007). The results also showed 
enhanced MafA expression which consolidates our previous suggestion about 
possible GSIS modulation by pyrrolnitrin. NeuroD gene expression increased 
due to pyrrolnitrin exposure; it has been reported that it is possible that NeuroD 
regulates PDX-1 (Kim et al., 2002; Wilson et al., 2003). Both T1D and T2D 
development in human have been linked recently with the disruption of 
production of the insulin gene transcription factors (Walker, 2004; Luzardo and 
Mathews, 2010), so that research on insulin gene regulation and transcription 
factor expression and drugs that modulate transcription factors have been 
investigated often. 
The current study has demonstrated the effects of pyrrolnitrin on insulin gene 
and transcription factor expression. Moreover; tests were made to demonstrate 
whether the insulin gene modulation is achieved via GSIS signals (GT-2, GK, 
CamKK1 and CaMK4). Interestingly, results showed different pattern to what 
was expected for regulation of these genes via GSIS; GT-2, CamKK1 and 
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CamK4 expression were significantly inhibited by pyrrolnitrin (10 & 100 ng/ml) 
suggesting that pyrrolnitrin has an inhibitory effect on GSIS, and maybe insulin 
exocytosis. In the case of GK, whose gene expression was highly up regulated 
after pyrrolnitrin exposure, suggesting enhanced intracellular glucose 
phosphorylation as was seen with phenazine. This supports the previous 
hypothesis that enhancement of insulin secretion by pyrrolnitrin may be 
attributed to its inhibitory effect on KATP channels (Macfarlane et al., 2000; Yu et 
al., 2004). However, a toxic concentrations pyrrolnitrin inhibited insulin gene 
transcription and secretion as previously described suggests that long-term 
exposure to sub-lethal concentrations could eventually inhibit insulin 
biosynthesis, which supports the hypothesis that pyrrolnitrin could contribute to 
diabetes in CF sufferers with chronic infection. 
The aim of the work in this chapter was to determine effects of pyrrolnitrin and 
phenazine on insulin gene expression and GSIS in INS-1 cells. In conclusion, at 
higher concentrations, phenazine and pyrrolnitrin show cytotoxicity to INS-1 
cells, whereas, sub-lethal concentrations of these compounds increased insulin 
secretion, i.e. they had a physiological effect on INS-1 cells. Phenazine, a 
redox-active compound, enhanced glucose metabolism and increased the 
intracellular ATP/ADP ratio, causing KATP inhibition and elevation of intracellular 
Ca2+ leading to insulin secretion. Increase in intracellular Ca2+ can also 
modulate CamKK1, CamK4 and insulin gene transcription through up regulation 
of MafA transcription. Moreover, redox activity has been linked with GSIS via 
glucose uptake through the up regulation of the GT-2, glucose metabolism via 
increase phosphorylation by GK and consequently intracellular ATP/ADP and 
insulin biosynthesis (Figure 4.8). 
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Pyrrolnitrin exposure at low concentration may be potentially toxic or inhibitory 
when either is long term exposure to sub lethal concentrations of pyrrolnitrin 
despite even the low concentrations. A potential application for such 
compounds may be by to use phenazine or phenazine like compounds in 
regulation of insulin secretion and gene expression experiments which may 
provide new information about the GSIS and regulation of the insulin gene in β-
cell. However, the most interesting finding is the ability of phenazine to enhance 
insulin gene expression via MafA. It has been reported by many studies that the 
Maf family of transcription factors are the main modulators contributing to eye 
lens cell differentiation and proliferation. Therefore, phenazine may have a 
potential application in studies about eye cells. Pyrrolnitrin or compounds 
derived from pyrrolnitrin, (compounds with a pyrrole group) might be a source 
for a new generation of anti-diabetic drugs. However, the probable application 
for such compounds could well be to use them as laboratorial insulinotropic 
compounds. 
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Figure 4.8: Schematic illustration of the effects of phenazine or pyrrolnitrin on 
GSIS and insulin secretion pathways in β-cell. Phenazine stimulates glucose 
oxidation via glycolysis and the TCA cycle (1, 2) and hence increases the 
ATP/ADP ratio (3) which blocks the KATP channel, causing depolarization of the 
cell membrane (4, 5) and an increase in the intracellular Ca2+ (6,7) thereby 
enhancing insulin exocytosis (via modification of insulin granule) (8.9). 
Increased intracellular Ca2+ also increases insulin gene expression via CamKK1 
& CamK4 (10). Secreted insulin binds to the IR (11) enhancing phosphorylation 
(12) thereby up regulating signalling pathways leading to  glucose uptake via 
GT-2 (13) and increasing intracellular glucose & insulin gene expression (14). 
Pyrrolnitrin may directly bind to the Kir.6.2 subunit of KATP (A) causing K
+ 
inhibition and depolarization of the cell membrane (B) and increase in Ca2+ 
influx and content (C) leading to increase insulin secretion (7, 8, 9) and insulin 
gene expression (D). 
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Chapter 5 
Screening microorganisms for binding of insulin and 
construction of a Burkholderia multivorans genomic library 
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5.1 Introduction 
Microorganisms and their products (protein and secondary metabolites) are 
considered potential environmental factors involved in causing pancreatic β-cell 
damage (Myers et al., 2003). Furthermore, it has been hypothesised recently 
that some microorganisms possess proteins with sequence homology to β-cell 
antigens, which can promote an autoimmune response against β-cells 
(MacFarlane et al., 2003; Fujinami et al., 2006). Some microbial proteins which 
share amino acid sequence homology to β-cell pancreatic auto-antigens may 
have a similar function, for example glutamic acid decarboxylase (GAD) from E. 
coli  has been suggested to bring about diabetic autoimmune response against 
human β-cells GAD65 (Mulder, 2005), and HSP60 in Ps. aeruginosa and 
HSP60 pancreatic β-cells antigen (Jensen et al., 2001). Many studies have 
shown the presence of similar insulin receptors or insulin binding proteins 
(IBPs) on bacteria and other microorganisms.  
In the current study it has been hypothesised that the IBP epitopes may be 
diabetogenic by triggering an autoimmune response against HIR on the basis of 
molecular mimicry, particularly in patients with CFRD who have long term 
infection with Burkholderia sp. Receptor ligand binding can be used to study the 
interactions of ligands (protein, substrate) with biomolecules (receptors) on the 
cell surface, and to form a complex to serve biological purposes e.g. 
(Downstream biochemical cascades) (Mahendrarajah et al., 2011). Studying 
receptor ligand binding is generally performed by incubating the receptor with 
ligand under specific condition such as temperature, pH and ionic 
concentration, for a certain period of time (Wilson and Walker, 2005). Enzyme 
labelled and radio labelled ligand (with isotopes such as H3, C14, P32, S35 and 
I135 ) are commonly used to follow ligand binding activity.  
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Amongst the techniques that can be used to characterise receptor by gene 
cloning, which is a technique involving taking a piece of DNA from one 
organism and inserting into a cloning host such as bacteria (e.g. E coli), 
mammalian cell line (e.g. CHO), or animal (transgenic animal) or plant 
(transgenic plant) in order to study the cloned DNA or produce encoded protein 
(Lodge et al., 2007). This technique is achieved predominantly using particular 
DNA transporter molecules called cloning vectors and in many cases these 
vectors are plasmids, circular DNA that can autonomously replicate in host 
cells. Cloning involves different strategies depending on the organism that is 
used to clone the gene. Among these strategies is the production of gene 
library, a collection of genes of an organism in recombinants representing the 
entire genome of an organism (Sambrook and Russell, 2001). The first step is 
to extract the genomic DNA of the organism whose gene library is to be created 
and then digest the DNA partially using restriction enzymes (RE) like Sau3A. 
These fragments are then ligated into vectors pre-digested with the same 
restriction enzymes or isoschizomer RE (e.g. BamHI) (Lodge et al., 2007). In 
the case of plasmids recombinant vectors are then introduced into the E coli by 
transformation. In the case of cosmid or bacteriophage, in vitro packing is used. 
Recombinant cells or plaques are then screened for expression of the desired 
gene or the gene is detected by molecular screening using specific probes 
(Wong, 2006).  
The aim of this chapter‘s work was to screen the microorganisms for insulin 
binding components using labelled ligand (Peroxidase labelled insulin) and to 
quantify the amount of insulin that bound to the microbial cells using FITC 
labelled insulin. This chapter also started characterisation and identification of 
insulin binding protein‘s using western ligand blotting and gene cloning.  
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5.2 Materials and Methods 
5.2.1 Insulin ligand binding assay with whole microbe cells 
A total of 45 microbial species were used in this study and are listed in (Table 
2.1). The peroxidase labelled insulin (Sigma, UK) was used to screen for insulin 
binding components on microbial cells. This assay was performed using 1.5 ml 
microcentrifuge tubes and 96 well plates. The microbes (bacteria, yeast strains) 
were produced using optimum growth conditions (Table 2.1) and each microbe 
culture was centrifuged in 1.5 ml microcentrifuge tubes for 3 minutes at 6500 × 
g at room temperature (RT).  
The cell pellet was resuspended and washed in 500 µl of 10 mM MOPS or PBS, 
then re-centrifuged and resuspended in 100 µl of the same buffer and 5 µl of 
insulin peroxidase (1µg/µl) was added and the tubes incubated for 10 min at 
room temperature. Next, cells were washed in PBS three times and finally 
resuspended in 100 µl of MOPS and transferred into 96 well Microtiter plates. 
To detect the binding of insulin, 100 µl of fresh DAB/ NiCl2 solution (Appendix 1) 
was added to each well and agitated thoroughly by pipetting and the plate was 
placed in the dark for a period of 10 min and photographic images were taken 
immediately.  
The same protocol was used for FITC labelled insulin (instead of insulin 
peroxidase) to detect the insulin binding components on microorganisms. 
Samples with no insulin label were prepared for each individual species as a 
negative control.  
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5.2.2 Quantification of insulin bound to cells of B. multivorans and A. 
salmonicida 
The bacteria were grown as described in section 2.2.1, three different dilutions 
were used 1:5 and 1:10 and undiluted. Aliquots of each dilution (100 µl) were 
plated out on triplicate LB agar plates to enumerate bacteria and some aliquots 
were exposed to FITC labelled insulin which was used to assess the amount of 
insulin binding both bacteria. The insulin binding assay was applied as 
mentioned above except different incubation times were used 1, 2, 5, 10, 15 
and 30 min followed by washing steps (Section 5.2.1). Dilutions of FITC labelled 
insulin (0.125, 0.25, .0.5, 1, 2, 3 µg) were used to create a standard curve. The 
fluorescence signals were measured using a fluorescence multi well plate 
reader (Cyto Fluor II- Preseptive Biosystem – Miami, USA).  
The fluorescence signal value of A. salmonicida (wild type, MT004) and B. 
multivorans were normalised for non-specific binding by subtracting the signal 
value produced within A. hydrophila and Ps. aeruginosa respectively. All values 
were normalised according to the concentration of FITC labelled insulin and the 
number of molecules bound per 109 cells were estimated for A. salmonicida and 
B. multivorans. The data was statically analysed as described in Section 2.2.7. 
5.2.3 Extraction and solubilisation of total protein  
Different protocols and procedure were followed in order to extract the IBP(s) 
from B. multivorans and A. salmonicida and optimise the conditions for 
producing active IBP(s) for western ligand blotting. The following protocols were 
used to prepare total bacterial lysates:- 
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5.2.3.1 Solubilisation of bacterial proteins for SDS-PAGE  
Total soluble cell proteins were extracted from strains of B. multivorans and the 
fish pathogen A. salmonicida using various extraction procedures. Bacteria 
were grown overnight at optimum conditions (2.2.1) and 1 ml culture volume 
were placed in 1.5 ml microcentrifuge tubes. The cells were centrifuged for 3 
min at 6500 × g and pellets were resuspended in 0.5 ml modified loading buffer 
Laemmli (1970) by reducing the SDS concentration to 0.02% instead of 0.2%. 
Cell pellets were also suspended in SDS loading buffer with or without 2β-
mercaptoethanol (Appendix 1). Furthermore, some samples were boiled for 5 
min and others were left at RT. Next, tubes were centrifuged at 6500 × g for 5 
min and supernatants were transferred into fresh tubes and stored at 4 °C until 
used in SDS-PAGE electrophoresis (Section 2.4.3). 
5.2.3.2 Solubilisation proteins using Triton X 100 & low concentration of 
SDS 
Some extractions were modified using the Triton X 100 (0.1 % W/V) instead of 
SDS in loading buffer as the Triton X100 is a non-polar detergent and a second 
modification was to reduce the SDS concentration in loading buffer to 0.02% 
instead of 0.2%. The pellets of 1ml growth were resuspended in 1 ml of 
extraction buffer and left for 15 min at 50 °C after which samples were 
centrifuged at 6500 × g for 10 min and supernatants were transferred into fresh 
tubes and stored at 4 °C for use in SDS-PAGE electrophoresis (Section 2.4.3). 
5.2.3.3 Solubilisation of proteins using SDS and lysozyme 
In order to extract B. multivorans and A. salmonicida proteins two techniques 
were used; the first used a low concentration of SDS (0.02%) and the second 
used MOPS buffer containing 50 ng/ml lysozyme. Tubes were incubated for 10 
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min at 55 °C for lysozyme to work and centrifuged at 6500 × g for 5 min and the 
supernatant transferred to a fresh tube with 20 µl of 2 mM protease inhibitor 
cocktail (P8465 Sigma, UK) was added and storage was at 4 °C. A volume of 
protein sample and equal volume of loading buffer containing 0.02 % SDS were 
mixed and run into SDS-PAGE electrophoresis. 
5.2.3.4 Extraction using sonication, low SDS and lysozyme  
Total protein was extracted from bacteria as described in Section 2.4.1 using 
sonication and lysozyme and solubilized by adding low SDS (0.02 %) loading 
buffer and aliquots were run into SDS-PAGE. 
5.2.4 SDS-PAGE coupled western ligand blotting  
Western ligand blotting was used in order to assess whether the interaction of 
insulin with the bacterial cell surface is mediated by a specific protein 
component. Various procedures were used to separate extracted proteins in 
different types of gel; blue native gel electrophoresis (BN-PAGE) (Nijtmans et 
al., 2002), native agarose protein electrophoresis (Kim et al., 2000) for protein –
protein complexes, SDS-PAGE, and native – PAGE (Laemmli, 1970). These 
were used in order to provide the chemo –physical conditions necessary for the 
components to retain capacity to bind insulin. This study used SDS-PAGE in 
which the SDS concentration was reduced to 0.05 % for proteins separated on 
polyacrylamide gels (10% or 12%) using methods described by Laemmli (1970) 
(Section 2.4.3).  
Proteins were transferred to nitrocellulose membrane using an electroblotter 
system (BIO-RAD) (Towbin et al., 1979) at 300 mA at RT for 1.5 h. Afterwards, 
the membrane was washed in MOPS buffer for 5 min and blocked with a 
blocking buffer developed in this study. Bovine serum albumin (BSA) in 10 mM 
MOPS (50 ml) for 1 hour at RT. Next, the blocking buffer was replaced with 50 
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ml of fresh blocking solution containing insulin-peroxidase (1µg/1ml) and the 
membrane was incubated for 2 hours with gentle shaking at RT. Afterwards, the 
membrane was washed 3 times in 50 ml of MOPS buffer with gentle shaking for 
10 min at RT. The blot was developed using DAB/NiCl2 enhancement.  
5.2.5 Construction of B. multivorans genomic DNA library  
5.2.5.1 Extraction of genomic DNA of B. multivorans 
Purified genomic DNA from B. multivorans was produced using a Qiagen 
extraction kit according to the supplier‘s instructions (Section 2.5.1). DNA 
concentration was measured (Section 2.5.5) and adjusted (Section 2.5.2) to 
produce 1µg/µl.  
5.2.5.2 Partial digestion of genomic DNA using Sau3A 
DNA was partially digested with Sau3A to generate appropriate size fragments 
for ligation into λ zap arms, pre-digested with BamHI. Digestions were 
performed in microcentrifuge tubes (1.5 ml) using different dilutions of the 
Sau3A enzyme. B. multivorans genomic DNA (20 µg) dissolved in 40 µl of MBW 
was mixed with 10 µl of 10 x restriction buffer. Next, 5µl aliquots of DNA were 
dispensed into nine microcentrifuge tubes, leaving 10 µl in the original tube 
(tube1). MBW was added to a final volume of 10 µl in tubes 2-9 and 18 µl in 
tube1. Sau3A restriction enzyme, 2 µl containing 8 units of enzyme was added 
to tube1 and mixed thoroughly. Next, 10 µl from tube 1 was transferred to tube 
2, and so to create 2 fold dilution series except tube 9 was left as control 
undigested. The tubes were incubated at 37 °C for 25 min after this the reaction 
was stopped by incubating the tubes at 65 °C for 5 min in order to denature the 
restriction enzyme. The digested & undigested DNA was analysed by running 2 
µl with a standard 1 kbp DNA ladder on agarose gel electrophoresis (Section 
2.5.6). Samples containing the required average size DNA fragment of 5-6 kbp 
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were selected for B. multivorans genomic library construction. 
5.2.5.3 Ligation of B. multivorans DNA with λ Zap express arms 
The λ Zap express vector can accommodate inserts ranging 0-12 kbp. The 
digested DNA 2 µl containing 0.4 µg was mixed with 1 µg dephosphorylated λ 
Zap express BamHI treated arms, after this 0.5 µl of 10 x of ligation buffer, 2 
units of T4 DNA ligase and MBW was added to final volume of 5 µl. The ligation 
was mixed thoroughly and pulse-centrifuged to ensure all contents were at the 
bottom of tube. The ligation was incubated overnight at 4 °C and after 1µl of the 
mixture was analysed by agarose gel electrophoresis with undigested, digested 
DNA and wild type λ DNA to assess the ligation efficiency.  
5.2.5.4 In vitro packaging ligated DNA using Gigapack III Gold System  
After ligation recombinant λ phage DNA was packaged using the Stratagene 
Gigapack III Gold system to generate intact recombinant phage particles. A 
Gigapack III Gold packaging system extract was removed from – 80 °C and 
quickly thawed by holding the tube between fingers. The ligated DNA (4 µl) was 
added immediately when contents thawed. The mixture was agitated gently to 
avoid air bubbles being introduced and the tube spun to ensure that all contents 
were at the bottom of the tube. Next, the tube was incubated at room 
temperature (22 °C) for not more than 2 h. SM buffer (Appendix 1) (500 µl) was 
added to the tube together with 20 µl of chloroform and the contents mixed 
gently. The tube was centrifuged briefly and the phage suspension was 
assayed directly and stored at 4 °C. 
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5.2.6 Assaying bacteriophage  
5.2.6.1 Preparation of host bacteria  
The packaged library suspension containing recombinant phage particles was 
assayed on E. coli XL1 Blue MRF` using NYZ medium (Appendix 1). X-gal & 
IPTG were used to ascertain the efficiency of ligation using blue/white 
screening. The number of recombinant plaques was determined and the 
amplified library was collected and the optimum titre was determined to achieve 
700 - 1000 plaques per plate.  
E. coli XL1 Blue was prepared as described by the supplier (Stratagene, USA). 
One single colony from an overnight streak plate was transferred to 50 ml of LB 
broth with supplement (Appendix 1) in a conical flask. The culture was 
incubated with shaking (200 rpm) at 30 °C (instead of 37 °C to keep the bacteria 
from over growing and subsequently the number of non-viable cells reduced. 
The bacteria were pelleted at 1000 × g for 10 min and resuspended gently in 25 
ml sterile MgSO4 solution (Appendix 1) and used directly to perform the assay 
or stored at 4 °C for not more than 48 h before use. 
5.2.6.2 Phage Assay 
The E. coli XL1 Blue cultures prepared in Section 5.2.6.1 was diluted using 
sterile MgSO4 (10 mM) solution to an OD600 of 0.5. After this, 200 µl aliquots of 
E. coli were used in the assay. The neat packaged phage (1µl) and serial 
dilutions of the packaged phage (10-1, 10
-2, 10-4, 10-6, 10-7, and 10-8) were added 
to aliquots of the bacteria. Tubes containing phage + bacteria were incubated at 
37 °C for 15 minutes to allow the phage to attach to the cells. Next, the samples 
were mixed with 3 ml molten, NZY top agar (46 °C) and poured on to NYZ agar 
plates. The plates were left to set for 10 min at RT and incubated at 37 °C 
                                                                                                                                            Chapter 5 
157 
overnight. The plaques were counted and the number of plaque forming units 
per millilitre (pfu/ml) recorded. 
5.2.6.3 Blue- white screening for recombinants   
Blue-white screening depends on the insertional inactivation of the β-
galactosidase gene carried on the phage vector. Recombinant phage no longer 
produces β-galactosidase which normally digests the synthetic sugar X-gal, so 
that the recombinant plaques will show no colour or a white colour. Whereas, 
the non-recombinant phage will produce intact β-galactosidase enzyme and 
consequently the plaques show a blue colour. The dilution of phage was added 
to 200 µl of freshly prepared E. coli cells at an OD600 of 0.5 and incubated at 37 
°C for 15 min after this the contents were added to 3 ml of molten NZY top agar 
(46 °C) containing 15 µl of IPTG (0.5 M) and 50 µl of X-gal (250 mg/ml) sterile 
stock solutions (Appendix 1).  
The contents were poured immediately onto NYZ agar plates and left for 10 min 
at room temperature to set and incubated overnight at 37 °C. The white and 
blue plaques were counted to assess the success of the gene bank. 
5.2.6.4 Amplifying the Zap genomic library  
The libraries prepared in lambda were generally amplified to prepare a large 
stable quantity of high titre stock. E. coli XL1 Blue was cultured and diluted to 
the appropriate cell concentration as mentioned above (Section 5.2.6.2) and 
aliquots of cells (1 ml) dispensed into sterile microcentrifuge tubes. Adequate 
tubes were prepared to plate out the whole packaged library volume. The 
packaged mixture was centrifuged briefly to avoid the chloroform and then 
dispensed into tubes of E. coli cells to final concentration 103 pfu / 200 µl cells 
until utilizing all the packaged library mixture. Tube contents were mixed well 
and incubated at 37 °C for 15 min. Each tube‘s contents were mixed with 3 ml 
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of molten NYZ top agar (46 °C) and poured onto NYZ agar plates and left to set 
for 10 min at RT and then incubated at 37 °C overnight to give near confluent 
lysis. The top soft agar layer of plates were scrubbed using a sterile spreader 
and removed into 50 ml polypropylene Falcon tubes with 5 ml of SM buffer to 
allow phage to diffuse out of the agar. Chloroform 20 µl was added to each tube 
to inactivate any non lysed bacteria and incubated overnight at 4 °C. After, cell 
debris and the agar were removed from all tubes by centrifugation for 30 min at 
4000 × g. The clear supernatants of all tubes were carefully recovered and 
placed into one sterile glass bottle. Chloroform was added to 0.3 % final 
concentration to the library stock and the tubes were stored at 4 °C. Some 
aliquots of the amplified library were placed in 7% DMSO at - 80 °C for long 
term storage.  
5.2.6.5 Screening genomic library for insulin binding 
The B. multivorans gene library in λ Zap was screened by ligand blotting to 
detect recombinant phage producing a protein associated with insulin binding. 
Aliquots of the amplified library were diluted with SM buffer (Appendix 1). The 
minimum number of plaques of B. multivorans to be screened was determined 
according to the formula below (Clarke and Carbon, 1976) where N= the 
number of individual clones, P= probability for representing a specific gene,  the 
f= average size of cloned fragments (kbp) and g= the size of genome (kbp).  
N=  
According to this formula with 5-6 kbp the average size of cloned fragments, 
about 1500 plaques needed to be screened to find the desired recombinant. 
However, and in case of this study more than 30,000 plaques were screened for 
recombinants that contained the IBP gene by using plaque ligand blotting. 
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Some samples were plated out with 25 µl of IPTG solution (250 mg/ml) in the 
soft agar to induce the promoter of lac Z fusions. Some samples were plated 
without IPTG to allow non-fusion production of foreign components. Plates were 
left to set at RT for 10 min and incubated at 37 °C overnight. 
Sterile gridlined nitrocellulose membrane (182 mm) was marked and numbered 
using a ballpoint pen to the centre and four quarters, transferred using two 
sterile forceps on to the surface of agar plates with plaques, avoiding air 
bubbles. The bottom of each plate was marked in the same fashion as the filter 
so that filters and the plate could be easy aligned after screening. The plaques 
were blotted onto gridlined nitrocellulose membranes for 1 h at 37 °C followed 
by 1 h incubation at 4 °C. The membranes were carefully transferred using 
forceps into petri dishes containing 20 ml of MOPS buffer and washed with 
gentle agitation for 10 min and the wash buffer was replaced with a fresh 20 ml 
of MOPS containing 3% (v/v) bovine serum albumin as blocking reagent. The 
membranes were gently shaken at RT for 1 hour. Next, the blocking buffer was 
replaced with a fresh 20 ml of same buffer containing insulin peroxidase 
(1µg/ml) and the membranes were gently shaken at RT for 1 h to allow binding 
to occur.  
The binding reagent was discarded and the membranes were washed with 20 
ml of MOPS buffer for 10 min with gentle shaking at room temperature for a 
total of three washes with the last wash using PBS. The binding activity was 
visualized by adding 20 ml of DAB /NiCl2 prepared in PBS (Appendix 1). The 
membranes were placed for 15 min in the dark until positive plaques developed. 
The developing solution was discarded and 20 ml of tap water was added to 
stop the reaction and positive plaques were noted. The positive plaques were 
identified on the master plates using the grids on the filters. In order to pick the 
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positive plaques, sterile Pasteur pipettes were used to stab and remove them 
into 200 µl of SM buffer in 1.5 ml microcentrifuge tubes. Chloroform 20 µl was 
added to inactivate the remaining bacteria. The tubes were placed at 4 °C 
overnight to release the phage into SM buffer. 
5.2.6.6 Secondary screening of insulin binding plaques  
Aliquots (loop full) of positive recombinant phage solution were streaked onto 
NYZ agar and overlaid with soft agar (3 ml) mixed with 200 µl E coli host (0.5 
OD) and left to set at RT for 10 min and incubated afterwards at 37 °C 
overnight. After incubation, plaques were blotted onto a piece of nitrocellulose 
membrane and the detection procedure was followed as mentioned before 
(Section, 5.2.7.5). The positive plaques were placed in 500 µl of SM buffer 
using pasture pipettes, and chloroform (20 µl) was added and the tubes were 
incubated at 4°C overnight to elute the phage. 
5.2.6.7 In vivo excision of insulin binding positive phagemids form 
recombinant λ Zap  
The λ Zap express vector is designed to excise recombinant pBK-CMV 
phagemids to facilitate further molecular analysis of cloned regions. E coli XL1 
Blue was used as the host to perform the pBK-CMV excision. The excision 
depends on the co-infection of E. coli with the recombinant phage and a mutant 
helper phage that carries an amber mutation preventing phagemid replication in 
E coli XL1 Blue and this allows only the excised phage to replicate in the host. 
Inside the co-infected E. coli proteins from helper phage recognize and nicks 
the DNA initiator strands of recombinant phage, a new DNA synthesis begins at 
the site of this nick to complete the vector downstream and the DNA signal will 
continue through the clone inserts until the termination signal position 3` of the 
initiator signal the single strand DNA is recognized by gene II protein product of 
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the helper phage, forming circular DNA containing the insert DNA between 
initiation and termination.  
Recombinant phage stocks were used for excising the recombinant phagemids. 
E. coli XL 1 Blue grown overnight at 30 °C in LB broth with supplements was 
centrifuged at 1000 × g for 10 min. The pellet was suspended in of MgSO4 
solution to an OD600 of 1. The recombinant phage stock was spun briefly to 
avoid the chloroform and 250 µl of the phage was added to 200 µl of E. coli in 
10 ml polypropylene tubes containing 1 µl of helper phage (1×106 pfu) and 
mixed well. The tubes were placed at 37 °C for 15 min to allow the phage to 
attach the cells and 3 ml of LB with supplements (Appendix 1) was added to 
each tube and incubated at 37 °C with shaking overnight. After incubation, the 
tubes were placed at 65-70 °C for 20 min to lyse the bacteria.  
The samples were centrifuged at 1000 × g for 5 min to pellet the cell debris. The 
supernatants containing excised phagemids packed as filamentous phage 
particles were transferred into fresh tubes and used to transfect the E. coli 
XLOROR. E. coli XLROR was grown overnight in 50 ml of LB with supplements 
at 30 °C, centrifuged and resuspended in MgSO4 to an OD = 1. Aliquots (200 
µl) were dispensed in microcentrifuge tubes then 100 µl or 10 µl of phagemid 
supernatant were added to the cells and the tubes were incubated at 37 °C for 
15 min and 300 µl of NYZ broth was added to each tube and incubated at 37 °C 
for 45 min to induce and express kanamycin gene resistance carried on the 
phagemid prior to plating 200 µl on to Kanamycin (50 µg/ml) LB selective media 
and incubating overnight at 37 °C. After incubation, single colonies were 
streaked on Kanamycin plates to purify the clones which contained recombinant 
pBK-CMV double strand phagemid vector. 
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5.2.6.8 Extraction and digestion of recombinant phagemids  
Purified phagemids were extracted using a miniprep plasmid extraction Kit 
(Sections 2.5.3 and 2.5.4) and 0.3 µg DNA of recombinant phagemids were 
digested using combinations of restriction enzymes EcoRI + PstI and EcoRI + 
SalI and fragments were separated by agarose gel electrophoresis (Section 
2.5.6). The recombinants E coli XLROR were grown overnight in 50 ml LB 
containing kanamycin 50 µg/ml to express the cloned genes encoding insulin 
binding proteins (components). 
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5.3 Results  
5.3.1 Insulin binding assay with whole cell microbes 
This experiment screened various types of microorganisms Gram negative and 
Gram positive bacteria, yeast and Actinomyces (Nocardia) for insulin binding 
capacity. A total of 40 bacterial and 5 yeast strains were examined to determine 
whether they exhibited any insulin binding activity (Appendix 2). The initial 
assay indicated only 3 out of the 45 strains examined exhibited insulin binding 
activity. B. multivorans and B. cenocepacia and A. salmonicida wild type all 
showed a dark colour reaction with DAB suggesting they possessed 
components which bound insulin (Figure 5.1). 
The fish pathogen A. salmonicida CM30 showed a strong reaction within 5 sec 
of adding the peroxidase substrate reagent, B. multivorans strains showed a 
positive result after 5 min. It was suspected that in the case of A. salmonicida 
insulin might be binding to the ―A‖ protein of this organism, an extra protein S-
layer encapsulating the bacterium. Thus a mutant of A. salmonicida (MT004) 
which lacked the A layer was subsequently tested and showed weaker and 
slower binding. In order to confirm this binding was with insulin and not with the 
conjugated peroxidase, all microorganisms that showed a positive binding 
activity were tested with same the peroxidase on its own and showed no 
reaction. All control wells (no insulin- peroxidase) showed no activity except Ps. 
fluorescens showed an activity in control and treatment wells revealing a 
peroxidase enzyme activity produced by this bacteria. Binding activity increased 
using MOPS buffer as binding buffer compared to PBS or Tris buffer. 
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B. multivorans        A. salmonicida CM30        A. salmonicida MT004       E. coli EMG1 
 
B  
                  
 
 
 
 
 
 
 
                 B. multivorans                                      A. salmonicida MT004                                                                                                                                                            
       
 
 
 
 
 
 
 
           A. salmonicida CM30                                                E. coli EMG1 
Figure 5.1: Peroxidase-labelled insulin (A) and FITC-labelled insulin (B) bind to 
cell surfaces of E. coli, A.salmonicida MT004, A.salmonicida CM30 and B. 
multivorans.  
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5.3.2 Quantification of insulin binding  
This test was done to quantify the amount of insulin bound to the cell surfaces 
of B. multivorans and A. salmonicida CM30 and the mutant MT004.  
Both wild type A. salmonicida CM30 and B. multivorans showed significant 
insulin binding at all the time points tested, however, the amount of insulin 
binding to the fish pathogen A. salmonicida CM30 was about 105 ng/109 cells 
after 15 min incubation time which was much higher compared to 28.3 and 21.1 
ng/109 cells binding to B. multivorans and the A. salmonicida MT004 A layer 
mutant, respectively (Figure 5.2). Furthermore, wild type A. salmonicida CM30 
and B. multivorans showed significant binding relatively early (after 1 min) 
compared to the mutant A. salmonicida MT004 which showed significant FITC-
insulin binding only after 10 min. 
Insulin binding to wild type A. salmonicida CM30 increased steadily with time; 
however, B. multivorans showed no significant increase in insulin binding up to 
5 min (13.1 ng/109 cells) but produced strong binding of 19.1 and 23.8 ng/109 
cells after 10 and 15 min, respectively. Whereas, the mutant A. salmonicida 
MT004 showed significant binding of 15.5 and 21.1 ng/109 cells only after 10 
and 15 min, respectively, with no significant binding at earlier times. 
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Figure 5.2: Quantification of the amount of FITC-labelled insulin bound to 109 
cells of A. salmonicida (CM30 & MT004) and B. multivorans. The data shown 
are means ± S.E. (n = 4). * indicates significant differences (p ≤ 0.05) compared 
to the control. a, ab and abc indicates significantly differences (p ≤ 0.05) 
compare to the amount of FITC bound at earlier times for the same bacterium. 
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5.3.3 Western ligand blotting of insulin binding protein  
Various protocols were applied during this work to separate bacterial proteins 
on different gels using native, SDS-PAGE (Laemmli, 1970), blue native (BN-
PAGE) (Nijtmans et al., 2002) and agarose gel electrophoresis (Henderson et 
al., 2000) and both Burkholderia and A. salmonicida samples initially showed no 
IBP bands using standard western ligand blotting. However, a modified 
procedure, i.e. extraction using sonication with low SDS (0.02%) loading buffer 
and a low concentration of lysozyme to solubilise the whole cell lysates, showed 
positive results compared to the conventional boiling extraction methods. 
Moreover, protein separation by SDS-PAGE with 0.05% SDS instead of 0.1% 
significantly enhanced post blotting protein binding. 
Western ligand blotting with an insulin peroxidase conjugate successfully 
revealed IBP bands with Burkholderia strains at approximately 30 and 20 kDa 
(Figure 5.3) but no IBPs were detected in lysates from either wild type A. 
salmonicida CM 30 or the A layer mutant MT004. 
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Figure 5.3: Western ligand blotting of whole cell soluble lysates of B. 
multivorans (1) and B. cenocepacia (2) showing binding of peroxidase labelled 
–insulin, to putative insulin binding proteins. 
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5.3.4 Construction B. multivorans genomic library  
5.3.4.1 Ligation of B. multivorans DNA into predigested λ Zap arms  
A genomic library of B. multivorans was constructed in λ Zap. The partial 
digestion of chromosomal DNA was achieved using serial dilutions of Sau3A 
(Section 5.2.5.2). The digested DNA was separated by agarose gel 
electrophoresis (Figure 5.4) alongside with 1 kbp DNA ladders and the range of 
fragment sizes was identified. The digestion lane 7 contained an average size 
of 5-6 kbp with 0.03 unit of Sau3A. DNA from this sample was deemed suitable 
for ligation within the BamHI sticky ends of λ Zap arms (Section 5.2.5.3). 
Subsequently, recombinant λ Zap with B. multivorans DNA inserts were 
generated (Figure 5.5) from ligation.  
5.3.4.2 Titration of gene bank and screening for recombinants  
The recombinant phage DNA was packaged into bacteriophage coats by in vitro 
packaging to produce infectious recombinant bacteriophages, representing a B. 
multivorans genomic library in λ Zap II. The library suspension titer was 5×106 
pfu /ml. At the same time the proportion of recombinant bacteriophage in the 
library was estimated by plating aliquots of library suspension on the plates with 
X-gal and IPTG. The recombinant phage rate was around 95 % (Figure 5.6). 
The library was successfully amplified (Section 5.2.6.4), harvested and tittered 
at 2 × 1010 pfu/ml. 
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Figure 5.4: Agarose gel electrophoresis of serial Sau3A digests of 1µg samples 
of genomic DNA of B. multivorans using two fold dilution of enzyme (2, 1, 0.5, 
0.25, 0.125 , 0.06 and - 0.03U ) Lane 1-7 respectively compare to the 
undigested sample (control) in lane 8.  
 
                        
Figure 5.5: Agarose gel electrophoresis of B. multivorans digested genomic 
DNA ligated within λ Zap arms. Standard λ DNA (Lane1), B. multivorans 
genomic DNA digested with Sau3A (Lane2) ligation mixture (lane3), 1kbp 
ladder (lane 4). 
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5.3.4.3 Screening B. multivorans genomic library for insulin binding 
activity   
A minimum of 1500 recombinant each containing an average 5-6 kbp insert 
were estimated to be screened to find one clone. Actually, 30000 plaques were 
screened for insulin binding protein. Nineteen positive plaques were identified 
showing insulin peroxidase activity as coloured halo or dot with DAB/NiCl2 
(Figure 5.7). The positive plaques recovered were rescreened again for insulin 
binding. Secondary screening of the positive plaques produced pure 
recombinants plaques. This was done by streaking positive plaques on NYZ 
agar and screening for IBP as before. After that only 8 clones (λ1- λ8) remained 
stable, continuing to bind insulin peroxidase.  
5.3.4.4 In vivo excision of positive insulin binding recombinant phagemids 
The positive recombinant bacteriophages were used to recover the internal 
recombinant phagemids pBK-CMV which carried IBP gene(s). The helper 
phage was used for excision of the recombinant pBK-CMV and used to 
transfect E coli XLROR. Transfectants were selected on Kanamycin plates; the 
internal phagemid was successfully created after helper phage co-transfection. 
The DNA of recombinant phagemids was separated on agarose gel 
electrophoresis and shown to be of a higher MW than pBR328 and non-
recombinant phagemids (Figure 5.8 A). Electrophoresis of digested DNA 
fragments of recombinant phagemids showed two patterns of inserts, phagemid 
p1 (6 examples) and p2 (two). Digests were produced using combinations of 
restriction enzymes EcoRI +PstI and EcoRI +SalI, respectively. The p1 insert 
totalled 2.6 kbp consisting of 3 DNA bands 1.6, 0.8 and 0.2 kbp and the p2 
showed 1 band of insert about 2.9 kbp total size (Figure 5.8 B).  
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Figure 5.6: Blue white Screening of B. multivorans genomic library generated in 
λ zap vector. 
 
 
                          
Figure 5.7: Screening of λ Zap B. multivorans gene library for insulin binding. 
The plaques were blotted onto a membrane, blocked and screened for binding 
of insulin peroxidase. The arrow refers to a positive binding of the peroxidase 
labelled insulin to a recombinant plaque producing the IBP. 
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Figure 5.8: (A) Agarose gel electrophoresis of recombinant phagemids (lane 
3,4,5,6 compared to non-recombinant pBK-CMV, lane 2, and pBR328 plasmid 
lane 1. (B) Digest of phagemids p2 (2) & p1 (4) digested by EcoRI +SalI and 
EcoRI +PstI respectively compared with undigested phagemids p2 & p1 (lane1 
& 3 respectively). 
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5.4 Discussion  
The current study screened 45 types of microbial species for the presence of 
cell surface components capable of binding with insulin hormone. The results 
showed strong binding activity with peroxidase labelled insulin for the fish 
pathogen A. salmonicida CM30 and opportunistic human pathogenic bacteria B. 
multivorans and B. cenocepacia. These positive strains showed no binding 
activity with just the peroxidase enzyme revealing the binding sites on these 
bacterial strains are binding sites for insulin and not for the peroxidase 
component. Hormone binding proteins or insulin binding proteins have been 
previously found among various types of microorganisms; bacteria, fungus and 
protozoa (Souza and López, 2004). Also it has been reported that some 
hormone-like and hormone binding proteins are produced by higher 
microorganisms such as fungi, including yeast, which can modulate intracellular 
signalling systems, cell proliferation, differentiation and other functional 
responses (Lenard, 1992).  
Insulin binding with some fungi like Neurospora and yeast like 
Schizosachoramyces sp and even protozoa have shown physiological 
responses which provided evidence about signalling including regulation of the 
glucose downstream metabolic pathway (Souza and López, 2004). These 
insulin binding proteins and functional responses are thus clearer in eukaryotic 
microbes such as yeast but less clear in prokaryotic single cell microbes. The 
insulin ligand binding assay revealed that B. multivorans and B. cenocepacia 
both bound insulin. The genus Burkholderia is made up of Gram negative 
protobacteria with over 40 species occupying a wide range of ecological 
habitats such as water and the rhizosphere. Members of the Burkholderia 
genus can cause serious human, animal and plant diseases. However, some 
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have been used to enhance plant growth and bioremediation (Jones et al., 
2001; Stoyanova et al., 2007). The Burkholderia cepacia complex (BCC) have 
emerged as a serious threat to CF patients causing pulmonary infection and 
necrotizing pneumonia leading to lung morbidity and mortality (Whitby et al., 
2000), BCC bacteria produce a number of virulence factors. Including 
lipopolysaccharides (LPS), is a strong endotoxin which contributes to the 
inflammatory nature of BCC infection of CF patients (Kenna et al., 2003). 
Furthermore, BCC produce a number of extracellular products including 
haemolysin, protease, lipases, ATP hydrolysing enzyme like Azurin (Punj et al., 
2003) and antimicrobial secondary metabolites (Li et al., 2008). BCC acquire 
iron by producing a number of iron binding siderophores, salisalic acid, 
ornibactin and pyochelin which are important virulence factors in initialization of 
colonisation (Peckham et al., 1996; Thomas, 2006). BCC members have 
multiple drug resistance and combinations of 3 or more types of antibiotics are 
used in order to treat BCC infections, immunomodulatory agents such as methyl 
prednisolone, immunoglobulin and cyclosporine are also used to treat infection 
(Burnie et al., 1995; Jones et al., 2001; Moore and Elborn, 2003). 
All Burkholderia genomovars have been identified in CF patients; however, B. 
cenocepacia and B. multivorans are the most commonly found being isolated 
from around 90% of CF patients. These genomovars often transfer among 
patients and even infect normal individuals in some cases and are known as the 
epidemic strains (Mahenthiralingam et al., 2002).  
Wood et al (1993) demonstrated for the first time insulin binding on the B. 
pseudomallei cell surface and estimated that there were 5000 insulin binding 
sites per cell, B. cepacia was reported to bind insulin (Kanai et al., 1996). 
Furthermore, another study noted increase in the B. cepacia growth rate after 
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the culture was incubated with insulin hormone for 24 h suggesting the bacteria 
can use insulin as a growth substrate (Jeromson et al., 1999). It was 
demonstrated that the commercial insulin markedly inhibits the growth of P. 
pseudomallei in vitro and in vivo (Woods et al., 1993), however, Simpson & 
Wuthiekanun, (2000) suggested that the preservative m-cresol in insulin 
commercial preparation caused inhibition of B. pseudomallei growth and not 
insulin. Moreover, the insulin receptors on B. pseudomallei and B. cepacia were 
suggested to be part of a signal transfer system such as for phospholipase or 
protein tyrosine phosphatase (Kanai et al., 1996).  
The current study shows a strong binding of insulin peroxidase and FITC insulin 
to wild type of A. salmonicida CM30 compared to the binding seen with an A-
layer mutant and B. multivorans. A study of the insulin binding protein of N. 
crassa showed that the protein was a signal transduction member interfering 
with glucose metabolism and 103 insulin binding sites were estimated per cell 
(Kole et al., 1991).  
The present study indicated for the first time an insulin binding activity within A. 
salmonicida, revealing a novel insulin binding protein. Wild type A. salmonicida 
produced strong binding with insulin but the A. salmonicida a mutant MT004 
which lacks the A-layer protein envelope, produced much lower insulin binding. 
The A-layer of A. salmonicida plays an important role in pathogenicity, 
facilitating resistance to phagocytosis and bacteriophage infection (Kaplin et al., 
1996; Nikoskelainen et al., 2005).  
A mutant lacking the A-layer is non-virulent A. salmonicida (Ellis, 1988; 
Marsden et al., 1996; Fast et al., 2009) and it was reported that the A-layer 
could be used as a vaccine and plays a protective role in fish against A. 
salmonicida infection (Arnesen et al., 2010).  
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Other binding studies indicate the ability of A. salmonicida to bind specifically 
some conserved proteins like collagen types I and IV and estimated that high 
amounts of radiolabelled collagen bound, and that collagen binding was fast 
and saturable with high affinity and irreversible (Trust et al., 1993). Fibronectin 
and laminin are basement membrane large extracellular glycoproteins and play 
a crucial biological role in cell adhesion and cell-cell contact in mammalian cells 
and have been reported to bind tightly to the A. salmonicida A-layer. However, 
neither A. salmonicida A-layer mutants nor A. hydrophila bind either of those 
proteins (Doig et al., 1992).  
It has also been shown that the A-layer plays an important role in an iron 
chelating – process via direct binding to the hydrophobic iron structure in a 
siderophore-independent A. salmonicida species. However, A-layer is the major 
siderophore receptor or chelator in siderophore dependent species in which 
siderophore like anguibactin, aerobactin, enterobactin, and hydroxamate 
siderophores mediate iron uptake mechanisms (Hirst et al., 1991; Fernandez et 
al., 1998). In addition to the A-layer contribution in siderophore binding, it was 
discovered that the A. salmonicida can bind porphyrin, the haemin protein to 
sequester iron which is correlated with many virulence factors like some 
protease and haemolysin etc. (Kay et al., 1985).  
SDS-PAGE and western ligand blotting were used in order to identify the insulin 
binding proteins. Various types of electrophoresis and blotting strategies were 
used in order to promote successful insulin binding. Many procedures were 
used to extract a solubilised active IBP(s). Low concentration of lysozyme in 
protein extraction, and low SDS used for cell wall lysis and in loading buffer and 
electrophoresis buffer showed positive results for insulin binding with B. 
multivorans & B. cenocepacia.  
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Furthermore, modification of SDS-PAGE and blotting conditions were useful to 
minimise ligand binding inhibition by SDS, by reducing SDS concentration of 
resolving and stacking gel as well as in the electrophoresis buffer. 
Protein blotting conditions were also altered using 300 mA for 90 min instead of 
40 mA for 24 h. Furthermore, the blocking solution of BSA dissolved in MOPS 
buffer instead of casein prepared in PBS buffer improved binding.  
Western ligand blotting for insulin binding proteins of B. multivorans & B. 
cenocepacia revealed 2 positive protein bands at about 30 and 20 kDa in each 
species of Burkholderia tested, and may represent active monomer proteins 
from a diametric protein complex, or alternatively, these proteins may be an 
insulin degrading enzymes which attacks the beta chain of insulin in  
mammalian cells (Wang et al., 2006). Similar enzymes have been discovered in 
microorganisms to utilize insulin and other oligo peptides (Kole et al., 1991). 
Some other microorganisms like N. crassa have been shown to possess two 
IBPs, at 55 kDa and 110 kDa  (Kole et al., 1991) and the protozoa Tetrahymena 
pyriformis also has two IBPs at 30 & 50 kDa (Christopher and Sundermann, 
1996) . 
Once IBPs were recognised, steps were taken to identify sequences 
responsible for IBP(s) in B. multivorans by creating a genomic library. The gene 
bank (or genomic library) is a powerful strategy to identify genes for unknown 
proteins with functional activity, moreover, gene cloning is increasingly being 
used for ligand binding studies in order to produce the native form of either the 
ligand or the receptors (Wilson and Walker, 2005; Lodge et al., 2007).  
Identifying proteins with insulin binding activity and determining its amino acid 
would reveal whether sequences share homology with the human insulin 
receptor. If so, this may initiate an autoimmune response against human insulin 
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receptor and subsequently be involved in development of diabetes, particularly 
in the case of patients with CF with chronic infection with strains belonging to 
the B. cepacia complex. A B. multivorans genomic library was successfully 
produced in λ Zap express vector to facilitate screening the library for insulin 
binding.   
Screening for insulin binding proteins in microorganisms particularly those 
associated with human was a starting point for this study to look for similarity 
between insulin binding proteins of microorganisms and (HIR) that might have a 
role in causing a diabetic autoimmune response. If the IBP(s) on microorganism 
share mimicries within HIR, then during infection the antigen presenting cells 
and macrophages will process those mimicries for those invaders 
(microorganisms) to the immune defence system leading to an autoimmune 
response against the same epitopes on HIR. This study presents a possible 
pathogenic role for microorganisms in developing diabetes in CFRD patients as 
they suffer from long term infection by B. cepacia II (B. multivorans), and B. 
cepacia III (B. cenocepacia) (Mahenthiralingam et al., 2002; Coutinho, 2007). 
However, in the case of A. salmonicida it could represent a potential risk for 
those consuming fish meat contaminated by A. salmonicida. In both cases 
human insulin bound on Burkholderia spp and A. salmonicida a can be 
processed as a foreign antigen, as it is seen as part of the bacterial protein 
during the host immune responses and subsequently lead to an autoimmune 
response to self-antigens such as insulin or insulin receptor and the individual 
may subsequently become diabetic. 
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In conclusion, this study indicates insulin binding proteins on microorganisms 
particularly Gram negative bacteria might play a role in causing a diabetic 
autoimmune response. It shows for the first time insulin binding to components 
on the cell envelope of the fish pathogen A. salmonicida and the greater part of 
insulin binding is mediated by the A-layer, however, the current study failed to 
produce IBP(s) by ligand blotting. Also, it has been confirmed that insulin 
binding occurs on B. multivorans and successful ligand blotting has identified 
two IBP bands of 20 and 30 kDa. Construction of a gene library will facilitate 
characterisation of IBPs in Burkholderia which in turn may contribute to our 
understanding of the development of diabetic autoimmune response particularly 
in case CF-related diabetes (CFRD). 
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Chapter 6 
Expression recombinant phagemids p1 & p2, sequencing and 
sequence analysis 
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6.1 Introduction 
Diabetes can be the result of an autoimmune response against self β-cell auto 
antigens leading to permanent damage which causes diabetes type 1 and 
recently autoimmunity has been implicated in diabetes type 2. Molecular 
mimicries between microorganisms (bacteria, virus, etc.) and self β-cell 
antigens have been hypothesised to trigger a diabetogenic immune response.  
Furthermore, it has been found that some microorganisms do possess proteins 
with sequence homology to β-cell antigens which could contribute to an 
autoimmune response against β-cells (MacFarlane et al., 2003; Fujinami et al., 
2006). Some microbial proteins which share amino acid sequence homology to 
β-cell pancreatic auto-antigens may have a similar function, heat shock 
protein60 (HSP60) from Ps. aeruginosa and HSP60 of pancreatic β-cells 
antigen (Jensen et al., 2001).  
IBPs of Burkholderia could result in the development of diabetic autoimmune 
response against insulin or insulin receptor, on the basis of molecular mimicry, 
particularly in CFRD suffers who often have Burkholderia infections and develop 
diabetes for unclear reasons. This chapter involves searching for linear 
molecular mimicry between proteins in the insulin associated pathway like 
insulin receptors and major β- pancreatic antigens and microbial proteins.  
The main aim of the work in this chapter was to identify the B. multivorans IBPs 
sequences via the cloned gene(s) encoding IBPs (Chapter 5) and then search 
databases for sequence homology of the translated sequences of IBP genes 
and protein sequences of HIR. The recombinant phagemids were used to 
express the IBP(s) in E. coli, the recombinant cells were grown and protein 
lysates were subjected to western ligand blotting and compared to the original 
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extract of B. multivorans. Southern blotting was used in order to confirm the 
origin of the DNA encoding IBP(s) was from B. multivorans. 
In order to identify the sequences encoding IBP(s), the recombinant phagemids 
(p1 & p2) were sequenced and analysed to identify possible ORF(s) start and 
stop codons and Shine Dalgarno ribosomal RNA binding domain (SD) 
sequences. ORFs were analysed and translated sequences used to identify 
homologues protein sequences and extract properties such as MW and 
transmembrane proteins. Translated proteins were specifically used to search 
for homology with the HIR to identify any molecular mimicries or linear epitopes 
between IBP(s) and HIR. The affinity of these epitopes to MHC I molecules was 
used to identify the possibility of presentation of these epitopes for 
immunological processing.  
6.2 Materials and Methods  
6.2.1 Expressing recombinant phagemids in E. coli  
Recombinant phagemids (p1 & p2) were grown in 50 ml LB (Section 2.2.2) 
containing 50 µg /ml kanamycin incubated at 37 °C overnight with shaking (120 
rpm). The total protein was extracted (Section 2.4.1) from the E. coli 
recombinant and from E. coli non-recombinant host bacteria and B. multivorans, 
as negative and positive controls, respectively. Cell lysates were subjected to 
western ligand blotting to detect insulin binding proteins (IBPs) (Section 5.2.4).  
6.2.2 Southern Blotting 
Southern hybridisation is a technique used to locate a particular gene sequence 
within an entire genome and was used to confirm the origin of the insert DNA 
within p1 & p2 was from B. multivorans. The genomic DNA of B. multivorans 
was digested using EcoR V, denatured and transferred from a gel to a 
membrane. Phagemids p1 & p2 DNA were used to prepare the digoxigenin 
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label probes encoding IBP(s) which were used to detect the complementary 
sequence in the digested genomic DNA on the membrane.  
6.2.2.1 Digoxigenin-Labelling of the DNA Template 
The hybridisation was performed using a digoxigenin DNA labelling kit (Roche 
Applied Science) in which the DNA probes were generated during replication 
using random primed labelling which by hybridization of random 
oligonucleotides to the denatured DNA template. The complementary DNA 
strand is synthesised by Klenow enzyme using the 3' OH termini of the random 
oligonucleotides as primers and  mixture of deoxy-riboneucleotides containing 
DIG-11-dUTP label for elongation. The p1 and p2 DNA was extracted and 
concentrated (Section 2.5.2) and used as DNA templates. DNA (500 ng) in 15 
µl of MBW in a 1.5 ml microcentrifuge tube was denatured by heating in a 
boiling water bath for 10 min followed by quickly chilling on ice. Next, hexa-
nucleotide mix (10 x) 2 µl, dNTP labell (2 µl) and Klenow enzyme (1 µl) was 
added, mixed, centrifuged briefly and incubated overnight at 37 °C. The same 
procedure was performed using pBR328 linearised by BamHI as a control 
labelling. 
6.2.2.2 Hybridization   
B. multivorans genomic DNA (2µg) was digested overnight using EcoRV 
restriction enzyme (Section 2.5.8) and separated on agarose gel 
electrophoresis (Section 2.5.6) alongside with pBR328 linearized by BamHI. 
The gel was electrophoresed for 3 h at 120 V until the front bromophenol blue 
dye reached to 2 cm to the end of the gel. The agarose gel was depurinated by 
submerging in 0.2 N HCl with gently shaking for 15 min followed by placing the 
gel in denaturation solution (Appendix 1) for 45 min with gentle shaking in order 
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to denature the double stranded DNA fragments. The denaturation solution was 
replaced with neutralization solution (Appendix 1) for 30 min at RT with constant 
agitation after this the neutralization solution was replaced with fresh amount of 
the same solution and left with shaking for 15 min. 
The DNA was transferred using the southern blotting capillary transfer system 
(Scot, UK). The apparatus was washed with MBW and filled with 2 litre of 10 × 
SSC buffer (Appendix 1). A filter paper wick was wetted and placed on the 
surface of blotting base and the agarose gel was placed in the centre of wick 
and aluminium foil was placed around the gel to cover the wick area around the 
gel to prevent short –circulating during transfer. A piece of positively charge 
nylon membrane, cut to the size of the gel and wetted with water and then with 
10 x SSC buffer was placed on the gel surface, a glass rod was passed over 
the membrane to remove air bubbles between the membrane and the gel. Two 
Whatman 3 mm filter papers (same size as membrane) were wetted in 10 x 
SSC and placed on the nylon membrane. Paper towels, 10 cm2 high were 
placed on the top of the filter papers and a 0.5 Kg weight was placed on top and 
left for 20 h to allow capillary transfer of the DNA to the nylon membrane. The 
membrane was removed carefully from the gel using forceps and placed on the 
transilluminator with wave length adjusted to 254 nm for 5 min for binding the 
DNA to the membrane by UV cross linking. The membrane was rinsed with 
MBW and left to air dry. The membrane was marked and cut into strips for use 
with different probes. The membrane stripes were pre-hybridized by immersing 
them in 30 ml of pre-hybridisation buffer (Appendix 1) at 68 ºC for 2 hours in a 
hybridisation oven. The pre-hybridisation solution was replaced with fresh 
amount of pre-hybridisation solution containing DNA probes 25 ng/ml which was 
pre-denatured by boiling for 5 min and placed directly in ice water bath prior to 
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use. The membranes were left overnight for hybridisation and were washed 
twice for 5 min in 30 ml of stringency buffer I (Appendix 1) with constant 
agitation at RT, and washed twice for 15 min in 30 ml of stringency buffer II 
(Appendix 1) at 65 ºC. The membranes were prepared for detection by rinsing 
for 5 min in 30 ml maleic acid buffer (Appendix 1) and then immersed in 50 ml 
blocking solution (Appendix 1) for 30 min at RT with gentle shaking. The 
blocking solution was replaced with a fresh amount of blocking solution 
containing 1:5000 Antidigoxigenin antibody–AP to final concentration of 150 
mu/ml. The membranes were washed twice with 50 ml washing buffer for 15 
min and equilibrated for 5 min in 10 ml detection buffer and incubated overnight 
in 20 ml of detection buffer containing 40 µl/ml from NBT/BCIP stock solution. 
The reaction was stopped by replacing the developing solution with TE buffer 
and images were taken. 
6.2.3 Sequencing the recombinant phagemids p1 and p2  
The pBK-CMV phagemid has two binding sites for T7 and T3 primers (forward 
and reverse respectively) for sequencing. Recombinant phagemids samples 
were commercially sequenced using read value sequencing by MWG 
Eurofins/Germany. 
6.2.4 Sequence analysis 
6.2.4.1 ORF gene motifs and predicted amino acid sequence 
Online sequence analysis software of the European Molecular Biology 
Laboratory (EMBL) was used in order to find ORFs by detecting possible ATG, 
TAC codons. The program also looks for stop codons TAA, TAG and TGA that 
terminate translation. Motifs like -10, -35 and SD sequences were also identified 
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using the NCBI identifier. EMBL tool was used to predict the MW of proteins 
encoded by the ORF(s).  
6.2.4.2 Sequence identification by Blast –n & p 
The ORFs sequences were used to search the Genbank database (NCBI) using 
the Blast-n algorithms to predict for protein encoded by the ORFs. Furthermore, 
Blast –p was used to look for significant similarity between proteins encoded by 
cloned ORFs and HIR and epitopes were predicted.  
6.2.4.3 Phylogenetic tree and evaluation relationship 
The tree was constructed using ClustalW2 programme online from European 
Bioinformatics Institute (EBI) multiple alignment of sequences from Blast-n of 
ORFs sequences encoding IBP(s). The phylogram showing evolutionary 
relationship and the degree of homology (100%) between sequences were 
edited to the tree. 
6.2.4.4 IBP topology prediction   
The online HMMTop software from ExPASy tools of the Swiss institute of 
Bioinformatics was used to predict the transmembrane α-helix domain into the 
IBPs structures. 
6.2.4.5 Molecular mimicries and linear epitopes prediction  
The molecular mimicries or homology between IBP (1, 2 and 3) of B. 
multivorans and HIR were predicted. The translated sequences of IBP(s) were 
searched against amino acid sequences of HIR accession number AAI17173 
(Appendix 2) using high sensitivity software online Blast P2 from ExPASy and 
proteomics tools from the Swiss Bioinformatics Institute.  
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6.3 Results 
6.3.1 Expressing recombinant phagemids in E. coli 
The insulin binding proteins from recombinants were detected using western 
ligand blotting using proteins extracted and solubilised from confluent lysis of E. 
coli XL1 Blue by recombinants λ1 & λ2 and from recombinant E. coli XLROLR 
carrying phagemids p1 and p2. Solubilised proteins were separated by SDS-
PAGE with molecular weight markers and transferred by electro blotting to a 
nitrocellulose membrane and subjected to western ligand blotting. Blotting 
revealed insulin peroxidase bands showing binding activity from of λ1 & λ2 
samples (Figure.6 Appendix 2). 
The total protein was then extracted from p1 or p2 E. coli recombinants as 
before and subjected to the western ligand blotting to detect the IBPs and the 
results showed p1 phagemid produced an insulin binding band of about 30 kDa, 
equivalent in size to one of the B. multivorans IBPs, revealing that p1 carries the 
gene for IBP1. Whereas, p2 showed two bands (IBP2 & IBP3) with MW 
identical to 20 & 30 kDa of IBPs in B. multivorans (Figure 6.1).  
6.3.2 Southern Blotting 
Southern hybridisation was used to verify the presence of p1 and p2 inserts 
DNA in the B. multivorans genome. Digoxigenin labelled probes of p1 and p2 
were prepared and used to identify the insulin binding genes on B. multivorans 
genomic DNA completely digested by EcoR V. The p1 probe hybridised 
successfully with two bands on the genomic DNA of B. multivorans and was 
smaller in size than linearized pBR328. The p2 hybridised with one sequence of 
chromosomal bands. The hybridisation referred that p1 may be resulted from 
ligation DNA fragments belonging to different regions on the B. multivorans 
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chromosomal DNA, whereas, the p2 identified one chromosomal band 
demonstrating that the p2 originate to one region of chromosomal DNA of B. 
multivorans (Figure 6.2). The sequence analysis of the p1 showed an EcoR V 
digestion site producing two fragments 2063 bp and 362 pb, whereas, no 
EcoRV restriction site was detected on the p2 sequences.  
6.3.3 Sequence analysis of p1 & p2 inserts  
6.3.3.1 ORF analysis and predicted amino acid sequences for p1  
The inserts in phagemids p1 and p2 were sequenced to identify the insulin 
binding protein genes and subsequently the proteins. The two inserts showed 
overlapping sequences and were 2600 and 2900 bp for p1 and p2 respectively. 
Theoretical ORFs identifier detected 3 and 4 ORFs on p1 and p2 respectively 
(Figure 6.3). All ORFs of p1 & p2 show high homology with sequence from B. 
multivorans. 
The ORFs sequence analyses identified 3 ORFs 1, 2, and 3 on the insert of p1 
(Figure 6.3). ORF1 (282 bp) sequences flanked by nucleotides 138-422 showed 
no clear gene motifs, apart from the start codon and stop codon (Figure 6.4). 
Nucleotide sequence blast showed that this sequence is related to the gene 
Ornibactin synthatase, part of the siderophore ornibactin pathway. The ORF2 
(636 bp) occurred at sequences 420-1061 (Figure 6.4), sequence blast showed 
high similarity to the Acetyl coA transferase gene of B. multivorans members.  
The ORF3 of p1 flanked by nucleotides (1155 - 2054) showed -35, -10 and SD 
sequences accompanying start and stop codons.   
The blast result for ORF3 showed a polypeptide with 299 amino acid residues 
and calculated MW 32.79 kDa and showed similarity with the outer membrane 
iron complex (Figure 6.5). 
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Figure 6.1: IBP produced by western ligand blotting of whole cell lyaste of 
E.coli XLROR recombinants with p1 phagemids (Lane 6, 7) recombinant with p2 
(Lane 5, 4) and B. multivorans (3, 2) and non-recombinant E coli (lane1). 
 
 
Figure 6.2: Southern blot of EcoRV –digested genomic DNA of B. multivorans 
using Dig- labelled p2 and p1 probes and linear (2 & 3 respectively). Lane 1 
shows pBR328 Dig probe binding to itself (control). 
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Figure 6.3: ORF analysis and gene arrangements and translation of inserted DNA of p1 and p2 recombinant phagemids using ORF 
finder programme online (http://www.ebi.ac.uk/Tools/sequence.html) indicating full gene in ORF3 in p1 and ORF1& 2 in p2.  
Phagemid-Insert 
size 
ORFs     Size 
bp 
Translation encoding sequence  No of 
a.a 
Protein (MW) 
 p1-(2600) ORF1 282 Ornibactin Synthatase  94 10 kDa 
ORF2 639 Acetyl CoA:N6-hydroxylysine acetyl transferase 213 22 kDa 
ORF3 897 Iron complex outer membrane receptor protein 299 32.79 kDa 
p2-(2750) ORF1 648 Predicted periplasmic or secreted lipoprotein 216 23 kDa 
ORF2 921 POT family proton-dependent oligopeptide transporter 307 33.6 kDa 
ORF3 729 Serine threonine phosphatase-1 243 26 kDa 
ORF4 156 No significant similarity 52 5.8 kDa 
T7 
T3 
T3 
P1 
P2 
   ORF1 (138-422)                  ORF2 (1061-420)                                       ORF3 (1155-2054)             
T7 
          ORF1 (119-769)                    ORF2 (860-1783)              ORF3 (1819-2550)                 ORF4 (2624-2782)                                              
(-35) Region (GGAAGGA)   Start codon (ATG or GTG)    
) 
  Stop codon (TAG or AA)   (-10) Region (TTCAA)   
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P1-ORF1 
61 TTTTTGAATTCTTTGCGCATCGCCAACATTCATCCGGGCATCACGGCCGACGGTTCGCCG 
121 TACCAGCGGCGCGGCGCATGGGCGACGCTCGATGCGCTGCACGGCGCGCGCGGCGAGCGC 
181 GTCGACTGGGCGACCGGCACGACGACGCCGGTCGCGCCCGTGACGATGACGGGCGCCTCG 
241 TTCCACTATGTCGACAACGGCATCGATTCCGGCGAGGTGATCTGCGACGTGCTCGACACG 
301 CCGATCGCGCCGGACGACACGATCCTCGAACTGCGCTGGAACAACTTCCAGCGCAGCCTG 
361.TTTCCGGCGCTCGAGCGCGGGCTGCATCTCCTCGCCGATCGCCACGACGCGGGAGCACTTGA 
Stop Codon  
P1-ORF2 
1061 Start Codon 
atggcaccgacgctgacgcaacccgaagaagcgatcgagacggccgacggcgacgtcgccgcc  
 M  A  P  T  L  T  Q  P  E  E  A  I  E  T  A  D  G  D  V  A  A   
998 
ttgcgcgatcacggcgccgatacggcgcccgccgccgaccgcgtgctcgacgcatggcggccc 
 L  R  D  H  G  A  D  T  A  P  A  A  D  R  V  L  D  A  W  R  P   
935  
gacgatccgccgggcgcgctgctcgccgagctcgtcgcgctgttcaataccgacgcacggcgc 
 D  D  P  P  G  A  L  L  A  E  L  V  A  L  F  N  T  D  A  R  R   
872 
gatgcggcgacgatcgcgctgccgatcgcgggcaccgacccggacgccgtcgccgcgtacgtc 
 D  A  A  T  I  A  L  P  I  A  G  T  D  P  D  A  V  A  A  Y  V 
809 
gcgcgcgcggtgcgcgaaggcgtgatcgacgcggcgcaacgcgcgggcgaccgccttgacgtg 
 A  R  A  V  R  E  G  V  I  D  A  A  Q  R  A  G  D  R  L  D  V 
746 
accacgtcgcgcgcgacgttctggcagcatccgcagccctggctgaaggcgcccgcgtcgggc 
 T  T  S  R  A  T  F  W  Q  H  P  Q  P  W  L  K  A  P  A  S  G   
683  
gggatgccgctgcgctacacgatcacgaacggccaccgtcatccggtgcggccgccgacgccg 
 G  M  P  L  R  Y  T  I  T  N  G  H  R  H  P  V  R  P  P  T  P   
620 
gccggcgagatctatgcgcgctacatgccgcaggtcgggatgacgttcagcctgcgcaccgtc 
 A  G  E  I  Y  A  R  Y  M  P  Q  V  G  M  T  F  S  L  R  T  V   
557 
gacgtcgacgcgcatgcggacctcttcagcggctggatgaatctcgatcgcgtcgcgcat  
 D  V  D  A  H  A  D  L  F  S  G  W  M  N  L  D  R  V  A  H  
494 
ttctgggatcagcgcggcacgcgcgacgagcatgccgcgtatctcgcggagcggctcgccgat 
 F  W  D  Q  R  G  T  R  D  E  H  A  A  Y  L  A  E  R  L  A  D 
431 ccgcacatgtag Stop Codon 
     P  H  M  *  
 
 
Figure 6.4: Nucleotide sequence of putative genes encoded by ORF1& 2 of p1. 
Initiation and termination codons are highlighted and the green segment 
represents vector DNA sequence. 
Start Codon /ORF1 
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P1-ORF3 
 
1060 CCCGATGATC TCGCGCGCCT GCAGGTCGAC ACTAGTGGAT CACGAAGGAC 
    1111 ATTTAGGAAG GCGACGGCAA CTTCAACTAT TACCGGAAGA GAGG 
    1155 gtggtcgctcggctatcagttcgagcacaacctgaactcgatgtg 
         V  V  A  R  L  S  V  R  A  Q  P  E  L  D  V  
    1200 gacgttccggcagaacacgcgatggatgcatctgtcgctcgacaa 
          D  V  P  A  E  H  A  M  D  A  S  V  A  R  Q  
    1245 cggctcggtgtggggagcgggcttcgccgacgaaacgctgaccga 
          R  L  G  V  G  S  G  L  R  R  R  N  A  D  R  
    1290 aatcaaccgctgggccggcgtgttccagatgaactacagccgctt 
          N  Q  P  L  G  R  R  V  P  D  E  L  Q  P  L  
    1335 cgacatcgacaacaacctcgagggccgttttgcgacgggtccgct 
          R  H  R  Q  Q  P  R  G  P  F  C  D  G  S  A  
    1380 ccagcacacgctgctgctcggttccagtacaaccgccagacggcg 
          P  A  H  A  A  A  R  F  Q  Y  N  R  Q  T  A  
    1425 accgatagcgaatggctcgccgccgcgccgacgctgaacctctac 
          T  D  S  E  W  L  A  A  A  P  T  L  N  L  Y  
    1470 aacccggtgtacacgccggtcacgacggccgtgttttccgatccg 
          N  P  V  Y  T  P  V  T  T  A  V  F  S  D  P  
    1515 gacaccacgtaccgcaccaacacgtacacgacgatgaacacgttc 
          D  T  T  Y  R  T  N  T  Y  T  T  M  N  T  F  
    1560 ggcctgtacgcgcaggaccagatcaagtggaaccgctggacgctg 
          G  L  Y  A  Q  D  Q  I  K  W  N  R  W  T  L  
    1605 acgctcggcggccgcgaggactgggtcaacatgcggatggacgat 
          T  L  G  G  R  E  D  W  V  N  M  R  M  D  D  
    1650 cgcgcggccggcacgcagtcgaaggccgacgtgtcggcgtttacg 
          R  A  A  G  T  Q  S  K  A  D  V  S  A  F  T  
    1695 ggccgcgtcggcctcacgtatcaggccggctacgggctgtcgccg 
          G  R  V  G  L  T  Y  Q  A  G  Y  G  L  S  P  
    1740 tatatcagctattcgacgtcgttcaatccgatcatcggcgtgagc 
          Y  I  S  Y  S  T  S  F  N  P  I  I  G  V  S  
    1885 ttgctcgacggcggggtgccgaagccgacgcgcggcagacagatc 
          L  L  D  G  G  V  P  K  P  T  R  G  R  Q  I  
    1930 gaagcgggcctgcgctggcagccgcccggcaagaacctgatgctg 
          E  A  G  L  R  W  Q  P  P  G  K  N  L  M  L  
    1975 aatgccgcgatctatcagatcaaccagaccaacggcgttacgccg 
          N  A  A  I  Y  Q  I  N  Q  T  N  G  V  T  P  
    2020 gcgctgctgacgcacgatccgagcggcacgaaatccgtgcagacc 
          A  L  L  T  H  D  P  S  G  T  K  S  V  Q  T  
    2065 ggggaagtgcgcgcgcgcgggatcgagctgagcgcaaccggcaag 
          G  E  V  R  A  R  G  I  E  L  S  A  T  G  K  
    2110 gtcacgccgaacctgtcgctgatcgcgtcgtacgcgtatcagtga  
          V  T  P  N  L  S  L  I  A  S  Y  A  Y  Q 
 
Figure 6.5: Nucleotide sequence of putative gene encoded by ORF3 in p1. 
Sequence includes putative -35, -10 and SD regions are underlined in black. 
Initiation and termination codons are highlighted in red and the green regions 
represents vector DNA sequence. 
SD  -10 -35 
Start Codon  
Stop codon 
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6.3.3.2 ORFs analysis and predicted amino acid sequences for p2  
The analyses for p2 identified 4 ORFs on of the DNA insert (Figure 6.3). ORF1 
representing between bases 119-769 with SD region and clear -35, -10 regions 
were identified (Figure 6.6). ORF1 encodes for a 216 amino acid polypeptide with 
calculated MW of 23 kDa. The Blast-n result of this sequence showed that the 
nucleotides have 100% homology with a sequence for the periplasmic secreted 
lipoprotein and transporters associated protein of B. multivorans. ORF2 showed 
no accompanying -35 and -10 regions but identified start and stop codons on the 
sequence 860-1783 nucleotides encoding a protein with 307 residues and 33.6 
kDa theoretical MW. However, the blast-n search of these ORFs nucleotides 
showed significant similarity with an oligopeptide transporter sequence in the 
Genbank database as well as the translated protein resulted from Blast-p (Figure 
6.6).  
ORF3 was flanked by sequences (1819-2550) with apparent -35, -10 motifs and 
start and stop codons, furthermore, the translated sequences produced a protein 
with 243 residues and ≈26 kDa MW with similarities to serine threonine 
phosphatase-1 in B. multivorans (Figure 6.7). ORF4 represented by nucleotides 
2624-2782 showed, no clear motifs except start and stop codons (Figure 6.7) and 
the blast results revealed no significant similarity. 
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P2-ORF1 -35              -10                 SD 
71 TTCTTTGGAC TCGCTCGTGT TTCAACTGCC GGTCAGCTAG GAGAACCG 
Start Codon  
atgaaaaccgacaagcagttgaagcaggatgtccaggacgaactggagtcagacccgtcgatcgattcgacccgtatcggtgtcgaggtg 
 M  K  T  D  K  Q  L  K  Q  D  V  Q  D  E  L  E  S  D  P  S  I  D  S  T  R  I  G  V  E  V 
209 
gctgaccggatcgtgacgctttcggggcacccgccgagctacgcggagaagctggcgatcgagcgcgcggcgaaccgcgtggccggtgtc 
 A  D  R  I  V  T  L  S  G  H  P  P  S  Y  A E  K  L  A  I  E  R  A  A  N  R  V  A  G  V 
299 
aaggcgctcgtcgtggacatgaccgtgcatctgccggacgacgacgtgcgcaccgacgaggacatcgcgaaggcggtacgctcggtgctg 
 K  A  L  V  V  D  M  T  V  H  L  P  D  D  D V  R  T  D  E  D  I  A  K  A  V  R  S  V  L 
389 
cactggacggtcggtctacatgacgacgcggtcaaggtgcaggtcgaacgcggctggatcacgttgtccggcaaggtcgactgggcatac 
 H  W  T  V  G  L  H  D  D  A  V  K  V  Q  V E  R  G  W  I  T  L  S  G  K  V  D  W  A  Y 
479 
cagagccacctggccgtgcgcgccatctcgcagatgcgcagcgtgacgggcgtgaccgaccacatcacggtacaggggacggtcggttcg 
 Q  S  H  L  A  V  R  A  I  S  Q  M  R  S  V T  G  V  T  D  H  I  T  V  Q  G  T  V  G  S        
569 
gacgacatcggcggaaacatcaaacgcgcgatcatgcgccacgcggagcgcgaggctaagcatatcgcgatcgaagtgcacgacggcacc 
 D  D  I  G  G  N  I  K  R  A  I  M  R  H  A E  R  E  A  K  H  I  A  I  E  V  H  D  G  T 
659 
gtgcggctgtccggaaaagtcggctcgttctccgaacgcaaggccgtgcgcggggccgcgtggtccgcgcgcggcgtgcgcgccgtcgtc 
 V  R  L  S  G  K  V  G  S  F  S  E  R  K  A V  R  G  A  A  W  S  A  R  G  V  R  A  V  V 
749 gacgatctggtggtcgagtaaGGTCGGTAGCCGGATGAGCAGTCCACGGAGATCAAGGAGGGC  
 D  D  L  V  V  E    Stop codon  
825               ORF2/Start Codon  
AGTCAAATGACACTTTCGGGTGAACTTCACGAAGCGGACTGGTCGGTCatgatgcacgcacctgtt 
              M  M  H  A  P V  
P2-ORF2 
979 
tcacaaacccgatcgtttacgacggtcttcctcatcgaaatgtgggagcgcttcggctactacggcatggccgcgctcctcgtcctcttc 
 S  Q  T  R  S  F  T  T  V  F L  I  E  M  W  E  R  F  G  Y  Y  G  M  A   A  L  L  V  L  F 
1884        
atggtcgacaggctcggtttcaccgacagccatgcgaacctcacgtggggtgcgttcaccgcactcgtctacgcctcgccgtcgatcggc 
 M  V  D  R  L  G  F  T  D  S H  A  N  L  T  W  G  A  F  T  A  L  V  Y  A  S  P  S  I  G 
1264  
ggctggatcggcgacaaggtgctcggcgcgcgccgcacgatgatcctcggcgcggccgtgctgtgcgccggctacctgatgctggcggtg 
 G  W  I  G  D  K  V  L  G  A R  R  T  M  I  L  G  A  A  V  L  C  A  G  Y  L  M  L  A  V   
1354 
ccgaacgacgcgctcgcctatatgtatgcgtcgctcggcgtgatcgtcgtcggcaacgggctgttcaaggccaacgcggcgaacctcgtg 
 P  N  D  A  L  A  Y  M  Y  A S  L  G  V  I  V  V  G  N  G  L  F  K  A  N  A  A  N  L  V   
1444 
cgccgcatctacgaaggcgacgacgcgcgcatcgacagcgcgttcacgatctactacatggcggtcaacatcggctcgacggtgtcgatg 
 R  R  I  Y  E  G  D  D  A  R I  D  S  A  F  T  I  Y  Y  M  A  V  N  I  G  S  T  V  S  M   
1534  
ctggcgacgccgtggatcaaggatcactggggctggcacaccgcgttcgcggtctgctgcggcggcatgctgctcgcgatcctgaacttc 
 L  A  T  P  W  I  K  D  H  W G  W  H  T  A  F  A  V  C  C  G  G  M  L  L  A  I  L  N  F   
 
1624 
atgctgatgcatcgcacgctggcgcacatcggctcgcagcccgacgacgagccgatccgctggaagcgcctcggggccgtcgcggcgggc 
 M  L  M  H  R  T  L  A  H  I G  S  Q  P  D  D  E  P  I  R  W  K  R  L  G  A  V  A  A  G   
 
1714 
ggcgtcgcgctcgcgctcgtcacgctgtacgtgctgcagcacaagcaactggcagtggcaagcgtgtggacggccgcggtcgcgattctc 
 G  V  A  L  A  L  V  T  L  Y V  L  Q  H  K  Q  L  A  V  A  S  V  W  T  A  A  V  A  I  L   
 
1804 
gcgatcttcgcgtacatgatcgcgaagtcggaacgctcggagcgcgccggcctgatcgccgcgctcgtgctgatcgcgcaggtgatcctg 
 A  I  F  A  Y  M  I  A  K  S E  R  S  E  R  A  G  L  I  A  A  L  V  L  I  A  Q  V  I  L   
 
1894 
ttcttcatcttctacgtgcagatgtcgacctcgctgacgctgttcgcgctgcgcaacgtcgatccgcgcttcatcctgttcggcacgacg 
 F  F  I  F  Y  V  Q  M  S  T S  L  T  L  F  A  L  R  N  V  D  P  R  F  I  L  F  G  T  T   
 
1984 ctgtaa Stop Codon 
      L   
 
Figure 6.6: Nucleotide sequence of putative gene encoded by ORF1& 2 in p2. 
ORF1 includes putative -35, -10 and region and SD. Initiation and termination 
codons are highlighted. 
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P2-ORF3 
 
      -35              -10              SD  
1780 TTGATGGTGT CTGGGCTCGA AACCGCCGCG CGGAGCGG  
1819 atgagcgcttccgccctcctccatcgtcatccggccaacgtcgcg 
      M  S  A  S  A  L  L  H  R  H  P  A  N  V  A  
1864 ggccgcgacttcgtcgtcggcgatctgcacggctgcgtcgatgcg 
      G  R  D  F  V  V  G  D  L  H  G  C  V  D  A  
1909 ctgcgcgcactgctgcgcgaggtgcgcttcgatccggcgcgcgac 
      L  R  A  L  L  R  E  V  R  F  D  P  A  R  D  
1954 cggctgttctcggtcggcgatctcgtcgaccgcgggccggcatcc 
      R  L  F  S  V  G  D  L  V  D  R  G  P  A  S  
1999 gaaaccgcgctcgagctgctcgatcgcccgtggtgtcacgtcgtg 
      E  T  A  L  E  L  L  D  R  P  W  C  H  V  V  
2044 cgcggcaatcacgaagaagtgctgagcctcgtcgcgcgcggcaag 
      R  G  N  H  E  E  V  L  S  L  V  A  R  G  K  
2082 ctgccggccgacgcatggcgcggcatcggcggcgactggggcgcc 
      L  P  A  D  A  W  R  G  I  G  G  D  W  G  A  
2134 gatctgccgcccgagcggctgcgcgcgtacgcggcgcgcgtcgac 
      D  L  P  P  E  R  L  R  A  Y  A  A  R  V  D  
2179 gcgctgccgctcgtgcgcgtgatcggcgaaggcgcgacgcgcttc 
      A  L  P  L  V  R  V  I  G  E  G  A  T  R  F  
2224 aacgtgctgcatgcggaattcttcggctcggacgccgatctagat 
      N  V  L  H  A  E  F  F  G  S  D  A  D  L  D  
2269 accggcgactatccgcccgacgtgcgcgagcggctgatctggggc 
      T  G  D  Y  P  P  D  V  R  E  R  L  I  W  G  
2314 cgcgatctcgtgcagggactcgtcgatccgggctggcaggccggc 
      R  D  L  V  Q  G  L  V  D  P  G  W  Q  A  G  
2359 ctctcgctgacctgcagcggccatacgccggtgcgcgtgccgcag 
      L  S  L  T  C  S  G  H  T  P  V  R  V  P  Q  
2404 cggatcggcgcgcaatggttcatcgatacgggtgcgttcgcaccg 
      R  I  G  A  Q  W  F  I  D  T  G  A  F  A  P  
2449 gccggccggctgacgctcgccgagccgcgcacgggacagacgtgg 
      A  G  R  L  T  L  A  E  P  R  T  G  Q  T  W  
2494 tcgatcacgcaggccgccgcacgcgaacgcggagcggccgcgtgg 
      S  I  T  Q  A  A  A  R  E  R  G  A  A  A  W  
2539 ccgctgccgtgaCGCCCGCACGACTGTCCGGCCGGACACCGCGACACA 
      P  L  P  *      Start Codon  
2587 CATACCGCCTCGAATGCACGGGCAGCGCAACGCCCGCATGCGCACCTACC 
2637 CGACCTGATTCAGCRSTCGAACACCGCGTCGATCGCGGAGCCGTTCCAGT 
2687 TGTACTCGAGATACGCCGCGTGATGGCAGTCGCGCAGCAGCGTCGTGCGA  
2737 AACGCCGCGAGGCATTCGCCGTGCGGATCGCGCACCGACGGAATAGA  
 
Figure 6.7: Nucleotide sequence of putative gene encoded by ORF3 & 4 in p2. 
ORF3 includes putative -35, -10, region and SD are underlined. Initiation and 
termination codons are highlighted. 
Stop Codon  
Start Codon  
Stop Codon  
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6.3.4 Identification of ORFs encoding protein receptors  
The blast results of the nucleotides sequences for the ORF(s) revealed three 
proteins with receptor and membrane function. The current study has 
hypothesised that the IBPs are receptor proteins and their MW should be 
approximately either 20 or 30 kDa. Accordingly, three ORF(s) could possibly 
encode IBP(s). ORF3 of p1 revealed a protein of 32.7 kDa (IBP1) representing 
a TonB- siderophore receptor (accession number AP009385.1) belonging to B. 
multivorans and the Blast-p of this sequence precisely revealed that this protein 
is an ornibactin siderophore receptor of B. multivorans and is found in other 
species of the BCC and other Burkholderia sp or TonB siderophore dependent 
receptor with (accession number CP000868.1) of B. multivorans and other 
Burkholderia species (Figure.6.8). 
ORFs 1, 2 in p2 have been suggested to produce possible IBP2 & 3 
respectively. ORF1, predicted to produce a 23 kDa (IBP2) protein called 
periplasmic or secreted lipoprotein in B. multivorans (accession number 
AP009387.1) and functionally is showing homology to an amino acid or peptide 
transporter in the Burkholderia genus only (Figure 6.9 A).  
The ORF2 blast results of p2 indicated that ORF2 encodes a 33.6 kDa (IBP3) 
protein transporter belonging to the proton amino acid, oligopeptide transporters 
family (POT) of B. multivorans (proteins with putative function of transportation 
of protein, oligopeptide and amino acids) in the Burkholderia genus (accession 
number AP009386 ) (Figure 6.9 B).  
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Figure 6.8: Phylogram rooted tree based on nucleotide sequence of p1-ORF3.  
The tree was constructed using the ClustalW2 programme multiple alignment of 
sequences using the Blast of ORF3 sequence. The phylogram shows 
evolutionary relationship and degree of homology between sequences from 
related bacteria. 
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Figure 6.9: Phylogram rooted tree based on nucleotide sequence of p2-ORF1 
& 2 (A & B respectively). The tree was constructed using the ClustalW2 
programme multiple alignment of sequences using the Blast of ORF3 
sequence. The phylogram shows evolutionary relationship and degree of 
homology between sequences, from related bacteria. 
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6.3.5 Topology prediction of IBPs sequences  
The translated sequences of putative IBPs were scanned for further 
confirmation that they may play a role as receptors for insulin. Putative IBP(s) 
sequences were searched for transmembrane α helix domains using TMMTop 
software. The IBP1 (siderophore ornibactin receptor) 299 residues encoded by 
ORF3 in recombinant phagemid p1 produced one α helix domain of 23 amino 
acids between residues 95 -117 (Figure 6.10).  
The IBP2 (periplasmic or secreted lipoprotein) is a 23 kDa protein with 
transportation activity and is composed of 216 residues encoded by ORF1 of p2 
(Figure 6.9 A). The protein topology prediction showed a soluble protein 
structure with no transmembrane helices (Figure 6.10). However, in the case of 
IBP3 encoded by ORF3 producing a 33.6 kDa peptide transporter belonging to 
the oligopeptide transporters family POT of B. multivorans, the transmembrane 
test revealed 9 transmembrane α-helices domains with 19 or 20 residues 
occurring at residues 24-43, 52-70, 79-96, 101-118, 139-158,171-189, 210-228, 
233-253 and 262-280 residues producing a typical transmembrane protein 
structure (Figure 6.10).  
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VVARLSVRAQ PELDVDVPAE HAMDASVARQ RLGVGSGLRR RNADRNQPLG 50  IBP1 
IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII  
 
RRVPDELQPL RHRQQPRGPF CDGSAPAHAA ARFQYNRQTA TDSEWLAAAP 100 
IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIHHHHHH  
 
TLNLYNPVYT PVTTAVFSDP DTTYRTNTYT TMNTFGLYAQ DQIKWNRWTL 150 
HHHHHHHHHH HHHHHHHOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO  
 
TLGGREDWVN MRMDDRAAGT QSKADVSAFT GRVGLTYQAG YGLSPYISYS 200 
OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO  
 
TSFNPIIGVS LLDGGVPKPT RKRQIEAGLR WQPPGKNLML NAAIYQINQT 250 
OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO  
 
NGVTPALLTH DPSGTKSVQT GEVRARGIEL SATGKVTPNL SLIASYAYQ 299 
OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOO 
 
MKTDKQLKQD VQDELESDPS IDSTRIGVEV ADRIVTLSGH PPSYAEKLAI 50  IBP2 
IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII  
 
ERAANRVAGV KALVVDMTVH LPDDDVRTDE DIAKAVRSVL HWTVGLHDDA 100 
IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII  
 
VKVQVERGWI TLSGKVDWAY QSHLAVRAIS QMRSVTGVTD HITVQGTVGS 150 
IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII  
 
DDIGGNIKRA IMRHAEREAK HIAIEVHDGT VRLSGKVGSF SERKAVRGAA 200 
IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIII  
 
WSARGVRAVV DDLVVE 216 
IIIIIIIIII IIIIII 
 
MMHAPVSQTR SFTTVFLIEM WERFGYYGMA ALLVLFMVDR LGFTDSHANL 50  IBP3 
IIIIIIIIII IIIIIIIIII IIIHHHHHHH HHHHHHHHHH HHHOOOOOOO  
 
TWGAFTALVY ASPSIGGWIG DKVLGARRTM ILGAAVLCAG YLMLAVPNDA 100 
OHHHHHHHHH HHHHHHHHHH IIIIIIIIHH HHHHHHHHHH HHHHHHOOOO  
 
LAYMYASLGV IVVGNGLFKA NAANLVRRIY EGDDARIDSA FTIYYMAVNI 150 
HHHHHHHHHH HHHHHHHHII IIIIIIIIII IIIIIIIIHH HHHHHHHHHH  
 
GSTVSMLATP WIKDHWGWHT AFAVCCGGML LAILNFMLMH RTLAHIGSQP 200 
HHHHHHHHOO OOOOOOOOOO HHHHHHHHHH HHHHHHHHHI IIIIIIIIII  
 
DDEPIRWKRL GAVAAGGVAL ALVTLYVLQH KQLAVASVWT AAVAILAIFA 250 
iiiiiiiiiH HHHHHHHHHH HHHHHHHHOO OOHHHHHHHH HHHHHHHHHH  
 
YMIAKSERSE RAGLIAALVL IAQVILFFIF YVQMSTSLTL FALRNVDPRF 300 
HHHIIIIIII IHHHHHHHHH HHHHHHHHHH OOOOOOOOOO OOOOOOOOOO  
 
ILFGTTL 307 
OOOOOOO 
 
Figure 6.10: Transmembrane helices prediction of putative IBPs (I indicating 
inside, O outsides and H transmembrane) using HMMTop software (Exapsy 
online tools) predicted transmembrane domain sequences appear in red in IBP1 
& IBP 3 and not for the soluble intracellular protein IBP2 (B). 
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6.3.6 Molecular mimicries and linear epitopes prediction  
Searches for linear epitopes with sequence homology between HIR subunit α 
and putative IBPs elicited 6 significant epitopes on IBP1 (outer membrane iron 
complex receptor) with statistically significant similarity to the HIR occurring at 
residues 979-1016, 780-801, 742-750,641-646, 595-606, and 316-330, with 12, 
9, 6, 4,6 and 7 identical residues and 15, 10, 9, 6, 6 and 9 positive residues 
respectively (Figure 6.11). The IBP2 protein (intracellular peptide transporter) 
produced 3 different epitopes which together cover a larger area on HIR 
compare to the IBP1, IBP2 epitopes occurring at residues 620-646, 558-587 
and 451-474 of HIR possessing 8, 8 and 8 identical residues as well as 13, 14 
and 13 positive residues respectively. The IBP3 (transmembrane peptide 
transporter protein) produced 2 putative epitopes occurring at residues 591-614 
producing 10 identical and 15 positive residues and residues 198-202 with just 
5 identical residues showing homology to HIR. 
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HIR 979 LRKRQPDGPLGPLYASSNPEYLSASDVFPCSVYVPDEW1016  
IBP1 60 LRHRQQ--PRGPFCDGSAPAHAAARFQYNRQTATDSEW 95  
                            + +    + 
 
HIR 780 PEEHRPFEKVVNKESLVISGLR 801     
IBP1 18 PAEHAMDASVARQRLGVGSGLR 39 
                     +              
 
HIR  742 VPRPSRKRR 750   641 LKWKPP 646 
IBP1 216 VPKPTRKRQ 224   235 LRWQPP 240                         
               +  +   +            + + 
 
HIR  595 TLVTFSDERRTY 606  316 PSGYTMNSSNLLCTP 330 
IBP1 113 TTAVFSDPDTTY 124  100 PSEQTLNLYNPVYTP 114 
                                    +     + 
                      
 
HIR 620  TNPSVPLDPISVSNSSSQIILKWKPPS 646 
IBP2 217 SDPSIDSTRIGVEVADRIVTLSGHPPS 43 
         ++  +         +   + 
 
HIR 558 VVDIDPPLRSNDPKSQNHPGWLMRGLKPWT 587 
IBP2 64 VVDMTVHLPDDDVRTDEDIAKAVRSVLHWT 93 
           +      +  ++       +  +         
                             
HIR  451 GKLFFHYNPKLCLSEIHKMEEVSG 474 
IBP2 114 GKVDWAYQSHLAVRAISQMRSVTG 137   
           + +       +    +    +                        
       
                        
HIR 591 IFVKTLVTFSDERR--TYGAKSDIIY 614 
IBP3 35 LFMVDRLGFTDSHANLTWGAFTALVY 60 
          +   +          +   +  + 
 
HIR  244 SQPDD 248 
IBP3 198 SQPDD 202          
 
 
Figure 6.11: Amino acid sequence homology between IBP(s) in B. multivorans 
and HIR using Blast P2 software, + refers to the positive amino acids with same 
polarity.  
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Table 6.1: Epitopes extracted from B. multivorans IBP(s), sequences and 
position on HIR. The black highlighted letters refer to positive amino acids.  
 
Epitopes  Position 
on HIR  
Similarity % 
 
Sequences  
IBP1-E1 794-801 60 KESLVISGLR 
IBP1-E2 742-750 100 VPRPSRKRR  
IBP1-E3 641-646 100 LKWKPP  
IBP1-E4 698-606 55.5 FSDERRTY 
IBP2-E5 558-565 62.5 VVDIDPPL 
IBP2-E6 466-474 66.66 IHKMEEVSG 
IBP3-E7 605-614 80 TYGAKSDIIY  
IBP3-E8 244-248 100 SQPDD  
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6.4 Discussion  
The construction of a genomic library in this study allowed the identification of 
IBP genes in Burkholderia and the determination of their amino acids 
sequences. Additionally, sequence homology between the human insulin 
receptor and Burkholderia IBP(s) was also facilitated. The molecular mimicries 
between HIR and Burkholderia IBP(s) may initiate an autoimmune response 
against human insulin receptor or insulin hormone and subsequently initiate 
diabetes, particularly in the case of CF patients suffering chronic infection with 
B. cepacia complex.  
The western ligand binding of solubilized proteins extracted from confluent 
lysates showed 3 additional proteins with molecular weight up 30 kDa or more 
bands particularly in p1 (Appendix 2). The insulin binding multiple bands are 
attributed to be chimerical proteins including peptide fractions from β-
galactosidase protein as confirmed by study of Coulton et al (1986). Also, 
production of recombinant IBP is achieved by inducing the promoter of β-
galactosidase possessing IBP in its sequence. Southern blotting using the p2 
probe indicated one positive band on Burkholderia DNA referred to sequences 
occurred on continuous chromosomal region, whereas, the p1 probe identified 
two bands which probably resulted from ligation of two fragments of B. 
multivorans DNA belonging to different places on the chromosomal DNA .  
Sequences determination of IBP(s) encoding genes in recombinant phagemids 
p1 and p2 was the major goal of this chapter‘s work. Expressing p1 and p2 in 
E.coli and then western ligand blotting results have clearly indicated a protein 
band produced by p1 (IBP1) with an apparent MW of 30 kDa. Whereas, p2 
expressed a couple of IBPs (IBP2 & IBP3) with theoretical MW of 20 & 30 kDa 
respectively which suggested that more than one IBP in B. multivorans.  
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The recombinant phagemids were sequenced and analysed. Sequence 
analysis identified 3 ORFs 1, 2 and 3 in the insert of the recombinant phagemid 
p1, all of which are involved in the synthesis, production and binding of iron 
siderophore compounds. ORF1 and 2 appear to be involved in the Ornibactin 
siderophore pathway (synthesis and regulation). Nucleotide sequence blasts of 
ORF1 proved that the sequence is ornibactin synthatase (OrbF) which plays a 
role in the release of iron from the ornibactin structure. ORF2 encodes Acetyl 
CoA: N6-hydroxylysine acetyl transferase gene (OrbL) of B. multivorans which 
is functionally connected to the ornibactin synthetase (Figure 6.12 B) (Agnoli et 
al., 2006; Yuhara et al., 2008) controlling transcription of genes responsible for 
ornibactin modification (Thomas, 2006). This study suggests that ORF1 & 2 
belong to genes involved in ornibactin siderophore pathway indicating putative 
intracellular functions without extracellular ligand binding components. 
Therefore, ORF1 and ORF2 are not likely to be directly involved in insulin 
binding at the cell membrane. The ORF3 sequence analysis determined start 
and stops codons, -35, -10 and SD motifs and encoded a 32.7 kDa protein 
(IBP1) and corresponded to the sequence of an Iron complex outer membrane 
receptor, or TonB siderophore dependent receptor (orbA) (Figure 6.12 B).  
The Blast p result of the translated protein of this sequence showed precisely 
that this protein represents a receptor for ornibactin siderophore. The iron 
complex outer membrane receptor comprises the iron chelated onto the 
siderophore complex receptor (Yuhara et al., 2008) . 
Western ligand blotting of E. coli recombinant with p1 produced a protein with 
MW approximately 30 kDa (Figure 6.1) which could represent a subunit of the 
ornibactin receptor (total MW of 78 kDa) (Sokol et al., 2000; Thomas, 2006) or 
could be a novel siderophore -like receptor protein. The blast results suggest 
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that the protein is an outer-membrane receptor protein, therefore, more likely to 
be one of the IBP(s). The Blast-n result also showed homology with the TonB 
siderophore dependent receptor which has been identified in many Gram 
negative bacteria to transport siderophore and Vitamin B12 from the outer 
membrane receptor to periplasmic space (Moeck and Coulton, 1998; Alice et 
al., 2006). The results also show the presence of a transmembrane α-helix 
domain (Figure 6. 10) suggesting that this protein is one of the transmembrane 
proteins whereas, no transmembrane α-helices were detected in the other 
proteins encoded by p1 ORFs.  
Iron plays a crucial role in modulating many virulence factor pathways and the 
genus Burkholderia produces up to four types of siderophore; pyochelin, 
ornibactin, cepabactin and cepachline (Crosa, 1989; Smalley et al., 2001). 
Ornibactin harbours a tetra peptide with two hydroxate groups and a single 
hydroxycarboxylate group. The main structure includes C-terminal ornithine, D-
aspartate with serine residue and threonine and N ornithine in addition to an 
acyl group that normally provides a carbon chain length of 4 or 6 or 8 which 
gives three types of ornibactin (Figure 6.12 A) (Stephan et al., 1993; Agnoli et 
al., 2006).  
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         R= CH3–, or CH3–CH2–CH2–, or CH3–CH2–CH2–CH2–CH2– 
 
 
 
Figure 6.12: Schematic diagram showing biosynthesis of Ornibactin 
siderophore of B multivorans (A) Ornibactin structure and carbon chain 
represented by R group. (B) Ornibactin biosynthesis and extra cellular 
ornibactin complex receptor ORBA that using TonB complex. Transport of ferric 
–ornibactin across the inner membrane (IM) requires a permease consisting of 
OrbB, OrbC and OrbD and the ferric ion is released by the action of OrbF. The 
amino acid precursors are modified by PvdA, PvdF, OrbG, OrbK and OrbL and 
converted into ornibactin by OrbI and OrbJ, adapted from Thomas (2006) . 
A 
B 
                                                                                                                                         Chapter 6 
209 
 
ORFs analysis of the p2 insert DNA sequence presented four open reading 
frames 1, 2, 3 and 4, ORF1 sequence (23 kDa) showed full gene motifs. The 
Blast-n result of ORF1 nucleotides showed similarity with periplasmic secreted 
lipoprotein or transporter-associated protein of B. multivorans and species of 
the same genus only (Figure 6.9 A). The protein encoded by ORF1 presumably 
represents a new member of the transporter system that appeared in Gram 
negative bacteria which exports molecules and toxic substances across the two 
membranes of the cell envelope (Paulsen et al., 1997; Tomii and Kanehisa, 
1998). Structurally, this peptide transporter system consists of four membrane 
associated domains, two of which are highly hydrophobic and two are located at 
the cytoplasmic face of the plasma membrane (Paulsen et al., 1997). 
In Gram negative bacteria the peptide transporter requires a substrate binding 
protein located in the periplasmic space or associated with the extracellular face 
of the plasma membrane (Steiner et al., 1995; Daniel et al., 2006). The blast 
results have shown that the protein encoded by ORF1 is IBP2 a peptide 
transporter with domain of proton-dependent oligopeptide transporter (POT) 
family the primary function of which is thought to be the transport of peptides or 
amino acid as nitrogen source and this peptide transporter has been involved in 
the recycling of cell wall peptides (Steiner et al., 1995; Yen et al., 2002). The α-
helix transmembrane domain prediction showed no transmembrane domain 
(Figure 6.10) suggesting this protein is one of the soluble transporters that work 
intracellular which subsequently confirm the blast results indicating that this is a 
periplasmic transporter.  
The periplasmic peptide transporter requires a membrane transporter or domain 
that mediates the peptide transportation from the environment outside the cells 
to the periplasmic and then to the cytoplasm. ORF2 encodes a 31.7 kDa protein 
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(IBP3), a transmembrane peptide transporter belonging to the proton amino- 
acid, oligopeptide transporters family of Burkholderia species (Figure 6.9 B). It 
contains a 9 α-helix domains (Figure 6.10) which can bind peptides and 
represents a typical transmembrane protein with a binding site. The POT 
transporter family is a group of ion-dependent peptide transporters derived from 
the ABC – transporters. This type of transporter has 2 highly hydrophobic 
transmembrane domains which were previously only seen in eukaryotic  
Saccharomyces cerevisiae and Candida albicans, but recently have been 
discovered in a limited number of bacterial species and other  prokaryotic cells 
(Tomii and Kanehisa, 1998; Saier, 2000; Preveral et al., 2009).  
The POT transporter is relatively different from those in eukaryotic as the 
bacterial transporter requires a peptide binding protein located in the 
periplasmic space cooperatively associated with extracellular transport (Chiang 
et al., 2004; Ronnestad et al., 2007). In the case of this study the IBP3 is likely 
to be a transmembrane peptide transporter which binds insulin and transports it 
to the periplasmic space, from which the insulin will be immobilised for 
hydrolysis and then transportation of amino acids is achieved by another type of 
cytoplasmic transporter (Figure 6.13). The current theory could also explain 
binding of insulin to fungi and yeast including other types of microorganisms.  
Moreover, it has been established that B. cepacia can utilize insulin as carbon 
energy source a (Jeromson et al., 1999). The Blast-n result of p2 ORF3 
nucleotides showed homology with serine/ threonine protein phosphatase 1 of 
B. multivorans. The serine /threonine protein phosphatase1 (PP1) can act in 
opposition to serine/threonine kinase and there is no obvious role for these 
proteins that has been found in Burkholderia. However, the role of 
serine/threonine kinases-phosphatase has been demonstrated as part of ATP 
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Figure 6.13: Schematic graph showing the peptide transportation across Gram 
negative bacteria as described by Steiner et al 1995. Transportation poly 
peptides firstly achieved by binding on to transmembrane transporter which 
then transport the polypeptides or oligo peptides to the periplasmic space in 
which the periplasmic transporter followed by peptide degradation producing 
amino acids or small oligo peptides ready to transport and use as energy 
source.  
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 cassette binding transporter (ABC transporter) gene in which the phosphatase 
encoded gene is always located adjacent to the transporter protein gene 
prompting a possible role in membrane transporters in Mycobacterium. More 
direct evidence has been provided about the involvement of serine /threonine 
kinases in the pathogenicity of M. tuberculosis and serine/threonine kinase / 
phosphatase was found on Streptococcus aglactiae membranes and the 
envelope of S. pneumonia, (Cozzone et al., 2004; Cozzone, 2005).  
This study suggests that the recombinant phagemid p2 carrying a transporter 
operon gene encoding the transmembrane transporter protein (IBP3) and 
periplasmic transporter protein (IBP2) controlled by a regulatory signal 
transduction enzyme (serine/threonine phosphatase). Thus, ORF3 is suggested 
to be a member of the signal transduction system which regulates a series of 
biological functions that are connected with cell wall receptors leading to insulin 
binding on the B. multivorans outer membrane. Furthermore, PP1 has been 
found in the nucleus of eukaryotic cells involved in many different cellular 
processes such as glycogen metabolism, calcium transport protein synthesis 
and intracellular transport (Stefaan and Brian, 1995). The Blast result also 
matches a Metallophosphoesterase or RES protein domain (accession number 
CP000869.1) part of a super family playing a key physiological role in the 
cellular pathway of signal transduction e.g. phosphoprotein phosphatase and 
DNA repair (DNA nuclease ) (Keppetipola and Shuman, 2008). However, ORF3 
is also suggested to be a member of the signal transduction system that 
regulates a series of biological activities connected with cell wall receptors 
leading to insulin binding on the B. multivorans cell wall. 
The current study identified for the first time that insulin binds to either the 
transmembrane ornibactin siderophore receptor (IBP1) of B. multivorans or a 
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member of the iron uptake system and is consistent to what was found in A. 
salmonicida, in which the A-layer is also involved in siderophore intake, as well 
as binding insulin. Moreover, insulin binding with a transmembrane protein on 
B. multivorans may also be attributed to the transmembrane oligopeptide 
transporter (IBP3) activity working cooperatively within a periplasmic 
oligopeptide transporter protein (IBP2) to utilize the oligopeptides like insulin as 
amino acid or nitrogen sources.  
The blast results also showed molecular mimicries shared between HIR and 
translated IBP(s) like IBP1-E2, IBP1-E3, IBP2-E6 and IBP3-E8 which may 
contribute to development of diabetic autoimmune response against HIR 
particularly in CF suffers with B. multivorans species. During infection there is 
also the chance to present the insulin bound on Burkholderia by antigen 
presenting cells (APC) as a foreign antigen leading to a diabetic immune 
response against insulin. Burkholderia IBP epitopes, or insulin bound to IBP‘s, 
could be presented by the MHC-II molecules of APC to the T- cell CD4 initiating 
the B-lymphocytes to produce antibodies, moreover Burkholderia can live 
intracellualrly inside macrophages and lung epithelial cells which will then 
present the IBP(s) epitopes via MHC-I to the T-cell CD8 and subsequently 
induce a cytotoxic T-cell leading to β-cell death. 
The current study suggests binding of insulin to B. multivorans via the ornibactin 
receptor siderophore receptor can occur which may mean that extracellular 
siderophore can bind with HIR and subsequently impede insulin binding to its 
intended receptor leading to inhibition of the glucose metabolism signal which 
causes apoptosis or insulin resistance particularly in pancreatic β-cells. 
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Chapter 7 
Molecular cloning of β-cell antigen glutamic acid decarboxylase  
(GAD65) using Halo tag technology, expression & purification 
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7.1 Introduction 
Autoimmune disease is an immune response driven by self- components, 
leading to the creation of autoantibodies against self-antigens. T1D is 
commonly attributed to a genetic susceptibility of the HLA genes, particularly 
HLA-DQ2 and HLA-DQ8, which are recently reported to contribute up to 90 % 
of the risk of developing T1D (van Lummel et al., 2011). In addition, a diabetic 
autoimmune response is also linked to T2D. However, the immune response 
initiators are still unclear (Lernmark, 2011). GAD65 auto-antibodies target 
epitopes, linear and conformational, distributed over the whole protein 
backbone, however, these epitopes or similar ones may occur in 
microorganisms, which raises the potential risk that these microbes could be 
environmental factors contributing to diabetic autoimmune responses via 
molecular mimicries (Judkowski et al., 2004). Studies of the GAD65 
autoantibodies from type1 diabetes patient‘s blood have purified GAD65 
autoantibodies and used them for detecting sequences involved in 
autoimmunity.  
The aim of the present study was to investigate the prevalence of molecular 
mimicries of the pancreatic GAD65 antigen in selected species of 
microorganisms, particularly bacterial species. So that a GAD65 antiserum or a 
GAD65 polyclonal antibody that covers the full length of the GAD65 was 
prepared in order to identify all possible epitopes with homology to the full 
length of GAD65. A search was made for microbial proteins presenting similar 
epitopes to GAD65 by creating GAD65 antiserum and using this antiserum to 
search the microorganisms for cross-reaction. Highly purified GAD65 antigen 
protein was prepared using Halo-tag technology, using the rat GAD65 gene 
cloned using PCR.  
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PCR cloning is a very powerful and common technique, fast and specific to the 
target clone gene with a particular function and for protein purification. The 
technique involves the use of PCR primers which recognize sequences flanking 
the ORF of the gene to be cloned. Those PCR primers have extra short DNA 
sequences with restriction enzyme sites incorporated into primer sequences 
(Wong, 2006). The GAD65 nucleotide reading frame sequence was inserted in 
frame with the halo-tag encoding sequence to produce a GAD65 –halo tag 
labelled protein (Promega, UK). 
Firstly, total RNA extracted from pancreatic β-cells (INS-1) was used to create 
total cDNA. Next, the GAD65 encoding sequence was amplified using specific 
primers which encoding restriction sites for both sides (N & C –terminals). The 
GAD65 reading frame amplicon was cloned into the expression vector pFN22A 
incorporated within the Halo tag sequences. The halo link has a protease 
digestible site to liberate expressed GAD65 protein during purification steps. 
The recombinant plasmid was then used to express GAD65 as a fusion protein 
in two cell systems; E. coli JM109 and a mammalian cell line (CHO). The fusion 
protein that was expressed (GAD65-Halotag fusion protein) was purified using 
an affinity chromatography to liberate GAD65 protein. The purified GAD65 was 
utilized to produce the GAD65 antiserum which was used to screen proteins of 
different types of microorganism for cross reaction (Figure 7.1).  
7.2 Materials and Methods  
7.2.1 Cell culture  
INS-1 and CHO were cultured and passage as detailed in Sections, 2.3.1 & 
2.3.2 respectively. 
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Figure 7.1: Flow chart illustrating the steps for cloning the GAD gene, 
production and purification of the GAD protein and raising polyclonal GAD 
antiserum which was used to screen microbial proteins followed by identifying 
the protein which can cross erect within GAD antiserum.  
Cloning GAD from pancreatic cells rat INS-1 
GAD protein expression & Purification 
Raise polyclonal GAD antiserum  
Screening microbial protein   
Pick proteins of interest    
Matrix Assisted Laser Desorption 
Ionisation Tandem mass spectrometry 
(MALDI -MS/MS)    
Determination of protein ID    
E coli  CHO 
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7.2.2 Molecular cloning of GAD65 gene 
7.2.2.1 Synthesizing total cDNA of INS-1 cells 
Total RNA was extracted from 107 cells of INS-1 as described in section 2.6.1. 
The RNA concentration was measured using a Nanodrop spectrophotometer 
(Section 2.5.5) and 4 µg of RNA was used to synthesize cDNA by mixing with 
1µl of oligo-dT primers (0.5 µg/µl) in a 200 µl PCR tube (Nuclease free). Tubes 
were tightly closed and put in a preheated thermal cycler PCR block at 72 °C for 
5 min, after which placed on ice water for 5 min, and then centrifuged at 10000 
× g for 10 sec to collect the mixture and stored on ice until used. 
Avian Myeloblastosis Virus (AMV) Reverse Transcriptase mix (200 U/µl) 
(Promega, UK) was prepared to synthesize the total cDNA by mixing the 
following components to a final volume of 15µl 
GO scripts reaction buffer (5X)  4 µl 
MgCl2 (25 mM)     3 µl 
Go Script reverse transcriptase  1 µl 
dNTPs (10mM)     1 µl 
MBW       6 µl 
Next, 5 µl (1000 ng/µl ) of the RNA mixture was mixed with 15 µl of reverse 
transcriptase mixture in microcentrifuge tubes (1.5 ml) (final volume 20 µl) and 
briefly centrifuged for a few seconds to collect the mixture to the tube bottom. 
Tubes were incubated in a preheated thermal cycler block for 5 min at 25 °C 
followed by 1 h incubation at 42 °C and 15 min at 70 °C for thermal inactivation 
of reverse transcription.  
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7.2.2.2 Amplification of GAD65 gene and optimisation of PCR condition 
A pair of primers was used to clone the GAD65 gene from INS-1 cells and 
producing sticky ends compatible with the ends of the Flexi cloning vector 
pFN22A (Promega, UK). The forward and reverse primers for the GAD65 gene 
were designed using online software provided by promega online services  
http://www.promega.com/techserv/tools/FlexiVectorTool/default.aspx.The 
forward primer had 35 bases and a SgfI restriction site, 5`-GCGT GCGA TCGC 
CATG GCAT CTCC GGGC TCTG GCT-3`, and the reverse primer had 45 
bases and a PmeI restriction site 5`- GCAG GTTT AAAC CAAA TCTT GTCC 
CAGG CGTT CGAT TTCT TCAA TG -3`. The PCR amplifications were 
performed using cDNA prepared previously (Section 7.2.2.1) and either 2 or 5 µl 
of total cDNA were mixed with 45 µl of the following master mix and MBW water 
added to total volume 50 µl.  
cDNA      2 or 5 µl 
F/primer (10 µM)    1 µl 
R/primer (10 µM)   1 µl 
dNTPs     1 µl 
GoTaq DNA polymerase   0.25 µl 
GOTaq buffer    10 µl 
MBW to final volume   50 µl 
The PCR was started at 94 °C for 2 min to denature the DNA followed by 30 
cycles set at 94 °C for 1 min, and different annealing temperatures were used 
60, 65, 67 or 69 °C for 1min followed by extension steps at 72 °C for 2 min. The 
products were separated in 0.8 % agarose gel electrophoresis (Section 2.5.6) 
and the bands that appeared at expected molecular size were excised from the 
gel and extracted using a clean-up system (Section 2.5.7). The purified 
products were used in the follow cloning protocol. 
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7.2.2.3 Cloning the GAD65 products into Halo tag Flexi vector pFN22A 
Flexi vector pFN22A was used to facilitate production of a fusion protein 
containing the halo-tag protein linked to the GAD65 protein. The GAD65 
amplicon produced by PCR (Section 7.2.2.2) was quantified, and its purity 
assessed (Section 2.5.5). The GAD65 DNA quality was confirmed by running 
aliquots in 0.8 % agarose gel and then stored at - 20 °C until used.  
7.2.2.4 Restriction digestion of GAD65 PCR product and pFN22A vector  
The purified GAD65 PCR product and pFN22A were digested using double 
digestion with restriction enzymes SgfI and PmeI in microcentrifuge tubes using 
following reaction components in a final volume of 20 µl. 
Flexi Digest Buffer (5X)   4µl 
GAD65 PCR Product   4µl (77 ng) 
pFN22A     2µl (200 ng) 
SgfI & PmeI     2µl (20 unit)  
MBW      8µl 
GAD65 and pFN22A digestion mixtures were incubated at 37 °C for 30 min, or 
15 min, respectively, after which both were placed at 65 °C for 20 min to 
inactivate the restriction enzymes and samples were run into an agarose gel. 
The digested GAD65 and plasmid DNA were treated using a PCR clean up kit 
(Section 2.5.7), and the purified products were quantified and checked again 
into an agarose gel. The samples stocks were stored in ice until ligation. 
7.2.2.5 Ligation of GAD65 PCR product into the pFN22A  
The ligation of these components was performed in a 1.5 ml microcentrifuge 
tube using the following mixture to final reaction volume of 20 µl. 
 
 
                                                                                                                                         Chapter 7 
221 
Ligase buffer (2X)    10µl 
pFN22A     1µl (50 ng) 
GAD DNA    1µl (75 ng)        
T4 DNA ligase   2µl (6 unit) 
MBW     6µl 
Tubes were incubated at room temperature for 1 h and some were left at 4 °C 
overnight. Next, ligation mixtures were used to transform E. coli JM109 
competent cells (Section 2.7.3) and samples were plated on LB plates with 
ampicillin (100 µg/ml). 
7.2.3 Screening transformants for recombinant plasmids  
7.2.3.1 Screening E. coli transformants for GAD65 recombinants 
Transformed colonies appeared on ampicillin plates after 24 h and were 
screened for plasmids with GAD65 inserts. Colonies were streaked onto 
ampicillin plates and single colonies were grown in LB broth overnight at 37 ºC. 
Plasmids were extracted using alkaline lysis method (Section 2.5.3) and run into 
0.8 % agarose gels alongside with non-recombinant pFN22A. Recombinants 
showing a higher molecular weight comparable to the plasmid control were 
used for further analysis.  
7.2.3.2 Screening recombinant plasmids using restriction enzymes 
Inserts in the recombinant plasmids were excised using the restriction enzymes 
SgfI and PmeI. Plasmid DNA digestions were performed in 1.5 ml of 
microcentrifuge tubes in a final volume of 20 µl containing.  
Digestion buffer (5x )  4 µl 
SgfI & PmeI enzyme  0.5 µl (20 U/µl) 
Plasmid DNA  5 µl (250 ng) 
MBW    10.5 µl 
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Samples were mixed thoroughly by pipetting and samples were incubated at 
37 °C for 2 h, followed by 65 °C for 10 min, and then chilled on ice for 5 min. 
Next, 5 µl of loading buffer was added and samples were loaded and run into 
agarose gels. 
7.2.3.3 Screening recombinant plasmids using PCR   
The GAD65 inserts were also checked using PCR amplification. Reactions were 
performed in PCR tubes (0.2 ml) using 2 µl of diluted plasmid DNA (20 ng/µl) as 
template and 48 µl of master mix (Section 7.2.2 2) making a final volume of 50 
µl. Amplification was carried out using the following conditions; denaturing at 
94 °C for 2 min followed by 30 cycles of 94 °C for 1 min, 69 °C for 2 min and 
72 °C for 2 min. The products were separated by 0.8% agarose gel 
electrophoresis and the images were captured. 
7.2.3.4 Preliminary checking of the GAD65 sequence by Bgl II digestion 
In order to confirm whether the PCR product amplified (Section 7.2.3.3) was for 
the GAD65 gene sequence, the GAD65 mRNA sequence was used to 
determine a theoretical restriction map using the EBI software online, this 
predicted the number and size of fragments after digestion with restriction 
enzyme. Restriction analysis revealed a restriction site for the restriction 
enzyme by Bgl II cleaving the GAD65 amplified gene sequence into two 
fragments (1073 bp and 694 bp). The PCR amplified products resulting from 
amplification of GAD65 recombinant plasmid were purified using the PCR 
product clean-up system (Section 2.5.7). The purified DNA was digested using 
Bgl II as previously described in Section 2.5.8 and the product run into an 
agarose gel.   
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7.2.3.5 Sequencing & sequence analysis of GAD65 recombinant plasmids  
The recombinant plasmids were commercially sequenced using the MWG 
Eurofins read value service (MWG, Germany ) for sequencing using the reverse 
reading primer associated with the pFN22A vector, 5-CTTC CTTT CGGG CTTT 
GTTAG-3. The second primer (reverse) was designed in this study, 5-ACGT 
GAAT GCGA TGAG CCTG-3. The sequences were analysed by Blast –n and 
checked for ORF, stop codon, and the fusion region, confirming the amino acid 
sequence of the TEV protease digestible site, furthermore, the sequences were 
carefully checked for mutations. 
7.2.4 Expression and purification of Halo-tag GAD65  
The successful recombinant plasmid pG1 (pF22A-GAD65) has T7 and cMVd1 
promoters allowing transcription and expression of the cloned gene in two hosts, 
E. coli and mammalian CHO, respectively. The GAD65-Halo tag protein was 
purified by affinity chromatography resin system (Promega, UK). In this 
technique the Halo tag sequence of the engineered GAD65 binds covalently 
and specifically to the affinity resin, allowing stringent washing for unbound 
protein. The GAD65 could then be released from the halo-tag protein with TEV 
protease. TEV protease was easily removed from the protein of interest as the 
TEV has a N-terminal histidine tag that binds to the His link resin and allows 
recovery of the purified protein.  
7.2.4.1 Expression and extraction of engineered GAD65 from E. coli JM109 
A single colony from a fresh culture of recombinant E. coli - pG1 was used to 
inoculate 10 ml volumes of LB medium containing 100 mg/ml ampicillin and 
0.05% glucose, with and without rhamnose (which was used as a stimulator for 
the T7 promoter) and incubated overnight at 37 °C with 120 rpm shaking speed.  
Cultures (0.5 ml) was used to inoculate 50 ml volumes of LB medium and 
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incubated overnight as before. The cells were collected by centrifugation at 
4000 × g for 20 min at 4 °C. Next, cells were suspended in 5 ml protein 
extraction buffer (Appendix 1) containing 100 µg/ml of lysozyme, 5µg/ml DNase 
I (final concentration) and 0.5 ml of protease inhibitor cocktail l (P8340, Sigma, 
UK), in conical tubes (20 ml) and sonicated on ice using 5 sec bursts with 5 sec 
cooling time for a total of 4 min. Afterwards, ATP and MgSO4 were added to a 
final concentration of 2 mM and 10 mM, respectively, and incubation was at 
37 °C for 10 min to dissociate the chaperonin proteins that bind the halo 
sequences during purification steps. The cell lysates were centrifuged at 10000 
× g for 30 min at 4 ºC and the supernatant transferred to a fresh 15 ml 
polypropylene tube and store at - 70 ºC until purification. 
7.2.4.2 CHO transfection optimisation   
The recombinant plasmid pG1 was also used to produce the GAD65-Halo tag 
fusion protein in mammalian host cells, Chinese hamster ovary cell line (CHO) 
by transfection in order to enhance the amount protein produced as it was more 
efficient in the mammalian cell in comparison to the E. coli. The transfection 
protocol used the chemical transfection reagent (TR) FUGENE HD (Promega, 
UK).  
The current study used transient transfection which allowed the highest number 
of transfectants to be available to produce an adequate amount of the GAD65 
protein. The transfection conditions were optimised to determine the appropriate 
amount of the TR producing the maximum of CHO transfectants cells. Tissue 
culture plates (96 well) were used to plate out the CHO cells to be transfected, 
using the protocol for adherent cells recommended by the supplier. CHO 
seeding density of 2×104 cell/well was used and incubation was as described 
(Section 2.3.2) for 24 h. Next, the depleted medium was replaced with 100 µl of 
                                                                                                                                         Chapter 7 
225 
fresh medium, followed by 2 µl of GAD65 recombinant plasmids pG1 DNA (200 
ng/ µl). Samples with different volumes of TR in separate wells to produce 
TR/DNA mixtures of 6:1, 5:1, 4:1, 3:1, 2:1 and 1:1 ratios to a final volume of 10 
µl in wells and incubated at room temperature for 15 min and then mixed briefly 
by pipetting. Alternatively, the TR/DNA mixture was added to the cells directly 
after removing the old medium and transfection was allowed for 10 min at RT 
and after that CHO growth medium was added and the plates were incubated 
for 48 h for expression. Total protein was extracted and subjected to dot blot to 
identify GAD65 expression. The TR/DNA ratio expressing the strongest reaction 
with GAD65 antibody was applied to large-scale production in 25 cm2 flasks. 
The total protein extracted from 107-109 CHO cell, were trypsinized (Section 
2.3.2) and resuspended in 2 ml of extraction buffer (Appendix 1) and subjected 
to sonication for 1 min as described in section 2.4.1. Afterwards, the cell lysates 
were mixed with 1ml of Triton –X100 (0.1%) and left on ice for 20 min and re-
sonicated as before, then centrifuged for 30 min for 10000 × g and the 
supernatant (2 µl) was checked for GAD production using dot blot and positive 
samples were stored at -70 ºC until purification. 
7.2.4.3 RT-PCR for GAD65 gene expression in CHO  
The TR/DNA ratio which produced the highest protein expression was used to 
assess GAD65 gene expression as a further confirmation for GAD65 
expression and transfection efficiency. CHO seeded in 6 well plate (106 cell / 
well) and transfection with pG1 applied using 3:1, 4:1, 5:1 or 6:1 TR/DNA 
mixture (Section 7.2.4.2). The total RNA was extracted and cDNA synthesised 
(Sections 2.6.1 & 2.6.2, respectively), PCR amplification was performed as 
described in 7.2.2.2. 
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7.2.4.4 Purification of GAD65 Halo Tag  
During the purification and cleaving process the protein lysates expressed by E. 
coli or CHO were treated separately and stored in separate tubes. The halotag 
purification system was used to purify the recombinant GAD65 using Halo Link 
Resin (Promega, UK) which has high affinity to halo tag sequence which was 
combined to the GAD65 sequence.  
Aliquots (4ml) of halo link resin were pipetted into 15 ml polypropylene tubes 
and centrifuged at 1000 × g for 5 min at RT, supernatants were discarded and 
resins were subjected to calibration steps. The resin equilibration was achieved 
by re-suspending the halo link resin in 10 ml of extraction buffer and mixing 
thoroughly until producing a homogenised suspension. Suspensions were spun 
at 1000 × g for 5 min and the supernatant removed. This step was repeated 
twice and after the third wash the resin was immediately mixed with 10 ml cell 
lysate of E. coli or CHO supernatant. Next, the lysate was resuspended by 
inverting the tube on a tube rotator for end over end mixing for 1 h at RT. Tubes 
were centrifuged as before and supernatants were transferred into fresh tubes 
and ATP and MgSO4 7H2O were added to a final concentration of 4 mM and 20 
mM, respectively. Tubes contents were mixed at RT for 30 min and the resin 
was then collected by centrifugation and washed 3 times with 10 ml volumes of 
extraction buffer as before.  
7.2.4.5 Cleavage of GAD65 Protein from the Halo tag  
After the third wash, the pelleted halo link resin was resuspended in 1.1 ml of 
TEV protease cleavage solution (Appendix 1) by pipetting until homogenised 
and transferred to a fresh 15 ml tube and incubated with agitation at RT for 1 h. 
After which, tubes were centrifuged at 3000 × g for 5 min and the supernatant 
was transferred to a fresh 15 ml tube. The resin was re-suspended again in 1 ml 
                                                                                                                                         Chapter 7 
227 
of extraction buffer for the second elution and mixed well by inverting and 
centrifuged as step before. Supernatant was added to the first elution sample to 
a 2 ml final volume. In order to remove the TEV residues, 50 µl of His link resin 
(resin has affinity to bind the TEV protease) was mixed with the eluted 
supernatants and mixed thoroughly at RT for 20 min. Next, the sample was 
centrifuged at 1000 × g for 5 min at 4 °C and the supernatant was aspirated off 
into a fresh 1.5 ml micro centrifuge tube. Protein samples from crude cell 
lysates and purified protein were subjected for characterisation.  
7.2.5 Characterization of the purified GAD65 protein  
7.2.5.1 SDS PAGE electrophoresis 
Aliquots of 12 µl of cleavage protein samples extracted from recombinant CHO 
and E. coli and were subjected to SDS-PAGE (Section 2.4.3) alongside protein 
standard markers (C1992, S8320 Sigma, UK) and total cell lysates for 
comparison. 
7.2.5.2 GAD65 protein Dot Blot 
Dot blots were performed using a Minifold I 96-Well Dot-Blot System 
(Schleicher & Schuell, Germany). Firstly the vacuum plenum was placed and 
then a filter support plate was placed on top followed by 10 × 12 cm of pre 
wetted Whatman filter paper. A piece of nitrocellulose membrane was cut to fit 
the 96-well block and soaked with washing buffer (Appendix 1) for 5 min. This 
was placed on the filter paper and the sample well plate was placed finally on 
top. Next, 2 µl of protein samples of transfected cell lysates and concentrated 
and diluted, purified GAD65 were loaded into the wells. Vacuum pressure was 
applied at 0.9 bars for 3 min and after the membrane was placed in 50 ml of 
blocking solution (Appendix 1) for 1.5 h with gentle shaking at RT.  
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The blocking solution was replaced with a fresh volume and the anti GAD65/67 
secondary antibody developed in rabbit (G6163 Sigma, Pool, UK detecting 
amino acids 570-585 DIDLIEEIERLGQDL on both types of GAD65) was added 
at 1:10000 and the membrane was incubated for 2 h with gentle shaking at RT.  
After that the blocking reagent was discarded and 100 ml of washing buffer was 
added to wash the membrane with shaking for 10 min at RT. The wash step 
was repeated for a total of 3 times. Next, anti-rabbit anti IgG antibody labelled 
with alkaline phosphatase (Sigma, Pool, UK) was mixed with 50 ml of washing 
solution to final concentration of 1:30000 and added to the membrane followed 
by incubation at RT for 1 h with gentle shaking. The membrane was washed as 
before and then 20 ml of alkaline phosphatase substrate (Appendix 1) was 
added and left for 24 h to visualize the protein antibody binding. Finally the 
membrane was dried out at RT and a digital image was captured. 
7.2.5.3 Quantification and concentration of the GAD65 protein  
The purified GAD65 protein concentration was measured using the Bradford 
method (Section 2.4.2) and the protein solution was concentrated using a 
centrifugal filter (Millipore, UK) reservoir type YM10, to obtain an appropriate 
concentration ( ≈1 mg/ml) adequate for a mouse immunisation protocol to 
produce GAD65 antiserum. Filters were inserted into 2 ml vial supplied with the 
kit and aliquots (500 µl) of each sample were pipetted into the reservoir tubes. 
The tubes were centrifuged for 30 min at 13000 × g in microcentrifuge, after 
which, the reservoir was removed from the vial and placed upside down into a 
fresh vial and centrifuged 3 min at 1000 × g. The reservoir was removed and 
the protein concentration measured and 2 µl samples were run into SDS-PAGE 
and the stock was kept at -20 °C until use.  
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7.2.6 GAD65 antiserum production and titration 
The purified protein GAD65 produced by mammalian CHO cells was used to 
produce the GAD65 antiserum. The antiserum was raised commercially using a 
Biogensis immunization protocol (Biogenesis, Germany). The GAD65 protein 
(1.2 mg/ml) was sent to the Biogenesis on dry ice. The immunization was 
performed using two mice according to a schedule over 49 days: -1st day – 1st 
immunisation/pre-immune serum (0.02 ml serum), 28th day -2nd immunisation , 
35th day – 3rd immunisation, 42nd day-4th immunisation, 49th day –final bleed (0.5 
ml serum). 
After 49 days, the GAD65 antiserum was received and divided into aliquots of 
50 µl stored in 200 µl microcentrifuge tubes at -20 °C. The optimum dilution of 
antiserum for detection purposes was determined using different dilutions of 
1:500, 1000, 2000, 4000, 6000, 8000 against 5 µg samples of GAD65 protein  
(prepared in Section 7.2.5.2) using dot blotting (Section 7.2.5.3). The optimum 
concentration was the dilution which gave the strongest reaction without 
background or nonspecific binding. Pre-immunisation serum was used as a 
control to check for nonspecific binding or nonspecific antibody cross reaction. 
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7.3 Results  
7.3.1 Cloning the GAD65 reading frame  
7.3.1.1 Amplification of the GAD65 reading Frame  
Total cDNA was synthesised from RNA of INS-1 cells and the full length GAD65 
reading frame was successfully amplified. PCR amplification of the GAD65 
reading frame sequence was optimised at different annealing temperatures 50, 
60 67 & 69 °C. The first three temperatures produced have shown additional 
DNA bands at about 0.5 kbp, in addition to the GAD65 band which appeared at 
the expected size of 1755 kbp. Furthermore, high primer dimmer was seen 
(Figure 7 .2 A, B and C). However, PCR amplification using 5 µl cDNA and 
69 °C annealing temperature produced a sharp and strong single band at the 
expected molecular size for the amplified GAD65 gene (Figure 7.2 D).  
7.3.1.2 Cloning the amplicon of GAD65 
The GAD65 PCR products amplified at 69 °C using Go tag DNA polymerase 
that produces an A overhang and SgfI and Pmel restriction site on both 5` and 
3` ends was purified using a PCR clean up kit. The highly pure samples were 
digested by restriction enzymes and separated by agarose gel electrophoresis 
and the GAD65 band was successfully recovered from the gel and purified.  
The vector pFN22A DNA was digested by SgfI and Pmel releasing the barnase 
gene band at 335 bp (Figure 7.3 lane 5 & 9), and the linear plasmid DNA was 
eluted from the gel and ligated within the GAD65 fragment to successfully 
produce recombinant pFN22A containing the GAD65 reading frame (instead of 
toxic barnase sequences), and recombinant plasmids were successfully 
transformed into E. coli JM109.  
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Figure 7.2: Amplification of the GAD65 reading frame by RT-PCR. Annealing 
temperature optimisation used 2 µl cDNA, at 60, 65 and 67 °C shown in A, B 
and C respectively and GAD65 amplification using 5 µl cDNA and  69 °C 
annealing temperature (D). 
A B 
C D 
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2 kbp 
1 kbp 
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7.3.1.3 Restriction digestion of recombinant plasmids  
Recombinant plasmids (pG1-pG20) were extracted from the transformants and 
samples were run into agarose gels. Plasmids with higher molecular weight 
(Appendix 2) then the vector only, were selected and digested with SgfI and 
Pmel. The results (Figure 7.3) show successful cloning and correct size inserts 
in 20 plasmids extracted from a total of 100 recombinant colonies subjected to 
screening. However, the majority of recombinant plasmids produced no inserts 
after restriction enzyme digestion examples are shown in Figure 7.4, lane 10 11, 
12. Example of recombinant plasmids producing the desired insert of GAD65 at 
the expected molecular size about 1755 bp are shown in Figure 7.4 lanes 2, 4, 
6, 7, 8.  
7.3.1.4 Preliminary checking of the GAD65 inserts  
The recombinant plasmids were subjected to PCR amplification for inserts 
representing the GAD65 encoding region, using the GAD65 primers used 
initially to amplify the GAD65 region from INS-1 cDNA. The amplification clearly 
produced a single band at the expected molecular size (1755 bp) (Figure 7.4 
lane 1&2), whereas, the plasmids which showed unsuccessful cloning after 
digestion produced a product at 600 bp (Figure 7.3 lane 3 & 4). In addition, the 
GAD65 region was double checked by digestion this PCR product by restriction 
enzymes as the GAD65 cDNA sequences supposed to produce two bands 
1073 bp and 694 bp after digestion with restriction enzyme Bgl II according to 
the cDNA restriction map of GAD65 region. The digestion of amplified DNA 
cloned in pG1-pG5 has shown two bands at the exact molecular size 
comparable to the1 kbp ladder (Figure 7.3 lane 7 & 9).  
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Figure 7.3: Preliminary identification of GAD65 encoding region from 
recombinants pG1 & pG2. Amplification GAD65 encoding region from pG1 & 
pG2 (lane 1 & 2) and unsuccessful cloned plasmids (lane 3 & 4) compare to the 
non-recombinant pFN22A (lane 5). The restriction digestion of GAD65 
amplicons DNA amplified from both PG1 & 2 using Bgl II (lane 7, 9) producing 
to DNA fragments 694 & 1073 respectively. 
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Figure 7.4: Excision of inserts from recombinant plasmid pG1-pG5 (lane 2, 4, 6, 
7 & 8) with SgfI and PmeI compared with recombinant undigested (lane 1&3) 
and digested the pFN22A (lane 5&9) producing barnase gene. Lane 10, 11 & 
12 show recombinant pFN22A with incorrect sequences or missing digestible 
sites. 
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7.3.2 GAD65 sequencing and sequence analysis  
Five recombinant plasmids (pG1-pG5) were sequenced and the results clearly 
confirmed the GAD65 1755 bp sequence was cloned. The full length of the 
GAD65 encoding sequence with sequence blast produced up to 100% similarity 
to GAD65 antigen cDNA from rat pancreatic β-cells (Figure 7.6). The blast 
results of the GAD65 sequence of pG1 and pG2 showed the full length 
sequences without any mutations or deletions which may impede the protein 
expression. However, the sequence analysis of the other plasmids (pG3, pG4 & 
pG5) expressed alteration in nucleotide sequences, as well as some deletions, 
creating different GAD65 reading frames. These were not used, sequencing 
results of pG1 & 2 showed no alteration of the TEV protease digestible 
encoding sequences.  
7.3.3 Selection of recombinant plasmids for expression  
Two recombinant plasmids (pG1 & pG2) carrying the GAD65 region with no 
sequence alteration producing correct GAD65 coding region were elected for 
protein production (Figure 7.5 A). However, recombinant plasmids pG1 & pG2 
produce full length sequences of GAD65 with no mutation or deletion (Figure 
7.6) in addition to the complete sequences of the digestible TEV protease site 
and SgfI & PmeI restriction sites (Figure 7.5 B). Plasmid pG1 was used to 
produce the GAD65 protein in both E. coli and CHO. 
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     Halo sequences      TEV site                   SgfI  
5'- 1080 CGAGCCAACC ACTGAGGATC TGTACTTTCA GAGCGTGCGAT/CGCCATGGCATCTCCG-3' 
                                         M    A   S   P  
              PmeI 
           5’- GCAGGTTT/A AAC CAA ATC TTG TCC CAG GCG TTC GAT-3' 
                                Stop codon    V     L     D      Q     G      L      R      E     I   
 
              
Figure 7.5: Schematic map of recombinant pG1 plasmid sequences (A), the 
map shows relevant sequences after the recombination halo tag and barnase 
gene (which was replaced by GAD65 region), TEV protease site and unique 
restriction sites of SgfI and Pmel and CMV and T7 promoters. The map 
achieved using full sequences of pG1 plasmid by using PlasMappar version 2 
(Dong et al., 2004). The full length sequences of restriction sites for SgfI & Pmel 
and TEV digestible site combined with halotag and GAD sequences (B).  
A 
B 
Halo-tag encoding region  
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1-ATGGCATCTCCGGGCTCTGGCTTTTGGTCCTTCGGATCTGAAGATGGCTCTGGGGATCCTGAGAAC 
  1- M--A--S--P--G--S--G--F--W--S--F--G--S--E--D--G--S--G--D--P--E--N--                                                   
 67 CCGGGAACAGCGAGAGCCTGGTGCCAGGTGGCCCAAAAGTTCACGGGCGGCATCGGAAACAAGCTA 
 23 -P--G--T--A--R--A--W--C--Q--V--A--Q--K--F--T--G--G--I--G--N--K--L--                                                                 
132 TGCGCTCTGCTCTACGGAGACTCTGAGAAGCCAGCAGAGAGCGGCGGGAGCGTGACCTCGCGGGCC 
 45 -C--A--L--L--Y--G--D--S--E--K--P--A--E--S--G--G--S--V--T--S--R--A--                                                                    
198 GCCACTCGGAAGGTCGCCTGCACCTGTGACCAAAAACCCTGCAGCTGCCCCAAAGGAGATGTCAAT 
 67 -A--T--R--K--V--A--C--T--C--D--Q--K--P--C--S--C--P--K--G--D--V--N--                                             
264 TATGCACTTCTCCACGCAACAGACCTGCTGCCAGCCTGTGAAGGAGAAAGGCCCACTCTCGCATTT 
89  -Y--A--L--L--H--A--T--D--L--L--P--A--C--E--G--E--R--P--T--L--A--F--                                                               
330 CTGCAAGATGTAATGAACATTTTGCTTCAGTACGTGGTGAAAAGTTTTGATAGATCAACTAAAGTG 
111 -L--Q--D--V--M--N--I--L--L--Q--Y--V--V--K--S--F--D--R--S--T--K--V--                                                         
396 ATTGATTTCCATTACCCCAATGAGCTTCTTCAAGAGTATAATTGGGAATTGGCAGACCAACCGCAA 
133 -I--D--F--H--Y--P--N--E--L--L--Q--E--Y--N--W--E--L--A--D--Q--P--Q--                                         
462 AATCTGGAGGAAATTTTGACGCACTGCCAAACAACTCTAAAATATGCGATTAAAACAGGGCATCCC 
155 -N--L--E--E--I--L--T--H--C--Q--T--T--L--K--Y--A--I--K--T--G--H--P--                                                                                                                                     
528 CGATATTTTAATCAGCTGTCTACCGGATTGGATATGGTTGGATTAGCAGCAGATTGGTTGACATCA 
177 -R--Y--F--N--Q--L--S--T--G--L--D--M--V--G--L--A--A--D--W--L--T--S--                                                       
594 ACAGCAAACACGAACATGTTTACCTATGAGATCGCCCCTGTATTTGTACTACTGGAATATGTGACA 
199 -T--A--N--T--N--M--F--T--Y--E--I--A--P--V--F--V--L--L--E--Y--V--T--                                                             
660 CTAAAGAAAATGAGGGAAATCATTGGCTGGCCAGGAGGCTCTGGCGATGGAATCTTTTCTCCTGGT 
221 -L--K--K--M--R--E--I--I--G--W--P--G--G--S--G--D--G--I--F--S--P--G--                                                                    
726 GGTGCCATCTCCAACATGTACGCCATGCTCATTGCCCGCTATAAGATGTTTCCAGAAGTCAAGGAA 
243 -G--A--I--S--N--M--Y--A--M--L--I--A--R--Y--K--M--F--P--E--V--K--E--                                                                    
792 AAGGGGATGGCGGCGGTGCCCAGGCTCATCGCATTCACGTCAGAGCATAGTCACTTTTCTCTCAAG 
265 -K--G--M--A--A--V--P--R--L--I--A--F--T--S--E--H--S--H--F--S--L--K--                                                                
858 AAGGGAGCTGCAGCCTTGGGGATCGGAACTGACAGCGTGATTCTGATTAAATGTGATGAGAGAGGG 
287 -K--G--A--A--A--L--G--I--G--T--D--S--V--I--L--I--K--C--D--E--R--G--                                                                    
924 AAAATGATCCCATCTGACCTTGAAAGAAGAATCCTTGAAGTCAAACAGAAAGGATTTGTTCCTTTC 
209 -K--M--I--P--S--D--L--E--R--R--I--L--E--V--K--Q--K--G--F--V--P--F--                                                               
990 CTGGTGAGTGCCACAGCTGGAACCACTGTGTACGGGGCTTTTGATCCTCTCTTGGCTGTAGCTGAC 
331 -L--V--S--A--T--A--G--T--T--V--Y--G--A--F--D--P--L--L--A--V--A--D--                                                             
1056 ATCTGCAAAAAATATAAGATCTGGATGCATGTGGATGCTGCTTGGGGTGGAGGGTTACTGATGTCT 
353  -I--C--K--K--Y--K--I--W--M--H--V--D--A--A--W--G--G--G--L--L--M--S--                                                                    
1122 CGGAAACACAAGTGGAAGCTGAACGGTGTGGAGAGGGCCAACTCTGTGACATGGAATCCCCACAAG 
375  –R--K--H--K--W--K--L--N--G--V--E--R--A--N--S--V--T--W--N--P--H--K--                                                                    
1188 ATGATGGGTGTCCCCTTGCAATGTTCGGCTCTCCTGGTCAGAGAGGAGGGACTGATGCAGAGCTGC 
397  -M--M--G--V--P--L--Q--C--S--A--L--L--V--R--E--E--G--L--M--Q--S--C--                                                                    
1254 AACCAGATGCATGCTTCCTACCTCTTTCAGCAAGATAAGCACTATGACCTGTCCTATGACACGGGA 
419  -N--Q--M--H--A--S--Y--L--F--Q--Q--D--K--H--Y--D--L--S--Y--D--T--G--                                                                   
1320 GACAAGGCCTTGCAGTGTGGACGCCACGTCGATGTCTTTAAATTATGGCTCATGTGGAGAGCAAAG 
441  -D--K--A--L--Q--C--G--R--H--V--D--V--F--K--L--W--L--M--W--R--A--K-                                                                    
1386 GGGACTACTGGATTTGAAGCTCACATTGATAAGTGTTTGGAGCTGGCAGAGTATTTATACAATATC 
463  -G--T--T--G--F--E--A--H--I--D--K--C--L--E--L--A--E--Y--L--Y--N--I--                                                                    
1452 ATTAAAAACCGAGAAGGATATGAAATGGTGTTCGATGGGAAGCCTCAGCACACAAATGTCTGCTTC 
485  -I--K--N--R--E--G--Y--E--M--V--F--D--G--K--P--Q---H--T--N--V--C--F--                                                                    
1518 TGGTTTGTACCTCCTAGTTTGCGAGTTCTGGAAGACAATGAAGAGAGAATGAGCCGCCTCTCAAAG 
507  -W--F--V--P--P--S--L--R--V--L--E--D--N--E--E--R--M--S--R--L--S--K--                                                                    
1584 GTGGCGCCAGTGATTAAAGCCAGAATGATGGAGTATGGGACCACAATGGTCAGCTACCAACCCTTA 
529  -V--A--P--V--I--K--A--R--M--M--E--Y--G--T--T--M--V--S--Y--Q--P--L--                                                                    
1650 GGAGATAAGGTCAACTTCTTCCGCATGGTCATCTCAAACCCTGCAGCAACTCACCAAGACATTGAC 
551  -G--D--K--V--N--F--F--R--M--V--I--S--N--P--A--A--T--H--Q--D--I--D--                                                                   
1716 TTCCTCATTGAAGAAATCGAACGCCTGGGACAAGATTTGTAA 
573  -F--L--I--E--E--I--E--R--L--G--Q--D--L  
                            
 
 
Figure 7.6: the GAD65 ORF sequence cloned into recombinant plasmid pG1 
expressing full length sequence 1755 bp and protein with 585 amino acids 
without any mutation confirming binding the GAD65 sequence.  
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7.3.4 Production and purification of GAD65 protein  
7.3.4.1 Expressing of recombinant GAD65 protein   
The recombinant plasmid pG1 encoding GAD65 was successfully transformed 
into competent E. coli JM109 and transformants were used to produce the 
protein intracellularly. Over expression of the GAD65 fusion protein was not 
toxic to the E. coli JM109 strain as the transformants grew, were grown properly 
in LB broth, with and without stimulators (rhamnose and glucose). The pG1 
plasmid was successfully transferred into CHO cells by a transient transfection 
protocol which was applied to express the GAD65 protein into CHO.   
The dot blot results showed a strong reaction of protein extracted from CHO 
cells treated with TR (3, 4, or 5 µl) and 200 ng plasmids as these concentrations 
produced strong dark blots. The CHO cells which were treated by the highest 
concentration of TR (6 µl) and lowest (1 or 2 µl) produced weak or no reaction 
(Figure 7.7). The TR/DNA complex which was added directly to the cells 
produced a strong reaction comparing the TR/DNA that mixed with growth 
medium. The dot blot of protein extracted from E. coli produced a strong 
reaction with GAD65 antibody compared to the samples extracted from 
transient transfection of CHO. 
7.3.4.2 GAD65 gene expression  
The CHO transfection efficiency was also measured by assaying GAD65 gene 
expression by RT-PCR. CHO transient transfection with recombinant plasmid 
pG1 was performed using the conditions producing strong reactions in the dot 
blot. Transfectants using TR/DNA 3:1, 4:1, 5:1, and 6:1 were used to assess the 
GAD65 gene expression. The recombinant CHO were grown in 96 well plates 
and subjected to the RT-PCR procedure. The results clearly shown bands of 
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the expected molecular size of GAD65, however, the strongest band was seen 
with amplified cDNA from samples treated with 1:4 µl TR/DNA (Figure 7.8). 
7.3.4.3 Extraction & purification of GAD65 protein  
The E. coli recombinant and transfected CHO cells were used to extract the 
engineered GAD65. E. coli transformants were grown and 100 ml of 
recombinant E. coli and 109 recombinant CHO were subjected separately to the 
purification procedure (7.2.4.4). The results show a recombinant protein of 97 
kDa was extracted successfully from both extracts (E. coli and CHO). The 
recombinant protein was composed of 65 kDa of GAD65 and 32 kDa of halo tag 
protein. The captured protein was cleaved by TVE protease to produce GAD65 
protein free from the halo link sequences and the results show clearly a protein 
with 65 kDa MW without any TVE contaminates which was removed from S-
TEV resin treatment (Section 7.2.4.5). However, the GAD65 purified protein 
concentration which was extracted from the transiently transfected CHO cell 
was relatively less than the amount of protein produced by E. coil. The CHO 
cells protein yield was 400 µg/ml, whereas, from E. coli it was about 1mg/ml. 
Therefore, the yield of purified protein was increased by concentration to 1.2 
mg/ml protein produced by CHO and 2.6 mg/ml of GAD65 protein produced by 
E. coli. Proteins were then subjected to the SDS-PAGE (Figure 7.9) and dot blot 
(Figure 7.10).  
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Figure 7.7: Dot blot of GAD65 protein expression showing optimization of 
transfection of CHO cells by pG1 recombinant plasmid screened without 
GAD65 antibody. Controls were CHO treated only by TR treated (1) and CHO 
treated by pG1 plasmid (200 ng) only (2). GAD65 protein expression from 
transfectants CHO (3, 4, 5, 6. 7 & 8) treated with TR/DNA 1:1, 2:1, 3:1, 4:1, 5:1 
and 6:1, respectively, detected by GAD65 antibody.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.8: RT-PCR of GAD65 gene expression in CHO transient transfectants 
carrying the GAD65 recombinant plasmid pG1. The lanes representing 
optimization of transfection for GAD65 gene expression using 200 ng plasmid 
DNA and 3,4,5 and 6 µl TR were produced in lanes 1,2,3,4 respectively and 
lane 5, 6 represents control treated DNA and control treated 3 µl transfection 
reagent, respectively.  
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Figure 7.9: SDS-PAGE of recombinant purified engineered 97 kDa Halo Tag -
GAD65 protein expressed in CHO cells and E. coli (lanes 1, 2 respectively), and 
the purified GAD65 after purification (lanes 3 & 4) total protein extracted from 
non-recombinant CHO (lane 5). 
 
 
 
 
 
 
Figure 7.10: Dot blot of GAD65 produced by CHO after protein concentration 
steps using 5 µl protein samples. 
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7.3.5 Titration of anti GAD65 antiserum  
The polyclonal sera were raised by Biogenes according to the immunization 
plan (Section 7.2.6). The serum was checked with the GAD65 protein produced 
by this study. GAD65 protein extracted from the INS-1 cells was used to titrate 
the serum producing strong reactions at dilution 1:500, 1:1000, Moderate 
reaction with 1:2000, 1:4000, and weak reaction at 1:6000 & 1:8000. The pre 
immune serum at 1:2000 dilution produced no reaction, as did the BSA protein 
as a negative control (Figure 7.11). Therefore, for the current study the 1:2000 
dilution was used for further studies. 
 
                                               
 
1:500         1:1000          1:2000         1:4000       1: 6000     1:8000 
 
 
                                   
 
Pre-immune sera (1:2000)       Control (BSA)         
 
 
Figure 7:11: Titration of the GAD65 antiserum using dilutions of antisera 
against the purified protein GAD65 produced in this study. Controls GAD65 
against pre immune sera (1:2000) and negative control for BSA. 
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7.4 Discussion  
GAD65 is an enzyme that catalyses the conversion of glutamic acid to amino 
butyric acid and CO2, GAD65 is a major autoantigen in T1D. The production 
and purification of this antigen has become a crucial initiative to researching the 
development of T1D and disease predication (Hagopian et al., 1993b; Zimmet, 
1996). Furthermore, GAD65 has been suggested as a therapeutic agent for 
T1D (Tuomilehto et al., 1994).  
The current study selected the GAD65 antigen amongst other pancreatic beta 
cell antigens to search for molecular mimicries in microorganisms (bacteria & 
yeast). GAD65 was chosen as it is one of the major β-cell antigens, and GAD65 
antibody is found in 70-80 % of T1D patients and predominantly seen against 
GAD65, developing as an autoimmune response (antibodies) during early 
childhood stages (Atkinson et al., 1990; Hagopian et al., 1993a; Hagopian et al., 
1993b; Myers et al., 2000). It was also verified that GAD65 autoimmunity 
mediates T2D in some cases producing latent antibodies diabetes mellitus 
(LADA) which has T2D symptoms leading to inhibition of insulin secretion and 
then develops T1D.  
The GAD65 enzymes function has been reported in a wide range of bacteria 
like E. coli, (Smith et al., 1992; Mulder, 2005), Lactobacillus (Kim et al., 2007), 
Bacteroides and Clostridium (Jilly et al., 1984) and some fungi such as yeast. 
Therefore, there was a possibility of molecular mimicries among the secondary 
structure of enzymes sharing similar function. For example, the secondary 
structure of GAD65 containing cofactor pyridoxal 5 phosphatase (PLP) binding 
domain sequence shares conformational epitopes (protein fold ) with other PLP 
depending proteins in bacteria such as the PLP sequence of ornithine 
decarboxylase and aspartate aminotransferase of Lactobacillus (Momany et al., 
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1995; Qu et al., 1998). Sequence similarity or linear epitopes were one of the 
main targets of this study, trying to find sequences similar between microbial 
proteins and beta cell GAD65 protein. The GAD65 antibodies (anti-serum) was 
used as a tool to search for proteins extracted from a range of microorganisms 
with epitopes that could play a role as initiators in the development of an 
autoimmune response. Consumption of food and water containing 
microorganisms and infections due to pathogenic bacteria were hypothesised 
as the main sources of exposure.  
 
The GAD65 antiserum (GAD65 polyclonal antibodies) was raised in this study 
to search for microbial proteins with GAD65 molecular mimicries. The Halo tag 
technology used cDNA library cloning or PCR cloning of the gene which 
encoded the GAD65 protein to produce the GAD65-halotag fusion protein. In 
the case of this study the GAD65 region was successfully amplified using 
primers having digestible restriction sites. The GAD65 reading frame was 
cloned within the halo tag of binary expression vector pFN22A. Recombinant 
plasmid pG1 transformed into the E. coli and transformation expressed a high 
number of transformants. However, some transformants had plasmids with no 
inserts or restriction digestion sites-missing plasmids post ligation (Figure 7.3 
lane 10, 11 & 12). The reason for this problem was the GAD65 fragments which 
were eluted from the gel after digestion which were contaminated with Exo-
nucleases diminishing the sticky ends of the insets and vector and creating a 
blunt end instead. To avoid this problem, the PCR products were re-purified 
using cleaning kit and checked aliquots into the agarose gel and used the rest 
in the digestion and ligation experiments which successfully produce highest 
number of recombinant plasmids. 
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The recombinant plasmids pG1 or pG2 successfully expressed GAD65 and 
showed similarity with GAD65 from pancreatic β-cells, corresponding to 95% for 
humans and 100% for rat GAD65 for the full length of the GAD65 sequences 
(1755 bp). The plasmid pG1 showed no mutation and was used to produce 
GAD65 protein.   
Recombinant pG1 encoding full length GAD65 (65 kDa) incorporated with halo-
tag protein encoding sequences (32 kDa) to produce the full length protein of 
GAD65-halo-tag protein (97 kDa). A two expression host system was used in 
this study, E. coli to produce the protein under the promoter T7, and CHO cells 
to produce protein in mammalian model under the cMVd1 promoter which is 
suitable for constitutive expression in mammalian cells. Transient transfection 
was used to express GAD65 in CHO as the plasmid pG1 has no selectable 
marker for selecting recombinants for permanent production. Therefore, CHO 
optimisation was performed for transfection ratio (DNA: TR) in order to 
determine the best conditions for producing a high number of transfectants and 
subsequently the highest protein concentration.  
GAD65 produced from different types of expression host, E. coli and CHO, was 
concentrated to 2.6 and 1.2 mg/ml respectively; however, GAD65 expressed in 
CHO, not from E coli, was used to prepare the GAD antiserum. The reason for 
this was to avoid any proteins of E coli contaminating the preparation which 
may be introduced during purification steps, which would produce antibody 
against E. coli antigens. This could have subsequently affect the results, as the 
GAD65 antiserum was used to screen microbial protein samples from different 
type of microorganisms including E. coli and other related species.  
The GAD65 protein in both forms 65 and 67 kDa encoding genes have been 
cloned previously by many studies and protein was produced extensively in 
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various types of microorganism especial E. coli (Huang et al., 1990; Yamashita 
et al., 1993; Park and Oh, 2007) as well as fungi and yeast like S. cerevisiae 
(Papakonstantinou et al., 2000).  
No complication was indicated in term of protein expression and post 
translational modification. The animal cells of which the monolayer adherent 
CHO cells are widely used to express various genes and recombinant proteins. 
Also, CHO has been used as animal model cells to express the cloned GAD65 
gene and GAD65 cDNA to study regulation mammalian expression of 
pancreatic and brain GAD65 and 67 (Papouchado et al., 1996; Schütt et al., 
1997). The studies also referred that expression GAD65 as fusion or tag protein 
has no effect on GAD65 enzymes catalytic activity or immune activity 
(Papakonstantinou et al., 2000). The current study has reported cloning and 
expression GAD65 from rat pancreatic cell INS-1 and expressing GAD65 
protein into either bacterial host (E. coli) or mammalian model (CHO) the 
GAD65 produced as tag protein (GAD65 + Halo tag sequences) designed for 
highly purified GAD65 protein. The Halo tag GAD65 provides the ability to 
produce abundant of GAD65 from transfectants bacterial or mammalian 
compare to GAD65 purification using GAD65 antibody which has been shown a 
limited amount produced by this method (Papakonstantinou et al., 2000). During 
this study the GAD65 antiserum was prepared to screen the microbial proteins 
for GAD molecular mimicries. 
The GAD65 protein, halo tag technology was efficiently used, in production 
GAD65 fusion protein with halo tag protein sequence. Affinity chromatography 
was used to prepare GAD65 free of the halo-tag. The full length of purified 
GAD65 antigen protein was used to develop GAD65 polyclonal antiserum. 
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Chapter 8 
Molecular mimicries epitopes between pancreatic antigen 
GAD65 and E. coli proteins 
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8.1 Introduction  
GAD65 is implicated in T1D formation via the development of autoimmunity 
against GAD65 in humans particularly in the early stages of childhood (Sabbah 
et al., 1996; Petersen et al., 1999; Bonifacio et al., 2000). Both humeral and T-
cell responses are involved and studies suggest microbial infection to be the 
main initiator of autoimmunity (Abulafia-Lapid et al., 2003; Fujinami et al., 2006).  
It has been proposed that molecular mimicries between the infections agents 
(bacteria and viruses) and the β-cell auto antigens are involved (Judkowski et 
al., 2004; Westall, 2006).  
This chapter continues on from work in chapter 7 in trying to identify bacteria 
with GAD65 molecular mimicries. The GAD65 antiserum prepared previously 
was used to examine proteins extracted from various types of bacteria and 
yeasts using a dot blot technique. Cross reacting positive protein samples were 
separated by SDS-PAGE in duplicate gels, one for blotting and a second was 
for staining and used to identify the corresponding positive blotted bands.  
Western blots were screened using GAD65 antiserum. Cross reacting proteins 
on blots were used to detect corresponding proteins on stained gels.  
These proteins were extracted from the gel and analysed by mass spectrometry 
(MS/MS). The MS data of each protein were used to search the MS database 
for exact protein identity and accession number. The full length sequences were 
extracted from the NCBI database and searched for similarity within GAD65 
protein sequences to find the linear epitopes between these proteins and 
GAD65. In addition, the number of identical and positive amino acids between 
bacterial epitopes and GAD65 protein were recorded and used to select 
possible epitopes. Such proteins may be classified as environmental factors, 
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which possibly contribute to the development of diabetes type 1 on the basis of 
molecular mimicry. 
8.1.1 Western blotting coupled proteomic technique  
Western blotting is an analytical technique that has been used for the last three 
decades to recognize certain protein sequences on antigens using specific 
antibody. The antibodies can recognize these epitopes or components amongst 
mixtures of biomolecules. In addition western blotting has also been used to 
identify particular components of protein structure, such as recognizing post 
translation modifications (Gravel, 2007).  
The basic principle of this technique is dependent on separating proteins by 
SDS-PAGE electrophoresis and then transferring these proteins to 
nitrocellulose membrane. Transferred protein (s) are detected by antibody and 
secondary antibody labelled with an enzyme and then a chromogenic substrate 
is used to detect enzyme activity and hence proteins of interest (Towbin et al., 
1979).  
Recently, recognition of proteins by western blotting has been enhanced by 
coupling blotting to 2 dimensional (2D) protein gel electrophoresis (Hu et al., 
2010). Proteins are run firstly into a pH gradient gel until all the proteins reach 
their PI, at which the protein‘s net charged will be zero, and proteins will now be 
separated according to molecular weight. Pieces of gel containing separated 
proteins are run horizontally into 1D SDS-PAGE. Proteins appear as dots which 
can be electro-transferred to a membrane and then detected using 
chemiluminescence or enzyme labelled antibody (O'connor and Hames, 2008). 
The positive binding of the antibody-antigen can be quantified.  
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8.1.2 The Proteomic Technique of Mass spectrometry  
Mass spectrometry (MS) is one of the analytical techniques which measures the 
mass/charge ratio of gas phases ion of protein peptide (Sparkman, 2000). The 
MS principle uses the ionization of chemical compounds to generate 
fragmented molecules, with particular charges and measures their mass-to-
charge ratios. Mass spectrometry is now used in a number of fields, including 
biochemistry (Siuzdak, 1994), biotechnology (Dalluge, 2000), microbiology 
(Seng et al., 2010; Welker and Moore, 2011) pharmacology and proteomics / 
functional genomics (White and Brown, 2004; Rudek et al., 2005). 
Recently, matrix assessed laser desorption / ionisation (MALDI) has been 
developed which uses electrospray ionization by laser. This has made it 
possible to ionise large thermally label biomolecules and transfer them to the 
GAS phase without dissociation, with the ability to analyse Mogadishu 
molecules. This allows determination of the composition of chemical structures, 
such as proteins and other compounds (Bernot, 2004). Identification of proteins 
or polypeptides proceeds with their extraction from a gel after 2D separation, 
followed by digestion with an endo-protease like trypsin, which cuts on the C-
terminal side of lysine or arginine to produce a peptide fragment. The mass of 
each fragment is determined by ―MALDI and the digested products are co-
crystallized with a solid phase matrix and presented on a metal surface to a 
laser which adsorbs them and the mass of each peptide is given by its speed of 
flight towards the detector. The original proteins are identified by comparison 
with the MS data with protein data taken from a protein database such as NCBI 
and Swiss Prot, MS can easily distinguish proteins from mixtures of 3 or more 
from organisms (Bernot, 2004).  
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8.2 Materials and Methods 
8.2.1 Microorganism culture  
A total of 45 strains of microorganisms (Table 2.1) were grown in 10 ml aliquots 
of an appropriate medium as described in Section 2.2.1 with shaking at 120 
RPM and cells were harvested and subjected to protein extraction. 
8.2.2 Extraction of total proteins 
Broth cultures were centrifuged for 3 min at 6000 × g and cell pellets were 
washed with 1ml of PBS and suspended in 2 ml of protein extraction buffer, and 
total protein was extracted from each culture as described in Section 2.4.1. 
Protein extracts were quantified by the Bradford method (Section 2.4.2).  
8.2.3 Screening microbial proteins using GAD65 antiserum by dot blot 
The microbial extracts were screened for immune active proteins that cross-
reacted with GAD65 antiserum as described previously in chapter 7. Proteins 
which cross react allow detection of possible molecular mimicries between 
microbial proteins and GAD65 antigen. Aliquots of 3-5 µl (20 µg) of total protein 
extracts from each microorganism were subjected to dot blot (Section 7.2.5.3). 
The membrane was blocked with blocking solution and then replaced with fresh 
blocking solution containing GAD65 antiserum (Section 7.2.6) using a dilution of 
1:2000 and incubated with gentle shaking for 1.5 h at RT. Next, the membrane 
was washed 3 times and then exposed to the secondary antibody with 
peroxidase label (1:6000) with shaking for 1h at RT followed by three washings 
and developed using DAB/NiCl2 for 20-30 min in the dark and images were 
taken. 
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8.2.4 Western blotting  
The total protein samples which showed a positive dot blot with anti-GAD65 
serum were screened for specific proteins mediating the cross reaction via 
western blotting. All samples were prepared using 0.5 ml of bacterial lysate (20 
µg/µl) mixed with 0.5 ml of SDS-PAGE loading buffer (Appendix 1) in 1.5 ml 
microcentrifuge tubes. Samples were placed in a boiling water bath for 5 min 
and then placed at 4 °C for 10 min. Next, samples were centrifuged and aliquots 
run into SDS-PAGE (Section 2.4.3). Resolving gel (10 %), stacking gel (5 %) 
and electrophoresis buffer (Appendix 1) were prepared as described by 
Laemmli (1970) using the original SDS concentration (0.2 %) as well as the 
loading buffer. Identical protein samples were run into two double gels; one was 
used for staining and second used for western blotting. The protein samples 
were loaded into the wells using different volumes of 5, 10, 15 and 20 µl 
alongside a protein standard marker (C1992, Sigma, UK). After electrophoresis, 
one gel was stained as described in Section 2.4.3 and the other gel was used to 
electro-blot the proteins onto a nitrocellulose membrane using the conditions 
described in Section 2.4.4.  
The membrane was blocked in 50 ml of blocking buffer (Appendix 1) with 
shaking at RT for 1 h. Afterwards, the blocking buffer was replaced with fresh 
30 ml of blocking buffer containing GAD65 serum (1:2000) and incubated at RT 
with gentle shaking for 1.5 h. The blocking buffer was discarded and the 
membrane was washed using 50 ml of washing buffer (Appendix 1) with 
shaking for 10 min at RT, repeated for a total of 3 times. Next, the washing 
buffer was replaced with fresh buffer (50 ml) containing anti-mouse IgG 
antibody peroxidase labelled (A 9917, Sigma, UK) (1:10000) and incubated at 
RT with gentle shaking for 1 h. The membrane was then washed as described 
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before and after last washing step, the washing buffer was replaced by 20 ml of 
developing buffer DAB NiCl2 (Appendix1) and left in the dark for colour 
development at RT for 15 min. Afterwards, the reaction mixture was discarded, 
the membrane was washed with MBW and images captured. The active bands 
were localized on the membrane and the molecular weight of each band was 
estimated. 
8.2.5 Localization of the GAD65 cross reactive protein on SDS-PAGE gel 
The blotted developed membrane was then stained with 20 ml of ponceau S 
solution (Appendix1) with gentle shaking for 10 min followed with 2-3 washes 
with 20 ml of DW until clear distinct protein bands appeared. The protein bands 
were used to detect the reactive bands on the second SDS-PAGE gel 
(Appendix 1) using band detection software (Quantity one software Bio-Rad, 
UK). All bands expressing a positive immune reaction with GAD65 serum were 
identified and excised from gels using a sharp razor. Excised bands were 
placed in separate 1.5 ml microcentrifuge tubes containing 1ml MBW. 
8.2.6 Identification E. coli protein bands using mass spectrometry  
Protein bands of E. coli were identified using MALDI mass spectrometry 
(MS/MS), at the Proteomics Facility, School of Biochemistry, and University of 
Bristol. The protein bands were cut into 1mm2 pieces and digested with 
sequencing grade trypsin (Promega, UK ) using a ProGest automated digestion 
system (Digilab Ltd, UK.). 
Trypsin was subjected to autolysis, generating fragments that can interfere with 
protein sequencing, HPLC or mass spectrometry analysis of the peptides. In 
addition, autolysis can result in the generation of pseudotrypsin, which has been 
shown to exhibit an additional chymotrypsin-like specificity.  
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The resulting peptides were analysed by MS and mass spectra were recorded 
in positive ion mode on an Applied Biosystems 4700 MALDI mass spectrometer. 
MS spectra were recorded in reflector mode. For MS/MS analysis the top 5 
most intense, non-tryptic, precursors were selected for fragmentation by 
collision induced dissociation. MS and MS/MS data were analysed using GPS 
Explorer 3.5 software (Applied Biosystems). MS/MS peaks were filtered to 
exclude peaks with a signal to noise ration less than 35 over a mass range of 
50 Da to 20 Da below the precursor mass. The data was analysed using the 
MASCOT algorithm (Matrix Science) using the NCBI database. A maximum 
number of missed cleavages of 1 and a charge state of +1 were assumed for 
precursor ions. A precursor tolerance of 100 ppm and an MS/MS fragment 
tolerance of 0.15 Da were used in the database search. Routinely, samples 
were analysed with methionine oxidation considered a variable modification. 
Protein ID‘s were determined for the top 20 hits from mass data for each of 5 
bands resulting from specific research on the E. coli database and other 
microorganisms to check for contamination. The protein yield or protein score of 
each band was determined and used as an indicator for the protein recovered 
from the gel and its purity. The protein accession numbers of each signal band 
were identified and the full length of the linear sequences was extracted, and 
the protein molecular weight used to search for the protein ID.  
8.2.7 Molecular mimicries prediction between GAD65 and E. coli proteins 
The immune active proteins of E. coli were detected using MS/MS and 
sequences were identified. The top 20 ID of proteins have been identified by 
MS data of individual band. The blast-p software from NCBI was used to search 
for homology between each protein and GAD65 sequences using high similarity 
parameters. The linear epitopes of each protein were extracted and numbers of 
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identical residues were identified. Also, the positive amino acids which include 
the identical residues plus the amino acids belonging to the same amino acid 
polarity group were determined.  
8.3 Results  
8.3.1 Screening microorganisms using GAD65 antiserum  
The GAD65 antiserum prepared in Section 7.2.6 was used to screen proteins 
extracted from selected microorganisms using a dot blot analysis. Results 
showed cross-reactivity with some microbial proteins. A strong dark coloured 
dot blot was produced with bacterial protein samples of species belong to the 
Enterobacteriaceae, particularly E. coli, Salmonella typhimurium and Serratia 
marcescens (Figure 8.1). A weaker reaction was seen with proteins extracted 
from Klebsiella aerogenes and Citrobacter freundii.  
The dot blot reaction colour intensity was quantified and peak densities 
recorded for individual microbial protein samples. The results showed a 
strongest reaction with Aeromonas hydrophila (500 peak density). The range of 
peak densities detected amongst the Enterobacteriaceae members was 320-
450. There was also a strong reaction with Vibrio anguillarum. Weak or non-
significant reactions were seen with other microorganisms except Rhizobium 
spp, P. aeruginosa, and Hafnia alvei. The yeast strains Zygosaccharomyces 
rouxii, Schizosaccharomyces octosporus and Saccharomyces carlsbergensis 
showed significant differences from the control and from other negative protein 
samples. The quantification measurements of the positive dot blots using the 
peak density analysis was used as an indicator of antigen antibody binding 
efficiency.  
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Figure 8.1: Initial screening of microbial protein samples for cross reaction against pancreatic antigen GAD65 antiserum using dot 
blotting. The values represent the peak density of each dot blot of microbial protein samples.  
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8.3.2 Western Blotting  
Bacterial lysates which expressed a positive dot blot reaction against GAD65 
polyclonal antiserum were subjected to western blotting to reveal proteins 
sharing linear epitopes within pancreatic β-cell antigen GAD65. A strong 
reaction was detected with protein samples extracted from some bacterial 
strains such as E. coli, C. freundii, S. typhimurium, K. aerogenes, and S. 
marcescens as well as A. hydrophila and V. anguillarum. The results showed 
strong bands of different MW position on the membrane. In the case of E. coli, 5 
protein bands (B1-B5) were detected with molecular weights of about 55, 40, 36, 
22, and 18 kDa, respectively (Figure 8.2). The E coli B3 band is appearing to be 
similar in size other Enterobacteriaceae protein bands and band 1 was of a 
similar size seen in S. marcescens and S. typhimurium. The protein samples of 
A. hydrophila produced three protein bands with MW ranged (35, 55, 60 kDa) 
and V. anguillarum produce one band of 35 kDa. 
Dilutions of E coli protein samples were run into gels and western blotting 
produced consistent results, 5 immune active bands (Figure 8.3) and these 
immune active bands were easily detected in SDS-PAGE gels and successfully 
excised, and stored in MBW and prepared for MS/MS identification. 
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Figure 8.2: Immune blotting of protein samples extracted and screened against 
GAD65 antiserum. Lane i, represents A. hydrophila, K. aerogenes (Lane ii & iii), 
lanes v, vi and vii represent S. typhimurium, S. marcescens and C. freundii 
respectively. Protein samples of E. coli (lanes viii and ix) and V. anguillarum 
(lane x).  
            i           ii       iii         iv           v        vi      vii      viii       ix         x         
12 kDa 
20 kDa 
30 kDa 
45 kDa 
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B1 
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B3 
B4 
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Figure 8.3: Western blotting of E. coli protein with GAD65 antiserum (A) using 
10 µl loading sample (1,2) and 20 µl (3,4) and 1:5 diluted sample (6). Identifying 
the immune-active protein bands on SDS-PAGE using 10 & 20 µl of sample and 
20 µl of 1:5 diluted samples (lane 2, 3, 4), respectively. 
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8.3.3 MS/MS Data of E coli proteins  
Five positive protein bands presenting cross reaction with GAD65 antibody 
were analysed using MS/MS. One of the most important parameters that should 
be noted about MS/MS sequence data generated is the ion score value. This 
number means that the corresponding peptide was run in the MS/MS mode of 
the mass spec and the resulting amino acid sequence matched the identified 
protein, the ion score values confirm the protein identity which increases the 
confidence in the ID. In these searches, any protein with a score > 62 is classed 
as having a significant identity and obviously the higher the score above this 
value the more significant the identity matches. All the analysed bands have 
given significant identity for at least one protein fragments and some contain 
multiple proteins homologous. In the case of the protein bands which gave more 
than one significant ID fragment the protein MW determined by western blotting 
was used to identify the protein. In the case of this study the protein with the 
highest score and identical MW to a protein band found by western blotting was 
used to scan for GAD65 linear epitopes. However, the top 20 proteins reported 
by MS/MS with significant protein identity also expressed significant similarity 
with putative epitopes similar to the GAD65 protein. 
8.3.4 Protein Identities     
The ion score and the mass of each peptide resulting from the digestion of band 
1 were used to search the database and both parameters revealed high 
significant protein identity (Table 8.1). According to the western blot, band1 was 
localized between 60-45 kDa MW of the protein standard markers (Figure 8.2) 
and the estimated MW was 47.2-50 kDa using band detecting program 
(Quantity one software Bio-Rad, UK). However, the blast results of mass data of 
fragment of this band against the E. coli data base showed a strong significant 
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ion score (200) identifying one protein, an outer membrane protein A (OmpA) 
(Figure 8.4) accession number (AC) gi/ 9120052 of E. coli strain UTI89.  
The theoretical MW of band2 which was seen on western blotting was about 40 
kDa and the MS/MS analysis for the first 20 proteins showed proteins with 
different MWs (18 - 40 kDa), 19 of which belong to different strains of E. coli.  
The results revealed a high score protein (135) OmpA which was also detected 
for b1 with having a MW of 40.08 kDa and the same accession number (gi/ 
9120052) belonging to E. coli strain UTI89. The western blot also showed 
GAD65 antisera producing immune activity against a protein with an estimated 
theoretical MW of 35 kDa (b3) Identification of this protein band 3 by MS/MS 
showed a high protein score (200) with strong similarity to a 33.9 kDa protein 
from E. coli format dehydrogenase (FD) accession number gi/300925913 
(Figure 8.4). 
The results also showed a cross reacting protein at 22 kDa MW (band 4) by 
western blotting of E. coli proteins. The peptide mass analysis extracted from 
MS/MS for band 4 showed a high protein score (93) and significant ion score for 
superoxide dismutase (SD) of E. coli IAI39 with 21.3 kDa and protein accession 
number gi/218699776. Finally, the western blotting of E. coli proteins showed a 
strong reaction with band 5, with a 18 - 20 kDa estimated MW. The MS analysis 
of protein extracted from band 5 showed protein with high significant a protein 
and ion score and the top 20 protein showed that the band 5 protein was either 
a 18.6 kDa DNA starvation protection protein (DspP) or a 22 kDa ferritin –like 
domain (FLD) protein of E. coli protein with accession number gi /91209847 and 
gi/300816460, respectively and ion score 221. 
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Table.8.1: The MS/MS data represents the peptide mass of E. coli protein 
fragments for bands (1-5) which can react with GAD65 antiserum. 
Peptides Mass  Sequences range A. A Sequences  
 
Band1 / Outer membrane protein A- gi/ 9120052- ion Score 200 
818.467 142-148 LGGMVWR 
1214.6348 346-356 AALIDCLAPDR 
1233.6295 142-152  LGGMVWRADTK 
1280.6648 280-291 DGSVVVLGYTDR 
1370.7394 346-357 AALIDCLAPDRR 
1486.7379 106-118 MPYKGDNINGAYK 
1654.8334 128-141 LGYPITDDLDIYTR 
2232.1848 219-241 FGQGEAAPVVAPAPAPAPEVQTK 
2600.4114 256-279 ATLKPEGQAALDQLYSQLSNLDPK 
3478.8103 188-218 LEYQWTNNIGDAHTIGTRPDNGMLSLGVSYR 
 
Band2 / Outer membrane protein A- gi/ 9120052- ion Score 135 
818.434 147-153 LGGMVWR 
1214.6135 347-357 AALIDCLAPDR 
1222.712 307-317 AQSVVDYLISK 
1233.6038 147-157 LGGMVWRADTK 
1280.6481 281-292 DGSVVVLGYTDR 
1370.7003 347-358 AALIDCLAPDRR 
1378.7444 306-317 RAQSVVDYLISK 
2600.3621 257-280 ATLKPEGQAALDQLYSQLSNLDPK 
2601.2979 164-188 NHDTGVSPVFAGGVEYAITPEIATR 
 
Band3 / Format dehydrogenase - gi/300925913- ion Score 200 
829.5217 91-96 LEWLIR 
1151.6145 190-199 ESMKTLASER 
1357.7317 12-24 SATNSITPPSQVR 
1456.7268 284-295 ADEEENNLHEEK 
1513.7573 11-24 RSATNSITPPSQVR 
1552.705  98-110 DGCMHCSDPGCLK 
1664.6648 97-110 kDGCMHCSDPGCLK 
 
Band4 / Superoxide dismutase - gi/218699776 ion Score 93 
859.4906 52-58 SLEEIIR 
1294.6244 118-128 NFGSGWTWlVK 
1381.6495 1-12 MSFKLPALPYAK 
1630.7567 93-108 VAEAIASFGSFADFK 
1694.8374 31-44 HHQTYVTNLNNLIK 
2014.9225 13-30 DALAPHISAETIEYHYGK 
2547.2092 169-189 NARPGYLEHFWALVNWEFVAK 
3680.7427 59-92 SSEGGVFNNAAQVNHTFYWNCLAPNAGGEPTGK 
3867.0647 134-168 LAIVSTSNAGTPLTTDATPLLTVDVWEHAYYIDYR 
 
Band5 / DNA starvation protection protein - gi /91209847 ion Score 221 
915.5387 28-35 ATVELLNR 
924.44 49-55 QAHWNMR 
951.5353 11-18 ATNLLYTR 
1020.5472 125-133 YAIVANDVR 
1043.6222 27-35 KATVELLNR 
1148.6332 125-134 YAIVANDVRK 
1485.7032 71-83 TALIDHLDTMAER 
1517.8641 36-48 QVIQFIDLSLITK 
1604.7936 120-133 ELADRYAIVANDAVR 
1676.7825 56-70 GANFIAVHEMLDGFR 
1692.7747 56-70 GANFIAVHEMLDGFR 
1768.847 154-167 DLDKFLWFIESNIE 
1932.9041 135-153 AIGEAKDDDTADILTAASR 
2263.0864 106-124 SYPLDIHNVQDHLKELADR 
2414.3337 28-48 ATVELLNRQVIQFIDLSLITK 
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Band 1 - Outer membrane protein A (OmpA) 
     1 mkdltvlsrw ryswrilddn eaqkmkktai aiavalagfa tvaqaapkdn twytgaklgw 
 61 sqyhdtgfip nngpthenql gagafggyqv npyvgfemgy dwlgrmpykg dningaykaq 
 121 gvqltaklgy pitddldiyt rlggmvwrad tkanvpggas fkdhdtgvsp vfaggveyai 
 181 tpeiatrley qwtnnigdah tigtrpdngm lslgvsyrfg qgeaapvvap apapapevqt 
 241 khftlksdvl ftfnkatlkp egqaaldqly sqlsnldpkd gsvvvlgytd rigsdaynqa 
 301 lserraqsvv dyliskgipa dkisargmge snpvtgntcd nvkqraalid clapdrrvei 
 361 evkgikdvvt qpqa 
 
Band 2 - Outer membrane protein A (OmpA) 
   1 msrspvkdlt vlsrwryswr ilddneaqkm kktaiaiava lagfatvaqa apkdntwytg 
 61 aklgwsqyhd tgfinnngpt henqlgagaf ggyqvnpyvg femgydwlgr mpykgsveng 
121 aykaqgvqlt aklgypitdd ldvytrlggm vwradtksnv ygknhdtgvs pvfaggveya 
181 itpeiatrle yqwtnnigda htigtrpdng mlslgvsyrf gqgeaapvva papapapevq 
241 tkhftlksdv lftfnkatlk pegqaaldql ysqlsnldpk dgsvvvlgyt drigsdaynq 
301 alserraqsv vdyliskgip adkisargmg esnpvtgntc dnvkqraali dclapdrrve 
361 ievkgikdvv tqpqa 
 
Band 3- Format dehydrogenase (FD)       
   1 mametqdiik rsatnsitpp sqvrdykaev aklidvstci gckacqvacs ewndirdtvg 
  61 nnigvydnpn dlsakswtvm rfseveqndk lewlirkdgc mhcsdpgclk acpaegaiiq 
 121 yangivdfqs eqcigcgyci agcpfdiprl npednrvykc tlcvdrvvvg qepacvktcp 
 181 tgaihfgtke smktlaserv aelktrgydn aglydpagvg gthvmyvlhh adkpnlyhgl 
 241 penpeisetv kfwkgiwkpl aavgfaatfa asifhyvgvg pnradeeenn lheekdeerk 
 
Band 4- Superoxide dismutase SD 
   1 msfklpalpy akDalaphis aetieyhygk hhqtyvtnln nlikgtafeg ksleeiirss 
  61 eggvfnnaaq vwnhtfywnc lapnaggept gkvaeaiaas fgsfadfkaq ftdaaiknfg 
 121 sgwtwlvkns dgklaivsts nagtplttda tplltvdvwe hayyidyrna rpgylehfwa 
 181 lvnwefvakn laa 
 
Band 5- DNA starvation / stationary phase protection protein Dps 
 1 mstaklvksk atnllytrnd vsdsekkatv ellnrqviqf idlslitkqa hwnmrganfi 
61 avhemldgfr talidhldtm aeravqlggv algttqvins ktplksypld ihnvqdhlke 
121 ladryaivan dvrkaigeak dddtadilta asrdldkflw fiesnie 
 
 
Figure 8.4: Full length sequences of E. coli proteins identified from bands 
detected by western blotting with GAD65 antiserum and analysed by MS/MS 
and extracted DATA matched against the E. coli Genbank protein database.   
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8.3.5 E. coli Outer membrane protein A (OmpA) bands 1 & 2 show linear 
epitopes on GAD65 
Both bands B1, B2 matched with one protein identity which was OmpA which 
produced homology to the C-terminal region of GAD65 between GAD65 
residues 512-542 producing 10 identical and 17 positive residues (Figure 8.5).  
The MS data of E. coli protein bands have identified proteins with identical or 
similar ion score in addition to the actual proteins identified by each band. 
These proteins expressed not just strong similarity to the protein bands but also 
produced similarity to the GAD65 protein. The protein of band 2 has been 
identified as OmpA, however, the peptides Mass data showed similarity to one 
of the E. coli elongation factor (EF) Accession number /NP 289886 which 
showed 2 epitopes similarity with GAD65 N-terminal sequences occurred on 
residues 139-153 and 104-117 respectively first one has 6 identical and 10 
positive residues, whereas, the second epitopes has 5 identical and 10 positive 
residues. Third epitopes produce homology to GAD65 C-terminal flanked by 
residues 530-547 sequence with 7 identical and 10 positive residues. 
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8.3.6 E. coli protein Format Dehydrogenase (FD) band 3 shows linear 
epitopes on GAD65 
The third protein, the beta subunit of FD produced 4 epitopes occurring at 
residues 317-327, 237-262, 541-565, 451-469 and having 4, 5, 7, and 6 
identical and 8,10,11 and 9 positive residues respectively. The results showed a 
45.25 kDa phage integrase protein (PIP) in E. coli E 22 with protein 
identification number gi/193063621, with a high ion score (120). Searching for 
homology between GAD65 and PIP amino acid sequences showed 4 epitopes, 
three of them occurred at the GAD65 C-terminus. These epitopes were at 
residues 419 – 452, 444 - 459, 454 - 488 and containing 12, 5 and 10 identical 
residues and 16, 8 and 16 positive residues, respectively. Whereas, the fourth 
epitope occurred at the GAD65 N-terminal sequence (residues 93-113) having 
8 identical and 11 positive residues. The C- terminal epitopes shared sequence 
localized at the same region on GAD65 (residues 454-459) between epitope 1 
and 2 and shared sequences (444-452) between epitope 1 and 3 (Figure 8.5). 
The top 20 blast results of MS data of band 3 also matched with a 19.68 kDa 
bacteriophage baseplate protein (BB) accession number gi/284920613 and a 
20.10 kDa hypothetical protein (HP) No gi/215486150 of E coli. The BB blast 
against GAD65 showed one epitope flanked by residues 105 -131 with strong 
similarity producing 8 identical residues and the 15 positive residues and the HP 
showed 4 epitopes produced 9,4,5 & 7 identical with 9,6,8 and 13 positive 
residues share within GAD65 sequences (Figure 8.5).  
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i & ii-Outer membrane protein A (OmpA-Band 1 & 2)      
OmpA    8-SWRILDDNEAQ--KMKKTAIAIAVALAGFAT-36 
GAD65 512-SLRVLEDNEERMSRLSKVAPVIKARMMEYGT-542 
 
1- Elongation factor (EF)  
EF    155-RELLSQYDFPGDDTP-169    53-APEEKARGITINTSHVEY-70   
GAD65 139-NELLQEYNWELADQP-153   530-APVIKARMMEYGTTMVSY-547 
 
208-DKPFLLPIEDVFSI-221 
104-ERPTLAFLQDVMNI-117 
  
iii-  Formate dehydrogenase protein (FD- Band3 )                       . 
FD    198-ERVAELKTRGY-208    212-GLYDPAG-VGGTHVMYVLHHADKPNL-236      
GAD65 317-RRILEVKQKGF-327    237-GIFSPGGAISNMYAMLIARYKMFPEV-262     
  
221-GTHVMYVLHHADKPNLYHGLPENP-244    248-ETVKFWKGIWKPLAAVGFAA-267 
541-GTTMVSYQPLGDKVNFFRMVISNP-565    451-DVFKLWL-MWRAKGTTGFEA-469  
 
1- Phage integrase protein (PIP) 
PIP    24-NGMHLLVHPNGSKYWRLQYRFGGKQKMLALGVYPDV-59   
GAD65 419-NQMHASYLFQQDKHYDLSYDTG--DKALQCGRHVDV-452 
 
379-IHKAEHLDERRLMLQW-394 106-HATNKKWSEEHSRRVLKSLED-126 
444-LQCGRHVDVFKLWLMW-459  93-HATDLLPACEGERPTLAFLQD-113 
 
100-QLAIEWHATNKKWSEEHSRRVLKSLEDNLFPAIGKR-135 
454-KLWLMWRAKGTTGFEAHIDKCLE-LAEYLYNIIKNR-488 
 
2- Bactriophage Baseplate (BB) 
  2-RTIEAMQRQLLGLIGRAVVKSISAATK-28                                        
105-RPTLAFLQDVMNILLQYVVKSFDRSTK-131 
 
3- Hypothetical Proteins (HP) 
69-EQGKVRPMYSLTKDGWIMVVMGFTG-93      67-IDEQGKVRP-75          
14-EDGSGDPENPGTARAWCQVAQKFTG-38     304-CDERGKMIP-312  
 
 40-DVLRKIEQVK-49      21-GEVVTTSRKIAKYFGKRHGDVLRKIEQVK-49    
314-DLERRILEVK-324    551-GDKVNFFRMVISNPAATHQDIDFLIEEIE-579 
 
Figure 8.5: Sequence homology between GAD65 and E .coli proteins of bands 
1,2 & 3 by western blotting and identified by MS. The dark grey shadowed 
residues are identical and the faint grey ones are positive residues.   
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8.3.7 E. coli protein Superoxide Dismutase (SD) band4 shows linear 
epitopes on GAD65 
The blast results between SD (band4) and GAD65 sequences showed 4 
epitopes, The first epitope expressed homology with residues at 326-362, 529 -
540, 269-283, and 8-20 on GAD65, containing 10, 6, 5, and 3 identical and 16, 
8, 8, and 8 positive residues. The analysis showed two 36 kDa proteins 
accession number gi/73854244 of E. coli transposase (TR), both of which 
showed homology to GAD65 occurring at residues 470-481 with 6 identical and 
8 positive residues (Figure 8.6).  
The results also showed homology with a 27 kDa small terminase subunit (ST) 
of E. coli accession number gi/293417396 expressing three epitopes at 
residues 204-210, 521-535 and 300-330 with 5, 7, 5 identical, 6, 9 and 15 
positive residues, respectively.  
The band 4 results also showed proteins with non-significant protein scores with 
MW 47, 50, 50.4, 51 and 52 kDa. Amongst these proteins a biotin carboxylase 
(BC), protein accession number gi / 9257125 laid epitopes with homology to 
GAD65 between residues 12-76 with 20 identical, 29 positive and two gaps. 
However, these proteins produce long strong epitopes rich glycine, alanine and 
aspartic acid residues. Furthermore, a protein of 47 kDa related to E. coli trigger 
factor (TF), protein ID/gi-91209509 showed two epitopes, one strong epitope 
occurred at residues 11-17 of GAD65 with 6 identical residues and the second 
epitope occurred at residues 293-343 with 14 identical and 19 positive residues 
(Figure 8.6).  
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iv- Superoxide Dismutase (SD- Band 4)  
   iSD 132-GKLAIVSTSNAGTPLTTDATPLLTV-------DVWEH-161  15-LAPHISAETIEY-26   150-ATPLLTVDVWEHAYY-164  
GAD65 326-GFVPFLVSATAGTTVYGAFDPLLAVADICKKYKIWMH-362 529-VAPVIKARMMEY-540  269-AVPRLIAFTSEHSHF-283    
 
  77-YWNCLAPNAGGEP-89 
   8-FWSFGSEDGSGDP-20  
 
1-Transposase (TR)  
    TR 239-HEDKLMTIAERL-250    
 GAD65 470-HIDKCLELAEYL-481 
 
2- Small terminase subunit (ST) 
   ST 125-MFTEEVA-131 207-ERLERELKPKPELKA-221  34-MLVKLAADQRTLKAIYSKELKAAKKRELLPF-64 
GAD65 204-MFTYEIA-210 521-ERMSRLSKVAPVIKA-535 300-ILIKCDERGKMIPSDLERRILEVKQKGFVPF-330 
 
3- Biotin carboxylase (BC) 
   BC 136  GSDGPLGDDMDKNRAIAKRIGYPVIIKASGGGGGRGMRVVRGD----AELAQSISMTRAEAKAAFSND-199 
GAD65  12 GSEDGSGDPENPGTA---RAWCQVAQKFTGGIGNKLCALLYGDSEKPAESGGSVTSRAATRKVACTCD-76 
 
4-Triggers factor (TF) 
   TF 262-FGVEDGS-269  210-GLGRRVTITIAADSIETAVKSELVNVAKKVRIDGFRKGKVPMNIVAQRYGA-260 
GAD65 11
_  FGSEDGS-17   293-GIGTDSVILIKCDERGKMIPSDLERRILEVKQKGFVPFLVSATAGTTVYGA-343 
 
Figure 8.6: Sequence homology between GAD65 and E .coli proteins produced by band 4 of western blotting and identified by MS. The 
bold shadowed residues are identical and the greys are positive residue.   
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8.3.8 E. coli DNA Starvation protection Protein (DspP) band5 shows linear 
epitopes on GAD65 
The fifth protein band showed homology with the DNA starvation protection 
protein with 1 epitope having two homologous regions with GAD65 at residues 
174-183 and 497-510 with 5 & 5 identical residues and 6 and 6 positive 
residues respectively (Figure 8.7). Interestingly, the band 5 results showed in 
addition to the DpsP protein, a 2 kDa, hypothetical protein (HP) of E. coli with 
15 residues produced putative epitopes at residues 215-223 and 431-436 on 
GAD65, both with 4 identical, and 8 and 5 positive residues respectively. The 
HP protein has 15 residues of which 12 residues (80%) showed homology to 
the GAD65 sequences.  
The results also detected a protein with the threshold protein score of 60. This 
protein is the 35 kDa L-arabinose transporter subunit (ATR) with protein ID/gi-
194430431 of E. coli. It produced epitopes that covered extended regions of 
GAD65 at N, middle and C –terminal regions. A Blast of ATR against GAD65 
detected two epitopes, one at residues 20-82 having 17 identical and 25 
positives and another at residues 335-363 with 8 identical and 13 positives 
(Figure 8.7). The blast also showed 5 small potential neighbouring epitopes 
occurring at residues 500-509, 381-392, 364-381, 164-179, 138-152 and have 
shown 4, 3, 4, 7 and 5 identical and 5, 8, 8, 8 and 8 positive residues 
respectively. 
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v- DNA starvation protection protein (Band5 / DspP) 
 
  DPS 223-GAPYYTNAVS-232  223-GAPYYTNAVSQVTP-236    
GAD65 174-GHPRYFNQLS-183  497-GKPQHTNVCFWFVP-510   
 
2- Hypothetical protein (HP)                    
      HP 3-LLQFIGMKK-11     10-KKYNLS-15  
GAD65 215-LLEYVTLKK-223   431-KHYDLS-436 
 
3- Arabinose transporter subunit (ATR) 
  ATR  35-PEEPWFQTEW-KFADKAGKDLGFEVIKIAVPDGEKTLNAIDSLAASGAKGFVICTPDPKLGSA-96   197-TKSNDIPGAFDAANSMLVQHPEVKHWLIV-225   
 GAD65 20-PENPGTARAWCQVAQKFTGGIGNKLCALLYGDSEKPAESGGSVTSRAATRKVACTCDQKPCSC-82   335-TAGTTVYGAFDPLLAVADICKKYKIWMHV-363   
 
ATR   215-QHPEVKHWLI-224 253-INGVDAVSELS-264 229-DSTVLGGVRATEGQGFK-246   1-QTEWKFADKAGKDLGF-56   35-PEEPWFQTEWKFADK-49  
GAD65 500-QHTNVCFWFV-509 381-LNGVERANSVT-392 364-DAAWGGGLLMSRKHKWK-381 164-QTTLKYAIKTGHPRYF-179 138-PNELLQEYNWELADQ-152     
 
 
Figure 8.7: Sequence homology between GAD65 and E .coli proteins produced by band 5 of western blotting and identified by MS. The 
bold shadowed residues are identical and the greys are positive residues.   
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8.4 Discussion  
GAD65 and insulin are the major pancreatic antigens which have been targeted 
by the autoimmune response in T1D, compared to other pancreatic antigens 
(Leslie et al., 1999). T1D is currently associated with autoantibodies (Al-Bukhari 
et al., 2002) and a T-cell autoimmune responses (Honeyman et al., 1998), 
however, the GAD autoimmunity is attributed to autoantibodies created by 
environmental or non-genetic factors, besides the genetic predisposition on 
HLA genes which were classified for a long time as the main cause of this 
disease. Microorganisms, food protein toxins and viral infections (Stene et al., 
2010) are considered possible diabetogenic environmental factors (MacFarlane 
et al., 2003; Goldberg and Krause, 2009). It would seem that both genetic and 
environmental factors contribute to the diabetic immunology response against 
particular pancreatic β-cell autoantigens.  
Immunological studies have used sera from diabetes patients with GAD 
autoantibodies for determining epitopes which are targeted during development 
of T1D and whether they are aimed at the N-terminal, C-terminal or middle of 
the GAD65 back bone. Using various techniques, it's also possible to 
distinguish conformational and linear epitopes and which of them are more 
associated with T1D. For example, the phage display (PD) or peptide library 
techniques by which epitope fragments (9 -20 aa) of the GAD65 protein are 
produced and then screened against GAD65 antisera derived from the blood of 
T1D patients (Myers et al., 2000). Linear epitopes were studied by producing 
GAD65 peptides (80-100 aa) as fusion proteins, which were purified and 
assayed for immune activity by ELISA or western blotting, using monoclonal 
antibodies specific to those regions (Fenalti and Rowley, 2008). 
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In the case of the present study the experiment was designed to use the full 
length GAD65 sequence to produce anti-serum instead of developing antibody 
against particular sequences, in order to make sure that all the GAD65 motifs 
(N, C and M) were involved. Moreover, the current study is the first to look 
specifically for GAD65 molecular mimicries in a range of microorganisms other 
than viruses by developing a polyclonal antiserum to search for molecular 
epitopes in bacteria which may be triggers for production of GAD65 
autoantibodies in T1D.  
The GAD65 antiserum was developed and used for screening total protein 
samples extracted from 45 strains of microorganisms during this study. The 
GAD65 serum was used in dot blots to find microorganisms whose protein 
could cross react with the GAD65 antibodies. The dot blot technique was used 
initially because this technique can quickly screen large numbers of 
microorganisms, identifying cross reacting of microorganisms which could then 
be analysed by western blotting to identify specific proteins which reacted with 
the GAD65 antibody.  
The initial assay produced strong reactions with the GAD65 serum compared to 
the control pre-immune serum suggesting that the animal used had no previous 
immune response against any of the microbes tested. The GAD65 antiserum 
produced strong reactions against protein samples from the Enterobacteriaceae 
(E. coli, Salmonella, Klebsiella, Citrobacter and Serratia). Initially, it was thought 
that this result is might be attributed to the fact that these microbes have their 
own GAD enzymes which may share epitopes with human GAD65 such as the 
PLP binding domain (Myers et al., 2000). However, this study has also looked 
for possible similarity between GAD65 from microbes and GAD65 from humans, 
using high similarly blast and identified many epitopes in E. coli, Streptococcus, 
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Protease and Aspergillus niger which only express a weak degree of similarity.  
Moreover, many studies have tried to identify sequence homology between 
pancreatic GAD65 and GAD65 from E. coli by testing diabetic and control sera 
with E. coli GAD65, using GAD65 solid phase ELISA and immunoblotting, which 
concluded no basis for cross-reactivity between the two antigens, and antibody 
reactivity to GAD65 in man, subsequently cannot arise from cross-reactivity to 
the E. coli GAD enzyme (Konidaris et al., 2003). 
However, the cross reaction of GAD65 antisera with proteins extracted from 
Enterobacteriaceae members is very interesting as many studies suggest that 
the autoimmune diabetes in T1D and in some cases of T2D, is linked 
extensively to the autoimmune response generated by gut invasive pathogenic 
bacteria and viral infection. Furthermore, the role of the bacterial microflora is 
also important in the induction of gut tolerance which protects against invading 
bacteria like E. coli by inducing systemic immunity (Dahlgren et al., 1991; 
Delzenne and Cani, 2011; Giongo et al., 2011). Some probiotics/ bacteria can 
stimulate antigen tolerance instead which reduces the diabetic autoimmunity via 
decrease intestinal inflammation (Majamaa and Isolauri, 1997; Vaarala, 2000; 
Yazdchi-Marandi et al., 2000).  
Studies have reported recently after screening data of T1D children that the 
collection of unhealthy microbial flora and pathogenic Enterobacteriaceae can 
cause disorders to the intestinal barrier, or a ‗leaky gut‘, producing a specific 
immune response against GAD65 and other pancreatic antigens like insulin and 
PTP, which ultimately may result in pancreatic β-cell destruction (Neu et al., 
2010; Hasham and Tomer, 2011). Moreover, a study has shown that T1D in 
children results from losing the balance of digestion system bacteria while 
healthy children all had very similar microbial mixes. The diabetic children all 
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had erratic combinations with less overall variety which can lead to some 
entering the blood stream and induce the destructive, diabetic autoimmune 
response (Mshvildadze and Neu, 2010; Gebel, 2011). 
The GAD65 western blotting results showed various patterns of reaction within 
Enterobacteriaceae members, however, E. coli produced the highest expressed 
and the highest number of bands (Figure.8.2) compared to the other species. 
However, the Enterobacteriaceae members pattern is very similar to the E. coli, 
this may be because these species are genetically and functionally similar. 
However, the western blotting against V. anguillarum and A. hydrophila 
produced different patterns and they belong to different families, Vibrionaceae 
(Dworkin and Falkow, 2006) and Aeromonadaceae (Aberoum and Jooyandeh 
2010; Martino et al., 2011) respectively.  
The MS/MS was used to identify the E. coli protein bands that cross reacted 
with GAD65 antiserum. The results expressed high protein scores (up to 200) 
for all tested proteins which raised confidence of protein identification. The 
peptides which resulted from trypsin proteolysis were produced significant 
numbers and collectively their mass matched particular proteins of E coli mass 
as well as mass results (Bernot, 2004; Fagerquist et al., 2009) the ion score of 
each protein significantly increased the probability of protein identity. Both ion 
score and peptide mass can exactly match peptide finger prints and subsequent 
sequences of individual peptides can confirm ID. The Mass spectra data were 
searched using Muscat software for identifying proteins in E. coli to confirm 
protein identity. The protein ID of the highest protein scores and an ion score of 
the top 20 proteins have been used to consider the individual protein bands 
identity. 
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The full length protein sequences extracted and the MW of each protein was 
confirmed to identify protein bands in western blotting. However, recently the 
MS protocol has been applied to protein separated in 2 D gel SDS-PAGE which 
involves the separation of the interested protein according to their PI values in 
horizontal electrophoresis followed by vertical electrophoresis into SDS-Page 
which produces proteins separated as dots which can be blotted separated from 
each other (Bernot, 2004; O'connor and Hames, 2008).  
The full length of proteins identified from E coli which cross reacted with GAD65 
serum were Outer membrane protein A (OmpA), Format Dehydrogenase (FD) 
Superoxide Dismutase (SD) and DNA starvation protection protein DspP 
(Figure 8.4) and these sequences were used to search for GAD65 molecular 
mimicries. The results identified epitope homologies mostly with middle and C 
terminal regions of GAD65. However, the epitopes with homology to the GAD65 
C-terminal sequences were more spread compared to those that occurred in 
the middle region (Figure 8.5). All proteins that produced homology to the 
GAD65 C-terminal sequences occurred in within residues 419-565.  
Some studies which used anti GAD65 antiserum from T1D patients against 
GAD65 regions presented by phage display technique reported that the 
autoimmune response against GAD65 in T1D is targeted at all regions on 
GAD65 (N, M, C-terminal), whereas, other studies particularly those that used 
GAD65 auto antibodies in most cases from T1D and during T2D mediating T1D 
and LADA diseases have targeted M, and C regions (Falorni et al., 2000) of 
GAD65 & 67 and limited antibodies detected against the N-terminal (Hampe et 
al., 2002; Maioli et al., 2004). 
Moreover, high affinity antibodies against epitopes located in the M, C regions 
occurring at aa sequences 96-444 and 445-585 respectively of GAD65 65 were 
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frequently found in multiple islet autoantibodies from children in early childhood 
(Bonifacio et al., 2000; Mayr et al., 2007). Studies have specified those GAD65 
C-terminal sequences present at residues 404-585 and central or middle aa 
sequences 240-444 contain conformational epitopes that are targeted by 
antibodies, are frequently reported in individuals with high risk of developing in 
T1D (Daw and Powers, 1995; Falorni et al., 1996; Syren et al., 1996).  
Whereas, the linear epitopes are also found on C & N –terminals occurring at 
aa on sequences 11-44 (Butler et al., 1993; Kim et al., 1994; Daw et al., 1996).  
Furthermore, studies which predicted the confirmation epitopes of GAD65 using 
fragments of GAD65 and immune-competition studies showed that the majority 
of GAD65 autoantibodies are directed against conformational epitopes and 
occurred on different regions of M & C terminals (Mauch et al., 1993; Richter et 
al., 1993). It was also found that a limited number of these autoantibodies can 
bind those discontinuous epitopes or the conformational epitopes after heating 
and SDS denaturation (Baekkeskov et al., 1990; Tuomi et al., 1994). 
In the case of the current study the cross reacting proteins showed homology to 
GAD65 at the C terminal and M regions may be considered as inducers for 
antibodies against GAD65 during immune responses that results from 
Enterobacteriaceae or E. coli intestinal infection (Mulder, 2005). Antibodies 
against E. coli epitopes may cross react within GAD65 auto-antigens 
particularly in individuals suffering genetic predisposition of HLA gene (DR4-
DQ8 & DR3-DQ2) in early childhood which then lead to subsequent 
autoimmune response against actual GAD65 antigens on pancreatic β-cells. 
It is reported that autoimmune response inducers in T1D, in individuals with 
genetic disorders are still not known (Lernmark, 2011), and this study 
suggested that microbial epitopes might play an important role as inducers in 
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addition to many environmental factors that have been recently proposed to be 
autoimmune response creators or guides.  
The current study results also showed that the MS /MS data of E coli bands 3, 4, 
5 have matched proteins with significant ID in addition to the proteins which 
have been identified (FD, SD & DpsP proteins) of individual bands. However, 
proteins like PIP, HP, of band 3 and ST of band 4 and HP, ATR of band 5 have 
also expressed strong homology after blast of their sequences against GAD65, 
but they have different MW from the actual bands. All those secondary proteins 
have shown a strong similarity to the GAD65 mainly at the C terminal which 
agrees with what has been reported previously. Furthermore, some proteins 
have epitopes to the middle sequences, whereas, many of the proteins have N- 
terminal epitopes, in addition to epitopes seen at the C and M regions (Table 
8.2). Some epitopes of these proteins hit more than one region on GAD65 for 
example protein HP, ATR and PIP (Figure 8.7). This result revealed that the 
MS/MS technique is a powerful technique whose data can be used in 
autoimmunity research to find the molecular mimicries between host antigens 
and the peptides from microbes. This study hypothesised for the first time a 
possible application for MS/MS in autoimmunity particularly in molecular 
mimicry field, in which MS/MS data of particular antigen can be used to search 
for molecular mimicries in microorganisms. In this case the homology will 
depend on charges and peptide mass instead of using the amino acid 
sequences as the only parameter in searching for homology.  
The current study also reported that some proteins produced a new type of 
epitope in addition to the previously report homologies between E. coli proteins 
and GAD65 with up to 80% similarity (Table 8.2). Proteins like PIP has 4 linear 
epitopes within GAD65, and has 3 separate epitopes sharing homology to the 
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same sequence on GAD65. The PIP epitopes has homology to the GAD65 at 
residues 444-459 which shared homology with epitopes at residues 444-452 
and 454-459 respectively (Figure 8.8 B). These types of homology may explain 
the increase in the number of antigen epitopes which are possessed by one 
microbial peptide in diminished immune tolerance to self-antigens.  
On the other hand, blast results also showed a single epitope of a protein of E. 
coli showing the same degree of similarity or homology appeared in different 
positions on linear GAD65 protein sequences and this was seen consistently in 
all protein bands. All of them have shown a similarity to more than one region 
on the GAD65 (Figure 8.8 A). Those types of epitopes may play a role in 
bringing about an autoimmune response against large sequences of GAD65 
antigen achieved by a single epitope of E. coli protein. Both types of microbial 
epitopes may explain the autoimmune response that is seen against GAD65 
protein. Previous, studies on autoimmunity suggested a cryptic mechanism by 
which the autoimmune response is created in autoimmune disease and 
reasoned that microbial proteins do not have enough similarity to create 
response on the basis of molecular mimicry. But this might now change. These 
epitopes can be presented by the MHC-II molecules of macrophages or the 
dendritic cells to the T- cell CD4 initiating the B-lymphocytes to produce 
antibodies cross reacting with GAD65 and subsequently β-cells destruction. 
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Table 8.2: The homology between E coli protein bands identified by MS/MS 
and GAD65 sequences including the number of identical and positive residues 
and sequence position on GAD65 sequence.  
 
Protein  Band   Epitopes 
No  
Position on 
GAD65 
Identical AA Positive AA & 
Max Similarity % 
1-OmpA B1 1 C-512-542 10 16    53% 
2-OmpA  B2 1 C-512-542 10 16    53% 
3-EF  B2 3 N-139-153 
N-104-117 
C-530-547 
6 
5 
7 
10    41% 
10    41% 
10    41% 
4-FD       B3 4 C-451-469 
M-317-327 
C-541-565 
M-237-262 
6 
4 
7 
5 
9     47% 
8     80% 
11    73% 
10    40% 
5-PIP B3 4 C-444-459 
C-454-488 
C-419-452 
N-93-113 
5 
10 
12 
8 
8     53% 
16    67% 
16    48% 
11    55% 
6-HP B3 4 N-14-38 
M-304-312 
M-314-324 
C-551-579 
9 
4 
5 
7 
9     37% 
6     75% 
8     80% 
13    45% 
7-BB B3 1 N-105-131 8 15    58% 
8-SD 
   
B4 4 M-326-362 
C-529-540 
M-269-283 
N-8-20 
10 
6 
5 
3 
16    44% 
8     72% 
8     57% 
8     67% 
9-TR B4 1 C-470-481 6 8     72%    
10-ST B4 3 C-521-535 
M-204-210 
M-300-330 
7 
5 
5 
9     64% 
6     85% 
15    50% 
11-BC B4 1 N-12-76 20 29    45% 
12-TF) B4 2 N-1-17 
M-293-343 
6 
14 
6     35% 
19    38% 
13-
DspP 
B5 2 C-497-510 
N-174-183 
5 
5 
6     46% 
6     67% 
14-HP B5 2 M-215-223  
C-431-436 
4
4 
8     89%  
5     83% 
15-ATR B5 6 N-20-82 
N-138-152 
N-164-179 
C-335-380 
C-381-392 
C-500-509 
17 
5 
7 
12 
3 
4 
25    40% 
8     53% 
8     50% 
21    47%  
8     67% 
5     56% 
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A 
    FD   221-GTHVMYVLHHADKPNLYHGLPENP-244 212-GLYDPAG-VGGTHVMYVLHHADKPNL-236    
 GAD65  541-GTTMVSYQPLGDKVNFFRMVISNP-565 237-GIFSPGGAISNMYAMLIARYKMFPEV-262 
                                     
    HP 21-GEVVTTSRKIAKYFGKRHGDVLRKIEQVK-49   40-DVLRKIEQVK-49   67-IDEQGKVRP-75  69-EQGKVRPMYSLTKDGWIMVVMGFTG-93  
GAD65 551-GDKVNFFRMVISNPAATHQDIDFLIEEIE-579 314-DLERRILEVK-324 304-CDERGKMIP-312 14-EDGSGDPENPGTARAWCQVAQKFTG-38  
  
  iSD 132-GKLAIVSTSNAGTPLTTDATPLLTV--------------DVWEH-161 150-ATPLLTVDVWEHAYY-164  
GAD65 326-GFVPFLVSATAGTTVYGAFDPLLAVADICKKYKIWMH-362 269-AVPRLIAFTSEHSHF-283    
   
  DPS 223-GAPYYTNAVSQVTP-236   223-GAPYYTNAVS-232       
GAD65 497-GKPQHTNVCFWFVP-510   174-GHPRYFNQLS-183 
 
  ATR 35-PEEPWFQTEW-KFADKAGKDLGFEVIKIAVPDGEKTLNAIDSLAASGAKGFVICTPDPKLGSA-96 197-TKSNDIPGAFDAANSMLVQHPEVKHWLIV225   
GAD65 20-PENPGTARAWCQVAQKFTGGIGNKLCALLYGDSEKPAESGGSVTSRAATRKVACTCDQKPCSC-82 335-TAGTTVYGAFDPLLAVADICKKYKIWMHV363   
  
  ATR  35-PEEPWFQTEWKFADK-49     41-QTEWKFADKAGKDLGF-56                                       215-QHPEVKHWLI-224           
GAD65 138-PNELLQEYNWELADQ-152   164-QTTLKYAIKTGHPRYF-179                                      500-QHTNVCFWFV-509                                                                      
B 
  PIP 24-NGMHLLVHPNGSKYWRLQYRFGGKQKMLALGVYPDV-59  379-IHKAEHLDERRLMLQW-394 100-QLAIEWHATNKKWSEEHSRRVLKSLEDNLFPAIGKR-135 
GAD65419-NQMHASYLFQQDKHYDLSYDTG--DKALQCGRHVDV-452 444-LQCGRHVDVFKLWLMW-459 454-KLWLMWRAKGTTGFEAHIDKCLE-LAEYLYNIIKNR-488 
   
                                                                               106-HATNKKWSEEHSRRVLKSLED-126 
                                                                                93-HATDLLPACEGERPTLAFLQD-113 
 
Figure 8.8: Sequences homology between GAD65 and E. coli proteins shows the homology between one single epitope (under line red 
and green) to multiple epitopes on GAD65 (A). The homology of multiple epitopes of E. coli protein to same and different epitopes on 
GAD65 (under line orange) sequences (B). 
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General Discussion  
The development of diabetes is a complex process which is dependent on 
genetic susceptibility and environmental factors. One of the possible 
environmental factors which contribute to the formation of diabetes is the 
exposure to certain microorganisms or their products (Tisch and McDevitt, 1996; 
MacFarlane et al., 2003; Biros et al., 2005). 
This was the first study that was designed to look for and identify a number of 
possible direct interactions between microorganisms and the insulin pathway, 
(the production of insulin and interaction of insulin with host components) which 
could possibly contribute to the formation of diabetes. 
In this study initially three lines of investigation which looked at the interaction of 
microbes with the insulin pathway were undertaken. Firstly, the toxicity of 
certain microbial products (secondary metabolites) to β-cells was tested.  
Secondly, the ability of microbes to bind insulin was surveyed with the view that 
any microbial insulin receptors which showed molecular mimicry with HIR may 
be able to induce an autoimmune response to HIR and / or to insulin bound to 
the microbial receptor. Thirdly, GAD has been recognised as a major pancreatic 
autoantigen, so a search was undertaken to find microbial proteins with 
molecular mimicry with mammalian GAD. Any of these 3 processes could 
possibly contribute to the formation of diabetes. 
It was envisaged that at least one of these 3 lines of investigation would be 
fruitful and possibly form the main line of research for the thesis. However, each 
of the initial 3 area‘s of research proved productive and individually any of the 3 
area‘s could have formed the basis for the thesis. A decision had to be made as 
to the direction of the rest of the thesis and it was decided to persist with each 
of the 3 lines of investigation, allowing the initial ground work to be done for 
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each of the 3 lines of research. Moreover, the remit before research was started 
was to investigate the interaction of microbes with the insulin pathway and this 
was seen to include all possible ways. 
Furthermore, it became evident that the microbes that infect individuals with CF 
may be involved in the development of CFRD and possibly other forms of 
diabetes. It was known from the literature that certain microbial products 
(secondary metabolites) can specifically interact with the insulin pathway 
leading either to enhanced insulin production or diabetogenic toxicity to 
pancreatic beta cells. The first part of the research looked at the effect of 
secondary metabolites, phenazine & pyrrolnitrin, produced extensively by the 
major infectants of CF patients, Burkholderia spp. and Pseudomonas 
aeruginosa for cytotoxicity to β-cells and modulation of the insulin pathway.  
Moreover, the extracellular products (supernatants) produced by both 
microorganisms were used to contribute to the cytotoxicity of the β-cells.  
About 90% of CF suffers develop CFRD. CF patients are exposed to relatively 
high concentrations of phenazine and/or pyrrolnitrin during infection of the lungs 
causing toxicity to the lung epithelial cells. Both bacteria produce these 
compounds into the bloodstream which may contribute to pancreatic β-cell 
death. It would be useful in the future to measure the concentration of each 
compound in the blood and pancreas and determine whether these compounds 
are metabolized by the liver. Moreover, the nature by which INS-1 cell death by 
these compounds needs investigating as to whether it is by triggering apoptosis 
signals or more likely through necrosis caused by ROS. 
This work also showed that these compounds interacted with beta cells to affect 
insulin transcription and secretion, modulating the insulin pathway. Patch 
clamping studies, investigating insulin gene expression and secretion, 
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transcription factors and Ca2+ concentration confirmed the direct regulation of 
the GSIS pathway by these compounds via specific regulation of glucose 
metabolism. But it would be better in the future to do a time course exposure for 
measuring Ca2+ content and electrophysiology to verify the time taken for whole 
GSIS induction.  
In this study it was hypothesised that increased Ca2+ concentration, elevated 
insulin gene expression and secretion, but it will be useful to draw a link 
between calcium influx and insulin gene expression and secretion by blocking 
calcium influx with chelators or other reagents and by determining if calcium 
influx alone can mimic the effect of the compounds. To start to answer these 
questions the CamK4 & CaKK1 gene expression was studied because those 
genes products regulate insulin gene expression in response to increase 
intracellular Ca2+. 
Furthermore, monitoring transcription factors, GT-2, GK, CamK4, and CaKK1 
gene expression requires confirmation with assays such as ELISA and western 
blotting to confirm the results at the protein expression level. However, the up 
regulation of those genes did indicate that the microbial compounds modulated 
signals of the GSIS pathway and glucose metabolism. In the future DNA 
microarray analysis of gene expression of the GSIS pathway in response to 
phenazine and pyrrolnitrin exposure could be done, to confirm whether these 
compounds can directly affect GSIS because of their redox activity. Alternatively, 
they may modulate via an as yet cryptic mechanism which might  reveal a new 
way of regulating the insulin pathway and may provide a new target for 
treatment in future by using these compounds or derived compounds. 
The second line of investigation revealed that insulin bound to Burkholderia sp 
and A. salmonicida. In the case of Burkholderia sp. it was hypothesised that the 
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molecular mimicry between IBPs and HIR might contribute to the development 
of CFRD by initiating antibody production against IBP during Burkholderia 
infection. These antibodies might cross-react with the HIR according to the 
homology of sequences within the IBP(s) and subsequently lead to insulin 
resistance or even the production of insulin antibody. A study could be done in 
the future to test all species of Burkholderia for insulin binding capacity. 
This was the first time that an insulin binding activity was found for the fish 
pathogen A. salmonicida. The vast majority of insulin binding to this bacterium 
appears to be via the A layer, however, this study also detected insulin binding 
in the A-layer mutant strain MT004, revealing that more than protein or 
component mediated insulin binding. The ability of A. salmonicida to bind insulin 
requires more research to identify the components and mechanisms involved. 
Furthermore, the binding between insulin and the A-layer could be useful as an 
application in the purification of insulin, and for quantifying insulin.  
The insulin that bound onto Burkholderia cells was confirmed as binding to a 
protein and not any other components by using western ligand blotting, in which 
many protocols were applied to optimise the protein preparation, blotting and 
binding conditions.  
The construction of a gene library of Burkholderia facilitated the cloning and 
sequence analysis of genes for two types of insulin binding components, the 
siderophore receptor (IBP1) and the peptide transporter membrane and 
periplasmic components, IBP3 and IBP2 respectively. The IBP(s) genes require 
more functional studies to confirm the insulin binding mechanisms that have 
been proposed by this study. There are many techniques which would be useful 
such as PCR cloning to express them and confirm the binding, gene silencing 
using RNA interference (iRNA), gene knockouts or blocking the binding site 
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using specific antibodies, and in-vitro transcription and translation and MS/MS 
analysis.  
The homology between the HIR and the Burkholderia sp. IBP(s) appeared at 
different epitopes, however, the sequence homology requires further 
immunological studies to confirm their immunogenicity in initiating an 
autoimmune response. For the antibodies to cross react, a phage display 
technique using HIR epitopes could be used to present those sequences and 
see if a cross - reaction does occur within antibodies raised against the IBP(s) 
of Burkholderia spp. In case of T-cells mediating immune responses it remains 
to be seen if it is possible to present the IBP(s) epitopes by the APC and 
macrophages (Martin and Mohr, 2000) to the immune system‘s cytotoxic T-cells 
because B. multivorans can be an intracellular pathogen, in addition to it‘s 
extracellular invasion mode. Therefore, Burkholderia bacteria can live inside the 
lung epithelial cells and APC like macrophages will present the IBP(s) epitopes 
via MHC-I to the cytotoxic T-cell possibly leading to pancreatic β-cell damage. 
Moreover, the macrophage could present those epitopes via MHC-II molecules 
to the CD4 helper T-cell, which plays a main role in immune response (Goldsby 
et al., 2000; Kindt et al., 2007). The second scenario hypothesised that may 
occur is that the insulin bound on the Burkholderia cell may be presented as a 
foreign antigen. Either scenario could produce a diabetic autoimmune response, 
particularly in immune compromise individuals like CF suffers. In order to verify 
this hypothesis, fluorescent microscopy and cytofluorometry could be used. 
Fluorescent labelled insulin hormone would first be bound to Burkhoderia 
bacteria and then the techniques would monitor the passing of the fluorescent 
labelled insulin signal to the macrophages, which will be produced inside or on 
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the cell membrane of the macrophages. For immunological confirmation animal 
models for CFRD may be useful to diabetes research. 
The third line of investigation searched for pancreatic antigen GAD65 antigen 
homology in protein samples from a range of microorganisms using anti-GAD65 
antibody. GAD sequence homology in microbial proteins may instigate 
antibodies which can cross react with the β-cell GAD65 causing β-cell 
destruction and subsequent development of T1D in genetically predisposed 
individuals, including children. Identification of the microbial proteins that can 
cross react with the anti-GAD65 antibody was the main aim of this research.  
A number of microorganisms showed cross reaction with the anti-GAD65 
antiserum and of these E. coli was chosen to investigate further. Molecular 
mimicry between GAD65 and E. coli proteins was detected. Strong sequence 
homology was found between microbial proteins and GAD65 particularly 
proteins like PIP and SD. However, the main finding which is unique to the 
present study is that all the E. coli proteins which cross-reacted with anti-
GAD65 antiserum possessed single or multiple epitopes whose sequence 
homology could be detected within multiple epitopes on the GAD65 sequence. 
These results could explain how molecular mimicry works between the 
microorganisms and the pancreatic antigens. The microbial epitopes expressed 
a strong homology to the GAD65 epitopes; however, their immunogenicity and 
ability to create antibodies that can cross react needs further studies. E coli 
were studied amongst strains which showed strong reaction with GAD 
antiserum because E coli is a prevalent strain within the human gut microflora 
compared to other positive bacterial species tested. However, in the future all of 
these species should be analysed in order to extend the knowledge about the 
possible types of proteins which could be diabetogenic. The E coli proteins that 
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were hypothesised to create an autoimmune cross reaction require more 
confirmation and this might be achieved by creating a phage display assay of 
GAD65 epitopes (conformational & linear) and subjecting them to cross reaction 
with antibody created against microbial epitopes. Moreover, the GAD65 
molecular mimicries need to be tested for immunogenicity presentation by T-
cells from genetically susceptible T1D patients whose HLA genes are 
predisposed, and see if they possess the ability to direct the immune response 
against self-antigens. However, those epitopes must also be tested for antibody 
autoimmunity by immunizing the T1D model NOD mice and see whether they 
will initiate an autoantibody which reacts with their own GAD65. 
This is the first study designed to look for the direct interaction between 
microorganisms and the insulin pathway and diabetes mellitus diseases. It 
tested three hypotheses affecting the insulin pathway and presenting a risk 
factor for pancreatic cell destruction. The role of microorganisms in CFRD was 
investigated by testing β-cell toxicity caused by secondary metabolites 
(pyrrolnitrin & phenazine) produced during long term infection. This part showed 
specific modulation of the β-cell pathway and GSIS (gene expression, insulin 
secretion, channel potential action). 
This study suggests that these microbial molecular mimicries can induce a 
humoral autoimmune response producing antibodies which can cross react with 
the linear epitopes of HIR initiated by the Burkholderia IBPs epitopes or 
antibodies cross reacting with GAD65 initiated by GAD molecular mimicry of 
one of the E. coli bacterial proteins (OmpA, FD, SD or DpsP). These cross 
reacting antibodies are initiated by bacterial infection whose antigens are 
presented by the MHC-II molecules of macrophages or the dendritic cells to the 
T- cell CD4 initiating the B-lymphocytes to produce antibodies and stimulated 
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macrophages (Goldsby et al., 2000). However, in the case of Burkholderia 
epitopes there is the possibility to stimulate the cytotoxic T-cell against the 
pancreatic beta cells in addition to the CD4 pathway. The T- cell cytotoxic 
pathway can also be stimulated because B. multivorans can be an intracellular 
pathogen in addition to their intercellular existence (Martin and Mohr, 2000). 
Therefore, Burkholderia can live inside lung epithelial cells and APC like 
macrophages, which will then present the IBP(s) epitopes via MHC-I to the T-
Cell CD8 and subsequently induce a cytotoxic T-cell pathway leading to β-cell 
death. The second scenario hypothesised may occur by presenting the insulin 
bound to the Burkholderia membrane as a foreign antigen via both pathways, 
which is more possible to occur and produce a diabetic autoimmune response, 
particularly in immune- compromise individuals like CFRD suffers. 
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Appendix 1 
Media preparation and formulation of reagents 
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SDS-PAGE reagent  
Buffer A 
Tris-HCL    0.75 M 
SDS     0.05 % 
The pH adjusted to 8.8 with NaOH . 
Buffer B 
Tris-HCl    0.025 M 
SDS     0.2 % 
The pH adjusted to 6.8 with HCI. 
Electrophoresis buffer  
Tris-HCl    25 mM 
Glycine    250 mM 
SDS     0.2 % 
The pH adjusted to 8.3 with NaOH. 
SDS-PAGE loading buffer (2X) 
Tris-HCL (0.5M)    2.5 ml 
SDS (10%) 0.2 ml 
B-mercaptoethanol    0.5 ml   
Bromophenol Blue (0.1%)   0.5 ml 
Glycerol                                         2 ml 
dd H2O    6.3 ml 
SDS -Solution (10%) 
SDS stock (10%) made in 100 ml volumes, filtrated using Whatman paper filter 
and stored at ambient temperature for no more than 1week. 
Ammonium persulphates (APS) 
10%W/V, solution in dd H2o was prepared immediately prior to use. 
Resolving gel 12.5% 
Buffer A    5.2 ml          
dd H2O    1.4 ml   
Acryl Mix (30:1)    4.4 ml 
APS     100 µl   
TEMED      30 µl 
Stacking gel (5%) 
Buffer B       2 ml          
dd H2O    1.3 ml   
Acryl Mix (30:1)    0.7 ml 
APS     100 µl 
TEMED     15 µl 
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Polyacrylamide gels staining buffer1/1L 
Coomassie brilliant Blue –R 1.25 gm 
Methanol    400 ml 
Glacial Acetic Acid   70  ml 
dd H2O    530 ml   
The staining solution was filtered by whatman No.1 filter paper. 
Distaining solution/1L 
Methanol    400 ml 
Glacial Acetic Acid   70 ml 
dd H2O    530 ml   
Blue native electrophoresis-PAGE (BN-PAGE)  
Sample buffer solutions 
Mopes /sucrose   440 mM sucrose, 20 mM mopes, 1 mM EDTA, 0.2 mM 
PMSF 
Aminocaproic acid   1ml in 50 mM Tris-HCl (pH7.0) 
Dodcylmaltoside     5% (W/V) 
Coomassie Blue G250  5% (W/V) 
Sample Buffer 
Mopes sucrose buffer  250µl 
Aminocaproic acid   40µl 
Dodecyl maltoside   20µl 
Comassi blue G250   10µl 
Gel Buffer PH 7.0 at 4 °C 
Acrylamide (Acryl Mix (30:1)      
Gel buffer (3X)  150 mM bis –Tris, 1.5mM Aminocaproic acid 
Anode Buffer   50 mM bis-tris –HCl 
Cathode Buffer A  50mM Tricine ,15mMbis tris – HCl  
Cathode Buffer B  Cathode Buffer A = 0.02% Coomassie Blue G250 
Casting the Gel Buffer 
Acrylamide    2.6 ml 
Gel buffer (3X)   3.33 ml 
Glycerol    2 ml       
H2O                                               1.98 ml 
APS (10%) 30 µl 
TEMED 3 µl 
Stacking Gel 
Acrylamide    0.4 ml 
Gel buffer (3X)   1.67 ml 
dd H2O    2.87 ml 
APS (10%)    5.5 µl  
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TEMED    3µl   
Protein agrose gel electrophorsis  
Buffer A 
Tris-HCl     25 mM (PH- 8.5) 
Glycine    19.2 mM 
Sample Buffer  
Glycerol    20 % 
Bromophenole blue   0.2 % 
Tris-base    0.12 M 
Horizontal agarose gel 
0.8 % W/V agrose gel dissolved in buffer A. 
Western ligand blotting reagents  
Transfer buffer / 2L 
Tris –HCl 6.1 gm 
Glycine    28.8 gm                                    
Methanol    400 ml 
dd H2O    1600 ml                                    
The pH adjusted to 8.3   
PBS dulbecco's 
One tablet (Oxoid) dissolved in 100 ml dd H2O .Sterilised by autoclaving for 15 
min at 151b/in2. 
Blocking reagent for ligand blotting 
3% W/V bovine serum albumin (BSA) in 10mM of MOPS buffer.  
Blocking reagent for western blotting 
3% W/V bovine serum albumin (BSA) prepared in washing buffer. 
Blocking Buffer  
PBS     0.1M 
Tween 20    0.1%  
BSA     3% 
Washing Buffer  
PBS     0.1 M 
Tween20    0.1 % 
DAB/Nickel chloride development solution  
PBS     100 ml 
DAB     0.06 gm 
NiCl2     0.03 gm 
Solution made freshly immediately prior to use in ligand blot development and 
the chromogenic reaction initiated by addition of 100 µl H2o2 solution. 
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Ponceau S staining buffer  
Prepared by dissolving 1 gm of Ponceau S in 100 ml of 10 % acetic acid.  
Culture medias 
LB Agar (1L) 
NaCl     10 g 
Tryptone    10 g  
Yeast extracts   5 g  
Agar     20 g  
H2O dye was added to a final volume of 1 litre, pH Adjusted to 7 with 5 N 
NaOH, Sterilised by autoclaving for 15 min at 15 lbs/in2. 
Bacteroides Bile Esculin Agar (BBE) /1L 
Oxgall     20 gm 
Pancreatic Digested Casein 15 gm 
Peptic digest of soybean meal   5 gm 
NaCl       5 gm 
Esculin      1 gm 
Ferric ammonium citrate  0.5 gm           
Gentamicin    0.1 gm 
Hemin            1 2.5 mg  
Vitamin K solution (10mM)     1 ml  
Agar      15 gm 
H2O dd was added to a final volume of 1 litre, pH Adjusted to 7.0 with 5 N 
NaOH, Sterilised by autoclaving for 15 min at 15 lbs/in2. 
LB Broth (1L) 
NaCl     10 g  
Tryptone    10 g  
Yeast extracts     5 g  
H2O dd was to a final volume of 1 litre, pH was adjusted to 7.0 with 5 N NaOH, 
Sterilised by autoclaving for 15 min at 15 lbs/in2. 
LB Broth with Supplements 
LB broth (1 litre), the following filter-sterilized supplements (MgSO4 and Maltose) 
to final concentration 10 and 2 mM respectively, were added prior to use. 
LB–Kanamycin Agar (1L) 
LB agar (1 liter ) was prepared, cooled to 55 °C and 4 ml of 12.5 mg/ml 
Kanamycin (filter sterilized) was added. 
LB– Kanamycin Broth (1L) 
LB broth (1 litre) was prepared, pH was adjusted to 7.0 with 5 N NaOH, 
Sterilised by autoclaving for 15 min at 15 lbs/in2 . Cool to 55 °C and 4 ml of 12.5 
mg/ml Kanamycin was added (filter sterilized). 
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NZY Agar (1L) 
  
NaCl     5 gm  
MgSO4 .7H2O   2 gm  
Yeast Extract   5 gm  
Casein hydrolysate   10 gm 
Agar     15 gm 
H2O dd was added to a final volume of 1 litre, pH adjusted to 7.0 with 5 N 
NaOH, Sterilised by autoclaving for 15 min at 15 lbs/in2. 
NZY Broth (1L) 
NaCl       5 gm  
MgSO4 .7H2O     2 gm  
Yeast Extracts     5 gm  
Casein hydrolysate   10 gm 
H2O dd was added to a final volume of 1 litre, pH adjusted to 7.0 with 5 N 
NaOH, sterilised by autoclaving for 15 min at 15 lbs/in2. 
NZY Top Agar (1L) 
NZY broth    1 litre 
Agrose    0.7% (w/v) 
Sterilised by autoclaving for 15 min at 15 lbs/in2. 
Miniprep plasmid DNA extraction reagents 
Solution B&D I 
Tris-base    25 mM 
EDTA     10 mM 
Glucose    50 mM  
The pH Adjusted to 8.0 with 5 N NaOH, sterilised by autoclaving for 15 min at 
15 lbs/in2. 
Solution B&D II 
SDS     1% 
NaOH     0.2 M                   
Solution B&D III 
Sodium Acetate   3M 
pH Adjusted to 4.8 with 5 N NaOH, sterilised by autoclaving for 15 min at 15 
lbs/in2. 
Solution B&D IV 
Tris-HCl    0.05 M 
Sodium Acetate   0.1 M 
The pH Adjusted to 8.0 with 5 N NaOH, Sterilised by autoclaving for 15 min at 
15 lbs/in2. 
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TE Buffer 
Tris-base    10 mM 
EDTA     1 mM  
pH Adjusted to 8.0 with 5 N NaOH, sterilised by autoclaving for 15 min at 15 
lbs/in2. 
DNA loading buffer (5X) 
TE Buffer      10 ml 
Ficoll     15 % 
Bromophenole blue   0.25% 
TBE buffer (5X)  
Tris-base    54 gm 
EDTA     20ml (EDTA 0.5 M, PH 8) 
Boric Acid    27.5 gm 
H2O dd was added to a final volume of 1 litre, pH Adjusted to 8.0 with 5 N 
NaOH, sterilised by autoclaving for 15 min at 15 lbs/in2. 
SM Buffer /1L 
NaCl     5.8 gm 
MgSO4 ·7H2O   2.0 gm  
Tris-HCl    50.0 ml (1 M, pH 7.5) 
Gelatine    5.0 ml   (2% (w/v)  
H2O dd was added to a final volume of 1 litre, pH Adjusted to 7.5 with 5 N 
NaOH, sterilised by autoclaving for 15 min at 15 lbs/in2. 
Blue /white screening 
X-gal solution 
5-bromo-4-chloro-3-indolyl-β—D-galactoside (X-gal) made up as stock solution 
250mg/ml indimethylformamide (DMF). Filters sterilised and store at 4ºC. 
IPTG solution 
Isopropyl-β-thiogalctopyranoside (IPTG) made up as stock solution 0.5M in 
molecular biology water. Filter sterilised and stored at 4 ºC. 
Southern blotting reagents  
SSc (20x) 
Na3C6H5O7    88 gm 
NaCl     175.32 gm 
H2O dd was added to a final volume of 1 litre, pH Adjusted to 7.0 with 5 N 
NaOH, Sterilised by autoclaving for 15 min at 15 lbs/in2. 
Denaturation solution  
NaCl     1.5 M 
NaOH     0.5 M  
 328 
 
Neutralization solution  
NaCl     1.5 M 
Tris-HCl    1 M  
H2O dd was added to a final volume of 1 litre, pH Adjusted to 8.0 with 5 N 
NaOH, Sterilised by autoclaving for 15 min .at 15 lbs/in2. 
Washing Buffer 
Maleic acid    0.1 M 
NaCl     0.15 M 
Tween-20    3% (v/v) added after autoclaving         
H2O dd was added to a final volume of 1 litre, pH adjusted to 7.5 with 5 N 
NaOH, sterilised by autoclaving for 15 min at 15 lbs/in2.  
Prehybrdisation buffer  
Dissolve 50 gm in 100 ml of detection buffer. 
Maleic acid buffer 
Maleic acid    0.1 M 
NaCl     0.15 M  
H2O dd was added to a final volume of 1 litre, pH adjusted to 7.5 with 5 N 
NaOH, Sterilised by autoclaving for 15 min at 15 lbs/in2. 
Detection buffer           
Tris-HCl    0.1 M    
NaCl     0.1 M  
H2O dd was added to a final volume of 1 litre, pH adjusted to 7.5 with 5 N 
NaOH, Sterilised by autoclaving for 15 min at 15 lbs/in2. 
Stringency buffer -1 
SSc     2 X 
SDS     0.1 % 
H2O dd was added to a final volume of 1 litre, pH adjusted to 7 with 5 N NaOH, 
Sterilised by autoclaving for 15 min at 15 lbs/in2. 
Stringency buffer -2 
SSc     0.5 X 
SDS     0.1 % 
Add dd H2O to a final volume of 1 litre, adjusted pH to 7.0 with 5 N NaOH, 
Sterilised by autoclaving for 15 min at 15 lbs/in2. 
Cytotoxicity effect of Microbial compounds on pancreatic (INS-1) 
Cell Culture of INS-1 cells 
RPMI 1640 
Glucose    11mM 
Glutamine    2mM 
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Foetal Bovine serum (FBS) 10% 
Penicillin    100 unit/ml 
Streptomycin    100 µg/ml 
Sodium Pyruvate   1 mM 
β-Mercaptoethanol   50 µM 
Cytotoxic agents stocks  
Pyrrolnitrin    10 mg/ml ethanol 
Phenazine    10 mg/ml acetone 
Patulin    10 mg/ml MBW 
Serial diluted stock solutions prepared from each compounds. 
Insulin Secretion Assay 
Insulin assay Buffer (IAB)/1L 
Na2HPO4    2.85 gm 
KH2PO4    0.675 gm 
NaCl     4.5 gm 
EDTA     1.86 gm 
BSA     2.5 gm (added last) 
Dissolved in 500ml MBW and buffer was adjusted to pH 7.4. 
Gey & Gey Buffer (10X) /L 
NaCl     1 M 
NaHCO3    250 mM 
KCl     3.7 gm 
M reagent 
MgCl2 .6 H2O   10.15 gm 
MgSO4 .7 H2O   3.7 gm 
Dissolved in 100 ml MBW and the buffer was adjusted to pH 7.4. 
P reagent 
Na2HPO4    7.1 gm 
KH2PO4     2 gm    
Dissolved in 100 ml MBW and the buffer was adjusted to pH 7.4. 
Gey & Gey (1x) 
Gey & Gey(10x)    100 ml 
ddH2O     900 ml 
M+P      2 ml aliquots 
CaCl2 (1M)     1 ml 
Buffer was adjusted to pH 7.4 
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Gey & Gey-A 
Gey & Gey (1x)    100 ml 
Glucose    0.2 mM 
BSA     0.1% 
Gey & Gey-B  
Gey & Gey (1x)   100 ml 
Glucose    20 mM 
BSA     0.1% 
Gey & Gey-C 
Gey & Gey (1x)    100 ml 
KCl     25 mM 
BSA     0.1 % 
Radioimmunoassay  
Crystalline human insulin  
Human insulin stock prepared as stock 8ng/ml in insulin assay buffer used to 
prepare one fold dilutions 8 ng-0.25 ng /ml to perform the standard curve. 
Hot Insulin  
125I insulin was prepared as stock (0.5 µCi/8ml IAB). 
Guinea Pig anti-bovine insulin antibody (ICN) 
ICN prepared as 1 in 20000 IAB. 
Gamma globulins reagents  
Gamma globulins   2 mg/ml PBS  
PEG 6000    30 % IAB 
Tween 20    0.05 % 
Gamma globulins prepared freshly in PBS and mixed with PEG reagents 1:1 
prior RIA assay and supplemented with 0.05% Tween 20.  
Protein extraction buffer  
Hepes     50 mM   
NaCl     150 mM 
DTT     1 mM 
EDTA     0.5 mM 
The buffer was prepared in dd H2O and the buffer was adjusted to pH=7.5.  
Cleavage Solution 
TEV Protease   66 µl 
Protein extraction buffer  1.1ml 
DNase Solution: 0.5mg/ml halotag buffer 
Lysozyme Stock: Lysozyme 10mg/ml halotag buffer 
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ATP Solution: 1M 
Alkaline Phosphatase Detection Buffer  
NaCl     0.1M 
Tris-OH    0.1M 
MgCl2     5 mM  
The buffer was prepared in dd H2O and the buffer was adjusted to pH=9.5, 5-
bromo-4-chloro-3-indolyl phosphate (BCIP) 0.02 % and p-nitro blue tetrazolium 
(NBT) 0.03% dissolved in DMF was added. 
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Appendix 2 
Data relevant for this study 
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Data relevant for chapter (3 & 4) pancreatic β-cells toxicity and  
 insulin pathway modulation by microbial compounds  
Figure 1 Sequencing results of insulin pathway amplicons confirming the ID of 
the insulin pathway genes that assessed by qRT-PCR during this study.  
Rattus norvegicus, insulin, mRNA NM_019129.2, the blue highlighted 
sequences is INS-1M primer binding sites and INS-1 primers are highlighted in 
red. 
          78 gcc ctgctcgtcc tctgggagcc caagcctgcc caggcttttg 
121 tcaaacagca cctttgtggt cctcacctgg tggaggctct gtacctggtg tgtggggaac 
181 gtggtttctt ctacacaccc aagtcccgtc gtgaagtgga ggacccgcaa gtgccacaac 
241 tggagctggg tggaggcccg gaggccgggg atcttcagac cttggcactg gaggttgccc 
301 ggcagaagcg tggcattgtg gatcagtgct gcaccagcat ctgctccctc taccaactgg 
361 agaactactg caactgagtc caccactccc cgcccacccc tctgcaatg 409  
 
 
Rattus norvegicus, mRNA NM_019130, the blue highlighted sequences is INS-
2M primer binding sites and INS-2 primers are highlighted in red. 
12 gatccgctt cctgcccctg ctggccctgc tcatcctctg ggagccccgc  
 61 cctgcccagg cttttgtcaa acagcacctt tgtggttctc acttggtgga agctctctac  
121 ctggtgtgtg gggagcgtgg attcttctac acacccatgt cccgccgcga agtggaggac  
181 ccacaagtgg cacaactgga gctgggtgga ggcc 214  
 
Rattus norvegicus, β-actin, mRNA NM_031144.2 primers binding sites are 
highlighted in red. 
     251 aggcccaaga gcaagagagg catcctgaccc tgaagtaccc cattgaacac 
301 ggcattgtca ccaactggga cgatatggag aagatttggc accacacttt ctacaatgag 
361 ctgcgtgtgg cccctgagga gcaccctgtg ctgctcaccg aggcccctct gaaccctaag 
421 gccaaccgtg aaaagatgac ccagatcatg tttgagacct tcaacacccc agccatgtac 
481 gtagccatcc aggctgtgtt gtccctgtat gcctctggtc gtaccactgg cattgtgatg 
541 gactccggag acggggtcac ccacactgtg cccatctatg agg 583 
Rattus norvegicus, Pdx1, mRNA NM_022852.3 primers binding sites are 
highlighted in red. 
163 gaggggtc cggtgccaga 
181 gttcagtgct aatccccctg cgtgcctgta catgggccgc cagcccccac ctccgccgac 
241 accccagttt gcaggctcgc tgggaacgct ggaacaggga agtcccccgg acatctcccc 
301 atacgaagtg cccccgc 183  
Rattus norvegicus, RIPE3b1/MafA , mRNA XR_008949.1 primers binding sites 
are highlighted in red. 
446 agctc cgcggcttca gcaaggagga ggtcatccga 
481 ctgaaacaga agcggcgcac gctcaagaac cgcggctacg cgcagtcgtg ccgcttcaag 
541 cgggtgcagc agcggcacat tctggagagc gagaagtgcc agctccagag ccaggtggag 
601 cagctgaagc tggaggtggg gcgt 624 
Rattus norvegicus, Beta2 /NeuroD, mRNA AF107728 primers binding sites are 
highlighted in red. 
629 cc agcgcttcct tcccggtgca tccctactcc 
661 taccagtccc ctggactgcc cagcccgccc tacggcacca tggacagctc ccatgtcttc 
721 cacgtcaagc cgccgccaca cgcctacagc gcagccctgg agcccttctt tgaaagcccc 
781 ctaactgatt gcaccagccc ttcctttgac ggacccctca gcccgccgct cagcatcaat 
841 ggc 843 
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Figure 1: Continued  
Rattus norvegicus, GK mRNA M25807.1 primers binding sites are highlighted in 
red. 
583 tcctgcta   ctatgaagac 
601 cgccaatgtg aggtcggcat gattgtgggc actggctgca atgcctgcta catggaggaa 
661 atgcagaatg tggagctggt ggaaggggat gagggacgca tgtgcgtcaa cacggagtgg 
721 ggcgccttcg gggactcggg cgagctggat gagttcctac tggagtatga ccggatggtg 
781 gatgaaagct cagcg 795 
 
Rattus norvegicus, Glut-2 mRNA NM_012879.2 primers binding sites are 
highlighted in red. 
 
194 acacccc actcatagtc acaccagcac atacgacacc agacgcctgg 
241 gaagaagaga ctgaaggatc tgctcacata gtcactatgc tctggtctct gtctgtgtcc 
301 agctttgcag taggcggaat ggtcgcctcg ttctttggtg ggtggctt 348 
Rattus norvegicus, Camk4, mRNA NM_0127272 sequences in red are primer 
binding sites to amplify Glut-2. 
859 ac attccaagcc ctccaacacc cgtgggtcac aggaaaagca gccaactttg 
1001 tccacatgga taccgctcag aaaaagcttc aagaattcaa tgctaggcgc aagcttaagg 
1061 cggcagtgaa ggctgtggtg gcctcttctc ggctgggaag tgccagcagc agtcacacca 
1121 acatccaaga aagcaacaaa gccagctcgg aggcacagcc cgcccaagac ggcaaggaca 
1181 agacagatc 1099 
Rattus norvegicus Camkk1, mRNA NM_031662 sequences in red are primer 
binding sites to amplify Glut-2. 
825 catcaa gccgtccaat 
841 ctgctccttg gggacgatgg gcacgtgaag atcgccgact ttggtgtcag caaccagttt 
901 gaggggaatg atgctcagct gtccagtacg gcagggaccc cagcattcat ggccccggag 
961 gccatctctg acaccggcca gagcttcagt gggaaggcct tggatgtatg ggccactggg 
1021 gtta 1024 
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Data relevant for chapter 3 & 4  (Insulin Binding ) 
 
Figure 2: Insulin binding assay with whole cell microbe using peroxidase 
labelled insulin Row A is control without insulin peroxidase and Row B treated 
with insulin Peroxidase and screening binding A salmonicida binding to FITC 
insulin binding.  
 
 
 
    
 1-Ps aeruginosa  2- Ps fluorescence   3- Ps putida  4- Rhizobium sp   5 - E coli   
 6- Citerobacter freundii 7- Klebsiella aerogenes 8-Acinetobacter acetii                            
9- Alcaligens viscosus 10- Burkholderia cepacia II 11-Salmonella typhimurium  
12- Erwinia caratovora.   
 
         
                                      
  
  1-Serratia marcescen 2-Hafnia alvei 3-Vibrio anguillarum 4-Bacteroides fragilis 
5-Chromobacterium violaceum 6- Proteus valgaris 7- Aeromonas salmonicida 8- Sarcina lutea 
9- Streptococcus pyogenes 10-Staphylococcus aureus 11- Micrococcus luteus 12-Bacillus 
subtillus.          
 
                              
                                                
   
1-Clostridium frundii 2-Lactobacillus casei 3-Listeria monocytogenes 4-Corynebacterium aqutica 
5-Brivibacterium linens 6-Microbacterium lacticum 7-Cellulomonase flavigena 8-Yersinia ruckri 
9-Mycobacterium phlei 10- Burkholderia cepacia III 11- Rhodococcus equi 12-Acetobacterium 
acetii.                       
 
 
                          
     
1-Zygosaccharomyces rouxii  2-Schizosaccharomyces pombe  3-Saccharomyces cerevisiae  
4-Schizosaccharomyces octosporus 5-Saccharomyces certsbergesis   6- Nocardia cellulans 
 7-Agrobacterium rhizogenes 8-Burkholderia thailendensis 9- Burkholderia cocoverenans. 
 A 
 B 
 1          2         3        4          5         6         7        8        9         10       11      12 
  1          2        3        4          5         6        7        8        9         10       11      12 
 A 
 B 
 1          2         3        4          5         6         7        8        9         10       11      12 
 A 
 B 
 1            2            3           4              5            6            7           8           9          
 A 
 B 
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Figure 3: continued  
             
                  A salmonicida CM30                         (bright field view)               
 
 
 
Figure 4: Western ligand of IBP(s) of E coli lyaset infected by phagemid p1 
(lane 1 & 2) & E coli lysat infected by phagemid p2 (lane 3, 4, 5,6 ) expressing 
multiple bands compare to Burkhoderia cepacia II (lane 7&8). 
 
 
 
 
 
 1      2       3       4      5     6       7       8 
 20 kDa 
30 kDa 
45 kDa 
60 kDa 
100 kDa 
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Figure 5: Full length DNA sequences of the insert of the phagemid p1.   
   1 GTACCCACCC GGGTGGAAAT CGATGGGCCC GCGGCCGCTC TAGAAGTACT CTCGAGAAGC  
  61 TTTTTGAATT CTTTGCGCAT CGCCAACATT CATCCGGGCA TCACGGCCGA CGGTTCGCCG  
 121 TACCAGCGGC GCGGCGCATG GGCGACGCTC GATGCGCTGC ACGGCGCGCG CGGCGAGCGC  
 181 GTCGACTGGG CGACCGGCAC GACGACGCCG GTCGCGCCCG TGACGATGAC GGGCGCCTCG  
 241 TTCCACTATG TCGACAACGG CATCGATTCC GGCGAGGTGA TCTGCGACGT GCTCGACACG  
 301 CCGATCGCGC CGGACGACAC GATCCTCGAA CTGCGCTGGA ACAACTTCCA GCGCAGCCTG  
 361 TTTCCGGCGC TCGAGCGCGG GCTGCATCTC CTCGCCGATC GCCACGACGC GGGAGCACTG  
 421 TGATGGCACC GACGCTGACG CAACCCGAAG AAGCGATCGA GACGGCCGAC GGCAACGTCG  
 481 CCGCCTGGCG CGATCACGGC GCCGATACGG CGCCCGCCGT CGACCGCGTG CTCGACGCAT  
 541 GGCGGCCCGA CGATCCGCCG GGCGCGCTGC TCGCCGAGCT CGTCGCGCTG TTCAATACCG  
 601 ACGCACGGCG CGATGCCGCG ACGATCGCGC TGCCGATCGC AGGCACCGAC CCGGACGCCG  
 661 TCGCGGCGTA CGTCGCGCGC GCGGTGCGCG AAGGCGTGAT CGACGCGGCG CAACGCGCGG  
 721 GCGACCGCCT TGACGTGACC ACGTCGCGCG CGACGTTCTG GCAGCATCCG CAGCCGTGGC  
 781 TGAAGGCGCC CGCGTCGGGC GGGATGCCGC TGCGCTACAC GATCACGAAC GGGCACCGTC  
 841 ATCCGGTGCG GCCGCCGACG CCGGCCGGCG AGATCTATGC GCGCTACATG CCGCAGGTCG  
 901 GGATGACGTT CAGCCTGCGC ACCGTCGACG TCGACGCGCA TGCGGACCTG TTCAGCGGCT  
 961 GGATGAATCT CGATCGCGTC GCGCATTTCT GGGATCAGCG CGGCACGCGC GATGAGCATG  
1021 CCGCGTATCT CGCGGAGCGG CTCGCCGATC CGCACATGCA TCCGATGATC TCGCGCGCCT  
1081 GCAGGTCGAC ACTAGTGGAT CACGAAGGAC ATTTTAGGAG GCGACGGCAA CTTCAACTAT  
1141 TACCGGAAGA AGGAGTGGTC GCTCGGCTAT CAGTTCGAGC ACAACCTGAA CTCGATGTGG  
1201 ACGTTCCGGC AGAACACGCG ATGGATGCAT CTGTCGCTCG ACAACGGCTC GGTGTGGGGA  
1261 GCGGGCTTCG CCGACGAAAC GCTGACCGAA ATCAACCGCT GGGCCGGCGT GTTCCAGATG  
1321 AACTACAGCC GCTTCGACAT CGACAACAAC CTCGAGGGCC GTTTTGCGAC GGGTCCGCTC  
1381 CAGCACACGC TGCTGCTCGG CTTCCAGTAC AACCGCCAGA CGGCGACCGA TAGCGAATGG  
1441 CTCGCCGCCG CGCCGACGCT GAACCTCTAC AACCCGGTGT ACACGCCGGT CACGACGGCC  
1501 GTGTTTTCCG ATCCGGACAC CACGTACCGC ACCAACACGT ACACGACGAT GAACACGTTC  
1561 GGCCTGTACG CGCAGGACCA GATCAAGTGG AACCGCTGGA CGCTGACGCT CGGCGGCCGC  
1621 GAGGACTGGG TCAACATGCG GATGGACGAT CGCGCGGCCG GCACGCAGTC GAAGGCCGAC  
1681 GTGTCGGCGT TTACGGGCCG CGTCGGCCTC ACGTATCAGG CCGGCTACGG GCTGTCGCCG  
1741 TATATCAGCT ATTCGACGTC GTTCAATCCG ATCATCGGCG TGAGCTTGCT CGACGGCGGG  
1801 GTGCCGAAGC CGACGCGCGG CAGACAGATC GAAGCGGGCC TGCGCTGGCA GCCGCCCGGC  
1861 AAGAACCTGA TGCTGAATGC CGCGATCTAT CAGATCAACC AGACCAACGG CGTTACGCCG  
1921 GCGCTGCTGA CGCACGATCC GAGCGGCACG AAATCCGTGC AGACCGGGGA AGTGCGCGCG  
1981 CGCGGGATCG AGCTGAGCGC AACCGGCAAG GTCACGCCGA ACCTGTCGCT GATCGCGTCG  
2041 TACGCGTATC AGACGGCGCG ATATCGGGAT AGCTGAGCGC AACGGCAAGG TCCACCCGGG  
2101 TGGAAATCGA TGGGCCCGCG GCCGCTCTAG AAGTACTCTC GAGAAGCTTT TTGAATTCTT 
2161 GGATCATCGG ATGCATGTGC GATCGGCGAG CCGCTCCGCG AGATACGCGC ATGCTCATCG 
2221 CGCGTGCCGC GCTGATCCCA GAAATGCGCG ACGCGATCGA GATTCATCCA GCCGCTGAAC 
2281 AGGTCCGCAT GCGCGTCGAC GTCGACGGTG CGCAGGCTGA ACGTCATCCC GACCTGCGGC  
2341 ATGTAGCGCG CATAGATCTC GCCGGCCGGA GTCGGCGGAC GCACCGGA 
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Figure 6: Full length DNA sequence of the insert of the phagemid p2.  
 
   1 TGGTACCCAC CCGGGTGGAG ATCGATGGGC CCGCGGCCGC TCTAGAAGTA CTCTCGAGAA  
  61 GCTTTTTGAA TTCTTTGGAC TCGCTCGTGT TTCAACTGCC GGTCAGCTAC GAGAACCGAT  
 121 GAAAACCGAC AAGCAGTTGA AGCAGGATGT CCAGGACGAA CTGGAGTCAG ACCCGTCGAT  
 181 CGATTCGACC CGTATCGGTG TCGAGGTGGC TGACCGGATC GTGACGCTTT CGGGGCACCC  
 241 GCCGAGCTAC GCGGAGAAGC TGGCGATCGA GCGCGCGGCG AACCGCGTGG CCGGTGTCAA  
 301 GGCGCTCGTC GTGGACATGA CCGTGCATCT GCCGGACGAC GACGTGCGCA CCGACGAGGA  
 361 CATCGCGAAG GCGGTACGCT CGGTGCTGCA CTGGACGGTC GGTCTACATG ACGACGCGGT  
 421 CAAGGTGCAG GTCGAACGCG GCTGGATCAC GTTGTCCGGC AAGGTCGACT GGGCATACCA  
 481 GAGCCACCTG GCCGTGCGCG CGATCTCGCA GATGCGCAGC GTGACGGGCG TGACCGACCA  
 541 CATCACGGTA CAGGGGACGG TCGGTTCGGA CGACATCGGC GGAAACATCA AACGCGCGAT  
 601 CATGCGCCAC GCGGAGCGCG AGGCTAAGCA TATCGCGATC GAAGTGCACG ACGGCACCGT  
 661 GCGGCTGTCC GGAAAAGTCG GCTCGTTCTC CGAACGCAAG GCCGTGCGCG GGGCCGCGTG  
 721 GTCCGCGCGC GGCGTGCGCG CCGTCGTCGA CGATCTGGTG GTCGAGTAAG GTCGGTAGCC  
 781 GGATGAGCAG TCCACGGAGA TCAAGGAGGG CAGTCAAATG ACACTTTCGG GTGAACTTCA  
 841 CGAAGCGGAC TGGTCGGTCA TGATCACGCC GAGCGACGCA TACATATAGG CGAGCGCGTC  
 901 GTTTCGGAAT CGACAGCATC AGGTAGCCGG CGCACAGCAC GGCCGCGCCT GAGGATCCCC  
 961 GATGCGATGG CGTTTGCTGT CAAGGCTCTG TTGCACGAGA ATTTCATGAG CTGTGGGAAC  
1021 GACGCGGCTT TCGCGTTAGC TGCGTGAAGC CACTATGACC ACAACTGACC GCGCTCACGG  
1081 CACCAAAGCT ACGGAAGACA ACAAACCGTA TCCGCTTCAT GCAATTCAGC TGGCCGACCT  
1141 CCGAGTGGTG GAGGTCAGCT TGCGTGCAAA TATGGATGTG GCAAAGAGCG ATCCGCCTGG  
1201 AACGTTTGAG CTTACTACCG GCCACGGCGT CTATGACGCC GAGCACAAGC GCATCCAGGT  
1261 GAAAGTTGCG GCCACAATGG GGCATCAAGA CGATGGAAAG TCACCGTTTG CGCTCAAGGT  
1321 CGAATCGCGC GCCTGCAGGT CGACACTAGT GGATCCGTCG CGCATCGTCG TGTTCCAGGA  
1381 TCGCGGCGCT CTATGCGGCC GCCATCGATC GTGTCGGGGC TCGCGGCCGC CGCGCGGCGC  
1441 GGATGAGCGC TTCCGCCCTC CTCCATCGTC ATCCGGCCAA CGTCGCGGGC CGCGACTTCG  
1501 TCGTCGGCGA TCTGCACGGC TGCGTCGATG CGCTGCGCGC ACTGCTGCGC GAGGTGCGCT  
1561 TCGATCCGGC GCGCGACCGG CTGTTCTCGG TCGGCGATCT CGTCGACCGC GGGCCGGCAT  
1621 CCGAAACCGC GCTCGAGCTG CTCGATCGCC CGTGGTGTCA CGTCGTGCGC GGCAATCACG  
1681 AAGAAGTGCT GAGCCTCGTC GCGCGCGGCA AGCTGCCGGC CGACGCATGG CGCGGCATCG  
1741 GCGGCGACTG GGGCGCCGAT CTGCCGCCCG AGCGGCTGCG CGCGTACGCG GCGCGCGTCG  
1801 AAGCGCTGCC GCTCGTGCGC GTGATCGGCG AAGGCGCGAC GCGCTTCAAC GTGCTGCATG  
1861 CGGAATTCTT CGGCTCGGAC GCCGATCTAG ATACCGGCGA CTATCCGCCC GACGTGCGCG  
1921 AGCGGCTGAT CTGGGGCCGC GATCTCGTGC AGGGACTCGT CGATCCGGGC TGGCAGGCCG  
1981 GCCTCTCGCT GACCTGCAGC GGCCATACGC CGGTGCGCGT GCCGCAGCGG ATCGGCGCGC  
2041 AATGGTTCAT CGATACGGGT GCGTTCGCAC CGGCCGGCCG GCTGACGCTC GCCGAGCCGC  
2101 GCACGGGACA GACGTGGTCG ATCACGCAGG CCGCCGCACG CGAACGCGGA GCGGCCGCGT  
2161 GGCCGCTGCC GTGACGCCCG CACGACTGTC CGGCCGGACA CCGCGACACA CATACCGCCT  
2221 CGAATGCACG GGCAGCGCAA CGCCCGCATG CGCACCTACC CGACCTGATT CAGCRSTCGA  
2281 ACACCGCGTC GATCGCGGAG CCGTTCCAGT TGTACTCGAG ATACGCCGCG TGATGGCAGT  
2341 CGCGCAGCAG CGTCGTGCGA AACGCCGCGA GGCATTCGCC GTGCGGATCG CGCACCGACG  
2401 GATAGACGAT CGCTGCGTCC GCTCCACGTG TGACGCTCGG GCGACACGCC TATGGAGCGC  
2461 TCGCAGATCA ATCGCGAGAT GCCGCGCCAC ACCCACCTTG TCCCCGTCGA ATCGCTCGAA  
2521 TGTCCGCAGG TACGCGACTG CTTCGGAAAA CCGCTCCCCG ATTATGCGCG CTGCAGCGGC  
2581 TGCTTCCTCG CGCATCTCGA GCGACGCCAG CGGTTCGTAT TTCTCGGGAG CCGAGAGCCG  
2641 GGCGGCAATG GCGTTTGGCA TGAAGTCGCC GTCATCGTCG ACATCATCTC GGTCGATACG  
2701 TGTGGCGAAG CGCTCCTGAC GGTTGACGAA CCTGCCGAAC TCTCGCTGCA GGCG  
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Figure 7: Full length protein sequences of human insulin receptor which was 
used to search the homology within B. multivorans IBP(s). 
Insulin receptor Homo sapiens    
 
   1 mgtggrrgaa aapllvavaa lllgaaghly pgevcpgmdi rnnltrlhel encsvieghl 
  61 qillmfktrp edfrdlsfpk limitdylll frvygleslk dlfpnltvir gsrlffnyal 
 121 vifemvhlke lglynlmnit rgsvrieknn elcylatidw srildsvedn yivlnkddne 
 181 ecgdicpgta kgktncpatv ingqfvercw thshcqkvcp tickshgcta eglcchsecl 
 241 gncsqpddpt kcvacrnfyl dgrcvetcpp pyyhfqdwrc vnfsfcqdlh hkcknsrrqg 
 301 chqyvihnnk cipecpsgyt mnssnllctp clgpcpkvch llegektids vtsaqelrgc 
 361 tvingsliin irggnnlaae leanlgliee isgylkirrs yalvslsffr klrlirgetl 
 421 eignysfyal dnqnlrqlwd wskhnltitq gklffhynpk lclseihkme evsgtkgrqe 
 481 rndialktng dqascenell kfsyirtsfd killrwepyw ppdfrdllgf mlfykeapyq 
 541 nvtefdgqda cgsnswtvvd idpplrsndp ksqnhpgwlm rglkpwtqya ifvktlvtfs 
 601 derrtygaks diiyvqtdat npsvpldpis vsnsssqiil kwkppsdpng nithylvfwe 
 661 rqaedselfe ldyclkglkl psrtwsppfe sedsqkhnqs eyedsagecc scpktdsqil 
 721 keleessfrk tfedylhnvv fvprpsrkrr slgdvgnvtv avptvaafpn tsstsvptsp 
 781 eehrpfekvv nkeslvisgl rhftgyriel qacnqdtpee rcsvaayvsa rtmpeakadd 
 841 ivgpvtheif ennvvhlmwq epkepngliv lyevsyrryg deelhlcvsr khfalergcr 
 901 lrglspgnys vriratslag ngswteptyf yvtdyldvps niakiiigpl ifvflfsvvi 
 961 gsiylflrkr qpdgplgply assnpeylsa sdvfpcsvyv pdewevsrek itllrelgqg 
1021 sfgmvyegna rdiikgeaet rvavktvnes aslreriefl neasvmkgft chhvvrllgv 
1081 vskgqptlvv melmahgdlk sylrslrpea ennpgrpppt lqemiqmaae iadgmaylna 
1141 kkfvhrdlaa rncmvahdft vkigdfgmtr diyetdyyrk ggkgllpvrw mapeslkdgv 
1201 fttssdmwsf gvvlweitsl aeqpyqglsn eqvlkfvmdg gyldqpdncp ervtdlmrmc 
1261 wqfnpkmrpt fleivnllkd dlhpsfpevs ffhseenkap eseelemefe dmenvpldrs 
1321 shcqreeagg rdggsslgfk rsyeehipyt hmnggkkngr iltlprsnps 
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Figure 8: Translated sequences of the putative ORF(s) detected on the insert of 
recombinant phagemid p1. 
 
Ornibactin synthatase  
 1 RIANIHPGIT ADGSPYQRRG AWATLDALHG ARGERVDWAT GTTTPVAPVT MTGASFHYVD  
61 NGIDSGEVIC DVLDTPIAPD DTILELRWNN FQRSLFPALE RGLHLLADRH DAGAL  
 
Acetyl CoA:N6-hydroxylysine acetyl transferase 
 
  1 MAPTLTQPEE AIETADGDVA ALRDHGADTA PAADRVLDAW RPDDPPGALL AELVALFNTD  
 61 ARRDAATIAL PIAGTDPDAV AAYVARAVRE GVIDAAQRAG DRDVTTSRAT FWQHPQPWLK  
121 APASGGMPLR YTITNGHLRH PVRPPTPAGE IYARYMPQVG MTFSLRTVDV DAHADLFSGW  
181 MNLDRVAHFW DQRGTRDEHA AYLAERLADP HM  
 
Ornibactin 
  1 VVARLSVRAQ PELDVDVPAE HAMDASVARQ RLGVGSGLRR RNADRNQPLG RRVPDELQPL  
 61 RHRQQPRGPF CDGSAPAHAA ARFQYNRQTA TDSEWLAAAP TLNLYNPVYT PVTTAVFSDP  
121 DTTYRTNTYT TMNTFGLYAQ DQIKWNRWTL TLGGREDWVN MRMDDRAAGT QSKADVSAFT  
181 GRVGLTYQAG YGLSPYISYS TSFNPIIGVS LLDGGVPKPT RGRQIEAGLR WQPPGKNLML  
241 NAAIYQINQT NGVTPALLTH DPSGTKSVQT GEVRARGIEL SATGKVTPNL SLIASYAYQ 
 
Figure 9: Translated sequences of the putative ORF(s) detected on the insert of 
recombinant phagemid p2 
 
Transporter periplasmic  
  1 MKTDKQLKQD VQDELESDPS IDSTRIGVEV ADRIVTLSGH PPSYAEKLAI ERAANRVAGV  
 61 KALVVDMTVH LPDDDVRTDE DIAKAVRSVL HWTVGLHDDA VKVQVERGWI TLSGKVDWAY  
121 QSHLAVRAIS QMRSVTGVTD HITVQGTVGS DDIGGNIKRA IMRHAEREAK HIAIEVHDGT  
181 VRLSGKVGSF SERKAVRGAA WSARGVRAVV DDLVVE  
 
Transmembrane transporter  
  1 MMHAPVSQTR SFTTVFLIEM WERFGYYGMA ALLVLFMVDR LGFTDSHANL TWGAFTALVY  
 61 ASPSIGGWIG DKVLGARRTM ILGAAVLCAG YLMLAVPNDA LAYMYASLGV IVVGNGLFKA  
121 NAANLVRRIY EGDDARIDSA FTIYYMAVNI GSTVSMLATP WIKDHWGWHT AFAVCCGGML  
181 LAILNFMLMH RTLAHIGSQP DDEPIRWKRl gavaaggval alVTLYVLQH KQLAVASVWT  
241 AAVAILAIFA YMIAKSERSE RAGLIAALVL IAQVILFFIF YVQMSTSLTL FALRNVDPRF 
301 ILFGTTL 
Serine threonine phosphatase 
  1 MSASALLHRH PANVAGRDFV VGDLHGCVDA LRALLREVRF DPARDRLFSV GDLVDRGPAS  
 61 ETALELLDRP WCHVVRGNHE EVLSLVARGK LPADAWRGIG GDWGADLPPE RLRAYAARVD  
121 ALPLVRVIGE GATRFNVLHA EFFGSDADLD TGDYPPDVRE RLIWGRDLVQ GLVDPGWQAG  
181 LSLTCSGHTP VRVPQRIGAQ WFIDTGAFAP AGRLTLAEPR TGQTWSITQA AARERGAAAW  
241 PLP  
 
Hypothetical protein  
1 GLGIVYPSVR DPHGECLAAF RTTLLRDCHH AAYLEYNWNG SAIDAVFELN QVG  
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Data relevant for chapter 7&8 (GAD molecular mimicry  
Figure 10: Extraction and purification of PG1 plasmids (lane 8) amongst non-
recombinant or fault recombinant plasmids compared to the pFN22A plasmids 
(lane 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Full length sequences of pancreatic antigen protein GAD65  
 
1 MASPGSGFWS FGSEDGSGDP ENPGTARAWC QVAQKFTGGI GNKLCALLYG  
 51 DSEKPAESGG SVTSRAATRK VACTCDQKPC SCPKGDVNYA LLHATDLLPA  
101 CEGERPTLAF LQDVMNILLQ YVVKSFDRST KVIDFHYPNE LLQEYNWELA  
151 DQPQNLEEIL THCQTTLKYA IKTGHPRYFN QLSTGLDMVG LAADWLTSTA  
201 NTNMFTYEIA PVFVLLEYVT LKKMREIIGW PGGSGDGIFS PGGAISNMYA  
251 MLIARYKMFP EVKEKGMAAV PRLIAFTSEH SHFSLKKGAA ALGIGTDSVI  
301 LIKCDERGKM IPSDLERRIL EVKQKGFVPF LVSATAGTTV YGAFDPLLAV  
351 ADICKKYKIW MHVDAAWGGG LLMSRKHKWK LNGVERANSV TWNPHKMMGV  
401 PLQCSALLVR EEGLMQSCNQ MHASYLFQQD KHYDLSYDTG DKALQCGRHV  
451 DVFKLWLMWR AKGTTGFEAH IDKCLELAEY LYNIIKNREG YEMVFDGKPQ  
501 HTNVCFWFVP PSLRVLEDNE ERMSRLSKVA PVIKARMMEY GTTMVSYQPL  
      551 GDKVNFFRMV ISNPAATHQD IDFLIEEIER LGQDL 
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Figure 12: Spectrum report generated from MS/MS analysis of E coli protein band 1 cross reacting with GAD65 antiserum.  
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Figure 13: Spectrum report generated from MS/MS analysis of E coli protein band 2 cross reacting with GAD65 antiserum. 
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Figure 14: Spectrum report generated from MS/MS analysis of E coli protein band 3 cross reacting with GAD65 antiserum. 
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Figure 15: Spectrum report generated from MS/MS analysis of E coli protein band 4 cross reacting with GAD65 antiserum. 
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Figure 16: Spectrum report generated from MS/MS analysis of E coli protein band 5 cross reacting with GAD65 antiserum. 
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Appendix 3 
Publications of this study 
 
 
 
 
 
 
